data_1aiw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1aiw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 118.136 -0.935 . . . . 0.0 113.362 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -125.58 -60.12 1.33 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.237 1.015 . . . . 0.0 110.249 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.64 -66.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.251 3.02 . . . . 0.0 104.948 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -154.11 25.42 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.092 0.957 . . . . 0.0 111.61 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.94 -165.03 1.27 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.583 0.629 . . . . 0.0 109.688 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.04 89.2 1.93 Allowed 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.353 -0.842 . . . . 0.0 109.472 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.6 t -83.64 118.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 108.239 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -45.17 135.29 5.28 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 120.767 1.621 . . . . 0.0 110.944 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -89.93 33.82 7.62 Favored 'Cis proline' 0 C--N 1.349 0.58 0 N-CA-C 115.685 1.379 . . . . 0.0 115.685 1.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -74.3 62.63 0.97 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.257 1.39 . . . . 0.0 108.867 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -51.68 160.82 0.59 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.098 1.359 . . . . 0.0 111.791 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.48 -31.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.345 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.7 t -153.36 167.53 29.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.315 0.9 OUTLIER -91.35 -30.55 16.48 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 131.177 3.791 . . . . 0.0 111.342 175.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 154.47 -43.06 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.549 3.94 . . . . 0.0 103.714 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -118.57 172.86 7.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.951 1.7 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.13 -57.5 5.31 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.98 -27.77 71.81 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.063 0.785 . . . . 0.0 115.063 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.08 142.44 43.12 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 119.215 1.507 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -60.33 132.94 90.64 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.58 166.86 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 119.119 2.699 . . . . 0.0 119.119 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 m -150.46 -12.38 0.25 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.017 -1.902 . . . . 0.0 110.837 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 179.06 174.29 0.72 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 120.182 1.356 . . . . 0.0 112.982 -175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -112.1 132.12 55.04 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.71 169.58 9.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.819 1.248 . . . . 0.0 110.093 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.72 125.09 4.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.084 1.354 . . . . 0.0 111.386 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.07 -9.62 56.44 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.002 -0.888 . . . . 0.0 113.815 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -84.31 124.78 31.62 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.289 1.545 . . . . 0.0 108.032 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -92.29 165.36 13.14 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.899 0.88 . . . . 0.0 113.24 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.4 tt -161.22 163.47 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.024 1.33 . . . . 0.0 107.834 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.31 146.32 19.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -148.31 108.81 4.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.1 mttp 39.09 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.766 2.026 . . . . 0.0 112.432 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 -50.63 1.5 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.148 1.356 . . . . 0.0 112.805 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.0 142.25 47.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.338 1.069 . . . . 0.0 111.957 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tp -102.17 131.88 48.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 129.029 2.932 . . . . 0.0 107.284 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -132.94 164.78 26.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.944 0.898 . . . . 0.0 109.902 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.0 m -134.02 143.36 48.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.806 1.242 . . . . 0.0 108.024 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 142.44 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.797 0.808 . . . . 0.0 109.176 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -84.39 -34.24 23.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.202 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -143.07 -69.85 0.33 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -161.34 125.61 3.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.916 1.687 . . . . 0.0 108.125 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -166.99 154.74 9.36 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.767 1.167 . . . . 0.0 111.435 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.01 32.01 1.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.879 1.671 . . . . 0.0 109.676 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -84.02 -103.86 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.059 0.457 . . . . 0.0 111.429 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.7 t -144.74 115.26 5.18 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -53.16 112.33 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.698 2.265 . . . . 0.0 112.542 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.82 -26.88 9.63 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.084 1.326 . . . . 0.0 111.721 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -78.37 70.28 4.69 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.359 1.08 . . . . 0.0 109.631 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 42.51 -111.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.805 1.642 . . . . 0.0 108.889 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t 59.65 -72.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.772 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.4 t -173.65 38.65 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.095 2.558 . . . . 0.0 107.146 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -112.08 154.49 25.33 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.615 1.198 . . . . 0.0 111.377 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -153.41 120.97 5.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -71.0 124.28 24.0 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.296 0.638 . . . . 0.0 109.933 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.86 -13.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.084 0.554 . . . . 0.0 112.134 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.29 -149.45 17.65 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -154.33 135.21 13.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 109.812 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.5 m -71.97 -46.87 55.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.994 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.311 -1.804 . . . . 0.0 106.509 -173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.1 m -77.28 75.15 3.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.281 1.038 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -20.59 -51.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 131.363 3.865 . . . . 0.0 115.304 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -8.6 5.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.315 1.446 . . . . 0.0 114.351 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.84 141.59 49.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.099 0.96 . . . . 0.0 108.924 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -29.51 105.13 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 128.086 2.554 . . . . 0.0 113.631 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.1 134.05 27.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -45.39 132.74 5.99 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 119.783 1.174 . . . . 0.0 111.425 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.61 43.25 3.11 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 121.593 1.605 . . . . 0.0 113.904 -0.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -76.39 64.28 2.1 Favored 'General case' 0 N--CA 1.428 -1.572 0 O-C-N 119.324 -2.11 . . . . 0.0 107.429 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -56.05 156.21 5.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.977 0.894 . . . . 0.0 110.888 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.91 -21.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.304 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.9 t -145.08 165.89 26.94 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.752 1.263 . . . . 0.0 112.63 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.298 85.8 tttt -97.14 -34.07 11.27 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 131.241 3.816 . . . . 0.0 109.363 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 162.92 -42.97 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 1 C-N-CA 132.896 4.478 . . . . 0.0 102.641 -172.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -117.56 155.06 30.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.462 1.505 . . . . 0.0 107.593 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.67 -60.43 3.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.696 1.598 . . . . 0.0 115.231 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.7 -4.22 61.07 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.842 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.31 152.4 43.31 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 119.426 1.613 . . . . 0.0 109.923 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.28 144.74 94.68 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.06 158.33 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 116.571 1.72 . . . . 0.0 116.571 -169.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 m -152.23 -17.43 0.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.067 0.947 . . . . 0.0 112.599 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 177.31 150.48 0.18 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.318 0.963 . . . . 0.0 110.516 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.73 141.32 32.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.6 166.19 13.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.378 1.071 . . . . 0.0 108.696 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.68 130.67 46.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.761 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.68 -6.5 69.39 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.386 -1.23 . . . . 0.0 113.273 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -85.61 143.24 28.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.911 1.855 . . . . 0.0 109.613 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -103.01 164.52 11.56 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 tt -161.74 156.73 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.876 1.27 . . . . 0.0 109.7 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.87 159.3 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 126.515 1.926 . . . . 0.0 109.78 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.5 t80 174.66 147.18 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.32 2.648 . . . . 0.0 107.13 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 40.94 44.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 113.326 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.46 24.85 25.33 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.494 2.473 . . . . 0.0 113.218 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -119.7 156.61 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.679 1.592 . . . . 0.0 107.211 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.441 ' CD2' ' CG1' ' A' ' 58' ' ' VAL . 12.8 tp -110.29 122.02 46.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.596 1.958 . . . . 0.0 107.863 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -125.77 150.28 47.88 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.673 0.67 . . . . 0.0 110.001 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 m -117.13 138.97 51.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.876 1.27 . . . . 0.0 108.359 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.96 142.37 36.73 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.172 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.47 -30.81 20.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.603 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -145.13 -141.27 0.12 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.838 1.655 . . . . 0.0 108.325 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -92.37 116.21 28.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.823 2.849 . . . . 0.0 106.165 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 t -163.83 148.35 10.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.492 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.63 13.04 9.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.326 1.85 . . . . 0.0 107.997 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.6 t -70.51 162.46 28.76 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.14 118.52 62.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.121 0.568 . . . . 0.0 110.289 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -41.1 122.37 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.941 3.761 . . . . 0.0 114.45 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.46 22.51 3.82 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.697 1.618 . . . . 0.0 114.471 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -123.88 26.67 7.53 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.514 1.157 . . . . 0.0 110.416 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -170.19 -79.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -174.56 177.67 2.09 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.7 1.2 . . . . 0.0 108.239 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.3 p 64.12 15.31 9.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.674 2.79 . . . . 0.0 112.903 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -126.21 142.6 51.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.954 1.302 . . . . 0.0 110.512 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -136.48 114.64 11.54 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.734 1.614 . . . . 0.0 107.556 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -62.91 140.68 58.85 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.395 0.617 . . . . 0.0 109.832 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' A' ' 38' ' ' LEU 0.278 0.3 OUTLIER -131.77 3.79 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.593 1.157 . . . . 0.0 112.439 -174.886 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.23 -170.55 34.45 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.5 p -161.37 167.76 25.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 m -57.58 -40.02 78.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.415 1.086 . . . . 0.0 110.885 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.598 0 CA-C-O 114.77 -2.538 . . . . 0.0 106.861 -173.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.042 0.448 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.71 80.97 0.28 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.776 1.274 . . . . 0.0 111.07 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.46 30.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.056 2.142 . . . . 0.0 111.8 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -58.09 -30.59 66.36 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.92 1.288 . . . . 0.0 111.212 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.49 161.92 14.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.316 1.046 . . . . 0.0 108.673 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.42 121.25 5.43 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.391 0.677 . . . . 0.0 110.1 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.15 135.11 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 117.624 -1.179 . . . . 0.0 108.541 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -46.07 133.59 7.1 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 120.057 1.299 . . . . 0.0 111.008 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -97.03 33.11 10.15 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 121.414 1.541 . . . . 0.0 113.875 -0.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.23 68.06 1.44 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -51.07 168.21 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.642 0.777 . . . . 0.0 112.328 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.78 -19.03 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.81 -72.17 0.59 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -171.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 tttt 48.83 -157.03 0.07 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 122.371 1.081 . . . . 0.0 111.787 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.34 -41.47 93.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.325 -1.761 . . . . 0.0 107.178 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -156.6 156.64 33.91 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.247 1.819 . . . . 0.0 107.191 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.98 -58.99 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.193 1.797 . . . . 0.0 114.796 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.33 -9.22 85.85 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.233 -0.759 . . . . 0.0 114.008 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.49 154.48 50.44 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -55.87 103.48 0.37 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 108.177 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -50.51 143.97 26.27 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.942 3.095 . . . . 0.0 118.2 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.7 p -132.99 -12.68 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -178.83 162.77 1.34 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.167 0.984 . . . . 0.0 113.427 -175.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -107.65 114.12 27.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.437 1.895 . . . . 0.0 108.582 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.0 166.26 12.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.499 1.119 . . . . 0.0 110.216 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.47 126.27 3.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.931 1.292 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.36 -2.73 80.94 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.316 -1.269 . . . . 0.0 114.648 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.26 121.56 29.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.437 2.119 . . . . 0.0 108.179 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -83.94 159.99 21.16 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.833 -1.167 . . . . 0.0 111.595 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.06 155.21 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.332 1.453 . . . . 0.0 107.753 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -101.96 153.73 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.07 0.948 . . . . 0.0 109.385 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -161.83 126.82 3.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.879 1.672 . . . . 0.0 107.34 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt 30.52 83.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.936 2.095 . . . . 0.0 112.951 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.63 -35.86 0.27 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -94.34 154.14 17.64 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.917 1.859 . . . . 0.0 112.867 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -107.03 124.7 50.02 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.327 2.651 . . . . 0.0 105.861 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.74 161.64 26.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.889 0.876 . . . . 0.0 110.114 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 m -136.93 144.54 43.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.21 150.32 26.28 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 122.057 0.932 . . . . 0.0 111.079 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.48 -34.05 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.858 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -140.39 -72.15 0.37 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.774 0.321 . . . . 0.0 111.64 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -159.31 133.15 7.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.836 1.655 . . . . 0.0 108.562 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 t -166.38 151.69 8.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.96 40.05 1.5 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.082 1.353 . . . . 0.0 107.55 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.5 t -130.49 156.4 44.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.388 1.075 . . . . 0.0 108.199 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -36.76 110.9 0.48 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.418 2.287 . . . . 0.0 113.098 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 134.62 62.41 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.286 2.657 . . . . 0.0 113.189 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.03 -53.06 3.38 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 m -81.13 47.76 1.05 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.966 0.906 . . . . 0.0 110.586 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -164.92 -117.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 m -163.93 168.85 18.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.996 1.719 . . . . 0.0 107.589 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 66.67 14.77 9.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.658 1.183 . . . . 0.0 112.501 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.64 155.69 24.01 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.694 1.598 . . . . 0.0 109.042 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 m -152.17 125.46 8.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.57 137.53 54.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.119 0.567 . . . . 0.0 110.495 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.85 -15.13 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.289 1.436 . . . . 0.0 110.739 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.17 -161.81 35.63 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -153.98 163.04 40.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.1 t -88.22 -17.13 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.13 2.172 . . . . 0.0 111.367 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.432 0 C-N-CA 126.569 1.948 . . . . 0.0 105.83 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 . . . . . 0 C--O 1.223 -0.326 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.8 m 45.68 27.7 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.236 2.214 . . . . 0.0 114.136 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.33 -21.34 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.111 2.564 . . . . 0.0 114.037 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -57.29 -37.41 72.38 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.28 0.632 . . . . 0.0 109.944 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.06 176.19 5.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.957 0.903 . . . . 0.0 109.635 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.76 98.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.782 0.833 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.41 128.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.928 1.291 . . . . 0.0 108.898 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -43.08 134.47 3.09 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.818 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -91.7 31.93 10.7 Favored 'Cis proline' 0 C--N 1.348 0.528 0 CA-C-N 120.239 1.121 . . . . 0.0 114.433 0.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -75.57 61.88 1.37 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.179 1.354 . . . . 0.0 109.311 177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -49.91 164.03 0.12 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.026 1.731 . . . . 0.0 113.578 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -79.82 -37.51 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.232 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -156.46 -171.64 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.278 0.945 . . . . 0.0 112.311 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.289 55.2 tttm -107.15 -45.63 4.09 Favored 'General case' 0 N--CA 1.412 -2.363 1 C-N-CA 132.942 4.497 . . . . 0.0 110.215 178.646 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 168.26 -44.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 131.603 3.961 . . . . 0.0 104.751 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -58.08 178.3 0.1 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 130.912 3.685 . . . . 0.0 116.923 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.12 37.44 4.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.878 2.871 . . . . 0.0 106.47 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.17 46.53 0.02 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.043 1.306 . . . . 0.0 111.473 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.76 152.63 18.57 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.91 119.4 51.3 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.85 154.71 16.18 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 117.708 2.157 . . . . 0.0 117.708 -174.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -151.09 4.52 0.46 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.34 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -175.79 168.73 3.05 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 121.356 1.889 . . . . 0.0 116.094 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.82 125.6 50.85 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -87.29 167.96 13.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.786 1.234 . . . . 0.0 111.192 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.08 127.13 8.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.985 1.314 . . . . 0.0 110.409 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -15.31 22.26 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.419 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -77.37 132.08 38.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.816 1.808 . . . . 0.0 108.929 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -94.66 162.38 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.664 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.4 tt -161.74 154.57 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.208 1.003 . . . . 0.0 108.315 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.3 156.38 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.233 . . . . 0.0 107.797 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -172.1 141.93 1.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.581 1.953 . . . . 0.0 106.942 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mttp 24.64 73.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.831 2.052 . . . . 0.0 113.034 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.51 38.07 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 128.955 3.169 . . . . 0.0 114.474 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -144.22 158.23 43.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.83 127.82 44.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 127.747 2.419 . . . . 0.0 107.867 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -126.26 166.76 16.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.799 1.239 . . . . 0.0 108.856 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -150.32 148.3 28.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.269 1.028 . . . . 0.0 108.366 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.56 148.32 25.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.684 1.194 . . . . 0.0 111.53 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -90.47 -32.73 16.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.569 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.9 p90 -142.57 -74.18 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.069 0.462 . . . . 0.0 112.223 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -160.21 119.58 2.78 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 127.597 2.359 . . . . 0.0 105.003 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -158.54 152.36 23.53 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.047 1.294 . . . . 0.0 112.096 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 8.84 5.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 109.578 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 m -77.58 155.03 31.79 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.31 139.02 80.48 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 119.667 1.121 . . . . 0.0 109.7 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.21 116.85 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.198 1.932 . . . . 0.0 112.724 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.1 25.88 70.08 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.279 -0.734 . . . . 0.0 112.1 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.6 p -59.99 -56.71 18.33 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.479 1.139 . . . . 0.0 110.191 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.07 -43.41 0.23 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.093 1.357 . . . . 0.0 111.325 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -166.75 -171.65 1.9 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 124.484 1.113 . . . . 0.0 109.142 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 p 65.67 5.9 3.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 130.854 3.662 . . . . 0.0 113.663 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.72 159.58 33.3 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 125.01 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -148.22 132.85 17.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.58 130.6 36.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.67 -13.54 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.637 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.12 -171.68 35.7 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 119.674 1.125 . . . . 0.0 112.339 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -107.83 87.54 2.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -32.69 -55.88 0.36 Allowed 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 127.257 2.223 . . . . 0.0 114.179 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.006 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.6 m -87.64 97.96 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.46 10.82 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.446 2.298 . . . . 0.0 111.828 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.16 -3.69 28.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.28 170.67 15.36 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.47 1.032 . . . . 0.0 110.356 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -59.7 121.3 11.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.45 131.39 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.034 0.934 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -43.12 134.02 3.16 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.766 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.81 30.2 14.29 Favored 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.595 1.248 . . . . 0.0 112.755 -0.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -76.14 62.94 1.77 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -49.69 159.36 0.38 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.945 0.878 . . . . 0.0 113.245 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.58 -43.16 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.467 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -90.46 139.08 31.03 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.417 1.103 . . . . 0.0 111.385 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -110.83 166.97 10.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.617 1.967 . . . . 0.0 109.958 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -67.42 -34.8 77.98 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.1 163.54 39.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.097 1.759 . . . . 0.0 106.909 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.93 -55.87 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.503 1.521 . . . . 0.0 114.082 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.79 5.38 79.46 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.485 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.86 171.16 55.06 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.516 1.158 . . . . 0.0 111.2 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.83 165.66 51.44 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.22 145.15 71.47 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.607 1.538 . . . . 0.0 108.669 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 m -141.66 -7.62 0.97 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.191 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 176.0 170.77 0.39 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.1 0.952 . . . . 0.0 111.775 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -112.67 111.16 21.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.742 1.617 . . . . 0.0 107.279 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -83.71 162.81 20.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 109.721 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.4 128.2 1.41 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.993 1.717 . . . . 0.0 112.593 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.31 -7.99 49.47 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.567 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.15 136.05 35.2 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.534 2.167 . . . . 0.0 106.825 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -98.87 159.24 15.09 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.64 -0.662 . . . . 0.0 112.002 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 tt -159.75 163.72 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.894 1.278 . . . . 0.0 108.784 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.4 165.75 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.12 -62.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -156.1 125.6 6.28 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.15 -42.8 0.17 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.123 2.773 . . . . 0.0 115.507 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -109.75 146.05 35.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.524 1.13 . . . . 0.0 112.253 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tp -97.35 127.53 43.4 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 129.057 2.943 . . . . 0.0 105.682 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.92 161.78 28.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.87 0.868 . . . . 0.0 110.759 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.5 m -138.99 145.52 39.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.83 147.99 26.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.991 0.9 . . . . 0.0 111.442 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -85.06 -36.08 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.097 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -142.52 -70.05 0.34 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.917 0.487 . . . . 0.0 111.389 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -158.53 138.47 12.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.524 1.53 . . . . 0.0 108.908 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -173.32 147.78 1.56 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.499 0.666 . . . . 0.0 109.96 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.87 26.37 4.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 153.07 19.63 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.626 1.571 . . . . 0.0 108.137 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -49.24 117.19 6.42 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.48 0.712 . . . . 0.0 110.012 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.36 120.52 4.49 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.294 2.663 . . . . 0.0 112.261 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.44 -23.78 29.21 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.394 -0.67 . . . . 0.0 111.794 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 t -77.11 59.37 1.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.604 1.202 . . . . 0.0 110.416 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 41.47 -109.06 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.474 1.909 . . . . 0.0 109.734 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t 58.27 -82.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.73 1.612 . . . . 0.0 111.038 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -150.77 28.32 0.7 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.372 1.469 . . . . 0.0 110.425 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.44 171.5 7.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.339 1.066 . . . . 0.0 112.784 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -162.98 130.75 3.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.954 2.102 . . . . 0.0 105.519 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -78.94 139.68 38.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.83 -16.87 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.911 1.284 . . . . 0.0 111.256 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.84 -167.3 39.79 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -144.78 156.6 44.13 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.687 1.195 . . . . 0.0 108.121 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.9 m -114.83 -68.59 0.91 Allowed 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 123.828 0.705 . . . . 0.0 111.093 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 CA-C-O 115.337 -2.268 . . . . 0.0 106.971 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 t -59.51 -52.56 65.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.231 1.015 . . . . 0.0 109.631 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 166.65 -63.79 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 131.161 3.784 . . . . 0.0 103.903 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -157.91 28.11 0.27 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.223 1.009 . . . . 0.0 111.314 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 179.34 5.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.312 0.506 . . . . 0.0 109.992 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.63 98.03 0.17 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.988 0.423 . . . . 0.0 109.9 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -105.88 137.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -46.51 135.57 7.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.092 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -94.33 31.42 12.37 Favored 'Cis proline' 0 C--N 1.349 0.567 0 N-CA-C 115.354 1.251 . . . . 0.0 115.354 1.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -77.67 59.77 2.06 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 121.272 1.851 . . . . 0.0 108.741 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -55.29 157.72 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.787 0.835 . . . . 0.0 112.893 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.39 -49.12 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.347 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -84.33 154.24 23.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.503 1.144 . . . . 0.0 109.541 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -126.01 168.14 14.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.944 2.098 . . . . 0.0 109.762 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.64 -31.29 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -160.57 160.15 31.45 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.388 1.475 . . . . 0.0 107.708 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.01 -61.79 0.62 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.141 1.776 . . . . 0.0 114.151 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.65 14.31 61.83 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.511 -0.605 . . . . 0.0 113.354 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 -169.38 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.365 1.083 . . . . 0.0 111.478 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.19 160.8 28.12 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -51.84 145.75 30.81 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.826 2.351 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 m -134.22 -29.95 1.21 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.274 0.63 . . . . 0.0 112.428 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 173.62 171.83 0.17 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.243 0.474 . . . . 0.0 111.057 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -111.17 140.32 45.82 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.61 167.72 9.94 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.574 1.15 . . . . 0.0 109.267 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.55 121.07 1.6 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.596 1.159 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.89 -11.59 70.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.155 1.36 . . . . 0.0 113.785 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -81.42 123.83 28.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.036 1.418 . . . . 0.0 109.26 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -89.14 162.56 15.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.962 1.705 . . . . 0.0 112.268 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.7 tt -168.07 165.94 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.849 1.26 . . . . 0.0 108.375 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.4 t -118.53 163.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.416 . . . . 0.0 108.011 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.97 -60.84 0.9 Allowed 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.47 106.73 3.15 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.22 -46.67 0.49 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.773 1.654 . . . . 0.0 114.204 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -87.64 145.26 26.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 112.039 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tp -99.18 133.23 43.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 130.31 3.444 . . . . 0.0 107.737 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -134.18 153.95 51.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.169 0.987 . . . . 0.0 109.243 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 m -125.76 135.62 52.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.845 0.858 . . . . 0.0 109.742 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.78 136.98 47.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.818 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.8 -36.29 17.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.451 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 11.5 p90 -138.61 -70.85 0.42 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.314 0.646 . . . . 0.0 110.127 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -159.61 130.34 5.82 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 128.146 2.579 . . . . 0.0 106.353 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -165.41 151.42 9.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.676 1.126 . . . . 0.0 111.32 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.9 19.43 2.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.369 1.868 . . . . 0.0 108.765 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -85.18 164.83 17.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.59 119.53 33.67 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.71 125.51 11.27 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.19 2.593 . . . . 0.0 112.02 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.27 -11.81 65.33 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.011 -0.883 . . . . 0.0 112.314 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 t -76.22 69.5 2.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.072 1.436 . . . . 0.0 109.102 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 43.11 -125.78 0.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.376 1.87 . . . . 0.0 109.285 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t 53.38 -132.25 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.146 0.578 . . . . 0.0 109.769 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -69.49 -80.56 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 129.59 3.156 . . . . 0.0 109.401 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -7.95 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.979 2.912 . . . . 0.0 116.538 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -89.31 114.58 25.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.16 -1.837 . . . . 0.0 107.264 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -67.74 132.82 48.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.48 10.5 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.855 0.862 . . . . 0.0 112.693 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.16 -155.59 16.33 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 p -85.01 167.05 16.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -50.5 -42.04 54.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.917 0.865 . . . . 0.0 111.577 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -1.012 0 C-N-CA 128.92 2.888 . . . . 0.0 104.486 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m 53.61 20.68 2.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.113 1.765 . . . . 0.0 113.232 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.17 -25.94 1.02 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.774 2.43 . . . . 0.0 114.321 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -58.37 -36.52 73.63 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.63 0.772 . . . . 0.0 110.889 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -171.96 3.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.592 0.757 . . . . 0.0 110.422 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.35 94.97 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.455 -0.778 . . . . 0.0 109.91 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.91 135.85 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 126.196 1.798 . . . . 0.0 108.234 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -44.28 132.18 4.54 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.71 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -95.54 32.59 10.88 Favored 'Cis proline' 0 C--N 1.35 0.649 0 CA-C-N 120.75 1.304 . . . . 0.0 114.931 1.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -76.45 57.24 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.095 1.316 . . . . 0.0 109.309 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -51.36 141.19 15.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.047 1.339 . . . . 0.0 112.899 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 t -77.61 -29.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 112.287 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.4 m -67.05 -18.4 65.34 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.34 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.991 1.716 . . . . 0.0 111.62 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t0 149.06 -45.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 1 C-N-CA 132.867 4.467 . . . . 0.0 105.361 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.1 p-90 -149.71 171.91 15.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 108.229 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.56 -53.89 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.441 1.896 . . . . 0.0 114.395 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.8 18.27 24.54 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.325 0.964 . . . . 0.0 112.239 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.94 145.7 35.51 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.865 0.833 . . . . 0.0 112.695 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -72.84 136.0 80.36 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -39.67 138.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 1 C-N-CA 125.406 4.071 . . . . 0.0 116.254 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -123.61 -30.63 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 172.87 164.81 0.13 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.555 1.07 . . . . 0.0 110.847 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -97.35 133.81 41.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 107.777 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.26 163.5 12.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.929 1.292 . . . . 0.0 110.305 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.92 122.66 1.78 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.898 1.279 . . . . 0.0 111.944 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.2 -3.69 70.71 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.667 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -83.01 118.18 23.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.499 2.149 . . . . 0.0 106.542 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -78.39 164.83 24.46 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.286 -0.884 . . . . 0.0 110.058 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.0 tt -161.51 159.39 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.689 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.59 155.18 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.502 1.521 . . . . 0.0 108.704 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -176.6 135.27 0.23 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.61 2.364 . . . . 0.0 107.357 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? 44.75 33.0 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.132 2.173 . . . . 0.0 115.128 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.54 77.75 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.798 1.189 . . . . 0.0 112.923 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.13 154.61 37.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -97.99 120.87 39.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.277 1.831 . . . . 0.0 108.191 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -123.56 159.43 29.21 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.828 0.851 . . . . 0.0 108.971 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -144.9 143.2 30.45 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.14 149.0 25.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.154 0.978 . . . . 0.0 109.788 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.57 -31.15 22.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.903 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.71 -72.94 0.28 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.628 0.728 . . . . 0.0 110.191 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -165.99 136.54 3.54 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.287 1.435 . . . . 0.0 109.982 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -176.31 155.38 1.46 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 119.157 0.89 . . . . 0.0 111.4 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.02 18.98 5.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.988 1.715 . . . . 0.0 108.09 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -84.42 171.22 12.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.05 121.4 35.76 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.77 115.76 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.624 2.216 . . . . 0.0 110.833 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 1.54 33.37 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.101 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -75.94 49.99 0.57 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.984 1.892 . . . . 0.0 111.314 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 42.98 -140.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.152 1.781 . . . . 0.0 109.216 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.2 t 44.11 -106.91 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 112.879 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 p -75.44 -5.99 47.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.931 2.092 . . . . 0.0 114.801 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -107.07 174.23 5.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.636 1.107 . . . . 0.0 112.87 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -163.42 135.36 5.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.908 2.083 . . . . 0.0 105.788 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -88.5 128.25 35.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.68 -15.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.184 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.16 -155.86 26.44 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 119.39 0.995 . . . . 0.0 111.696 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -89.9 135.71 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.03 99.44 6.1 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.512 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 m -91.0 87.61 6.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -49.29 -34.53 15.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.7 1.6 . . . . 0.0 113.091 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.1 -18.4 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.336 1.054 . . . . 0.0 112.825 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.67 -175.81 2.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.91 102.44 0.6 Allowed 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.954 -0.467 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.54 125.62 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -47.73 138.19 9.55 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.603 -0.685 . . . . 0.0 110.79 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.82 35.43 7.7 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 N-CA-C 114.925 1.087 . . . . 0.0 114.925 1.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -75.33 65.19 1.61 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 121.532 1.969 . . . . 0.0 109.897 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -50.38 154.77 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.841 0.856 . . . . 0.0 112.465 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -84.03 -41.55 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.783 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.4 m -106.03 155.04 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.457 1.122 . . . . 0.0 113.371 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -103.58 150.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.034 2.134 . . . . 0.0 106.752 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.56 -34.35 77.69 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.648 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -141.04 158.31 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.417 1.087 . . . . 0.0 108.672 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.67 -61.29 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.288 1.835 . . . . 0.0 114.071 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.53 10.74 72.34 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.458 -0.634 . . . . 0.0 113.309 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.59 171.17 52.66 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 118.57 1.185 . . . . 0.0 110.885 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 168.39 19.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.36 133.02 55.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 108.348 -1.443 . . . . 0.0 108.348 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -128.05 -13.16 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.825 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 177.36 167.97 0.62 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.45 1.023 . . . . 0.0 113.292 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.61 139.5 42.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.62 168.59 8.98 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.233 1.013 . . . . 0.0 109.051 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.01 121.58 2.15 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.827 1.251 . . . . 0.0 111.487 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.15 -15.7 54.98 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.017 0.818 . . . . 0.0 113.75 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -76.57 121.77 23.65 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.108 1.454 . . . . 0.0 108.737 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -87.7 164.03 16.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.272 1.429 . . . . 0.0 112.313 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 tt -164.6 154.52 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.912 1.685 . . . . 0.0 106.992 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.41 156.34 9.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -152.13 -108.24 0.05 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -73.7 87.79 1.71 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.973 0.806 . . . . 0.0 108.994 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.24 -40.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 130.332 3.825 . . . . 0.0 117.045 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -102.37 164.06 11.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.919 0.888 . . . . 0.0 111.478 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tp -80.76 131.48 35.43 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.694 2.398 . . . . 0.0 107.739 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.04 153.31 46.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.085 1.354 . . . . 0.0 108.453 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.9 m -137.77 146.27 43.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.282 0.633 . . . . 0.0 109.632 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.14 144.24 33.22 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.891 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -92.74 -30.04 15.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.904 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -141.73 -73.88 0.31 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 111.998 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.49 119.39 2.65 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.791 2.836 . . . . 0.0 106.117 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 t -163.01 150.89 13.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 120.111 1.323 . . . . 0.0 112.115 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.28 12.99 6.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.932 2.093 . . . . 0.0 107.941 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 t -74.93 172.64 11.92 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.07 118.38 42.22 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 109.987 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.61 140.26 36.93 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.668 2.246 . . . . 0.0 111.829 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.27 -10.8 60.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.598 -1.112 . . . . 0.0 112.157 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -79.02 54.97 1.7 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.795 1.798 . . . . 0.0 110.513 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 42.34 -146.32 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.116 2.166 . . . . 0.0 112.038 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 m 40.78 -100.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.508 2.323 . . . . 0.0 113.762 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.4 p -78.21 -4.13 46.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.05 139.08 51.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 119.117 0.871 . . . . 0.0 110.692 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -133.17 122.82 24.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 113.476 -1.693 . . . . 0.0 106.955 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -69.33 138.6 53.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.16 -12.02 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.93 -159.27 32.01 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 120.248 1.385 . . . . 0.0 110.819 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -149.98 -176.67 5.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.424 1.09 . . . . 0.0 108.304 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.2 m -122.68 -69.71 0.81 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.948 0.899 . . . . 0.0 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.997 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.87 -57.35 3.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.341 1.067 . . . . 0.0 108.36 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 163.89 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 130.455 3.502 . . . . 0.0 105.083 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.14 4.09 0.45 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 113.04 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.85 178.92 7.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.165 0.893 . . . . 0.0 111.926 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.57 100.84 0.07 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.339 1.056 . . . . 0.0 110.747 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.97 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -45.57 133.96 6.17 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.334 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.8 32.86 10.5 Favored 'Cis proline' 0 C--N 1.353 0.777 0 CA-C-N 121.198 1.464 . . . . 0.0 114.375 0.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.84 66.58 2.13 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 120.276 1.398 . . . . 0.0 107.306 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -60.38 161.25 7.54 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.433 1.493 . . . . 0.0 112.145 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -81.99 -26.02 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.839 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.5 m -153.09 175.81 12.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 112.297 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.288 88.5 tttt -111.4 -47.08 3.21 Favored 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 130.475 3.51 . . . . 0.0 109.936 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 159.98 -45.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.195 1 C-N-CA 131.954 4.102 . . . . 0.0 103.768 -172.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -61.63 169.66 2.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.0 2.52 . . . . 0.0 113.526 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.33 39.26 2.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.227 2.211 . . . . 0.0 107.06 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.7 48.08 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.057 1.313 . . . . 0.0 110.806 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.91 156.58 21.52 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -57.44 124.89 69.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.767 1.284 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -55.32 146.13 63.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.151 1.901 . . . . 0.0 113.311 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.19 2.87 0.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.019 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -175.29 166.95 3.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.005 1.383 . . . . 0.0 114.624 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -115.72 123.11 47.48 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.561 1.544 . . . . 0.0 107.784 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -95.55 157.87 15.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.344 1.458 . . . . 0.0 110.518 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.69 123.96 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.119 1.767 . . . . 0.0 112.397 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.58 -13.61 51.21 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 117.523 -1.71 . . . . 0.0 114.644 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -80.68 143.71 32.82 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 121.229 2.514 . . . . 0.0 107.758 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 m -103.28 157.62 16.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.74 165.81 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.32 151.36 23.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.676 0.671 . . . . 0.0 109.888 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -154.58 124.96 6.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? 35.87 73.9 0.08 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.124 1.77 . . . . 0.0 111.918 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 -46.32 0.54 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.028 1.775 . . . . 0.0 114.07 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -68.49 141.53 55.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.563 1.182 . . . . 0.0 111.763 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 tp -98.58 123.97 43.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 128.882 2.873 . . . . 0.0 106.474 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.93 169.19 11.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.457 1.103 . . . . 0.0 109.735 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -149.79 150.09 31.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 148.89 25.68 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 122.022 0.915 . . . . 0.0 112.207 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -92.21 -35.37 13.85 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 110.011 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -144.87 -72.82 0.26 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.409 0.684 . . . . 0.0 110.726 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -156.45 133.78 10.69 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.807 1.643 . . . . 0.0 109.12 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -168.92 151.78 5.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.886 0.766 . . . . 0.0 111.35 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.79 17.66 3.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.317 1.847 . . . . 0.0 107.47 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.2 t -85.47 166.71 16.11 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.99 119.78 33.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.21 117.44 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.192 2.594 . . . . 0.0 112.189 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 -25.95 14.16 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.632 1.11 . . . . 0.0 111.331 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.9 t -76.08 61.45 1.55 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.491 1.146 . . . . 0.0 111.153 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 45.18 -119.44 0.77 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.436 1.494 . . . . 0.0 108.766 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t 66.43 -63.91 0.24 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.58 1.952 . . . . 0.0 113.017 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -178.51 32.64 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 129.665 3.186 . . . . 0.0 107.083 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -109.7 149.08 30.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.693 1.133 . . . . 0.0 110.776 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -144.79 127.97 16.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -77.37 137.45 38.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.75 -17.15 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.678 1.191 . . . . 0.0 111.001 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.63 -151.55 19.13 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.354 0.979 . . . . 0.0 111.359 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -141.26 138.57 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.14 1.776 . . . . 0.0 107.786 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.3 m -74.71 98.21 3.4 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.257 1.456 0 O-C-N 125.328 1.642 . . . . 0.0 109.382 175.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 121.248 0.547 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.294 1.5 m 15.25 69.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 131.546 3.938 . . . . 0.0 114.558 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.25 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.394 2.278 . . . . 0.0 113.549 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -56.33 -32.52 64.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.51 0.724 . . . . 0.0 111.059 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.84 169.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.616 1.166 . . . . 0.0 109.949 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -48.33 120.34 3.57 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.33 1.052 . . . . 0.0 109.975 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -105.99 126.71 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -48.33 135.84 12.3 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.703 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.46 28.47 16.51 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 119.989 1.032 . . . . 0.0 114.208 -0.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -74.64 67.79 1.59 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.873 1.215 . . . . 0.0 108.677 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -48.34 160.35 0.16 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.927 0.891 . . . . 0.0 111.609 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -34.17 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.909 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -170.37 -167.91 0.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.336 1.065 . . . . 0.0 113.152 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.261 41.4 mtpt -101.2 -33.01 10.26 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 131.375 3.87 . . . . 0.0 108.457 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 159.23 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 129.426 3.09 . . . . 0.0 106.28 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -117.73 153.86 32.68 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.425 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.73 -63.58 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.228 1.811 . . . . 0.0 114.152 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.52 0.66 54.77 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.384 -0.675 . . . . 0.0 113.144 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.6 128.03 10.1 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -58.87 115.6 12.45 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -42.57 130.88 5.27 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.733 2.289 . . . . 0.0 114.074 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -128.54 -15.18 4.56 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.164 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 177.68 164.08 0.61 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.503 1.047 . . . . 0.0 111.221 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -98.23 125.77 43.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -92.96 169.91 10.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.646 1.179 . . . . 0.0 109.184 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.83 127.46 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.065 0.946 . . . . 0.0 111.387 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.2 -11.65 54.02 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.61 -1.106 . . . . 0.0 113.474 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -81.39 136.84 35.73 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.685 1.743 . . . . 0.0 109.954 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.0 m -104.89 163.39 12.56 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.364 1.066 . . . . 0.0 112.786 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.53 155.63 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.175 0.99 . . . . 0.0 109.004 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 t -102.29 150.63 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -138.65 -138.28 0.13 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.27 84.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.932 1.696 . . . . 0.0 111.336 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.83 -27.48 0.18 Allowed Glycine 0 CA--C 1.538 1.486 0 C-N-CA 128.716 3.055 . . . . 0.0 114.729 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -87.14 151.35 23.27 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.984 1.714 . . . . 0.0 111.591 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -104.76 128.16 52.79 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.189 2.995 . . . . 0.0 107.362 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -129.29 157.56 41.52 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.279 1.032 . . . . 0.0 110.365 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -131.7 140.51 49.32 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.606 1.163 . . . . 0.0 109.425 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.47 140.87 34.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 109.8 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -90.34 -32.58 16.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.348 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -139.35 -70.75 0.4 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.094 0.473 . . . . 0.0 111.734 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -161.47 123.89 3.03 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 126.269 1.828 . . . . 0.0 107.219 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -163.61 143.91 8.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.737 1.153 . . . . 0.0 111.731 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.15 13.79 9.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.793 2.037 . . . . 0.0 106.823 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -73.89 162.34 29.19 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.484 1.113 . . . . 0.0 108.503 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.84 121.26 67.2 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.07 131.27 21.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.843 2.362 . . . . 0.0 112.393 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.53 65.95 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.734 -1.036 . . . . 0.0 112.957 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.3 t -76.95 62.03 2.05 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.648 1.724 . . . . 0.0 110.381 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 51.98 -138.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.31 . . . . 0.0 108.667 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.4 t 57.33 -139.55 0.87 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.121 0.873 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -62.41 -74.97 0.08 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.678 2.791 . . . . 0.0 110.095 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -19.54 114.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.738 2.415 . . . . 0.0 114.508 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.255 23.4 m -118.47 125.3 49.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 113.197 -1.819 . . . . 0.0 107.034 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -68.6 140.06 55.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.711 0.232 . . . . 0.0 110.462 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 -16.07 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 111.292 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.6 -154.45 24.23 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.223 0.92 . . . . 0.0 111.053 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 p -160.27 167.68 27.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.455 1.902 . . . . 0.0 107.125 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.1 m -50.63 -65.48 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 127.401 2.28 . . . . 0.0 105.051 -172.619 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.3 t -71.48 -60.97 1.95 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 150.53 -60.69 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 130.027 3.331 . . . . 0.0 106.278 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -151.59 32.01 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.75 178.82 4.44 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.033 0.833 . . . . 0.0 110.603 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -61.19 98.26 0.08 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -109.26 124.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 124.538 1.135 . . . . 0.0 109.945 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -39.67 132.97 1.36 Allowed Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.003 1.321 . . . . 0.0 110.833 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -85.93 18.31 30.47 Favored 'Cis proline' 0 CA--C 1.535 0.559 0 CA-C-N 120.465 1.202 . . . . 0.0 114.881 0.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -74.6 64.47 1.21 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.217 1.371 . . . . 0.0 109.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -54.16 152.61 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.643 0.777 . . . . 0.0 111.685 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -70.54 -42.99 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.209 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.5 t -100.02 149.87 23.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.942 1.353 . . . . 0.0 110.985 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -101.62 169.17 9.01 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.943 2.097 . . . . 0.0 107.687 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -39.84 86.29 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -146.42 162.04 39.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.702 1.601 . . . . 0.0 107.688 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.8 -60.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.562 1.545 . . . . 0.0 113.702 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.27 60.89 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.124 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.17 -159.67 23.23 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.135 0.967 . . . . 0.0 111.564 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -118.66 159.29 44.74 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.362 1.465 . . . . 0.0 107.521 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.58 136.2 21.02 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.359 2.04 . . . . 0.0 110.943 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.5 m -136.4 -18.47 1.48 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.81 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 178.86 156.71 0.48 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -84.79 124.02 31.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.29 153.77 40.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.62 133.69 46.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.64 -2.02 49.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.035 -1.425 . . . . 0.0 113.401 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -90.19 147.68 23.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.29 2.045 . . . . 0.0 107.953 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 m -90.85 160.91 15.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.237 -0.289 . . . . 0.0 111.334 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.24 138.09 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.7 t -106.36 157.81 6.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -151.54 -92.94 0.06 Allowed 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -76.53 52.94 0.83 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.313 1.845 . . . . 0.0 110.739 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.83 -36.01 1.23 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.833 2.635 . . . . 0.0 111.663 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -71.42 141.94 50.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.086 0.954 . . . . 0.0 110.491 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.25 115.68 28.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 129.385 3.074 . . . . 0.0 106.136 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -113.94 171.47 7.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.064 0.946 . . . . 0.0 109.213 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 m -151.14 146.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.68 137.73 39.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.399 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.89 79.17 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.783 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -146.66 -140.66 0.11 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.368 2.267 . . . . 0.0 112.942 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -79.18 115.15 18.67 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 130.17 3.388 . . . . 0.0 113.38 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.95 143.63 6.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.166 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.61 30.68 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.873 2.069 . . . . 0.0 106.746 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.8 t -83.39 -133.93 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.889 0.876 . . . . 0.0 108.955 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.49 110.09 55.68 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.72 113.92 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.401 2.734 . . . . 0.0 111.815 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.28 -0.32 37.78 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.6 p -77.02 44.37 0.39 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.461 2.13 . . . . 0.0 112.153 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 t70 42.13 -149.66 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.07 2.148 . . . . 0.0 111.579 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m 50.59 -76.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.145 2.578 . . . . 0.0 114.267 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -83.84 -53.59 5.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.967 1.707 . . . . 0.0 109.991 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.62 164.49 21.36 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.694 1.997 . . . . 0.0 112.749 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -159.1 138.37 11.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -88.27 138.47 31.41 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 109.705 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -14.65 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.621 1.169 . . . . 0.0 111.66 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 -152.17 20.91 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.04 140.01 20.1 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.07 1.348 . . . . 0.0 108.769 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.9 m -74.35 -53.34 9.85 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.808 0.813 . . . . 0.0 109.505 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.068 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -173.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -69.99 -55.59 9.18 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 121.671 0.748 . . . . 0.0 109.895 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.35 -67.23 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 130.571 3.548 . . . . 0.0 104.428 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -156.51 26.15 0.34 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.979 0.912 . . . . 0.0 111.631 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.44 -165.96 1.47 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.575 0.625 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -71.83 85.09 0.94 Allowed 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.23 124.43 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.202 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -38.07 131.04 0.97 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.771 1.229 . . . . 0.0 111.85 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -90.21 23.77 24.23 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 120.445 1.195 . . . . 0.0 114.244 0.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.71 66.1 1.42 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.896 1.225 . . . . 0.0 109.53 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -51.95 156.91 1.38 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.964 0.888 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.29 -31.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.834 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.7 m -151.56 167.24 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.262 11.4 tmtt? -82.6 -38.99 22.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.449 2.299 . . . . 0.0 113.535 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.4 t70 167.56 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 1 C-N-CA 132.529 4.332 . . . . 0.0 102.713 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -111.51 175.41 5.44 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 128.194 2.598 . . . . 0.0 107.375 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.21 -55.8 5.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.43 66.95 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.308 0.883 . . . . 0.0 115.308 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.5 163.93 38.72 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.004 1.402 . . . . 0.0 111.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 164.9 51.4 Favored Pre-proline 0 C--O 1.217 -0.606 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.81 156.53 56.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.066 2.488 . . . . 0.0 114.352 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 m -141.07 -28.24 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 0.0 111.849 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -178.59 170.4 1.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 111.249 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -105.75 126.66 52.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.08 160.97 13.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.054 1.342 . . . . 0.0 109.435 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.76 125.88 2.92 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 111.715 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.59 -13.09 54.04 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.882 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.35 144.83 32.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 120.406 2.103 . . . . 0.0 107.781 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -98.71 158.74 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.756 0.422 . . . . 0.0 110.997 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.41 144.33 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.05 150.92 12.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.057 0.543 . . . . 0.0 110.594 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -156.91 133.48 10.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 46.35 33.79 2.01 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.457 1.903 . . . . 0.0 113.165 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.52 9.71 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.986 2.231 . . . . 0.0 112.576 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -78.11 139.94 39.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.629 1.214 . . . . 0.0 110.008 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.51 128.05 36.42 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 129.126 2.97 . . . . 0.0 107.615 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -128.26 167.61 16.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.519 1.127 . . . . 0.0 108.631 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -148.77 147.12 28.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.97 148.97 21.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.72 1.247 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -89.89 -36.42 15.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -132.09 -79.37 0.51 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.05 0.453 . . . . 0.0 111.852 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -157.44 132.62 8.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.777 2.031 . . . . 0.0 107.913 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -167.49 153.65 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.236 0.926 . . . . 0.0 110.107 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.29 34.24 0.65 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.675 1.59 . . . . 0.0 108.943 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 p -88.64 -100.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.189 0.596 . . . . 0.0 111.294 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.55 110.34 4.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.6 111.44 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.948 3.099 . . . . 0.0 113.586 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.71 -27.81 10.08 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.909 1.243 . . . . 0.0 111.867 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.1 t -76.47 65.47 2.34 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.323 1.062 . . . . 0.0 110.959 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 50.94 -128.21 2.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 t 72.45 -47.99 0.68 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.722 1.609 . . . . 0.0 112.813 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 -64.33 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.998 2.919 . . . . 0.0 105.906 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -11.91 121.54 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 129.074 2.95 . . . . 0.0 116.932 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 m -120.24 118.83 31.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 112.597 -2.092 . . . . 0.0 106.206 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -71.3 140.51 50.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -2.37 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.03 -152.53 24.24 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -147.64 142.14 26.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.779 1.232 . . . . 0.0 109.096 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 m -67.68 -46.51 72.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.726 0.774 . . . . 0.0 109.642 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--O 1.257 1.454 0 CA-C-O 115.559 -2.162 . . . . 0.0 105.25 -174.899 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.1 t -67.95 -52.63 33.87 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 121.215 0.531 . . . . 0.0 111.825 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 157.01 -57.6 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 130.517 3.527 . . . . 0.0 105.88 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -149.74 -5.6 0.36 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.393 1.077 . . . . 0.0 113.319 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.52 174.39 11.62 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.201 0.909 . . . . 0.0 112.024 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -54.31 103.85 0.09 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.524 1.13 . . . . 0.0 110.126 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.32 135.82 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 108.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -43.66 132.18 3.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.196 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -98.25 36.29 7.05 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 121.135 1.441 . . . . 0.0 113.593 -0.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -76.26 62.49 1.78 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.538 1.063 . . . . 0.0 108.738 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -52.55 150.89 4.61 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.458 1.103 . . . . 0.0 112.992 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -95.25 -29.52 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.231 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -64.33 -41.31 96.86 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.565 1.075 . . . . 0.0 111.407 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 mttt 57.29 -178.84 0.05 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.458 1.503 . . . . 0.0 112.79 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.54 -17.44 61.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.088 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -158.21 -74.33 0.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.743 0.701 . . . . 0.0 110.902 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.88 -52.6 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.11 0.564 . . . . 0.0 110.645 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.77 -11.86 54.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.705 0.669 . . . . 0.0 111.74 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.22 -177.05 32.84 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 122.11 0.839 . . . . 0.0 113.958 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -62.55 158.85 46.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.267 1.027 . . . . 0.0 110.338 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -64.49 168.26 13.35 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.114 1.876 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -154.2 -29.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.408 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 164.59 169.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.705 1.202 . . . . 0.0 110.418 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -107.02 128.15 54.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.09 162.59 13.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.728 1.211 . . . . 0.0 109.123 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.08 122.4 1.03 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.865 1.666 . . . . 0.0 112.012 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -15.27 45.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.475 -1.181 . . . . 0.0 114.384 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -76.19 138.53 40.72 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.534 2.167 . . . . 0.0 106.482 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -108.12 152.67 24.23 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.071 -0.393 . . . . 0.0 111.431 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -148.83 162.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.071 1.348 . . . . 0.0 107.659 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -116.02 151.37 17.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -157.07 119.47 3.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 40.36 76.21 0.07 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.726 2.011 . . . . 0.0 111.283 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.36 -47.11 0.68 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.913 1.72 . . . . 0.0 114.201 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -73.81 142.13 46.18 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.982 0.913 . . . . 0.0 113.122 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tp -97.35 129.49 44.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 130.161 3.384 . . . . 0.0 107.236 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -133.19 156.29 47.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.83 0.852 . . . . 0.0 109.845 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.5 m -130.42 144.7 51.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.224 1.41 . . . . 0.0 107.701 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.9 149.92 24.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.058 0.932 . . . . 0.0 110.302 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.42 -33.42 17.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.942 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -143.46 -70.68 0.31 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.786 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -156.94 138.16 13.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.162 2.185 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -171.67 147.46 2.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.73 36.39 2.0 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.559 1.544 . . . . 0.0 107.616 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 m -126.56 153.0 45.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.667 1.187 . . . . 0.0 109.24 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.5 t -36.31 110.58 0.46 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.589 1.956 . . . . 0.0 112.787 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.01 138.16 43.68 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.073 3.182 . . . . 0.0 114.126 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.45 -43.67 1.59 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.997 0.808 . . . . 0.0 112.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.9 t -73.37 -41.89 62.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.619 0.767 . . . . 0.0 111.597 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.85 -111.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -161.26 171.36 18.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.144 1.378 . . . . 0.0 108.554 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 64.73 18.36 11.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -112.61 157.52 21.11 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.116 1.766 . . . . 0.0 109.351 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 m -152.03 119.86 6.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -68.7 142.03 55.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 109.784 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.39 -6.97 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.3 1.04 . . . . 0.0 112.352 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.42 -155.44 26.4 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 p -154.04 150.06 27.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.935 1.294 . . . . 0.0 108.302 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -86.08 -47.09 9.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 122.266 1.031 . . . . 0.0 109.412 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 129.885 3.274 . . . . 0.0 105.024 -175.0 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.3 m -98.58 -23.94 15.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.704 1.138 . . . . 0.0 109.925 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.59 20.61 12.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.916 1.287 . . . . 0.0 112.138 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -162.47 -45.21 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.928 1.291 . . . . 0.0 110.024 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.97 173.41 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -70.45 122.78 20.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.2 136.89 30.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 125.556 1.543 . . . . 0.0 109.71 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -46.08 133.22 7.17 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.045 1.293 . . . . 0.0 111.802 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -95.54 36.82 6.64 Favored 'Cis proline' 0 C--N 1.353 0.81 0 CA-C-N 121.563 1.594 . . . . 0.0 113.52 -0.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.76 66.04 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -59.82 147.69 37.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.403 0.62 . . . . 0.0 110.305 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.6 -43.76 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.544 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -91.48 146.72 23.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 122.626 1.203 . . . . 0.0 109.553 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -115.72 166.65 11.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.154 2.182 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -58.0 -34.83 70.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.393 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -158.49 170.26 22.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.607 1.963 . . . . 0.0 106.848 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.38 -60.69 0.48 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.781 1.632 . . . . 0.0 113.808 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.81 24.07 29.38 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.849 0.738 . . . . 0.0 112.062 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 -174.81 49.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 121.829 0.683 . . . . 0.0 113.19 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.82 154.45 75.64 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.58 154.28 31.46 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.214 1.943 . . . . 0.0 110.011 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.73 -4.89 0.31 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.81 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 165.59 167.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.22 1.008 . . . . 0.0 113.705 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -114.62 137.52 51.79 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.577 1.551 . . . . 0.0 107.099 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.21 168.65 9.22 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.366 1.066 . . . . 0.0 109.28 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.14 124.34 2.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 111.85 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.53 -14.43 55.29 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.701 1.143 . . . . 0.0 113.501 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -78.65 126.63 31.0 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.172 1.486 . . . . 0.0 109.204 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 p -91.5 164.13 13.91 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.886 1.674 . . . . 0.0 112.285 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.56 153.95 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.55 153.4 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 118.48 0.582 . . . . 0.0 109.521 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -161.38 129.17 4.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 33.16 74.2 0.06 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.136 1.774 . . . . 0.0 112.247 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.07 -40.7 0.33 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.677 2.084 . . . . 0.0 115.089 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -78.37 145.5 35.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.607 1.194 . . . . 0.0 112.716 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tp -101.82 126.8 48.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 129.837 3.255 . . . . 0.0 106.923 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.75 152.76 49.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.443 0.697 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.1 m -128.63 140.04 51.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 109.203 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 141.76 40.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.865 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.41 -39.51 13.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.428 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -133.5 -71.47 0.51 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -159.28 135.75 9.18 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 127.732 2.413 . . . . 0.0 106.561 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -168.19 157.05 9.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.236 0.926 . . . . 0.0 110.507 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.56 21.12 0.92 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.848 1.659 . . . . 0.0 109.277 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.5 p -91.25 164.23 13.96 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.7 t -52.14 111.81 2.8 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.388 0.675 . . . . 0.0 109.326 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.21 122.69 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.337 3.358 . . . . 0.0 113.445 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.84 -23.15 34.71 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.468 1.032 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 m -76.24 66.92 2.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.284 1.042 . . . . 0.0 110.666 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 47.2 -126.7 1.65 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.996 1.319 . . . . 0.0 108.847 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m 65.07 -40.87 0.29 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.467 2.307 . . . . 0.0 115.94 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p 179.34 -69.82 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.264 2.626 . . . . 0.0 106.224 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -8.91 112.98 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.723 3.209 . . . . 0.0 116.124 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.4 m -108.88 113.16 25.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 112.805 -1.998 . . . . 0.0 106.264 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -66.79 134.34 51.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.13 -9.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.686 0.794 . . . . 0.0 111.185 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.68 -167.64 32.63 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.103 0.865 . . . . 0.0 111.593 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -122.79 123.22 40.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -31.44 68.15 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.518 0 CA-C-O 114.84 -2.505 . . . . 0.0 107.05 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.8 t -64.75 -47.21 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.476 0.655 . . . . 0.0 111.951 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 155.98 -61.04 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 130.705 3.602 . . . . 0.0 104.849 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.1 0.85 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.463 1.105 . . . . 0.0 113.259 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.72 -175.29 5.2 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.092 0.86 . . . . 0.0 111.838 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.52 94.0 0.04 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.814 0.845 . . . . 0.0 111.003 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 p -96.6 131.81 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.0 135.73 11.33 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.856 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -93.87 33.47 9.62 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.636 1.263 . . . . 0.0 114.706 0.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -74.5 66.95 1.44 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.999 1.272 . . . . 0.0 108.336 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -50.86 160.86 0.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.989 1.316 . . . . 0.0 113.251 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.21 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.938 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -110.9 147.78 33.87 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.773 2.829 . . . . 0.0 107.728 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -66.68 -29.11 69.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -152.63 157.87 41.6 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.624 1.17 . . . . 0.0 108.243 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.78 -60.73 0.69 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.363 1.865 . . . . 0.0 114.615 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.38 5.71 84.61 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.863 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.62 150.71 27.12 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.922 1.361 . . . . 0.0 110.677 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -68.67 151.59 97.16 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.43 157.96 20.67 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 CA-C-N 119.655 0.912 . . . . 0.0 112.729 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 t -157.74 9.74 0.17 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.333 -1.318 . . . . 0.0 110.804 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -178.14 170.49 1.8 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-O 122.647 1.213 . . . . 0.0 113.843 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -115.06 98.56 6.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.874 2.07 . . . . 0.0 105.77 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.29 165.57 13.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.887 -0.508 . . . . 0.0 111.872 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.86 132.07 11.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.324 1.05 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 -10.06 34.93 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.338 -1.257 . . . . 0.0 113.339 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -78.99 156.41 28.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 120.062 1.931 . . . . 0.0 106.479 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -117.94 166.26 12.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.534 0.734 . . . . 0.0 110.524 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 tt -162.38 160.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -116.62 151.37 18.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.71 0.687 . . . . 0.0 109.729 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -162.62 134.85 5.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt 49.59 32.22 4.79 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.84 1.656 . . . . 0.0 112.686 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.09 -19.24 23.2 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.71 2.1 . . . . 0.0 112.874 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -85.53 145.1 27.55 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.702 1.251 . . . . 0.0 109.591 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tp -93.45 129.47 39.61 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.313 2.645 . . . . 0.0 107.178 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -127.62 164.78 21.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.346 1.058 . . . . 0.0 108.381 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.7 m -146.24 145.6 30.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.36 144.5 26.36 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 111.108 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -93.45 -36.54 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.378 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -132.91 -78.01 0.49 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.281 0.563 . . . . 0.0 112.112 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -157.55 132.95 9.01 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -167.07 147.84 5.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.45 1.023 . . . . 0.0 111.022 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.3 15.72 4.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.158 1.383 . . . . 0.0 107.921 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -77.46 163.31 26.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.56 127.9 90.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -45.33 122.4 4.58 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.528 2.818 . . . . 0.0 112.844 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.09 -24.95 27.76 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.167 0.889 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -76.92 75.58 3.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.333 1.066 . . . . 0.0 109.558 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.81 -131.43 0.74 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 110.051 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t 67.7 -54.77 0.49 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.394 2.277 . . . . 0.0 113.979 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 p -172.45 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.548 1.139 . . . . 0.0 109.886 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -18.68 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.427 3.091 . . . . 0.0 116.715 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 m -143.43 130.99 21.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 112.583 -2.099 . . . . 0.0 107.057 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -74.0 141.21 45.86 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.6 -6.23 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.268 1.027 . . . . 0.0 113.027 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.7 -151.42 22.82 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -153.85 154.22 33.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.448 1.099 . . . . 0.0 109.324 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 m -87.27 -53.81 4.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 110.029 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 p -9.95 84.98 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 130.568 3.547 . . . . 0.0 117.037 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.22 -23.8 9.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.009 2.524 . . . . 0.0 112.892 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -54.5 -38.06 66.05 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.21 152.65 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -46.84 122.43 4.3 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.468 0.707 . . . . 0.0 109.967 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.18 130.77 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 119.173 0.897 . . . . 0.0 109.096 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -47.98 136.48 11.04 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.523 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -91.49 24.03 24.98 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.944 1.016 . . . . 0.0 113.876 0.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -73.17 68.75 1.01 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 119.859 1.209 . . . . 0.0 109.807 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -52.22 157.05 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.741 0.782 . . . . 0.0 112.043 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.24 -21.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -145.15 166.83 24.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.063 0.935 . . . . 0.0 113.16 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.271 51.0 tttp -96.9 -40.1 9.07 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 128.543 2.737 . . . . 0.0 110.313 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 174.75 -40.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 1 C-N-CA 133.217 4.607 . . . . 0.0 102.926 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -113.57 166.52 11.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.76 -68.08 0.39 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.45 11.38 1.15 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.42 155.74 27.4 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.258 1.529 . . . . 0.0 110.187 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.9 121.05 42.79 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -50.94 152.95 9.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.449 2.1 . . . . 0.0 116.654 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 m -152.37 -17.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.081 0.952 . . . . 0.0 112.23 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 179.38 164.19 0.96 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.752 1.16 . . . . 0.0 110.973 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -100.09 141.49 32.85 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.72 169.76 8.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.735 1.214 . . . . 0.0 109.404 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.97 122.03 2.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.622 1.169 . . . . 0.0 111.358 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 -19.06 48.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.863 1.221 . . . . 0.0 113.215 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -76.92 131.98 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.257 1.528 . . . . 0.0 110.503 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.93 163.5 12.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.2 1.8 . . . . 0.0 112.087 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.5 tt -167.02 149.42 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.176 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.92 153.61 3.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.407 1.003 . . . . 0.0 108.554 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -158.21 115.49 2.91 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 39.45 78.58 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.041 1.736 . . . . 0.0 112.132 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.27 -42.86 0.53 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.017 1.294 . . . . 0.0 115.825 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -81.57 145.39 30.67 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 122.041 0.924 . . . . 0.0 111.996 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tp -99.44 125.47 45.17 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 129.143 2.977 . . . . 0.0 106.317 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.06 167.35 13.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.31 1.044 . . . . 0.0 108.749 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -148.59 142.88 26.17 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.72 144.21 29.51 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.148 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -95.73 -35.29 11.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.097 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -131.38 -75.42 0.52 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.382 0.426 . . . . 0.0 111.53 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -159.96 125.61 4.12 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.939 2.096 . . . . 0.0 107.921 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 t -167.41 150.57 6.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.979 1.263 . . . . 0.0 111.863 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.21 5.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.783 2.033 . . . . 0.0 108.061 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -71.26 162.99 28.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.39 120.6 53.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.89 122.98 9.04 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.211 2.608 . . . . 0.0 112.615 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.5 -30.44 9.62 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.4 m -75.94 73.38 2.84 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.534 1.167 . . . . 0.0 110.44 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 55.94 -133.2 1.54 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.806 1.242 . . . . 0.0 108.948 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t 59.52 -152.88 0.39 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -54.41 13.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.909 -0.494 . . . . 0.0 109.899 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -13.5 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.953 2.901 . . . . 0.0 117.505 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 m -117.97 126.89 53.2 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.44 2.296 . . . . 0.0 106.399 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.02 141.91 47.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -15.9 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.583 1.153 . . . . 0.0 111.873 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.92 -177.56 47.58 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.0 1.273 . . . . 0.0 112.213 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.5 p -137.03 110.86 8.15 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.932 1.693 . . . . 0.0 107.285 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.8 m -74.04 -37.89 64.16 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 t -82.75 -48.75 10.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.261 1.024 . . . . 0.0 110.241 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.85 -55.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.845 3.258 . . . . 0.0 105.146 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -152.16 -2.68 0.27 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.615 1.166 . . . . 0.0 112.736 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.59 157.98 30.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.569 1.077 . . . . 0.0 111.07 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -39.5 106.85 0.06 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 126.509 1.924 . . . . 0.0 112.742 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.3 132.02 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.545 1.138 . . . . 0.0 108.762 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.61 133.77 6.27 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.597 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.27 34.42 8.57 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 120.982 1.386 . . . . 0.0 114.422 0.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -76.71 59.53 1.57 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.164 1.347 . . . . 0.0 108.118 176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . 0.267 7.2 m95 -55.66 156.83 4.5 Favored 'General case' 0 N--CA 1.412 -2.352 0 C-N-CA 129.356 3.062 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.38 -26.82 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.652 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 t -156.05 173.67 16.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 124.345 2.022 . . . . 0.0 116.0 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.38 -172.01 2.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 130.42 3.488 . . . . 0.0 106.499 171.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.44 -30.56 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.937 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -131.66 152.46 50.84 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 110.156 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.72 -63.35 0.52 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.89 2.076 . . . . 0.0 115.108 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 3.37 69.92 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.962 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.92 147.26 34.78 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 120.199 2.0 . . . . 0.0 111.069 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.35 120.16 80.06 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -38.74 159.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.838 3.692 . . . . 0.0 121.153 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 2.93 0.43 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 112.134 -2.303 . . . . 0.0 109.515 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 178.16 172.24 0.68 Allowed 'General case' 0 C--N 1.349 0.552 0 CA-C-N 120.307 1.412 . . . . 0.0 113.657 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -110.09 139.02 45.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.97 169.29 8.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.353 1.461 . . . . 0.0 109.281 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.26 123.86 2.62 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.922 1.289 . . . . 0.0 112.052 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.17 -17.24 18.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.761 0.696 . . . . 0.0 113.751 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -75.03 128.22 35.05 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -100.76 164.67 11.75 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.3 tt -161.59 173.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.215 1.406 . . . . 0.0 108.233 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.89 153.24 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.032 1.333 . . . . 0.0 110.452 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -158.05 114.19 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 41.18 81.74 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.617 2.367 . . . . 0.0 112.231 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.4 -44.05 0.58 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.57 1.557 . . . . 0.0 114.755 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.61 146.67 40.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.895 0.878 . . . . 0.0 111.739 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.0 tp -106.11 129.17 54.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 130.45 3.5 . . . . 0.0 106.993 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -132.33 162.46 30.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.267 1.027 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.0 m -134.53 144.58 48.09 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.335 1.454 . . . . 0.0 109.096 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.69 145.85 27.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.124 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -86.8 -32.59 20.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.443 1.497 . . . . 0.0 111.492 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -148.96 -65.16 0.23 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 111.101 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -159.86 134.88 7.98 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 127.564 2.346 . . . . 0.0 107.629 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -174.32 144.29 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.057 0.844 . . . . 0.0 111.573 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.81 14.64 9.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.715 2.006 . . . . 0.0 107.932 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.52 165.81 23.86 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.3 t -57.24 118.69 26.18 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.493 -0.765 . . . . 0.0 108.954 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.05 119.17 5.67 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.551 2.168 . . . . 0.0 110.75 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.55 -26.72 9.36 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.3 t -73.43 80.14 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -41.17 139.67 0.93 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.777 1.631 . . . . 0.0 111.413 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t 163.57 -49.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.795 2.438 . . . . 0.0 106.301 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 t -146.56 11.06 1.11 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.979 1.712 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -113.54 156.41 23.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.26 1.024 . . . . 0.0 108.903 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -153.32 126.02 8.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -72.85 140.56 47.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.23 0.468 . . . . 0.0 110.004 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -17.13 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.901 1.281 . . . . 0.0 111.053 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.37 -157.35 29.78 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -154.27 140.72 18.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.886 1.674 . . . . 0.0 106.77 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.58 -44.28 11.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.553 0.615 . . . . 0.0 111.136 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 110.768 -0.086 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.9 t -74.76 -58.59 3.19 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 122.198 0.999 . . . . 0.0 108.558 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.24 -58.02 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 129.747 3.219 . . . . 0.0 104.803 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -152.15 32.32 0.53 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.943 0.897 . . . . 0.0 112.117 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.03 155.63 24.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -32.54 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.587 1.955 . . . . 0.0 113.87 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -88.76 122.97 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -48.66 137.92 12.33 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 120.92 1.691 . . . . 0.0 109.998 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -92.21 36.12 6.64 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 120.612 1.254 . . . . 0.0 114.708 0.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -74.3 66.57 1.32 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.068 1.303 . . . . 0.0 107.86 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -50.55 164.44 0.13 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.533 1.533 . . . . 0.0 113.025 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.94 -33.0 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.139 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -144.57 172.63 12.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.266 86.8 tttt -99.49 -57.73 2.09 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.816 3.246 . . . . 0.0 109.582 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -158.07 -50.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.905 5.682 . . . . 0.0 101.913 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -113.28 175.26 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -58.88 3.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.06 -21.13 63.41 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.22 153.43 48.44 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -59.93 131.88 89.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.89 160.34 25.8 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 N-CA-C 117.944 2.248 . . . . 0.0 117.944 -173.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -151.86 -7.92 0.22 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 112.448 -2.16 . . . . 0.0 110.4 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -174.41 173.29 3.0 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.58 123.3 41.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.745 2.418 . . . . 0.0 105.941 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.6 169.2 11.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.192 0.997 . . . . 0.0 111.669 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.77 128.16 20.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.7 66.6 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.061 -1.411 . . . . 0.0 113.977 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.66 136.74 33.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.582 2.191 . . . . 0.0 106.252 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.1 m -98.36 157.51 16.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.224 0.535 . . . . 0.0 112.208 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 tt -152.05 162.9 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 t -121.86 145.4 28.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.655 0.661 . . . . 0.0 109.519 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -167.34 167.77 13.72 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 40.33 39.68 0.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.957 1.253 . . . . 0.0 112.933 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.39 36.79 54.18 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.963 1.744 . . . . 0.0 112.413 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -150.82 157.22 42.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.939 1.296 . . . . 0.0 110.194 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 tp -87.73 132.12 34.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.984 2.514 . . . . 0.0 109.392 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.74 156.79 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.515 1.126 . . . . 0.0 108.59 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 m -137.2 145.2 43.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.58 153.93 21.43 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.35 1.071 . . . . 0.0 110.584 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -91.08 -32.84 15.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.715 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -138.89 -146.0 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.483 1.513 . . . . 0.0 109.551 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.15 115.9 28.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.751 2.421 . . . . 0.0 106.038 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -157.46 156.57 32.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.131 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.79 20.06 4.19 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.418 1.887 . . . . 0.0 108.049 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -79.9 -179.35 6.92 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.23 120.47 73.4 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.51 127.37 25.73 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.572 2.848 . . . . 0.0 115.551 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.62 -38.41 1.05 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 123.688 0.661 . . . . 0.0 112.759 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -65.72 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.414 0.607 . . . . 0.0 110.814 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.88 179.89 6.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.551 0.691 . . . . 0.0 110.948 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -47.24 164.92 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.838 3.255 . . . . 0.0 115.508 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.2 p 71.95 4.72 5.12 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.637 2.775 . . . . 0.0 114.649 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -117.2 149.23 40.73 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.779 1.231 . . . . 0.0 110.85 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 m -136.69 118.51 15.14 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.95 139.59 48.76 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.57 12.19 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.076 0.55 . . . . 0.0 112.257 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.33 -150.86 17.91 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t -89.42 176.78 6.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -73.47 96.1 2.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 O-C-N 125.017 1.448 . . . . 0.0 109.724 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -37.12 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 129.243 3.017 . . . . 0.0 116.45 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.63 -27.17 10.56 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.789 2.436 . . . . 0.0 111.342 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -54.3 -33.37 58.59 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.82 176.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.31 1.444 . . . . 0.0 109.067 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -60.37 118.41 6.41 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.84 137.06 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -55.52 135.24 70.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 120.704 1.593 . . . . 0.0 110.824 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -99.37 31.17 11.47 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 121.382 1.529 . . . . 0.0 113.319 -1.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -74.76 65.06 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -48.59 152.41 0.96 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.88 0.848 . . . . 0.0 112.316 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.97 -25.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.137 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 m -153.19 169.99 21.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.527 1.632 . . . . 0.0 115.037 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.48 -166.5 1.09 Allowed 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 129.439 3.096 . . . . 0.0 108.305 173.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -53.97 -44.57 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.621 -2.081 . . . . 0.0 107.823 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -128.49 153.36 47.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.392 1.877 . . . . 0.0 109.728 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.44 -63.48 0.44 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.493 1.917 . . . . 0.0 115.174 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 4.73 79.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.677 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.76 154.0 46.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-N 120.487 2.144 . . . . 0.0 110.988 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.0 113.31 8.86 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -37.79 147.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 1 C-N-CA 125.746 4.297 . . . . 0.0 117.412 -173.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 p -139.74 -8.01 1.25 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -178.52 158.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 119.152 0.887 . . . . 0.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -99.21 113.77 26.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.15 164.27 21.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.238 1.815 . . . . 0.0 110.615 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.63 127.51 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 120.804 -1.185 . . . . 0.0 112.603 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 -14.37 48.92 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.956 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.06 139.9 35.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.688 2.744 . . . . 0.0 107.216 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 p -94.25 164.65 12.95 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.262 -0.899 . . . . 0.0 111.919 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 tt -156.86 151.35 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -98.8 150.1 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -159.93 116.47 2.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 38.23 77.3 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.971 2.109 . . . . 0.0 112.541 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.63 -42.09 0.55 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.59 1.567 . . . . 0.0 113.981 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -78.24 151.08 33.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.083 0.944 . . . . 0.0 112.14 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -105.3 124.13 49.02 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 128.94 2.896 . . . . 0.0 106.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.55 168.92 11.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.6 m -150.82 148.84 28.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.76 146.92 25.42 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.921 0.867 . . . . 0.0 112.166 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -87.56 -36.4 17.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -139.14 -71.97 0.4 Allowed 'General case' 0 C--N 1.339 0.122 0 CA-C-O 120.889 0.376 . . . . 0.0 111.623 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -159.73 128.94 5.21 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.353 1.461 . . . . 0.0 108.454 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 t -166.55 150.98 7.53 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 119.134 0.879 . . . . 0.0 111.307 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.89 15.28 4.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.907 1.683 . . . . 0.0 107.996 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 p -87.9 172.02 9.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.41 123.82 83.93 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 111.607 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.26 140.25 72.38 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.513 2.808 . . . . 0.0 114.671 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.38 -45.73 2.11 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.655 1.121 . . . . 0.0 111.699 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -73.23 -45.14 57.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.503 0.721 . . . . 0.0 112.646 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.5 -167.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.583 1.182 . . . . 0.0 114.152 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -57.76 140.92 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.758 3.223 . . . . 0.0 117.459 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t 62.39 23.41 13.88 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 128.142 2.577 . . . . 0.0 113.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -107.58 152.08 24.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.286 1.041 . . . . 0.0 111.116 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 m -153.63 134.09 13.55 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.62 138.47 37.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.579 0.752 . . . . 0.0 109.801 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.98 -4.37 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.084 0.954 . . . . 0.0 111.218 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.05 -151.65 23.77 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -145.77 156.37 43.55 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 107.491 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.9 t -67.44 -34.09 76.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.836 0.827 . . . . 0.0 111.047 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.514 0 CA-C-O 115.006 -2.426 . . . . 0.0 107.022 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.783 0.325 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.277 0.1 OUTLIER -7.66 85.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 130.041 3.336 . . . . 0.0 115.844 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.72 64.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.434 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -57.99 -32.9 68.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.995 0.918 . . . . 0.0 110.467 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.01 171.17 7.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.727 1.211 . . . . 0.0 108.636 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -64.21 129.8 41.4 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.72 130.84 55.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 C-N-CA 124.454 1.101 . . . . 0.0 110.326 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -43.13 133.89 3.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.704 1.138 . . . . 0.0 110.975 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.48 31.08 11.68 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.613 1.255 . . . . 0.0 114.36 0.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -73.4 67.7 1.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.033 1.288 . . . . 0.0 108.252 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -54.82 151.73 8.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.751 -0.593 . . . . 0.0 111.383 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.62 -43.7 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -105.16 160.53 15.0 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 122.811 1.291 . . . . 0.0 112.733 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -116.67 162.21 18.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.126 2.57 . . . . 0.0 108.596 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.76 -30.67 70.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -157.03 156.59 33.14 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 108.89 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 73.7 0.05 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.039 1.736 . . . . 0.0 111.852 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.95 -20.1 0.76 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.316 1.436 . . . . 0.0 111.512 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.11 175.41 48.22 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.321 1.06 . . . . 0.0 110.895 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.36 151.2 87.59 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.71 139.6 23.94 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.132 1.888 . . . . 0.0 109.497 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.05 -7.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.625 -1.179 . . . . 0.0 112.922 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 176.4 164.76 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -111.38 140.37 46.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -108.48 173.4 6.33 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.849 1.26 . . . . 0.0 108.679 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.75 129.31 26.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.692 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.47 68.15 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.606 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -84.62 127.14 33.92 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.54 1.67 . . . . 0.0 109.611 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -89.47 166.41 13.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.374 1.07 . . . . 0.0 113.838 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 tt -170.91 154.25 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.665 1.586 . . . . 0.0 108.575 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.1 t -107.59 159.41 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -155.32 -66.64 0.12 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -117.32 96.35 5.38 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.838 1.655 . . . . 0.0 109.625 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.01 15.24 0.01 OUTLIER Glycine 0 CA--C 1.531 1.056 1 C-N-CA 131.005 4.145 . . . . 0.0 117.64 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -143.71 160.68 40.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.142 -1.211 . . . . 0.0 109.012 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -89.4 124.14 34.19 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 127.208 2.203 . . . . 0.0 106.643 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -121.54 152.36 39.29 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.156 0.982 . . . . 0.0 108.628 178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.4 m -134.18 145.31 49.1 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.26 146.41 28.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.539 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -90.41 -32.17 16.54 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.792 1.637 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -148.7 -140.76 0.1 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.221 2.208 . . . . 0.0 107.601 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -87.02 126.4 34.72 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 127.849 2.46 . . . . 0.0 108.48 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.8 143.54 8.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.34 43.17 1.77 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.863 1.265 . . . . 0.0 108.637 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -138.8 161.36 37.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -31.32 105.02 0.22 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 128.938 2.895 . . . . 0.0 113.769 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -51.06 138.4 43.91 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 124.379 3.386 . . . . 0.0 113.889 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.65 -36.83 0.59 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.158 1.361 . . . . 0.0 113.446 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.0 m -76.08 -45.58 33.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 112.382 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -97.37 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.982 0.355 . . . . 0.0 111.486 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -168.23 175.46 6.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t 63.99 21.05 12.47 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.448 1.099 . . . . 0.0 109.834 -177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -123.09 140.43 53.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 124.236 1.014 . . . . 0.0 109.702 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -136.27 120.93 18.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.793 1.637 . . . . 0.0 106.677 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -70.73 134.05 47.13 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.08 -15.56 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.997 1.319 . . . . 0.0 111.802 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.33 160.8 29.62 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -112.01 144.98 40.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 m -117.93 -48.72 2.54 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.281 0.632 . . . . 0.0 111.598 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.933 -172.208 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 p -71.55 82.7 0.83 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.391 1.091 . . . . 0.0 111.194 176.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -39.8 -39.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.995 3.318 . . . . 0.0 113.866 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.03 -35.24 64.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.075 0.95 . . . . 0.0 111.029 179.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.94 153.87 18.06 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.505 1.122 . . . . 0.0 108.01 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -43.56 118.62 1.42 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.523 1.129 . . . . 0.0 111.476 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.69 127.68 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -49.7 135.07 19.58 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.335 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -93.07 25.15 23.26 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 121.321 1.507 . . . . 0.0 115.337 0.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -72.98 66.8 0.82 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.82 1.191 . . . . 0.0 108.119 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -53.58 154.79 3.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.38 -45.85 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.545 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -94.04 153.77 17.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 122.691 1.234 . . . . 0.0 110.179 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -112.72 166.8 11.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.39 2.276 . . . . 0.0 108.915 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.74 -32.66 74.23 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -157.35 158.65 36.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.993 1.317 . . . . 0.0 108.202 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.95 -61.21 0.67 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.262 1.825 . . . . 0.0 114.376 -177.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.47 12.88 65.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.541 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.17 -166.1 41.75 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.42 1.11 . . . . 0.0 111.625 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.24 160.68 26.41 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.923 1.289 . . . . 0.0 107.819 177.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.56 149.13 10.45 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.392 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.7 m -146.02 -19.35 0.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.308 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 177.85 166.05 0.69 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.365 0.984 . . . . 0.0 113.006 -175.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.66 113.41 26.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.57 167.97 16.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.662 0.785 . . . . 0.0 109.633 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.35 126.88 3.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.977 1.311 . . . . 0.0 111.877 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -8.18 57.98 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.153 178.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.37 126.45 32.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.661 1.73 . . . . 0.0 108.703 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -86.49 162.58 18.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.127 1.771 . . . . 0.0 112.518 -178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -163.95 150.15 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.085 1.354 . . . . 0.0 108.224 177.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.52 155.52 5.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -167.21 125.18 1.28 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 108.363 175.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 43.4 55.99 4.54 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 123.682 1.706 . . . . 0.0 111.44 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -36.06 1.11 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.704 2.573 . . . . 0.0 114.256 177.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -70.87 145.39 50.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.275 1.036 . . . . 0.0 110.443 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -101.95 119.66 39.14 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 129.088 2.955 . . . . 0.0 106.287 178.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -123.84 156.27 36.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.398 0.679 . . . . 0.0 110.051 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.8 m -132.58 143.01 49.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.583 1.153 . . . . 0.0 108.312 177.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.77 144.89 34.73 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.882 0.873 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.65 -37.68 17.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.334 -177.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 18.1 p90 -144.69 -67.46 0.32 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.561 0.696 . . . . 0.0 110.368 -177.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -155.42 142.05 18.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.821 2.448 . . . . 0.0 107.614 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -176.36 145.42 0.58 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 45.55 0.92 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.326 1.851 . . . . 0.0 106.516 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 56.2 p -106.96 -105.56 0.33 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.377 1.071 . . . . 0.0 113.106 -174.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.3 t -145.39 117.28 5.17 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.81 130.94 23.96 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.064 2.509 . . . . 0.0 115.885 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.79 -42.27 1.29 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.545 1.545 . . . . 0.0 113.025 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.8 m -59.33 -57.14 14.32 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.58 -25.43 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p 89.0 179.28 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.773 2.829 . . . . 0.0 110.48 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t 78.76 28.34 0.43 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 -170.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -136.39 157.34 47.04 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 129.772 3.229 . . . . 0.0 106.591 -175.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -155.25 120.19 4.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.73 128.71 36.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.32 -13.04 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.369 1.068 . . . . 0.0 110.423 178.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.59 -156.64 28.38 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.63 134.8 14.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 88.5 m -91.21 -42.49 10.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.319 0.509 . . . . 0.0 111.921 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.921 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -171.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 t -53.44 -53.59 49.18 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.53 1.059 . . . . 0.0 111.566 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 151.88 -61.17 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.373 3.469 . . . . 0.0 106.467 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -151.68 2.8 0.39 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.2 -171.27 3.33 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.421 1.01 . . . . 0.0 111.098 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -69.65 97.76 1.09 Allowed 'General case' 0 C--N 1.338 0.096 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.66 124.89 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -42.14 132.79 2.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 119.487 1.04 . . . . 0.0 111.15 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.72 27.29 15.01 Favored 'Cis proline' 0 C--N 1.35 0.638 0 N-CA-C 115.888 1.457 . . . . 0.0 115.888 1.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -74.71 66.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.153 1.342 . . . . 0.0 107.617 175.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -58.1 176.14 0.18 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 112.388 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.83 -33.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.12 -66.85 0.84 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -171.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.5 tttm 53.51 -167.26 0.07 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 123.611 1.672 . . . . 0.0 112.487 -170.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -82.0 -40.3 22.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.3 2.64 . . . . 0.0 109.996 176.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -79.81 174.61 11.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.842 2.057 . . . . 0.0 114.566 -175.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.41 39.91 3.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.198 2.199 . . . . 0.0 106.923 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.09 47.58 0.04 OUTLIER Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.374 1.464 . . . . 0.0 110.623 -177.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.25 -157.49 9.78 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -78.09 -174.78 0.47 Allowed Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -110.12 158.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.909 1.739 . . . . 0.0 113.373 178.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -150.92 -12.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.39 0.676 . . . . 0.0 112.049 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 178.6 164.07 0.77 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.342 0.974 . . . . 0.0 111.02 -177.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -112.37 149.65 32.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.654 1.182 . . . . 0.0 108.078 177.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.18 172.71 8.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.66 0.784 . . . . 0.0 110.471 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.22 123.25 2.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.485 1.514 . . . . 0.0 112.088 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -14.37 40.7 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.463 1.03 . . . . 0.0 113.779 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.49 118.06 21.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.295 1.547 . . . . 0.0 109.633 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -80.76 166.69 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 111.928 179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 tt -165.9 151.83 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -109.22 156.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -138.98 -126.56 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.36 84.19 1.44 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.277 1.399 . . . . 0.0 108.933 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.84 -45.28 0.87 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 127.993 2.711 . . . . 0.0 113.022 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -68.93 143.43 54.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.79 0.836 . . . . 0.0 111.675 -176.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.42 122.53 43.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 129.96 3.304 . . . . 0.0 106.621 177.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -122.84 170.79 9.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.824 1.25 . . . . 0.0 109.242 178.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -148.75 144.63 27.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.81 145.9 27.01 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.41 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -95.47 -31.39 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.221 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -134.18 -73.77 0.48 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 111.307 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -158.4 135.95 10.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.441 2.296 . . . . 0.0 108.441 -177.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -168.9 149.99 4.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.21 0.914 . . . . 0.0 109.677 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.97 37.0 0.86 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.131 1.772 . . . . 0.0 108.038 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.3 p -94.7 -103.93 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.018 0.927 . . . . 0.0 111.888 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.4 112.92 4.73 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.66 1.984 . . . . 0.0 106.056 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.1 121.02 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.421 2.747 . . . . 0.0 113.128 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.88 -17.59 57.7 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.995 0.807 . . . . 0.0 113.05 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -77.31 74.66 3.87 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.993 1.396 . . . . 0.0 109.453 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 t70 51.69 -132.19 1.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.362 1.065 . . . . 0.0 108.691 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t 57.7 -150.58 0.44 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.267 0.94 . . . . 0.0 109.136 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.45 -51.83 39.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.815 0.846 . . . . 0.0 109.702 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -20.06 130.66 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.156 2.582 . . . . 0.0 116.22 -175.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -136.77 128.76 29.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -75.3 141.03 43.48 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -14.06 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.87 1.268 . . . . 0.0 111.635 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.82 -148.12 13.31 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.553 1.069 . . . . 0.0 110.693 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -157.98 135.83 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.279 1.431 . . . . 0.0 108.827 178.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.7 m -68.11 -49.52 60.65 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.675 0.75 . . . . 0.0 109.235 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 -175.067 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.4 t -54.34 -48.81 70.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.859 0.754 . . . . 0.0 112.907 -179.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 104.87 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.25 3.02 . . . . 0.0 108.458 -175.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.61 40.82 1.11 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.45 173.7 13.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.701 1.137 . . . . 0.0 109.093 174.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -48.83 107.3 0.13 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 125.189 1.396 . . . . 0.0 112.187 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.9 131.01 48.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.206 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -44.2 133.04 4.42 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.926 1.239 . . . . 0.0 110.404 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.9 35.97 7.43 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 121.202 1.465 . . . . 0.0 113.908 0.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.22 61.44 1.16 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.764 1.165 . . . . 0.0 108.237 176.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -55.38 156.02 4.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.775 0.798 . . . . 0.0 112.819 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -76.12 -53.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.608 178.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -80.82 143.31 32.9 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -124.61 165.91 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 112.069 -176.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -45.21 95.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.331 -1.758 . . . . 0.0 109.904 177.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.283 1.7 m95 21.24 166.4 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 136.471 5.908 . . . . 0.0 124.845 -177.365 . . . . . . . . 3 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 120.69 57.3 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 2 C-N-CA 136.595 5.958 . . . . 0.0 100.825 -173.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.28 59.34 3.37 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.647 2.546 . . . . 0.0 107.295 -173.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.35 -148.15 7.35 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 123.483 0.563 . . . . 0.0 111.949 -178.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -131.09 163.8 46.71 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.635 1.174 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.38 150.26 26.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.836 3.024 . . . . 0.0 110.477 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.91 -17.79 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.219 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -179.68 168.41 1.37 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -178.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -114.91 131.11 56.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.629 1.972 . . . . 0.0 107.567 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.58 165.05 11.32 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.968 0.907 . . . . 0.0 109.626 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.23 123.68 2.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.666 1.186 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.79 -12.43 57.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.157 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.77 139.31 39.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.263 2.031 . . . . 0.0 105.795 177.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -105.93 156.83 17.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.918 0.487 . . . . 0.0 111.079 -178.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -157.52 168.77 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.389 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.15 149.38 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.385 0.674 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.04 134.3 16.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.037 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 50.74 27.69 3.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.958 1.703 . . . . 0.0 113.915 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.0 -22.13 27.21 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 126.477 1.989 . . . . 0.0 112.231 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.97 138.08 36.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.424 1.112 . . . . 0.0 109.247 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 tp -91.54 131.19 37.15 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 128.45 2.7 . . . . 0.0 108.435 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -135.52 159.45 41.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 109.666 178.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -132.95 142.42 48.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.446 1.498 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.22 150.21 27.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.163 0.983 . . . . 0.0 111.077 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.776 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -139.91 -75.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -161.25 125.98 3.54 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.27 2.228 . . . . 0.0 106.506 -176.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 t -168.1 154.47 7.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.835 1.198 . . . . 0.0 111.608 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.42 20.69 4.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.238 1.815 . . . . 0.0 106.737 174.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -82.21 146.96 29.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.3 t -46.88 121.98 7.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.788 0.835 . . . . 0.0 109.192 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.44 127.69 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.171 2.581 . . . . 0.0 113.831 -179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.47 22.77 73.36 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.521 178.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 p -66.36 -71.57 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.307 1.053 . . . . 0.0 110.616 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -146.14 -32.67 0.34 Allowed 'General case' 0 C--O 1.23 0.069 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m -156.48 168.1 28.42 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.214 -0.929 . . . . 0.0 112.039 -174.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 p 70.53 0.39 3.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 130.303 3.441 . . . . 0.0 114.412 177.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.66 171.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.908 1.283 . . . . 0.0 112.573 -178.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -158.92 124.07 4.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.48 144.5 42.02 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.92 -6.52 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.873 0.869 . . . . 0.0 112.927 -178.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.49 -152.15 23.66 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 p -156.51 152.36 27.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.448 1.099 . . . . 0.0 109.029 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.93 -46.22 14.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.323 1.058 . . . . 0.0 108.91 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 129.86 3.264 . . . . 0.0 104.482 -174.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.4 159.73 53.91 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.9 -30.79 25.62 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.545 1.138 . . . . 0.0 113.362 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -125.58 -60.12 1.33 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.237 1.015 . . . . 0.0 110.249 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.64 -66.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.251 3.02 . . . . 0.0 104.948 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -154.11 25.42 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.092 0.957 . . . . 0.0 111.61 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.94 -165.03 1.27 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.583 0.629 . . . . 0.0 109.688 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.04 89.2 1.93 Allowed 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.353 -0.842 . . . . 0.0 109.472 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.6 t -83.64 118.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 108.239 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -45.17 135.29 5.28 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 120.767 1.621 . . . . 0.0 110.944 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -89.93 33.82 7.62 Favored 'Cis proline' 0 C--N 1.349 0.58 0 N-CA-C 115.685 1.379 . . . . 0.0 115.685 1.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -74.3 62.63 0.97 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.257 1.39 . . . . 0.0 108.867 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -51.68 160.82 0.59 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.098 1.359 . . . . 0.0 111.791 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.48 -31.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.345 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.7 t -153.36 167.53 29.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.315 0.9 OUTLIER -91.35 -30.55 16.48 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 131.177 3.791 . . . . 0.0 111.342 175.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 154.47 -43.06 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.549 3.94 . . . . 0.0 103.714 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -118.57 172.86 7.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.951 1.7 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.13 -57.5 5.31 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.98 -27.77 71.81 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.063 0.785 . . . . 0.0 115.063 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.08 142.44 43.12 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 119.215 1.507 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -60.33 132.94 90.64 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.58 166.86 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 119.119 2.699 . . . . 0.0 119.119 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 m -150.46 -12.38 0.25 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.017 -1.902 . . . . 0.0 110.837 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 179.06 174.29 0.72 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 120.182 1.356 . . . . 0.0 112.982 -175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -112.1 132.12 55.04 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.71 169.58 9.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.819 1.248 . . . . 0.0 110.093 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.72 125.09 4.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.084 1.354 . . . . 0.0 111.386 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.07 -9.62 56.44 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.002 -0.888 . . . . 0.0 113.815 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -84.31 124.78 31.62 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.289 1.545 . . . . 0.0 108.032 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -92.29 165.36 13.14 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.899 0.88 . . . . 0.0 113.24 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.4 tt -161.22 163.47 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.024 1.33 . . . . 0.0 107.834 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.31 146.32 19.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -148.31 108.81 4.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.1 mttp 39.09 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.766 2.026 . . . . 0.0 112.432 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 -50.63 1.5 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.148 1.356 . . . . 0.0 112.805 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.0 142.25 47.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.338 1.069 . . . . 0.0 111.957 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tp -102.17 131.88 48.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 129.029 2.932 . . . . 0.0 107.284 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -132.94 164.78 26.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.944 0.898 . . . . 0.0 109.902 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.0 m -134.02 143.36 48.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.806 1.242 . . . . 0.0 108.024 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 142.44 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.797 0.808 . . . . 0.0 109.176 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -84.39 -34.24 23.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.202 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -143.07 -69.85 0.33 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -161.34 125.61 3.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.916 1.687 . . . . 0.0 108.125 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -166.99 154.74 9.36 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.767 1.167 . . . . 0.0 111.435 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.01 32.01 1.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.879 1.671 . . . . 0.0 109.676 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -84.02 -103.86 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.059 0.457 . . . . 0.0 111.429 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.7 t -144.74 115.26 5.18 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -53.16 112.33 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.698 2.265 . . . . 0.0 112.542 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.82 -26.88 9.63 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.084 1.326 . . . . 0.0 111.721 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -78.37 70.28 4.69 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.359 1.08 . . . . 0.0 109.631 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 42.51 -111.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.805 1.642 . . . . 0.0 108.889 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t 59.65 -72.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.772 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.4 t -173.65 38.65 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.095 2.558 . . . . 0.0 107.146 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -112.08 154.49 25.33 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.615 1.198 . . . . 0.0 111.377 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -153.41 120.97 5.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -71.0 124.28 24.0 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.296 0.638 . . . . 0.0 109.933 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.86 -13.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.084 0.554 . . . . 0.0 112.134 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.29 -149.45 17.65 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -154.33 135.21 13.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 109.812 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.5 m -71.97 -46.87 55.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.994 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.311 -1.804 . . . . 0.0 106.509 -173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.73 -149.5 46.59 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -156.29 139.89 15.96 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.1 m -77.28 75.15 3.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.281 1.038 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -20.59 -51.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 131.363 3.865 . . . . 0.0 115.304 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -8.6 5.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.315 1.446 . . . . 0.0 114.351 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.84 141.59 49.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.099 0.96 . . . . 0.0 108.924 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -29.51 105.13 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 128.086 2.554 . . . . 0.0 113.631 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.1 134.05 27.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -45.39 132.74 5.99 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 119.783 1.174 . . . . 0.0 111.425 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.61 43.25 3.11 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 121.593 1.605 . . . . 0.0 113.904 -0.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -76.39 64.28 2.1 Favored 'General case' 0 N--CA 1.428 -1.572 0 O-C-N 119.324 -2.11 . . . . 0.0 107.429 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -56.05 156.21 5.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.977 0.894 . . . . 0.0 110.888 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.91 -21.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.304 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.9 t -145.08 165.89 26.94 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.752 1.263 . . . . 0.0 112.63 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.298 85.8 tttt -97.14 -34.07 11.27 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 131.241 3.816 . . . . 0.0 109.363 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 162.92 -42.97 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 1 C-N-CA 132.896 4.478 . . . . 0.0 102.641 -172.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -117.56 155.06 30.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.462 1.505 . . . . 0.0 107.593 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.67 -60.43 3.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.696 1.598 . . . . 0.0 115.231 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.7 -4.22 61.07 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.842 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.31 152.4 43.31 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 119.426 1.613 . . . . 0.0 109.923 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.28 144.74 94.68 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.06 158.33 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 116.571 1.72 . . . . 0.0 116.571 -169.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 m -152.23 -17.43 0.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.067 0.947 . . . . 0.0 112.599 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 177.31 150.48 0.18 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.318 0.963 . . . . 0.0 110.516 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.73 141.32 32.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.6 166.19 13.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.378 1.071 . . . . 0.0 108.696 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.68 130.67 46.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.761 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.68 -6.5 69.39 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.386 -1.23 . . . . 0.0 113.273 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -85.61 143.24 28.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.911 1.855 . . . . 0.0 109.613 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -103.01 164.52 11.56 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 tt -161.74 156.73 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.876 1.27 . . . . 0.0 109.7 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.87 159.3 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 126.515 1.926 . . . . 0.0 109.78 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.5 t80 174.66 147.18 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.32 2.648 . . . . 0.0 107.13 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 40.94 44.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 113.326 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.46 24.85 25.33 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.494 2.473 . . . . 0.0 113.218 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -119.7 156.61 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.679 1.592 . . . . 0.0 107.211 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.441 ' CD2' ' CG1' ' A' ' 58' ' ' VAL . 12.8 tp -110.29 122.02 46.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.596 1.958 . . . . 0.0 107.863 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -125.77 150.28 47.88 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.673 0.67 . . . . 0.0 110.001 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 m -117.13 138.97 51.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.876 1.27 . . . . 0.0 108.359 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.96 142.37 36.73 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.172 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.47 -30.81 20.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.603 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -145.13 -141.27 0.12 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.838 1.655 . . . . 0.0 108.325 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -92.37 116.21 28.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.823 2.849 . . . . 0.0 106.165 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 t -163.83 148.35 10.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.492 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.63 13.04 9.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.326 1.85 . . . . 0.0 107.997 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.6 t -70.51 162.46 28.76 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.14 118.52 62.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.121 0.568 . . . . 0.0 110.289 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -41.1 122.37 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.941 3.761 . . . . 0.0 114.45 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.46 22.51 3.82 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.697 1.618 . . . . 0.0 114.471 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -123.88 26.67 7.53 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.514 1.157 . . . . 0.0 110.416 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -170.19 -79.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -174.56 177.67 2.09 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.7 1.2 . . . . 0.0 108.239 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.3 p 64.12 15.31 9.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.674 2.79 . . . . 0.0 112.903 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -126.21 142.6 51.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.954 1.302 . . . . 0.0 110.512 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -136.48 114.64 11.54 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.734 1.614 . . . . 0.0 107.556 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -62.91 140.68 58.85 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.395 0.617 . . . . 0.0 109.832 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' A' ' 38' ' ' LEU 0.278 0.3 OUTLIER -131.77 3.79 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.593 1.157 . . . . 0.0 112.439 -174.886 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.23 -170.55 34.45 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.5 p -161.37 167.76 25.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 m -57.58 -40.02 78.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.415 1.086 . . . . 0.0 110.885 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.598 0 CA-C-O 114.77 -2.538 . . . . 0.0 106.861 -173.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 53.62 35.24 51.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.451 1.024 . . . . 0.0 112.727 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.97 140.72 40.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.224 1.41 . . . . 0.0 111.088 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.71 80.97 0.28 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.776 1.274 . . . . 0.0 111.07 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.46 30.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.056 2.142 . . . . 0.0 111.8 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -58.09 -30.59 66.36 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.92 1.288 . . . . 0.0 111.212 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.49 161.92 14.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.316 1.046 . . . . 0.0 108.673 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.42 121.25 5.43 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.391 0.677 . . . . 0.0 110.1 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.15 135.11 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 117.624 -1.179 . . . . 0.0 108.541 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -46.07 133.59 7.1 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 120.057 1.299 . . . . 0.0 111.008 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -97.03 33.11 10.15 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 121.414 1.541 . . . . 0.0 113.875 -0.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.23 68.06 1.44 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -51.07 168.21 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.642 0.777 . . . . 0.0 112.328 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.78 -19.03 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.81 -72.17 0.59 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -171.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 tttt 48.83 -157.03 0.07 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 122.371 1.081 . . . . 0.0 111.787 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.34 -41.47 93.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.325 -1.761 . . . . 0.0 107.178 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -156.6 156.64 33.91 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.247 1.819 . . . . 0.0 107.191 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.98 -58.99 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.193 1.797 . . . . 0.0 114.796 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.33 -9.22 85.85 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.233 -0.759 . . . . 0.0 114.008 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.49 154.48 50.44 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -55.87 103.48 0.37 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 108.177 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -50.51 143.97 26.27 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.942 3.095 . . . . 0.0 118.2 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.7 p -132.99 -12.68 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -178.83 162.77 1.34 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.167 0.984 . . . . 0.0 113.427 -175.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -107.65 114.12 27.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.437 1.895 . . . . 0.0 108.582 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.0 166.26 12.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.499 1.119 . . . . 0.0 110.216 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.47 126.27 3.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.931 1.292 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.36 -2.73 80.94 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.316 -1.269 . . . . 0.0 114.648 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.26 121.56 29.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.437 2.119 . . . . 0.0 108.179 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -83.94 159.99 21.16 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.833 -1.167 . . . . 0.0 111.595 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.06 155.21 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.332 1.453 . . . . 0.0 107.753 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -101.96 153.73 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.07 0.948 . . . . 0.0 109.385 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -161.83 126.82 3.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.879 1.672 . . . . 0.0 107.34 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt 30.52 83.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.936 2.095 . . . . 0.0 112.951 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.63 -35.86 0.27 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -94.34 154.14 17.64 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.917 1.859 . . . . 0.0 112.867 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -107.03 124.7 50.02 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.327 2.651 . . . . 0.0 105.861 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.74 161.64 26.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.889 0.876 . . . . 0.0 110.114 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 m -136.93 144.54 43.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.21 150.32 26.28 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 122.057 0.932 . . . . 0.0 111.079 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.48 -34.05 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.858 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -140.39 -72.15 0.37 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.774 0.321 . . . . 0.0 111.64 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -159.31 133.15 7.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.836 1.655 . . . . 0.0 108.562 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 t -166.38 151.69 8.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.96 40.05 1.5 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.082 1.353 . . . . 0.0 107.55 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.5 t -130.49 156.4 44.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.388 1.075 . . . . 0.0 108.199 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -36.76 110.9 0.48 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.418 2.287 . . . . 0.0 113.098 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 134.62 62.41 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.286 2.657 . . . . 0.0 113.189 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.03 -53.06 3.38 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 m -81.13 47.76 1.05 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.966 0.906 . . . . 0.0 110.586 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -164.92 -117.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 m -163.93 168.85 18.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.996 1.719 . . . . 0.0 107.589 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 66.67 14.77 9.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.658 1.183 . . . . 0.0 112.501 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.64 155.69 24.01 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.694 1.598 . . . . 0.0 109.042 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 m -152.17 125.46 8.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.57 137.53 54.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.119 0.567 . . . . 0.0 110.495 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.85 -15.13 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.289 1.436 . . . . 0.0 110.739 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.17 -161.81 35.63 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -153.98 163.04 40.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.1 t -88.22 -17.13 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.13 2.172 . . . . 0.0 111.367 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.432 0 C-N-CA 126.569 1.948 . . . . 0.0 105.83 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.053 0.454 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.22 37.25 93.68 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -75.67 63.78 1.63 Allowed 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 125.207 1.403 . . . . 0.0 109.299 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.8 m 45.68 27.7 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.236 2.214 . . . . 0.0 114.136 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.33 -21.34 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.111 2.564 . . . . 0.0 114.037 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -57.29 -37.41 72.38 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.28 0.632 . . . . 0.0 109.944 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.06 176.19 5.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.957 0.903 . . . . 0.0 109.635 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.76 98.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.782 0.833 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.41 128.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.928 1.291 . . . . 0.0 108.898 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -43.08 134.47 3.09 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.818 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -91.7 31.93 10.7 Favored 'Cis proline' 0 C--N 1.348 0.528 0 CA-C-N 120.239 1.121 . . . . 0.0 114.433 0.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -75.57 61.88 1.37 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.179 1.354 . . . . 0.0 109.311 177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -49.91 164.03 0.12 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.026 1.731 . . . . 0.0 113.578 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -79.82 -37.51 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.232 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -156.46 -171.64 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.278 0.945 . . . . 0.0 112.311 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.289 55.2 tttm -107.15 -45.63 4.09 Favored 'General case' 0 N--CA 1.412 -2.363 1 C-N-CA 132.942 4.497 . . . . 0.0 110.215 178.646 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 168.26 -44.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 131.603 3.961 . . . . 0.0 104.751 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -58.08 178.3 0.1 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 130.912 3.685 . . . . 0.0 116.923 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.12 37.44 4.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.878 2.871 . . . . 0.0 106.47 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.17 46.53 0.02 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.043 1.306 . . . . 0.0 111.473 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.76 152.63 18.57 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.91 119.4 51.3 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.85 154.71 16.18 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 117.708 2.157 . . . . 0.0 117.708 -174.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -151.09 4.52 0.46 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.34 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -175.79 168.73 3.05 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 121.356 1.889 . . . . 0.0 116.094 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.82 125.6 50.85 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -87.29 167.96 13.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.786 1.234 . . . . 0.0 111.192 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.08 127.13 8.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.985 1.314 . . . . 0.0 110.409 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -15.31 22.26 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.419 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -77.37 132.08 38.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.816 1.808 . . . . 0.0 108.929 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -94.66 162.38 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.664 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.4 tt -161.74 154.57 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.208 1.003 . . . . 0.0 108.315 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.3 156.38 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.233 . . . . 0.0 107.797 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -172.1 141.93 1.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.581 1.953 . . . . 0.0 106.942 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mttp 24.64 73.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.831 2.052 . . . . 0.0 113.034 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.51 38.07 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 128.955 3.169 . . . . 0.0 114.474 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -144.22 158.23 43.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.83 127.82 44.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 127.747 2.419 . . . . 0.0 107.867 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -126.26 166.76 16.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.799 1.239 . . . . 0.0 108.856 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -150.32 148.3 28.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.269 1.028 . . . . 0.0 108.366 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.56 148.32 25.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.684 1.194 . . . . 0.0 111.53 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -90.47 -32.73 16.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.569 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.9 p90 -142.57 -74.18 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.069 0.462 . . . . 0.0 112.223 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -160.21 119.58 2.78 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 127.597 2.359 . . . . 0.0 105.003 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -158.54 152.36 23.53 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.047 1.294 . . . . 0.0 112.096 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 8.84 5.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 109.578 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 m -77.58 155.03 31.79 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.31 139.02 80.48 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 119.667 1.121 . . . . 0.0 109.7 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.21 116.85 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.198 1.932 . . . . 0.0 112.724 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.1 25.88 70.08 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.279 -0.734 . . . . 0.0 112.1 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.6 p -59.99 -56.71 18.33 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.479 1.139 . . . . 0.0 110.191 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.07 -43.41 0.23 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.093 1.357 . . . . 0.0 111.325 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -166.75 -171.65 1.9 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 124.484 1.113 . . . . 0.0 109.142 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 p 65.67 5.9 3.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 130.854 3.662 . . . . 0.0 113.663 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.72 159.58 33.3 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 125.01 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -148.22 132.85 17.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.58 130.6 36.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.67 -13.54 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.637 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.12 -171.68 35.7 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 119.674 1.125 . . . . 0.0 112.339 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -107.83 87.54 2.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -32.69 -55.88 0.36 Allowed 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 127.257 2.223 . . . . 0.0 114.179 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.006 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.29 151.44 17.17 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.33 158.52 20.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.522 -0.987 . . . . 0.0 109.223 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.6 m -87.64 97.96 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.46 10.82 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.446 2.298 . . . . 0.0 111.828 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.16 -3.69 28.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.28 170.67 15.36 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.47 1.032 . . . . 0.0 110.356 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -59.7 121.3 11.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.45 131.39 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.034 0.934 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -43.12 134.02 3.16 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.766 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.81 30.2 14.29 Favored 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.595 1.248 . . . . 0.0 112.755 -0.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -76.14 62.94 1.77 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -49.69 159.36 0.38 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.945 0.878 . . . . 0.0 113.245 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.58 -43.16 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.467 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -90.46 139.08 31.03 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.417 1.103 . . . . 0.0 111.385 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -110.83 166.97 10.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.617 1.967 . . . . 0.0 109.958 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -67.42 -34.8 77.98 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.1 163.54 39.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.097 1.759 . . . . 0.0 106.909 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.93 -55.87 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.503 1.521 . . . . 0.0 114.082 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.79 5.38 79.46 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.485 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.86 171.16 55.06 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.516 1.158 . . . . 0.0 111.2 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.83 165.66 51.44 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.22 145.15 71.47 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.607 1.538 . . . . 0.0 108.669 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 m -141.66 -7.62 0.97 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.191 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 176.0 170.77 0.39 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.1 0.952 . . . . 0.0 111.775 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -112.67 111.16 21.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.742 1.617 . . . . 0.0 107.279 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -83.71 162.81 20.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 109.721 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.4 128.2 1.41 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.993 1.717 . . . . 0.0 112.593 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.31 -7.99 49.47 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.567 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.15 136.05 35.2 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.534 2.167 . . . . 0.0 106.825 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -98.87 159.24 15.09 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.64 -0.662 . . . . 0.0 112.002 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 tt -159.75 163.72 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.894 1.278 . . . . 0.0 108.784 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.4 165.75 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.12 -62.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -156.1 125.6 6.28 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.15 -42.8 0.17 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.123 2.773 . . . . 0.0 115.507 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -109.75 146.05 35.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.524 1.13 . . . . 0.0 112.253 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tp -97.35 127.53 43.4 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 129.057 2.943 . . . . 0.0 105.682 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.92 161.78 28.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.87 0.868 . . . . 0.0 110.759 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.5 m -138.99 145.52 39.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.83 147.99 26.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.991 0.9 . . . . 0.0 111.442 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -85.06 -36.08 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.097 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -142.52 -70.05 0.34 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.917 0.487 . . . . 0.0 111.389 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -158.53 138.47 12.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.524 1.53 . . . . 0.0 108.908 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -173.32 147.78 1.56 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.499 0.666 . . . . 0.0 109.96 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.87 26.37 4.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 153.07 19.63 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.626 1.571 . . . . 0.0 108.137 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -49.24 117.19 6.42 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.48 0.712 . . . . 0.0 110.012 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.36 120.52 4.49 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.294 2.663 . . . . 0.0 112.261 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.44 -23.78 29.21 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.394 -0.67 . . . . 0.0 111.794 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 t -77.11 59.37 1.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.604 1.202 . . . . 0.0 110.416 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 41.47 -109.06 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.474 1.909 . . . . 0.0 109.734 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t 58.27 -82.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.73 1.612 . . . . 0.0 111.038 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -150.77 28.32 0.7 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.372 1.469 . . . . 0.0 110.425 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.44 171.5 7.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.339 1.066 . . . . 0.0 112.784 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -162.98 130.75 3.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.954 2.102 . . . . 0.0 105.519 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -78.94 139.68 38.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.83 -16.87 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.911 1.284 . . . . 0.0 111.256 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.84 -167.3 39.79 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -144.78 156.6 44.13 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.687 1.195 . . . . 0.0 108.121 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.9 m -114.83 -68.59 0.91 Allowed 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 123.828 0.705 . . . . 0.0 111.093 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 CA-C-O 115.337 -2.268 . . . . 0.0 106.971 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.45 163.94 37.6 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.8 -30.59 14.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.417 1.109 . . . . 0.0 112.447 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 t -59.51 -52.56 65.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.231 1.015 . . . . 0.0 109.631 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 166.65 -63.79 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 131.161 3.784 . . . . 0.0 103.903 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -157.91 28.11 0.27 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.223 1.009 . . . . 0.0 111.314 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 179.34 5.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.312 0.506 . . . . 0.0 109.992 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.63 98.03 0.17 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.988 0.423 . . . . 0.0 109.9 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -105.88 137.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -46.51 135.57 7.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.092 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -94.33 31.42 12.37 Favored 'Cis proline' 0 C--N 1.349 0.567 0 N-CA-C 115.354 1.251 . . . . 0.0 115.354 1.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -77.67 59.77 2.06 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 121.272 1.851 . . . . 0.0 108.741 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -55.29 157.72 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.787 0.835 . . . . 0.0 112.893 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.39 -49.12 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.347 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -84.33 154.24 23.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.503 1.144 . . . . 0.0 109.541 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -126.01 168.14 14.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.944 2.098 . . . . 0.0 109.762 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.64 -31.29 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -160.57 160.15 31.45 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.388 1.475 . . . . 0.0 107.708 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.01 -61.79 0.62 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.141 1.776 . . . . 0.0 114.151 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.65 14.31 61.83 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.511 -0.605 . . . . 0.0 113.354 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 -169.38 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.365 1.083 . . . . 0.0 111.478 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.19 160.8 28.12 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -51.84 145.75 30.81 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.826 2.351 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 m -134.22 -29.95 1.21 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.274 0.63 . . . . 0.0 112.428 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 173.62 171.83 0.17 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.243 0.474 . . . . 0.0 111.057 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -111.17 140.32 45.82 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.61 167.72 9.94 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.574 1.15 . . . . 0.0 109.267 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.55 121.07 1.6 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.596 1.159 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.89 -11.59 70.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.155 1.36 . . . . 0.0 113.785 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -81.42 123.83 28.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.036 1.418 . . . . 0.0 109.26 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -89.14 162.56 15.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.962 1.705 . . . . 0.0 112.268 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.7 tt -168.07 165.94 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.849 1.26 . . . . 0.0 108.375 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.4 t -118.53 163.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.416 . . . . 0.0 108.011 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.97 -60.84 0.9 Allowed 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.47 106.73 3.15 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.22 -46.67 0.49 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.773 1.654 . . . . 0.0 114.204 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -87.64 145.26 26.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 112.039 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tp -99.18 133.23 43.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 130.31 3.444 . . . . 0.0 107.737 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -134.18 153.95 51.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.169 0.987 . . . . 0.0 109.243 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 m -125.76 135.62 52.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.845 0.858 . . . . 0.0 109.742 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.78 136.98 47.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.818 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.8 -36.29 17.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.451 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 11.5 p90 -138.61 -70.85 0.42 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.314 0.646 . . . . 0.0 110.127 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -159.61 130.34 5.82 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 128.146 2.579 . . . . 0.0 106.353 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -165.41 151.42 9.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.676 1.126 . . . . 0.0 111.32 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.9 19.43 2.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.369 1.868 . . . . 0.0 108.765 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -85.18 164.83 17.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.59 119.53 33.67 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.71 125.51 11.27 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.19 2.593 . . . . 0.0 112.02 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.27 -11.81 65.33 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.011 -0.883 . . . . 0.0 112.314 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 t -76.22 69.5 2.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.072 1.436 . . . . 0.0 109.102 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 43.11 -125.78 0.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.376 1.87 . . . . 0.0 109.285 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t 53.38 -132.25 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.146 0.578 . . . . 0.0 109.769 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -69.49 -80.56 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 129.59 3.156 . . . . 0.0 109.401 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -7.95 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.979 2.912 . . . . 0.0 116.538 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -89.31 114.58 25.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.16 -1.837 . . . . 0.0 107.264 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -67.74 132.82 48.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.48 10.5 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.855 0.862 . . . . 0.0 112.693 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.16 -155.59 16.33 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 p -85.01 167.05 16.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -50.5 -42.04 54.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.917 0.865 . . . . 0.0 111.577 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -1.012 0 C-N-CA 128.92 2.888 . . . . 0.0 104.486 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.0 114.28 0.61 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -75.37 52.07 0.59 Allowed 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.715 1.206 . . . . 0.0 110.337 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m 53.61 20.68 2.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.113 1.765 . . . . 0.0 113.232 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.17 -25.94 1.02 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.774 2.43 . . . . 0.0 114.321 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -58.37 -36.52 73.63 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.63 0.772 . . . . 0.0 110.889 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -171.96 3.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.592 0.757 . . . . 0.0 110.422 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.35 94.97 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.455 -0.778 . . . . 0.0 109.91 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.91 135.85 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 126.196 1.798 . . . . 0.0 108.234 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -44.28 132.18 4.54 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.71 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -95.54 32.59 10.88 Favored 'Cis proline' 0 C--N 1.35 0.649 0 CA-C-N 120.75 1.304 . . . . 0.0 114.931 1.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -76.45 57.24 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.095 1.316 . . . . 0.0 109.309 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -51.36 141.19 15.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.047 1.339 . . . . 0.0 112.899 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 t -77.61 -29.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 112.287 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.4 m -67.05 -18.4 65.34 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.34 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.991 1.716 . . . . 0.0 111.62 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t0 149.06 -45.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 1 C-N-CA 132.867 4.467 . . . . 0.0 105.361 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.1 p-90 -149.71 171.91 15.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 108.229 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.56 -53.89 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.441 1.896 . . . . 0.0 114.395 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.8 18.27 24.54 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.325 0.964 . . . . 0.0 112.239 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.94 145.7 35.51 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.865 0.833 . . . . 0.0 112.695 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -72.84 136.0 80.36 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -39.67 138.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 1 C-N-CA 125.406 4.071 . . . . 0.0 116.254 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -123.61 -30.63 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 172.87 164.81 0.13 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.555 1.07 . . . . 0.0 110.847 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -97.35 133.81 41.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 107.777 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.26 163.5 12.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.929 1.292 . . . . 0.0 110.305 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.92 122.66 1.78 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.898 1.279 . . . . 0.0 111.944 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.2 -3.69 70.71 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.667 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -83.01 118.18 23.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.499 2.149 . . . . 0.0 106.542 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -78.39 164.83 24.46 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.286 -0.884 . . . . 0.0 110.058 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.0 tt -161.51 159.39 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.689 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.59 155.18 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.502 1.521 . . . . 0.0 108.704 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -176.6 135.27 0.23 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.61 2.364 . . . . 0.0 107.357 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? 44.75 33.0 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.132 2.173 . . . . 0.0 115.128 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.54 77.75 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.798 1.189 . . . . 0.0 112.923 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.13 154.61 37.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -97.99 120.87 39.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.277 1.831 . . . . 0.0 108.191 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -123.56 159.43 29.21 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.828 0.851 . . . . 0.0 108.971 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -144.9 143.2 30.45 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.14 149.0 25.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.154 0.978 . . . . 0.0 109.788 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.57 -31.15 22.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.903 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.71 -72.94 0.28 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.628 0.728 . . . . 0.0 110.191 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -165.99 136.54 3.54 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.287 1.435 . . . . 0.0 109.982 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -176.31 155.38 1.46 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 119.157 0.89 . . . . 0.0 111.4 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.02 18.98 5.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.988 1.715 . . . . 0.0 108.09 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -84.42 171.22 12.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.05 121.4 35.76 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.77 115.76 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.624 2.216 . . . . 0.0 110.833 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 1.54 33.37 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.101 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -75.94 49.99 0.57 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.984 1.892 . . . . 0.0 111.314 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 42.98 -140.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.152 1.781 . . . . 0.0 109.216 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.2 t 44.11 -106.91 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 112.879 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 p -75.44 -5.99 47.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.931 2.092 . . . . 0.0 114.801 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -107.07 174.23 5.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.636 1.107 . . . . 0.0 112.87 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -163.42 135.36 5.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.908 2.083 . . . . 0.0 105.788 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -88.5 128.25 35.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.68 -15.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.184 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.16 -155.86 26.44 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 119.39 0.995 . . . . 0.0 111.696 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -89.9 135.71 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.03 99.44 6.1 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.512 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 121.375 0.607 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.69 51.23 0.4 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 105.759 -2.936 . . . . 0.0 105.759 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -167.13 175.75 7.28 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 129.278 3.031 . . . . 0.0 106.092 -173.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 m -91.0 87.61 6.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -49.29 -34.53 15.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.7 1.6 . . . . 0.0 113.091 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.1 -18.4 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.336 1.054 . . . . 0.0 112.825 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.67 -175.81 2.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.91 102.44 0.6 Allowed 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.954 -0.467 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.54 125.62 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -47.73 138.19 9.55 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.603 -0.685 . . . . 0.0 110.79 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.82 35.43 7.7 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 N-CA-C 114.925 1.087 . . . . 0.0 114.925 1.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -75.33 65.19 1.61 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 121.532 1.969 . . . . 0.0 109.897 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -50.38 154.77 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.841 0.856 . . . . 0.0 112.465 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -84.03 -41.55 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.783 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.4 m -106.03 155.04 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.457 1.122 . . . . 0.0 113.371 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -103.58 150.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.034 2.134 . . . . 0.0 106.752 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.56 -34.35 77.69 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.648 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -141.04 158.31 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.417 1.087 . . . . 0.0 108.672 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.67 -61.29 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.288 1.835 . . . . 0.0 114.071 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.53 10.74 72.34 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.458 -0.634 . . . . 0.0 113.309 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.59 171.17 52.66 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 118.57 1.185 . . . . 0.0 110.885 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 168.39 19.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.36 133.02 55.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 108.348 -1.443 . . . . 0.0 108.348 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -128.05 -13.16 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.825 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 177.36 167.97 0.62 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.45 1.023 . . . . 0.0 113.292 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.61 139.5 42.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.62 168.59 8.98 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.233 1.013 . . . . 0.0 109.051 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.01 121.58 2.15 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.827 1.251 . . . . 0.0 111.487 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.15 -15.7 54.98 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.017 0.818 . . . . 0.0 113.75 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -76.57 121.77 23.65 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.108 1.454 . . . . 0.0 108.737 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -87.7 164.03 16.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.272 1.429 . . . . 0.0 112.313 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 tt -164.6 154.52 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.912 1.685 . . . . 0.0 106.992 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.41 156.34 9.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -152.13 -108.24 0.05 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -73.7 87.79 1.71 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.973 0.806 . . . . 0.0 108.994 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.24 -40.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 130.332 3.825 . . . . 0.0 117.045 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -102.37 164.06 11.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.919 0.888 . . . . 0.0 111.478 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tp -80.76 131.48 35.43 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.694 2.398 . . . . 0.0 107.739 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.04 153.31 46.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.085 1.354 . . . . 0.0 108.453 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.9 m -137.77 146.27 43.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.282 0.633 . . . . 0.0 109.632 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.14 144.24 33.22 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.891 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -92.74 -30.04 15.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.904 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -141.73 -73.88 0.31 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 111.998 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.49 119.39 2.65 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.791 2.836 . . . . 0.0 106.117 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 t -163.01 150.89 13.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 120.111 1.323 . . . . 0.0 112.115 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.28 12.99 6.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.932 2.093 . . . . 0.0 107.941 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 t -74.93 172.64 11.92 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.07 118.38 42.22 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 109.987 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.61 140.26 36.93 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.668 2.246 . . . . 0.0 111.829 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.27 -10.8 60.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.598 -1.112 . . . . 0.0 112.157 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -79.02 54.97 1.7 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.795 1.798 . . . . 0.0 110.513 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 42.34 -146.32 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.116 2.166 . . . . 0.0 112.038 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 m 40.78 -100.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.508 2.323 . . . . 0.0 113.762 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.4 p -78.21 -4.13 46.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.05 139.08 51.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 119.117 0.871 . . . . 0.0 110.692 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -133.17 122.82 24.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 113.476 -1.693 . . . . 0.0 106.955 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -69.33 138.6 53.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.16 -12.02 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.93 -159.27 32.01 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 120.248 1.385 . . . . 0.0 110.819 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -149.98 -176.67 5.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.424 1.09 . . . . 0.0 108.304 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.2 m -122.68 -69.71 0.81 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.948 0.899 . . . . 0.0 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.997 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 121.16 0.505 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.39 44.28 85.0 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -54.34 -42.77 70.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.108 0.963 . . . . 0.0 110.055 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.87 -57.35 3.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.341 1.067 . . . . 0.0 108.36 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 163.89 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 130.455 3.502 . . . . 0.0 105.083 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.14 4.09 0.45 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 113.04 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.85 178.92 7.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.165 0.893 . . . . 0.0 111.926 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.57 100.84 0.07 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.339 1.056 . . . . 0.0 110.747 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.97 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -45.57 133.96 6.17 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.334 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.8 32.86 10.5 Favored 'Cis proline' 0 C--N 1.353 0.777 0 CA-C-N 121.198 1.464 . . . . 0.0 114.375 0.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.84 66.58 2.13 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 120.276 1.398 . . . . 0.0 107.306 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -60.38 161.25 7.54 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.433 1.493 . . . . 0.0 112.145 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -81.99 -26.02 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.839 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.5 m -153.09 175.81 12.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 112.297 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.288 88.5 tttt -111.4 -47.08 3.21 Favored 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 130.475 3.51 . . . . 0.0 109.936 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 159.98 -45.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.195 1 C-N-CA 131.954 4.102 . . . . 0.0 103.768 -172.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -61.63 169.66 2.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.0 2.52 . . . . 0.0 113.526 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.33 39.26 2.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.227 2.211 . . . . 0.0 107.06 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.7 48.08 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.057 1.313 . . . . 0.0 110.806 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.91 156.58 21.52 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -57.44 124.89 69.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.767 1.284 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -55.32 146.13 63.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.151 1.901 . . . . 0.0 113.311 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.19 2.87 0.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.019 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -175.29 166.95 3.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.005 1.383 . . . . 0.0 114.624 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -115.72 123.11 47.48 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.561 1.544 . . . . 0.0 107.784 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -95.55 157.87 15.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.344 1.458 . . . . 0.0 110.518 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.69 123.96 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.119 1.767 . . . . 0.0 112.397 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.58 -13.61 51.21 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 117.523 -1.71 . . . . 0.0 114.644 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -80.68 143.71 32.82 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 121.229 2.514 . . . . 0.0 107.758 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 m -103.28 157.62 16.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.74 165.81 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.32 151.36 23.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.676 0.671 . . . . 0.0 109.888 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -154.58 124.96 6.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? 35.87 73.9 0.08 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.124 1.77 . . . . 0.0 111.918 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 -46.32 0.54 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.028 1.775 . . . . 0.0 114.07 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -68.49 141.53 55.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.563 1.182 . . . . 0.0 111.763 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 tp -98.58 123.97 43.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 128.882 2.873 . . . . 0.0 106.474 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.93 169.19 11.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.457 1.103 . . . . 0.0 109.735 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -149.79 150.09 31.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 148.89 25.68 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 122.022 0.915 . . . . 0.0 112.207 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -92.21 -35.37 13.85 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 110.011 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -144.87 -72.82 0.26 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.409 0.684 . . . . 0.0 110.726 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -156.45 133.78 10.69 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.807 1.643 . . . . 0.0 109.12 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -168.92 151.78 5.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.886 0.766 . . . . 0.0 111.35 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.79 17.66 3.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.317 1.847 . . . . 0.0 107.47 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.2 t -85.47 166.71 16.11 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.99 119.78 33.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.21 117.44 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.192 2.594 . . . . 0.0 112.189 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 -25.95 14.16 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.632 1.11 . . . . 0.0 111.331 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.9 t -76.08 61.45 1.55 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.491 1.146 . . . . 0.0 111.153 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 45.18 -119.44 0.77 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.436 1.494 . . . . 0.0 108.766 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t 66.43 -63.91 0.24 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.58 1.952 . . . . 0.0 113.017 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -178.51 32.64 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 129.665 3.186 . . . . 0.0 107.083 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -109.7 149.08 30.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.693 1.133 . . . . 0.0 110.776 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -144.79 127.97 16.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -77.37 137.45 38.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.75 -17.15 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.678 1.191 . . . . 0.0 111.001 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.63 -151.55 19.13 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.354 0.979 . . . . 0.0 111.359 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -141.26 138.57 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.14 1.776 . . . . 0.0 107.786 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.3 m -74.71 98.21 3.4 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.257 1.456 0 O-C-N 125.328 1.642 . . . . 0.0 109.382 175.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.04 171.37 39.28 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -75.61 71.93 2.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.804 0.842 . . . . 0.0 109.551 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.294 1.5 m 15.25 69.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 131.546 3.938 . . . . 0.0 114.558 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.25 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.394 2.278 . . . . 0.0 113.549 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -56.33 -32.52 64.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.51 0.724 . . . . 0.0 111.059 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.84 169.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.616 1.166 . . . . 0.0 109.949 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -48.33 120.34 3.57 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.33 1.052 . . . . 0.0 109.975 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -105.99 126.71 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -48.33 135.84 12.3 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.703 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.46 28.47 16.51 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 119.989 1.032 . . . . 0.0 114.208 -0.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -74.64 67.79 1.59 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.873 1.215 . . . . 0.0 108.677 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -48.34 160.35 0.16 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.927 0.891 . . . . 0.0 111.609 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -34.17 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.909 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -170.37 -167.91 0.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.336 1.065 . . . . 0.0 113.152 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.261 41.4 mtpt -101.2 -33.01 10.26 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 131.375 3.87 . . . . 0.0 108.457 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 159.23 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 129.426 3.09 . . . . 0.0 106.28 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -117.73 153.86 32.68 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.425 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.73 -63.58 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.228 1.811 . . . . 0.0 114.152 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.52 0.66 54.77 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.384 -0.675 . . . . 0.0 113.144 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.6 128.03 10.1 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -58.87 115.6 12.45 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -42.57 130.88 5.27 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.733 2.289 . . . . 0.0 114.074 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -128.54 -15.18 4.56 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.164 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 177.68 164.08 0.61 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.503 1.047 . . . . 0.0 111.221 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -98.23 125.77 43.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -92.96 169.91 10.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.646 1.179 . . . . 0.0 109.184 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.83 127.46 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.065 0.946 . . . . 0.0 111.387 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.2 -11.65 54.02 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.61 -1.106 . . . . 0.0 113.474 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -81.39 136.84 35.73 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.685 1.743 . . . . 0.0 109.954 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.0 m -104.89 163.39 12.56 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.364 1.066 . . . . 0.0 112.786 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.53 155.63 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.175 0.99 . . . . 0.0 109.004 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 t -102.29 150.63 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -138.65 -138.28 0.13 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.27 84.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.932 1.696 . . . . 0.0 111.336 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.83 -27.48 0.18 Allowed Glycine 0 CA--C 1.538 1.486 0 C-N-CA 128.716 3.055 . . . . 0.0 114.729 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -87.14 151.35 23.27 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.984 1.714 . . . . 0.0 111.591 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -104.76 128.16 52.79 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.189 2.995 . . . . 0.0 107.362 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -129.29 157.56 41.52 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.279 1.032 . . . . 0.0 110.365 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -131.7 140.51 49.32 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.606 1.163 . . . . 0.0 109.425 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.47 140.87 34.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 109.8 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -90.34 -32.58 16.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.348 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -139.35 -70.75 0.4 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.094 0.473 . . . . 0.0 111.734 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -161.47 123.89 3.03 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 126.269 1.828 . . . . 0.0 107.219 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -163.61 143.91 8.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.737 1.153 . . . . 0.0 111.731 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.15 13.79 9.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.793 2.037 . . . . 0.0 106.823 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -73.89 162.34 29.19 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.484 1.113 . . . . 0.0 108.503 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.84 121.26 67.2 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.07 131.27 21.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.843 2.362 . . . . 0.0 112.393 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.53 65.95 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.734 -1.036 . . . . 0.0 112.957 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.3 t -76.95 62.03 2.05 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.648 1.724 . . . . 0.0 110.381 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 51.98 -138.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.31 . . . . 0.0 108.667 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.4 t 57.33 -139.55 0.87 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.121 0.873 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -62.41 -74.97 0.08 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.678 2.791 . . . . 0.0 110.095 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -19.54 114.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.738 2.415 . . . . 0.0 114.508 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.255 23.4 m -118.47 125.3 49.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 113.197 -1.819 . . . . 0.0 107.034 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -68.6 140.06 55.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.711 0.232 . . . . 0.0 110.462 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 -16.07 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 111.292 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.6 -154.45 24.23 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.223 0.92 . . . . 0.0 111.053 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 p -160.27 167.68 27.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.455 1.902 . . . . 0.0 107.125 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.1 m -50.63 -65.48 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 127.401 2.28 . . . . 0.0 105.051 -172.619 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.48 174.56 46.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -37.36 61.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.826 0.851 . . . . 0.0 110.587 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.3 t -71.48 -60.97 1.95 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 150.53 -60.69 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 130.027 3.331 . . . . 0.0 106.278 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -151.59 32.01 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.75 178.82 4.44 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.033 0.833 . . . . 0.0 110.603 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -61.19 98.26 0.08 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -109.26 124.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 124.538 1.135 . . . . 0.0 109.945 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -39.67 132.97 1.36 Allowed Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.003 1.321 . . . . 0.0 110.833 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -85.93 18.31 30.47 Favored 'Cis proline' 0 CA--C 1.535 0.559 0 CA-C-N 120.465 1.202 . . . . 0.0 114.881 0.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -74.6 64.47 1.21 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.217 1.371 . . . . 0.0 109.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -54.16 152.61 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.643 0.777 . . . . 0.0 111.685 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -70.54 -42.99 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.209 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.5 t -100.02 149.87 23.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.942 1.353 . . . . 0.0 110.985 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -101.62 169.17 9.01 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.943 2.097 . . . . 0.0 107.687 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -39.84 86.29 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -146.42 162.04 39.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.702 1.601 . . . . 0.0 107.688 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.8 -60.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.562 1.545 . . . . 0.0 113.702 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.27 60.89 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.124 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.17 -159.67 23.23 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.135 0.967 . . . . 0.0 111.564 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -118.66 159.29 44.74 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.362 1.465 . . . . 0.0 107.521 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.58 136.2 21.02 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.359 2.04 . . . . 0.0 110.943 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.5 m -136.4 -18.47 1.48 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.81 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 178.86 156.71 0.48 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -84.79 124.02 31.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.29 153.77 40.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.62 133.69 46.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.64 -2.02 49.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.035 -1.425 . . . . 0.0 113.401 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -90.19 147.68 23.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.29 2.045 . . . . 0.0 107.953 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 m -90.85 160.91 15.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.237 -0.289 . . . . 0.0 111.334 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.24 138.09 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.7 t -106.36 157.81 6.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -151.54 -92.94 0.06 Allowed 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -76.53 52.94 0.83 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.313 1.845 . . . . 0.0 110.739 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.83 -36.01 1.23 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.833 2.635 . . . . 0.0 111.663 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -71.42 141.94 50.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.086 0.954 . . . . 0.0 110.491 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.25 115.68 28.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 129.385 3.074 . . . . 0.0 106.136 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -113.94 171.47 7.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.064 0.946 . . . . 0.0 109.213 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 m -151.14 146.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.68 137.73 39.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.399 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.89 79.17 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.783 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -146.66 -140.66 0.11 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.368 2.267 . . . . 0.0 112.942 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -79.18 115.15 18.67 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 130.17 3.388 . . . . 0.0 113.38 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.95 143.63 6.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.166 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.61 30.68 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.873 2.069 . . . . 0.0 106.746 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.8 t -83.39 -133.93 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.889 0.876 . . . . 0.0 108.955 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.49 110.09 55.68 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.72 113.92 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.401 2.734 . . . . 0.0 111.815 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.28 -0.32 37.78 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.6 p -77.02 44.37 0.39 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.461 2.13 . . . . 0.0 112.153 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 t70 42.13 -149.66 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.07 2.148 . . . . 0.0 111.579 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m 50.59 -76.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.145 2.578 . . . . 0.0 114.267 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -83.84 -53.59 5.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.967 1.707 . . . . 0.0 109.991 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.62 164.49 21.36 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.694 1.997 . . . . 0.0 112.749 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -159.1 138.37 11.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -88.27 138.47 31.41 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 109.705 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -14.65 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.621 1.169 . . . . 0.0 111.66 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 -152.17 20.91 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.04 140.01 20.1 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.07 1.348 . . . . 0.0 108.769 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.9 m -74.35 -53.34 9.85 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.808 0.813 . . . . 0.0 109.505 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.068 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -173.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ptt? . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.205 0.526 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.46 36.46 2.04 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.65 -49.98 55.7 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.228 1.811 . . . . 0.0 110.426 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -69.99 -55.59 9.18 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 121.671 0.748 . . . . 0.0 109.895 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.35 -67.23 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 130.571 3.548 . . . . 0.0 104.428 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -156.51 26.15 0.34 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.979 0.912 . . . . 0.0 111.631 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.44 -165.96 1.47 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.575 0.625 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -71.83 85.09 0.94 Allowed 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.23 124.43 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.202 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -38.07 131.04 0.97 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.771 1.229 . . . . 0.0 111.85 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -90.21 23.77 24.23 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 120.445 1.195 . . . . 0.0 114.244 0.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.71 66.1 1.42 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.896 1.225 . . . . 0.0 109.53 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -51.95 156.91 1.38 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.964 0.888 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.29 -31.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.834 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.7 m -151.56 167.24 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.262 11.4 tmtt? -82.6 -38.99 22.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.449 2.299 . . . . 0.0 113.535 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.4 t70 167.56 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 1 C-N-CA 132.529 4.332 . . . . 0.0 102.713 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -111.51 175.41 5.44 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 128.194 2.598 . . . . 0.0 107.375 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.21 -55.8 5.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.43 66.95 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.308 0.883 . . . . 0.0 115.308 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.5 163.93 38.72 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.004 1.402 . . . . 0.0 111.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 164.9 51.4 Favored Pre-proline 0 C--O 1.217 -0.606 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.81 156.53 56.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.066 2.488 . . . . 0.0 114.352 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 m -141.07 -28.24 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 0.0 111.849 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -178.59 170.4 1.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 111.249 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -105.75 126.66 52.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.08 160.97 13.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.054 1.342 . . . . 0.0 109.435 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.76 125.88 2.92 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 111.715 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.59 -13.09 54.04 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.882 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.35 144.83 32.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 120.406 2.103 . . . . 0.0 107.781 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -98.71 158.74 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.756 0.422 . . . . 0.0 110.997 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.41 144.33 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.05 150.92 12.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.057 0.543 . . . . 0.0 110.594 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -156.91 133.48 10.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 46.35 33.79 2.01 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.457 1.903 . . . . 0.0 113.165 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.52 9.71 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.986 2.231 . . . . 0.0 112.576 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -78.11 139.94 39.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.629 1.214 . . . . 0.0 110.008 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.51 128.05 36.42 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 129.126 2.97 . . . . 0.0 107.615 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -128.26 167.61 16.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.519 1.127 . . . . 0.0 108.631 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -148.77 147.12 28.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.97 148.97 21.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.72 1.247 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -89.89 -36.42 15.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -132.09 -79.37 0.51 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.05 0.453 . . . . 0.0 111.852 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -157.44 132.62 8.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.777 2.031 . . . . 0.0 107.913 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -167.49 153.65 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.236 0.926 . . . . 0.0 110.107 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.29 34.24 0.65 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.675 1.59 . . . . 0.0 108.943 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 p -88.64 -100.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.189 0.596 . . . . 0.0 111.294 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.55 110.34 4.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.6 111.44 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.948 3.099 . . . . 0.0 113.586 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.71 -27.81 10.08 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.909 1.243 . . . . 0.0 111.867 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.1 t -76.47 65.47 2.34 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.323 1.062 . . . . 0.0 110.959 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 50.94 -128.21 2.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 t 72.45 -47.99 0.68 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.722 1.609 . . . . 0.0 112.813 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 -64.33 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.998 2.919 . . . . 0.0 105.906 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -11.91 121.54 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 129.074 2.95 . . . . 0.0 116.932 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 m -120.24 118.83 31.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 112.597 -2.092 . . . . 0.0 106.206 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -71.3 140.51 50.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -2.37 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.03 -152.53 24.24 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -147.64 142.14 26.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.779 1.232 . . . . 0.0 109.096 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 m -67.68 -46.51 72.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.726 0.774 . . . . 0.0 109.642 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--O 1.257 1.454 0 CA-C-O 115.559 -2.162 . . . . 0.0 105.25 -174.899 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 121.278 0.561 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.98 37.11 93.31 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -31.96 -45.77 0.11 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 129.31 3.044 . . . . 0.0 113.721 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.1 t -67.95 -52.63 33.87 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 121.215 0.531 . . . . 0.0 111.825 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 157.01 -57.6 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 130.517 3.527 . . . . 0.0 105.88 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -149.74 -5.6 0.36 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.393 1.077 . . . . 0.0 113.319 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.52 174.39 11.62 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.201 0.909 . . . . 0.0 112.024 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -54.31 103.85 0.09 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.524 1.13 . . . . 0.0 110.126 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.32 135.82 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 108.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -43.66 132.18 3.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.196 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -98.25 36.29 7.05 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 121.135 1.441 . . . . 0.0 113.593 -0.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -76.26 62.49 1.78 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.538 1.063 . . . . 0.0 108.738 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -52.55 150.89 4.61 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.458 1.103 . . . . 0.0 112.992 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -95.25 -29.52 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.231 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -64.33 -41.31 96.86 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.565 1.075 . . . . 0.0 111.407 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 mttt 57.29 -178.84 0.05 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.458 1.503 . . . . 0.0 112.79 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.54 -17.44 61.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.088 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -158.21 -74.33 0.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.743 0.701 . . . . 0.0 110.902 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.88 -52.6 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.11 0.564 . . . . 0.0 110.645 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.77 -11.86 54.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.705 0.669 . . . . 0.0 111.74 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.22 -177.05 32.84 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 122.11 0.839 . . . . 0.0 113.958 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -62.55 158.85 46.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.267 1.027 . . . . 0.0 110.338 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -64.49 168.26 13.35 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.114 1.876 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -154.2 -29.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.408 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 164.59 169.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.705 1.202 . . . . 0.0 110.418 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -107.02 128.15 54.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.09 162.59 13.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.728 1.211 . . . . 0.0 109.123 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.08 122.4 1.03 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.865 1.666 . . . . 0.0 112.012 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -15.27 45.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.475 -1.181 . . . . 0.0 114.384 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -76.19 138.53 40.72 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.534 2.167 . . . . 0.0 106.482 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -108.12 152.67 24.23 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.071 -0.393 . . . . 0.0 111.431 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -148.83 162.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.071 1.348 . . . . 0.0 107.659 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -116.02 151.37 17.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -157.07 119.47 3.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 40.36 76.21 0.07 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.726 2.011 . . . . 0.0 111.283 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.36 -47.11 0.68 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.913 1.72 . . . . 0.0 114.201 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -73.81 142.13 46.18 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.982 0.913 . . . . 0.0 113.122 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tp -97.35 129.49 44.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 130.161 3.384 . . . . 0.0 107.236 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -133.19 156.29 47.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.83 0.852 . . . . 0.0 109.845 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.5 m -130.42 144.7 51.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.224 1.41 . . . . 0.0 107.701 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.9 149.92 24.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.058 0.932 . . . . 0.0 110.302 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.42 -33.42 17.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.942 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -143.46 -70.68 0.31 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.786 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -156.94 138.16 13.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.162 2.185 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -171.67 147.46 2.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.73 36.39 2.0 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.559 1.544 . . . . 0.0 107.616 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 m -126.56 153.0 45.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.667 1.187 . . . . 0.0 109.24 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.5 t -36.31 110.58 0.46 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.589 1.956 . . . . 0.0 112.787 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.01 138.16 43.68 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.073 3.182 . . . . 0.0 114.126 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.45 -43.67 1.59 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.997 0.808 . . . . 0.0 112.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.9 t -73.37 -41.89 62.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.619 0.767 . . . . 0.0 111.597 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.85 -111.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -161.26 171.36 18.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.144 1.378 . . . . 0.0 108.554 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 64.73 18.36 11.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -112.61 157.52 21.11 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.116 1.766 . . . . 0.0 109.351 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 m -152.03 119.86 6.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -68.7 142.03 55.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 109.784 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.39 -6.97 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.3 1.04 . . . . 0.0 112.352 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.42 -155.44 26.4 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 p -154.04 150.06 27.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.935 1.294 . . . . 0.0 108.302 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -86.08 -47.09 9.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 122.266 1.031 . . . . 0.0 109.412 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 129.885 3.274 . . . . 0.0 105.024 -175.0 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -132.82 52.32 0.83 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p30 39.2 -126.29 0.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.516 1.526 . . . . 0.0 110.165 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.3 m -98.58 -23.94 15.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.704 1.138 . . . . 0.0 109.925 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.59 20.61 12.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.916 1.287 . . . . 0.0 112.138 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -162.47 -45.21 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.928 1.291 . . . . 0.0 110.024 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.97 173.41 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -70.45 122.78 20.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.2 136.89 30.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 125.556 1.543 . . . . 0.0 109.71 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -46.08 133.22 7.17 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.045 1.293 . . . . 0.0 111.802 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -95.54 36.82 6.64 Favored 'Cis proline' 0 C--N 1.353 0.81 0 CA-C-N 121.563 1.594 . . . . 0.0 113.52 -0.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.76 66.04 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -59.82 147.69 37.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.403 0.62 . . . . 0.0 110.305 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.6 -43.76 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.544 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -91.48 146.72 23.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 122.626 1.203 . . . . 0.0 109.553 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -115.72 166.65 11.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.154 2.182 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -58.0 -34.83 70.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.393 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -158.49 170.26 22.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.607 1.963 . . . . 0.0 106.848 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.38 -60.69 0.48 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.781 1.632 . . . . 0.0 113.808 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.81 24.07 29.38 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.849 0.738 . . . . 0.0 112.062 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 -174.81 49.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 121.829 0.683 . . . . 0.0 113.19 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.82 154.45 75.64 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.58 154.28 31.46 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.214 1.943 . . . . 0.0 110.011 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.73 -4.89 0.31 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.81 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 165.59 167.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.22 1.008 . . . . 0.0 113.705 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -114.62 137.52 51.79 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.577 1.551 . . . . 0.0 107.099 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.21 168.65 9.22 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.366 1.066 . . . . 0.0 109.28 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.14 124.34 2.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 111.85 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.53 -14.43 55.29 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.701 1.143 . . . . 0.0 113.501 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -78.65 126.63 31.0 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.172 1.486 . . . . 0.0 109.204 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 p -91.5 164.13 13.91 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.886 1.674 . . . . 0.0 112.285 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.56 153.95 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.55 153.4 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 118.48 0.582 . . . . 0.0 109.521 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -161.38 129.17 4.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 33.16 74.2 0.06 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.136 1.774 . . . . 0.0 112.247 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.07 -40.7 0.33 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.677 2.084 . . . . 0.0 115.089 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -78.37 145.5 35.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.607 1.194 . . . . 0.0 112.716 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tp -101.82 126.8 48.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 129.837 3.255 . . . . 0.0 106.923 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.75 152.76 49.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.443 0.697 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.1 m -128.63 140.04 51.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 109.203 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 141.76 40.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.865 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.41 -39.51 13.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.428 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -133.5 -71.47 0.51 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -159.28 135.75 9.18 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 127.732 2.413 . . . . 0.0 106.561 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -168.19 157.05 9.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.236 0.926 . . . . 0.0 110.507 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.56 21.12 0.92 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.848 1.659 . . . . 0.0 109.277 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.5 p -91.25 164.23 13.96 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.7 t -52.14 111.81 2.8 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.388 0.675 . . . . 0.0 109.326 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.21 122.69 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.337 3.358 . . . . 0.0 113.445 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.84 -23.15 34.71 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.468 1.032 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 m -76.24 66.92 2.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.284 1.042 . . . . 0.0 110.666 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 47.2 -126.7 1.65 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.996 1.319 . . . . 0.0 108.847 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m 65.07 -40.87 0.29 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.467 2.307 . . . . 0.0 115.94 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p 179.34 -69.82 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.264 2.626 . . . . 0.0 106.224 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -8.91 112.98 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.723 3.209 . . . . 0.0 116.124 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.4 m -108.88 113.16 25.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 112.805 -1.998 . . . . 0.0 106.264 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -66.79 134.34 51.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.13 -9.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.686 0.794 . . . . 0.0 111.185 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.68 -167.64 32.63 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.103 0.865 . . . . 0.0 111.593 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -122.79 123.22 40.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -31.44 68.15 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.518 0 CA-C-O 114.84 -2.505 . . . . 0.0 107.05 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.56 139.69 6.25 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -33.55 -47.25 0.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.923 2.489 . . . . 0.0 113.734 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.8 t -64.75 -47.21 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.476 0.655 . . . . 0.0 111.951 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 155.98 -61.04 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 130.705 3.602 . . . . 0.0 104.849 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.1 0.85 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.463 1.105 . . . . 0.0 113.259 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.72 -175.29 5.2 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.092 0.86 . . . . 0.0 111.838 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.52 94.0 0.04 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.814 0.845 . . . . 0.0 111.003 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 p -96.6 131.81 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.0 135.73 11.33 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.856 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -93.87 33.47 9.62 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.636 1.263 . . . . 0.0 114.706 0.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -74.5 66.95 1.44 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.999 1.272 . . . . 0.0 108.336 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -50.86 160.86 0.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.989 1.316 . . . . 0.0 113.251 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.21 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.938 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -110.9 147.78 33.87 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.773 2.829 . . . . 0.0 107.728 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -66.68 -29.11 69.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -152.63 157.87 41.6 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.624 1.17 . . . . 0.0 108.243 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.78 -60.73 0.69 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.363 1.865 . . . . 0.0 114.615 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.38 5.71 84.61 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.863 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.62 150.71 27.12 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.922 1.361 . . . . 0.0 110.677 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -68.67 151.59 97.16 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.43 157.96 20.67 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 CA-C-N 119.655 0.912 . . . . 0.0 112.729 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 t -157.74 9.74 0.17 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.333 -1.318 . . . . 0.0 110.804 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -178.14 170.49 1.8 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-O 122.647 1.213 . . . . 0.0 113.843 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -115.06 98.56 6.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.874 2.07 . . . . 0.0 105.77 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.29 165.57 13.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.887 -0.508 . . . . 0.0 111.872 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.86 132.07 11.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.324 1.05 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 -10.06 34.93 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.338 -1.257 . . . . 0.0 113.339 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -78.99 156.41 28.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 120.062 1.931 . . . . 0.0 106.479 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -117.94 166.26 12.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.534 0.734 . . . . 0.0 110.524 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 tt -162.38 160.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -116.62 151.37 18.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.71 0.687 . . . . 0.0 109.729 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -162.62 134.85 5.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt 49.59 32.22 4.79 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.84 1.656 . . . . 0.0 112.686 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.09 -19.24 23.2 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.71 2.1 . . . . 0.0 112.874 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -85.53 145.1 27.55 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.702 1.251 . . . . 0.0 109.591 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tp -93.45 129.47 39.61 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.313 2.645 . . . . 0.0 107.178 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -127.62 164.78 21.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.346 1.058 . . . . 0.0 108.381 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.7 m -146.24 145.6 30.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.36 144.5 26.36 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 111.108 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -93.45 -36.54 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.378 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -132.91 -78.01 0.49 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.281 0.563 . . . . 0.0 112.112 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -157.55 132.95 9.01 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -167.07 147.84 5.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.45 1.023 . . . . 0.0 111.022 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.3 15.72 4.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.158 1.383 . . . . 0.0 107.921 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -77.46 163.31 26.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.56 127.9 90.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -45.33 122.4 4.58 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.528 2.818 . . . . 0.0 112.844 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.09 -24.95 27.76 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.167 0.889 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -76.92 75.58 3.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.333 1.066 . . . . 0.0 109.558 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.81 -131.43 0.74 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 110.051 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t 67.7 -54.77 0.49 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.394 2.277 . . . . 0.0 113.979 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 p -172.45 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.548 1.139 . . . . 0.0 109.886 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -18.68 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.427 3.091 . . . . 0.0 116.715 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 m -143.43 130.99 21.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 112.583 -2.099 . . . . 0.0 107.057 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -74.0 141.21 45.86 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.6 -6.23 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.268 1.027 . . . . 0.0 113.027 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.7 -151.42 22.82 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -153.85 154.22 33.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.448 1.099 . . . . 0.0 109.324 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 m -87.27 -53.81 4.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 110.029 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtt . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.4 31.14 79.75 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.892 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -80.99 68.05 7.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.161 1.385 . . . . 0.0 108.015 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 p -9.95 84.98 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 130.568 3.547 . . . . 0.0 117.037 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.22 -23.8 9.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.009 2.524 . . . . 0.0 112.892 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -54.5 -38.06 66.05 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.21 152.65 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -46.84 122.43 4.3 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.468 0.707 . . . . 0.0 109.967 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.18 130.77 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 119.173 0.897 . . . . 0.0 109.096 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -47.98 136.48 11.04 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.523 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -91.49 24.03 24.98 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.944 1.016 . . . . 0.0 113.876 0.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -73.17 68.75 1.01 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 119.859 1.209 . . . . 0.0 109.807 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -52.22 157.05 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.741 0.782 . . . . 0.0 112.043 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.24 -21.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -145.15 166.83 24.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.063 0.935 . . . . 0.0 113.16 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.271 51.0 tttp -96.9 -40.1 9.07 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 128.543 2.737 . . . . 0.0 110.313 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 174.75 -40.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 1 C-N-CA 133.217 4.607 . . . . 0.0 102.926 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -113.57 166.52 11.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.76 -68.08 0.39 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.45 11.38 1.15 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.42 155.74 27.4 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.258 1.529 . . . . 0.0 110.187 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.9 121.05 42.79 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -50.94 152.95 9.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.449 2.1 . . . . 0.0 116.654 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 m -152.37 -17.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.081 0.952 . . . . 0.0 112.23 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 179.38 164.19 0.96 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.752 1.16 . . . . 0.0 110.973 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -100.09 141.49 32.85 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.72 169.76 8.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.735 1.214 . . . . 0.0 109.404 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.97 122.03 2.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.622 1.169 . . . . 0.0 111.358 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 -19.06 48.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.863 1.221 . . . . 0.0 113.215 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -76.92 131.98 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.257 1.528 . . . . 0.0 110.503 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.93 163.5 12.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.2 1.8 . . . . 0.0 112.087 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.5 tt -167.02 149.42 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.176 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.92 153.61 3.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.407 1.003 . . . . 0.0 108.554 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -158.21 115.49 2.91 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 39.45 78.58 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.041 1.736 . . . . 0.0 112.132 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.27 -42.86 0.53 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.017 1.294 . . . . 0.0 115.825 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -81.57 145.39 30.67 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 122.041 0.924 . . . . 0.0 111.996 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tp -99.44 125.47 45.17 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 129.143 2.977 . . . . 0.0 106.317 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.06 167.35 13.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.31 1.044 . . . . 0.0 108.749 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -148.59 142.88 26.17 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.72 144.21 29.51 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.148 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -95.73 -35.29 11.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.097 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -131.38 -75.42 0.52 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.382 0.426 . . . . 0.0 111.53 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -159.96 125.61 4.12 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.939 2.096 . . . . 0.0 107.921 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 t -167.41 150.57 6.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.979 1.263 . . . . 0.0 111.863 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.21 5.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.783 2.033 . . . . 0.0 108.061 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -71.26 162.99 28.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.39 120.6 53.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.89 122.98 9.04 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.211 2.608 . . . . 0.0 112.615 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.5 -30.44 9.62 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.4 m -75.94 73.38 2.84 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.534 1.167 . . . . 0.0 110.44 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 55.94 -133.2 1.54 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.806 1.242 . . . . 0.0 108.948 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t 59.52 -152.88 0.39 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -54.41 13.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.909 -0.494 . . . . 0.0 109.899 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -13.5 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.953 2.901 . . . . 0.0 117.505 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 m -117.97 126.89 53.2 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.44 2.296 . . . . 0.0 106.399 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.02 141.91 47.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -15.9 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.583 1.153 . . . . 0.0 111.873 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.92 -177.56 47.58 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.0 1.273 . . . . 0.0 112.213 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.5 p -137.03 110.86 8.15 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.932 1.693 . . . . 0.0 107.285 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.8 m -74.04 -37.89 64.16 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.269 0.557 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.83 41.59 94.15 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -43.95 -35.81 2.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.997 2.119 . . . . 0.0 113.586 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 t -82.75 -48.75 10.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.261 1.024 . . . . 0.0 110.241 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.85 -55.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.845 3.258 . . . . 0.0 105.146 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -152.16 -2.68 0.27 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.615 1.166 . . . . 0.0 112.736 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.59 157.98 30.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.569 1.077 . . . . 0.0 111.07 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -39.5 106.85 0.06 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 126.509 1.924 . . . . 0.0 112.742 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.3 132.02 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.545 1.138 . . . . 0.0 108.762 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.61 133.77 6.27 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.597 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.27 34.42 8.57 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 120.982 1.386 . . . . 0.0 114.422 0.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -76.71 59.53 1.57 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.164 1.347 . . . . 0.0 108.118 176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . 0.267 7.2 m95 -55.66 156.83 4.5 Favored 'General case' 0 N--CA 1.412 -2.352 0 C-N-CA 129.356 3.062 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.38 -26.82 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.652 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 t -156.05 173.67 16.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 124.345 2.022 . . . . 0.0 116.0 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.38 -172.01 2.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 130.42 3.488 . . . . 0.0 106.499 171.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.44 -30.56 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.937 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -131.66 152.46 50.84 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 110.156 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.72 -63.35 0.52 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.89 2.076 . . . . 0.0 115.108 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 3.37 69.92 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.962 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.92 147.26 34.78 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 120.199 2.0 . . . . 0.0 111.069 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.35 120.16 80.06 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -38.74 159.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.838 3.692 . . . . 0.0 121.153 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 2.93 0.43 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 112.134 -2.303 . . . . 0.0 109.515 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 178.16 172.24 0.68 Allowed 'General case' 0 C--N 1.349 0.552 0 CA-C-N 120.307 1.412 . . . . 0.0 113.657 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -110.09 139.02 45.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.97 169.29 8.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.353 1.461 . . . . 0.0 109.281 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.26 123.86 2.62 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.922 1.289 . . . . 0.0 112.052 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.17 -17.24 18.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.761 0.696 . . . . 0.0 113.751 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -75.03 128.22 35.05 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -100.76 164.67 11.75 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.3 tt -161.59 173.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.215 1.406 . . . . 0.0 108.233 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.89 153.24 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.032 1.333 . . . . 0.0 110.452 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -158.05 114.19 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 41.18 81.74 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.617 2.367 . . . . 0.0 112.231 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.4 -44.05 0.58 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.57 1.557 . . . . 0.0 114.755 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.61 146.67 40.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.895 0.878 . . . . 0.0 111.739 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.0 tp -106.11 129.17 54.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 130.45 3.5 . . . . 0.0 106.993 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -132.33 162.46 30.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.267 1.027 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.0 m -134.53 144.58 48.09 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.335 1.454 . . . . 0.0 109.096 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.69 145.85 27.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.124 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -86.8 -32.59 20.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.443 1.497 . . . . 0.0 111.492 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -148.96 -65.16 0.23 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 111.101 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -159.86 134.88 7.98 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 127.564 2.346 . . . . 0.0 107.629 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -174.32 144.29 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.057 0.844 . . . . 0.0 111.573 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.81 14.64 9.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.715 2.006 . . . . 0.0 107.932 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.52 165.81 23.86 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.3 t -57.24 118.69 26.18 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.493 -0.765 . . . . 0.0 108.954 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.05 119.17 5.67 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.551 2.168 . . . . 0.0 110.75 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.55 -26.72 9.36 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.3 t -73.43 80.14 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -41.17 139.67 0.93 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.777 1.631 . . . . 0.0 111.413 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t 163.57 -49.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.795 2.438 . . . . 0.0 106.301 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 t -146.56 11.06 1.11 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.979 1.712 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -113.54 156.41 23.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.26 1.024 . . . . 0.0 108.903 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -153.32 126.02 8.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -72.85 140.56 47.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.23 0.468 . . . . 0.0 110.004 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -17.13 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.901 1.281 . . . . 0.0 111.053 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.37 -157.35 29.78 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -154.27 140.72 18.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.886 1.674 . . . . 0.0 106.77 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.58 -44.28 11.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.553 0.615 . . . . 0.0 111.136 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.7 168.55 54.62 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.81 -42.57 36.5 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.628 0.771 . . . . 0.0 110.768 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.9 t -74.76 -58.59 3.19 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 122.198 0.999 . . . . 0.0 108.558 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.24 -58.02 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 129.747 3.219 . . . . 0.0 104.803 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -152.15 32.32 0.53 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.943 0.897 . . . . 0.0 112.117 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.03 155.63 24.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -32.54 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.587 1.955 . . . . 0.0 113.87 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -88.76 122.97 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -48.66 137.92 12.33 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 120.92 1.691 . . . . 0.0 109.998 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -92.21 36.12 6.64 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 120.612 1.254 . . . . 0.0 114.708 0.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -74.3 66.57 1.32 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.068 1.303 . . . . 0.0 107.86 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -50.55 164.44 0.13 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.533 1.533 . . . . 0.0 113.025 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.94 -33.0 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.139 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -144.57 172.63 12.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.266 86.8 tttt -99.49 -57.73 2.09 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.816 3.246 . . . . 0.0 109.582 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -158.07 -50.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.905 5.682 . . . . 0.0 101.913 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -113.28 175.26 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -58.88 3.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.06 -21.13 63.41 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.22 153.43 48.44 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -59.93 131.88 89.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.89 160.34 25.8 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 N-CA-C 117.944 2.248 . . . . 0.0 117.944 -173.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -151.86 -7.92 0.22 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 112.448 -2.16 . . . . 0.0 110.4 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -174.41 173.29 3.0 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.58 123.3 41.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.745 2.418 . . . . 0.0 105.941 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.6 169.2 11.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.192 0.997 . . . . 0.0 111.669 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.77 128.16 20.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.7 66.6 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.061 -1.411 . . . . 0.0 113.977 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.66 136.74 33.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.582 2.191 . . . . 0.0 106.252 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.1 m -98.36 157.51 16.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.224 0.535 . . . . 0.0 112.208 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 tt -152.05 162.9 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 t -121.86 145.4 28.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.655 0.661 . . . . 0.0 109.519 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -167.34 167.77 13.72 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 40.33 39.68 0.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.957 1.253 . . . . 0.0 112.933 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.39 36.79 54.18 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.963 1.744 . . . . 0.0 112.413 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -150.82 157.22 42.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.939 1.296 . . . . 0.0 110.194 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 tp -87.73 132.12 34.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.984 2.514 . . . . 0.0 109.392 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.74 156.79 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.515 1.126 . . . . 0.0 108.59 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 m -137.2 145.2 43.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.58 153.93 21.43 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.35 1.071 . . . . 0.0 110.584 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -91.08 -32.84 15.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.715 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -138.89 -146.0 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.483 1.513 . . . . 0.0 109.551 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.15 115.9 28.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.751 2.421 . . . . 0.0 106.038 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -157.46 156.57 32.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.131 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.79 20.06 4.19 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.418 1.887 . . . . 0.0 108.049 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -79.9 -179.35 6.92 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.23 120.47 73.4 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.51 127.37 25.73 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.572 2.848 . . . . 0.0 115.551 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.62 -38.41 1.05 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 123.688 0.661 . . . . 0.0 112.759 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -65.72 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.414 0.607 . . . . 0.0 110.814 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.88 179.89 6.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.551 0.691 . . . . 0.0 110.948 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -47.24 164.92 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.838 3.255 . . . . 0.0 115.508 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.2 p 71.95 4.72 5.12 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.637 2.775 . . . . 0.0 114.649 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -117.2 149.23 40.73 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.779 1.231 . . . . 0.0 110.85 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 m -136.69 118.51 15.14 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.95 139.59 48.76 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.57 12.19 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.076 0.55 . . . . 0.0 112.257 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.33 -150.86 17.91 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t -89.42 176.78 6.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -73.47 96.1 2.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 O-C-N 125.017 1.448 . . . . 0.0 109.724 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 ttp . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.72 46.77 0.02 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.07 69.72 2.68 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.849 1.66 . . . . 0.0 108.204 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -37.12 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 129.243 3.017 . . . . 0.0 116.45 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.63 -27.17 10.56 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.789 2.436 . . . . 0.0 111.342 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -54.3 -33.37 58.59 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.82 176.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.31 1.444 . . . . 0.0 109.067 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -60.37 118.41 6.41 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.84 137.06 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -55.52 135.24 70.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 120.704 1.593 . . . . 0.0 110.824 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -99.37 31.17 11.47 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 121.382 1.529 . . . . 0.0 113.319 -1.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -74.76 65.06 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -48.59 152.41 0.96 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.88 0.848 . . . . 0.0 112.316 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.97 -25.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.137 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 m -153.19 169.99 21.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.527 1.632 . . . . 0.0 115.037 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.48 -166.5 1.09 Allowed 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 129.439 3.096 . . . . 0.0 108.305 173.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -53.97 -44.57 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.621 -2.081 . . . . 0.0 107.823 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -128.49 153.36 47.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.392 1.877 . . . . 0.0 109.728 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.44 -63.48 0.44 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.493 1.917 . . . . 0.0 115.174 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 4.73 79.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.677 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.76 154.0 46.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-N 120.487 2.144 . . . . 0.0 110.988 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.0 113.31 8.86 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -37.79 147.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 1 C-N-CA 125.746 4.297 . . . . 0.0 117.412 -173.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 p -139.74 -8.01 1.25 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -178.52 158.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 119.152 0.887 . . . . 0.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -99.21 113.77 26.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.15 164.27 21.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.238 1.815 . . . . 0.0 110.615 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.63 127.51 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 120.804 -1.185 . . . . 0.0 112.603 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 -14.37 48.92 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.956 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.06 139.9 35.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.688 2.744 . . . . 0.0 107.216 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 p -94.25 164.65 12.95 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.262 -0.899 . . . . 0.0 111.919 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 tt -156.86 151.35 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -98.8 150.1 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -159.93 116.47 2.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 38.23 77.3 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.971 2.109 . . . . 0.0 112.541 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.63 -42.09 0.55 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.59 1.567 . . . . 0.0 113.981 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -78.24 151.08 33.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.083 0.944 . . . . 0.0 112.14 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -105.3 124.13 49.02 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 128.94 2.896 . . . . 0.0 106.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.55 168.92 11.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.6 m -150.82 148.84 28.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.76 146.92 25.42 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.921 0.867 . . . . 0.0 112.166 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -87.56 -36.4 17.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -139.14 -71.97 0.4 Allowed 'General case' 0 C--N 1.339 0.122 0 CA-C-O 120.889 0.376 . . . . 0.0 111.623 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -159.73 128.94 5.21 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.353 1.461 . . . . 0.0 108.454 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 t -166.55 150.98 7.53 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 119.134 0.879 . . . . 0.0 111.307 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.89 15.28 4.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.907 1.683 . . . . 0.0 107.996 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 p -87.9 172.02 9.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.41 123.82 83.93 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 111.607 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.26 140.25 72.38 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.513 2.808 . . . . 0.0 114.671 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.38 -45.73 2.11 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.655 1.121 . . . . 0.0 111.699 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -73.23 -45.14 57.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.503 0.721 . . . . 0.0 112.646 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.5 -167.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.583 1.182 . . . . 0.0 114.152 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -57.76 140.92 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.758 3.223 . . . . 0.0 117.459 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t 62.39 23.41 13.88 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 128.142 2.577 . . . . 0.0 113.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -107.58 152.08 24.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.286 1.041 . . . . 0.0 111.116 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 m -153.63 134.09 13.55 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.62 138.47 37.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.579 0.752 . . . . 0.0 109.801 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.98 -4.37 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.084 0.954 . . . . 0.0 111.218 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.05 -151.65 23.77 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -145.77 156.37 43.55 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 107.491 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.9 t -67.44 -34.09 76.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.836 0.827 . . . . 0.0 111.047 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.514 0 CA-C-O 115.006 -2.426 . . . . 0.0 107.022 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.18 -152.94 12.12 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 119.524 1.057 . . . . 0.0 112.685 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -66.91 80.79 0.11 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.261 1.424 . . . . 0.0 110.363 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.277 0.1 OUTLIER -7.66 85.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 130.041 3.336 . . . . 0.0 115.844 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.72 64.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.434 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -57.99 -32.9 68.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.995 0.918 . . . . 0.0 110.467 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.01 171.17 7.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.727 1.211 . . . . 0.0 108.636 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -64.21 129.8 41.4 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.72 130.84 55.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 C-N-CA 124.454 1.101 . . . . 0.0 110.326 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -43.13 133.89 3.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.704 1.138 . . . . 0.0 110.975 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.48 31.08 11.68 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.613 1.255 . . . . 0.0 114.36 0.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -73.4 67.7 1.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.033 1.288 . . . . 0.0 108.252 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -54.82 151.73 8.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.751 -0.593 . . . . 0.0 111.383 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.62 -43.7 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -105.16 160.53 15.0 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 122.811 1.291 . . . . 0.0 112.733 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -116.67 162.21 18.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.126 2.57 . . . . 0.0 108.596 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.76 -30.67 70.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -157.03 156.59 33.14 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 108.89 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 73.7 0.05 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.039 1.736 . . . . 0.0 111.852 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.95 -20.1 0.76 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.316 1.436 . . . . 0.0 111.512 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.11 175.41 48.22 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.321 1.06 . . . . 0.0 110.895 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.36 151.2 87.59 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.71 139.6 23.94 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.132 1.888 . . . . 0.0 109.497 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.05 -7.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.625 -1.179 . . . . 0.0 112.922 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 176.4 164.76 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -111.38 140.37 46.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -108.48 173.4 6.33 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.849 1.26 . . . . 0.0 108.679 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.75 129.31 26.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.692 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.47 68.15 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.606 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -84.62 127.14 33.92 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.54 1.67 . . . . 0.0 109.611 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -89.47 166.41 13.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.374 1.07 . . . . 0.0 113.838 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 tt -170.91 154.25 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.665 1.586 . . . . 0.0 108.575 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.1 t -107.59 159.41 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -155.32 -66.64 0.12 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -117.32 96.35 5.38 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.838 1.655 . . . . 0.0 109.625 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.01 15.24 0.01 OUTLIER Glycine 0 CA--C 1.531 1.056 1 C-N-CA 131.005 4.145 . . . . 0.0 117.64 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -143.71 160.68 40.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.142 -1.211 . . . . 0.0 109.012 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -89.4 124.14 34.19 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 127.208 2.203 . . . . 0.0 106.643 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -121.54 152.36 39.29 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.156 0.982 . . . . 0.0 108.628 178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.4 m -134.18 145.31 49.1 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.26 146.41 28.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.539 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -90.41 -32.17 16.54 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.792 1.637 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -148.7 -140.76 0.1 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.221 2.208 . . . . 0.0 107.601 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -87.02 126.4 34.72 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 127.849 2.46 . . . . 0.0 108.48 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.8 143.54 8.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.34 43.17 1.77 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.863 1.265 . . . . 0.0 108.637 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -138.8 161.36 37.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -31.32 105.02 0.22 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 128.938 2.895 . . . . 0.0 113.769 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -51.06 138.4 43.91 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 124.379 3.386 . . . . 0.0 113.889 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.65 -36.83 0.59 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.158 1.361 . . . . 0.0 113.446 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.0 m -76.08 -45.58 33.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 112.382 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -97.37 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.982 0.355 . . . . 0.0 111.486 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -168.23 175.46 6.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t 63.99 21.05 12.47 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.448 1.099 . . . . 0.0 109.834 -177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -123.09 140.43 53.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 124.236 1.014 . . . . 0.0 109.702 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -136.27 120.93 18.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.793 1.637 . . . . 0.0 106.677 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -70.73 134.05 47.13 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.08 -15.56 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.997 1.319 . . . . 0.0 111.802 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.33 160.8 29.62 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -112.01 144.98 40.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 m -117.93 -48.72 2.54 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.281 0.632 . . . . 0.0 111.598 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.933 -172.208 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.432 0.635 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.46 150.52 13.64 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 107.303 -2.319 . . . . 0.0 107.303 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.29 149.29 0.4 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.278 1.031 . . . . 0.0 108.509 -177.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 p -71.55 82.7 0.83 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.391 1.091 . . . . 0.0 111.194 176.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -39.8 -39.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.995 3.318 . . . . 0.0 113.866 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.03 -35.24 64.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.075 0.95 . . . . 0.0 111.029 179.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.94 153.87 18.06 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.505 1.122 . . . . 0.0 108.01 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -43.56 118.62 1.42 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.523 1.129 . . . . 0.0 111.476 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.69 127.68 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -49.7 135.07 19.58 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.335 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -93.07 25.15 23.26 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 121.321 1.507 . . . . 0.0 115.337 0.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -72.98 66.8 0.82 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.82 1.191 . . . . 0.0 108.119 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -53.58 154.79 3.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.38 -45.85 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.545 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -94.04 153.77 17.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 122.691 1.234 . . . . 0.0 110.179 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -112.72 166.8 11.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.39 2.276 . . . . 0.0 108.915 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.74 -32.66 74.23 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -157.35 158.65 36.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.993 1.317 . . . . 0.0 108.202 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.95 -61.21 0.67 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.262 1.825 . . . . 0.0 114.376 -177.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.47 12.88 65.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.541 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.17 -166.1 41.75 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.42 1.11 . . . . 0.0 111.625 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.24 160.68 26.41 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.923 1.289 . . . . 0.0 107.819 177.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.56 149.13 10.45 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.392 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.7 m -146.02 -19.35 0.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.308 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 177.85 166.05 0.69 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.365 0.984 . . . . 0.0 113.006 -175.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.66 113.41 26.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.57 167.97 16.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.662 0.785 . . . . 0.0 109.633 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.35 126.88 3.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.977 1.311 . . . . 0.0 111.877 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -8.18 57.98 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.153 178.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.37 126.45 32.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.661 1.73 . . . . 0.0 108.703 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -86.49 162.58 18.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.127 1.771 . . . . 0.0 112.518 -178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -163.95 150.15 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.085 1.354 . . . . 0.0 108.224 177.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.52 155.52 5.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -167.21 125.18 1.28 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 108.363 175.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 43.4 55.99 4.54 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 123.682 1.706 . . . . 0.0 111.44 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -36.06 1.11 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.704 2.573 . . . . 0.0 114.256 177.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -70.87 145.39 50.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.275 1.036 . . . . 0.0 110.443 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -101.95 119.66 39.14 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 129.088 2.955 . . . . 0.0 106.287 178.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -123.84 156.27 36.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.398 0.679 . . . . 0.0 110.051 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.8 m -132.58 143.01 49.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.583 1.153 . . . . 0.0 108.312 177.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.77 144.89 34.73 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.882 0.873 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.65 -37.68 17.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.334 -177.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 18.1 p90 -144.69 -67.46 0.32 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.561 0.696 . . . . 0.0 110.368 -177.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -155.42 142.05 18.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.821 2.448 . . . . 0.0 107.614 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -176.36 145.42 0.58 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 45.55 0.92 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.326 1.851 . . . . 0.0 106.516 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 56.2 p -106.96 -105.56 0.33 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.377 1.071 . . . . 0.0 113.106 -174.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.3 t -145.39 117.28 5.17 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.81 130.94 23.96 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.064 2.509 . . . . 0.0 115.885 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.79 -42.27 1.29 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.545 1.545 . . . . 0.0 113.025 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.8 m -59.33 -57.14 14.32 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.58 -25.43 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p 89.0 179.28 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.773 2.829 . . . . 0.0 110.48 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t 78.76 28.34 0.43 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 -170.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -136.39 157.34 47.04 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 129.772 3.229 . . . . 0.0 106.591 -175.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -155.25 120.19 4.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.73 128.71 36.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.32 -13.04 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.369 1.068 . . . . 0.0 110.423 178.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.59 -156.64 28.38 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.63 134.8 14.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 88.5 m -91.21 -42.49 10.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.319 0.509 . . . . 0.0 111.921 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.921 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -171.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 121.313 0.578 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.11 112.71 5.22 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -26.51 -49.67 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.562 2.745 . . . . 0.0 114.966 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 t -53.44 -53.59 49.18 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.53 1.059 . . . . 0.0 111.566 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 151.88 -61.17 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.373 3.469 . . . . 0.0 106.467 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -151.68 2.8 0.39 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.2 -171.27 3.33 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.421 1.01 . . . . 0.0 111.098 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -69.65 97.76 1.09 Allowed 'General case' 0 C--N 1.338 0.096 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.66 124.89 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -42.14 132.79 2.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 119.487 1.04 . . . . 0.0 111.15 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.72 27.29 15.01 Favored 'Cis proline' 0 C--N 1.35 0.638 0 N-CA-C 115.888 1.457 . . . . 0.0 115.888 1.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -74.71 66.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.153 1.342 . . . . 0.0 107.617 175.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -58.1 176.14 0.18 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 112.388 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.83 -33.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.12 -66.85 0.84 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -171.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.5 tttm 53.51 -167.26 0.07 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 123.611 1.672 . . . . 0.0 112.487 -170.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -82.0 -40.3 22.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.3 2.64 . . . . 0.0 109.996 176.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -79.81 174.61 11.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.842 2.057 . . . . 0.0 114.566 -175.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.41 39.91 3.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.198 2.199 . . . . 0.0 106.923 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.09 47.58 0.04 OUTLIER Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.374 1.464 . . . . 0.0 110.623 -177.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.25 -157.49 9.78 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -78.09 -174.78 0.47 Allowed Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -110.12 158.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.909 1.739 . . . . 0.0 113.373 178.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -150.92 -12.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.39 0.676 . . . . 0.0 112.049 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 178.6 164.07 0.77 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.342 0.974 . . . . 0.0 111.02 -177.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -112.37 149.65 32.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.654 1.182 . . . . 0.0 108.078 177.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.18 172.71 8.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.66 0.784 . . . . 0.0 110.471 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.22 123.25 2.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.485 1.514 . . . . 0.0 112.088 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -14.37 40.7 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.463 1.03 . . . . 0.0 113.779 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.49 118.06 21.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.295 1.547 . . . . 0.0 109.633 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -80.76 166.69 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 111.928 179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 tt -165.9 151.83 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -109.22 156.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -138.98 -126.56 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.36 84.19 1.44 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.277 1.399 . . . . 0.0 108.933 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.84 -45.28 0.87 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 127.993 2.711 . . . . 0.0 113.022 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -68.93 143.43 54.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.79 0.836 . . . . 0.0 111.675 -176.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.42 122.53 43.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 129.96 3.304 . . . . 0.0 106.621 177.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -122.84 170.79 9.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.824 1.25 . . . . 0.0 109.242 178.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -148.75 144.63 27.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.81 145.9 27.01 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.41 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -95.47 -31.39 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.221 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -134.18 -73.77 0.48 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 111.307 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -158.4 135.95 10.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.441 2.296 . . . . 0.0 108.441 -177.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -168.9 149.99 4.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.21 0.914 . . . . 0.0 109.677 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.97 37.0 0.86 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.131 1.772 . . . . 0.0 108.038 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.3 p -94.7 -103.93 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.018 0.927 . . . . 0.0 111.888 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.4 112.92 4.73 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.66 1.984 . . . . 0.0 106.056 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.1 121.02 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.421 2.747 . . . . 0.0 113.128 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.88 -17.59 57.7 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.995 0.807 . . . . 0.0 113.05 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -77.31 74.66 3.87 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.993 1.396 . . . . 0.0 109.453 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 t70 51.69 -132.19 1.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.362 1.065 . . . . 0.0 108.691 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t 57.7 -150.58 0.44 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.267 0.94 . . . . 0.0 109.136 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.45 -51.83 39.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.815 0.846 . . . . 0.0 109.702 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -20.06 130.66 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.156 2.582 . . . . 0.0 116.22 -175.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -136.77 128.76 29.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -75.3 141.03 43.48 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -14.06 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.87 1.268 . . . . 0.0 111.635 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.82 -148.12 13.31 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.553 1.069 . . . . 0.0 110.693 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -157.98 135.83 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.279 1.431 . . . . 0.0 108.827 178.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.7 m -68.11 -49.52 60.65 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.675 0.75 . . . . 0.0 109.235 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 -175.067 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptm . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.705 0.764 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.23 66.41 2.9 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -16.44 -57.45 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.413 3.085 . . . . 0.0 115.853 -176.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.4 t -54.34 -48.81 70.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.859 0.754 . . . . 0.0 112.907 -179.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 104.87 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.25 3.02 . . . . 0.0 108.458 -175.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.61 40.82 1.11 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.45 173.7 13.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.701 1.137 . . . . 0.0 109.093 174.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -48.83 107.3 0.13 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 125.189 1.396 . . . . 0.0 112.187 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.9 131.01 48.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.206 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -44.2 133.04 4.42 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.926 1.239 . . . . 0.0 110.404 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.9 35.97 7.43 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 121.202 1.465 . . . . 0.0 113.908 0.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.22 61.44 1.16 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.764 1.165 . . . . 0.0 108.237 176.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -55.38 156.02 4.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.775 0.798 . . . . 0.0 112.819 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -76.12 -53.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.608 178.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -80.82 143.31 32.9 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -124.61 165.91 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 112.069 -176.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -45.21 95.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.331 -1.758 . . . . 0.0 109.904 177.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.283 1.7 m95 21.24 166.4 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 136.471 5.908 . . . . 0.0 124.845 -177.365 . . . . . . . . 3 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 120.69 57.3 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 2 C-N-CA 136.595 5.958 . . . . 0.0 100.825 -173.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.28 59.34 3.37 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.647 2.546 . . . . 0.0 107.295 -173.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.35 -148.15 7.35 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 123.483 0.563 . . . . 0.0 111.949 -178.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -131.09 163.8 46.71 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.635 1.174 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.38 150.26 26.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.836 3.024 . . . . 0.0 110.477 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.91 -17.79 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.219 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -179.68 168.41 1.37 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -178.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -114.91 131.11 56.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.629 1.972 . . . . 0.0 107.567 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.58 165.05 11.32 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.968 0.907 . . . . 0.0 109.626 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.23 123.68 2.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.666 1.186 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.79 -12.43 57.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.157 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.77 139.31 39.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.263 2.031 . . . . 0.0 105.795 177.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -105.93 156.83 17.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.918 0.487 . . . . 0.0 111.079 -178.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -157.52 168.77 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.389 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.15 149.38 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.385 0.674 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.04 134.3 16.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.037 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 50.74 27.69 3.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.958 1.703 . . . . 0.0 113.915 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.0 -22.13 27.21 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 126.477 1.989 . . . . 0.0 112.231 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.97 138.08 36.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.424 1.112 . . . . 0.0 109.247 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 tp -91.54 131.19 37.15 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 128.45 2.7 . . . . 0.0 108.435 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -135.52 159.45 41.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 109.666 178.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -132.95 142.42 48.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.446 1.498 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.22 150.21 27.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.163 0.983 . . . . 0.0 111.077 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.776 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -139.91 -75.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -161.25 125.98 3.54 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.27 2.228 . . . . 0.0 106.506 -176.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 t -168.1 154.47 7.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.835 1.198 . . . . 0.0 111.608 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.42 20.69 4.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.238 1.815 . . . . 0.0 106.737 174.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -82.21 146.96 29.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.3 t -46.88 121.98 7.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.788 0.835 . . . . 0.0 109.192 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.44 127.69 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.171 2.581 . . . . 0.0 113.831 -179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.47 22.77 73.36 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.521 178.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 p -66.36 -71.57 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.307 1.053 . . . . 0.0 110.616 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -146.14 -32.67 0.34 Allowed 'General case' 0 C--O 1.23 0.069 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m -156.48 168.1 28.42 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.214 -0.929 . . . . 0.0 112.039 -174.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 p 70.53 0.39 3.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 130.303 3.441 . . . . 0.0 114.412 177.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.66 171.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.908 1.283 . . . . 0.0 112.573 -178.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -158.92 124.07 4.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.48 144.5 42.02 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.92 -6.52 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.873 0.869 . . . . 0.0 112.927 -178.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.49 -152.15 23.66 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 p -156.51 152.36 27.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.448 1.099 . . . . 0.0 109.029 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.93 -46.22 14.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.323 1.058 . . . . 0.0 108.91 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 129.86 3.264 . . . . 0.0 104.482 -174.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.1 m-20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 118.136 -0.935 . . . . 0.0 113.362 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -125.58 -60.12 1.33 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.237 1.015 . . . . 0.0 110.249 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.64 -66.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.251 3.02 . . . . 0.0 104.948 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -154.11 25.42 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.092 0.957 . . . . 0.0 111.61 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.94 -165.03 1.27 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.583 0.629 . . . . 0.0 109.688 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.04 89.2 1.93 Allowed 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.353 -0.842 . . . . 0.0 109.472 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 3' ' ' ASP . 98.6 t -83.64 118.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 108.239 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -45.17 135.29 5.28 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 120.767 1.621 . . . . 0.0 110.944 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -89.93 33.82 7.62 Favored 'Cis proline' 0 C--N 1.349 0.58 0 N-CA-C 115.685 1.379 . . . . 0.0 115.685 1.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -74.3 62.63 0.97 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.257 1.39 . . . . 0.0 108.867 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 7.1 m95 -51.68 160.82 0.59 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.098 1.359 . . . . 0.0 111.791 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.48 -31.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.345 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.7 t -153.36 167.53 29.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.315 0.9 OUTLIER -91.35 -30.55 16.48 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 131.177 3.791 . . . . 0.0 111.342 175.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 154.47 -43.06 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.549 3.94 . . . . 0.0 103.714 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -118.57 172.86 7.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.951 1.7 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.13 -57.5 5.31 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.98 -27.77 71.81 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.063 0.785 . . . . 0.0 115.063 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.08 142.44 43.12 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 119.215 1.507 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -60.33 132.94 90.64 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 72.8 Cg_exo -53.58 166.86 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 119.119 2.699 . . . . 0.0 119.119 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 m -150.46 -12.38 0.25 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.017 -1.902 . . . . 0.0 110.837 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 179.06 174.29 0.72 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 120.182 1.356 . . . . 0.0 112.982 -175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -112.1 132.12 55.04 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.71 169.58 9.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.819 1.248 . . . . 0.0 110.093 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -44.72 125.09 4.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.084 1.354 . . . . 0.0 111.386 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.07 -9.62 56.44 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.002 -0.888 . . . . 0.0 113.815 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -84.31 124.78 31.62 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.289 1.545 . . . . 0.0 108.032 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -92.29 165.36 13.14 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.899 0.88 . . . . 0.0 113.24 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.4 tt -161.22 163.47 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.024 1.33 . . . . 0.0 107.834 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.31 146.32 19.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -148.31 108.81 4.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.1 mttp 39.09 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.766 2.026 . . . . 0.0 112.432 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 -50.63 1.5 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.148 1.356 . . . . 0.0 112.805 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.0 142.25 47.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.338 1.069 . . . . 0.0 111.957 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 58' ' ' VAL . 5.1 tp -102.17 131.88 48.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 129.029 2.932 . . . . 0.0 107.284 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -132.94 164.78 26.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.944 0.898 . . . . 0.0 109.902 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.0 m -134.02 143.36 48.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.806 1.242 . . . . 0.0 108.024 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 142.44 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.797 0.808 . . . . 0.0 109.176 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -84.39 -34.24 23.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.202 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 19.0 p90 -143.07 -69.85 0.33 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -161.34 125.61 3.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.916 1.687 . . . . 0.0 108.125 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -166.99 154.74 9.36 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.767 1.167 . . . . 0.0 111.435 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HA ' ' CH2' ' A' ' 13' ' ' TRP . . . -143.01 32.01 1.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.879 1.671 . . . . 0.0 109.676 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -84.02 -103.86 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.059 0.457 . . . . 0.0 111.429 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.7 t -144.74 115.26 5.18 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HA ' ' CD2' ' A' ' 55' ' ' TRP . 45.3 Cg_exo -53.16 112.33 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.698 2.265 . . . . 0.0 112.542 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.82 -26.88 9.63 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.084 1.326 . . . . 0.0 111.721 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -78.37 70.28 4.69 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.359 1.08 . . . . 0.0 109.631 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 42.51 -111.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.805 1.642 . . . . 0.0 108.889 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t 59.65 -72.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.772 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.4 t -173.65 38.65 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.095 2.558 . . . . 0.0 107.146 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD2' ' HA ' ' A' ' 49' ' ' PRO . 89.9 m95 -112.08 154.49 25.33 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.615 1.198 . . . . 0.0 111.377 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -153.41 120.97 5.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -71.0 124.28 24.0 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.296 0.638 . . . . 0.0 109.933 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -101.86 -13.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.084 0.554 . . . . 0.0 112.134 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.29 -149.45 17.65 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -154.33 135.21 13.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 109.812 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.5 m -71.97 -46.87 55.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.994 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.311 -1.804 . . . . 0.0 106.509 -173.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.1 m -77.28 75.15 3.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.281 1.038 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -20.59 -51.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 131.363 3.865 . . . . 0.0 115.304 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -62.13 -8.6 5.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.315 1.446 . . . . 0.0 114.351 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.84 141.59 49.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.099 0.96 . . . . 0.0 108.924 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -29.51 105.13 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 128.086 2.554 . . . . 0.0 113.631 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.1 134.05 27.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -45.39 132.74 5.99 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 119.783 1.174 . . . . 0.0 111.425 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.61 43.25 3.11 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 121.593 1.605 . . . . 0.0 113.904 -0.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -76.39 64.28 2.1 Favored 'General case' 0 N--CA 1.428 -1.572 0 O-C-N 119.324 -2.11 . . . . 0.0 107.429 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -56.05 156.21 5.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.977 0.894 . . . . 0.0 110.888 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.91 -21.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.304 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.9 t -145.08 165.89 26.94 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.752 1.263 . . . . 0.0 112.63 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.298 85.8 tttt -97.14 -34.07 11.27 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 131.241 3.816 . . . . 0.0 109.363 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 162.92 -42.97 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 1 C-N-CA 132.896 4.478 . . . . 0.0 102.641 -172.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -117.56 155.06 30.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.462 1.505 . . . . 0.0 107.593 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.67 -60.43 3.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.696 1.598 . . . . 0.0 115.231 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.7 -4.22 61.07 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.842 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.31 152.4 43.31 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 119.426 1.613 . . . . 0.0 109.923 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.28 144.74 94.68 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.06 158.33 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 116.571 1.72 . . . . 0.0 116.571 -169.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 m -152.23 -17.43 0.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.067 0.947 . . . . 0.0 112.599 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 177.31 150.48 0.18 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.318 0.963 . . . . 0.0 110.516 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.73 141.32 32.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.6 166.19 13.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.378 1.071 . . . . 0.0 108.696 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -56.68 130.67 46.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.761 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.68 -6.5 69.39 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.386 -1.23 . . . . 0.0 113.273 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -85.61 143.24 28.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.911 1.855 . . . . 0.0 109.613 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -103.01 164.52 11.56 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 tt -161.74 156.73 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.876 1.27 . . . . 0.0 109.7 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.87 159.3 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 126.515 1.926 . . . . 0.0 109.78 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.5 t80 174.66 147.18 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.32 2.648 . . . . 0.0 107.13 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 40.94 44.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 113.326 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.46 24.85 25.33 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.494 2.473 . . . . 0.0 113.218 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -119.7 156.61 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.679 1.592 . . . . 0.0 107.211 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.598 ' CD2' HG13 ' A' ' 58' ' ' VAL . 12.8 tp -110.29 122.02 46.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.596 1.958 . . . . 0.0 107.863 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -125.77 150.28 47.88 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.673 0.67 . . . . 0.0 110.001 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 m -117.13 138.97 51.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.876 1.27 . . . . 0.0 108.359 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.96 142.37 36.73 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.172 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -87.47 -30.81 20.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.603 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 33.0 p90 -145.13 -141.27 0.12 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.838 1.655 . . . . 0.0 108.325 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -92.37 116.21 28.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.823 2.849 . . . . 0.0 106.165 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 t -163.83 148.35 10.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.492 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.63 13.04 9.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.326 1.85 . . . . 0.0 107.997 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.6 t -70.51 162.46 28.76 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.14 118.52 62.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.121 0.568 . . . . 0.0 110.289 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -41.1 122.37 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.941 3.761 . . . . 0.0 114.45 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.46 22.51 3.82 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.697 1.618 . . . . 0.0 114.471 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -123.88 26.67 7.53 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.514 1.157 . . . . 0.0 110.416 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -170.19 -79.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -174.56 177.67 2.09 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.7 1.2 . . . . 0.0 108.239 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.3 p 64.12 15.31 9.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.674 2.79 . . . . 0.0 112.903 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -126.21 142.6 51.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.954 1.302 . . . . 0.0 110.512 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -136.48 114.64 11.54 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.734 1.614 . . . . 0.0 107.556 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -62.91 140.68 58.85 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.395 0.617 . . . . 0.0 109.832 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.598 HG13 ' CD2' ' A' ' 38' ' ' LEU 0.278 0.3 OUTLIER -131.77 3.79 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.593 1.157 . . . . 0.0 112.439 -174.886 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.23 -170.55 34.45 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.5 p -161.37 167.76 25.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 m -57.58 -40.02 78.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.415 1.086 . . . . 0.0 110.885 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.598 0 CA-C-O 114.77 -2.538 . . . . 0.0 106.861 -173.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.042 0.448 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.71 80.97 0.28 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.776 1.274 . . . . 0.0 111.07 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.46 30.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.056 2.142 . . . . 0.0 111.8 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -58.09 -30.59 66.36 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.92 1.288 . . . . 0.0 111.212 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.49 161.92 14.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.316 1.046 . . . . 0.0 108.673 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.42 121.25 5.43 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.391 0.677 . . . . 0.0 110.1 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.15 135.11 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 117.624 -1.179 . . . . 0.0 108.541 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -46.07 133.59 7.1 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 120.057 1.299 . . . . 0.0 111.008 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -97.03 33.11 10.15 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 121.414 1.541 . . . . 0.0 113.875 -0.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.23 68.06 1.44 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 32.3 m95 -51.07 168.21 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.642 0.777 . . . . 0.0 112.328 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.78 -19.03 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.81 -72.17 0.59 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -171.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 tttt 48.83 -157.03 0.07 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 122.371 1.081 . . . . 0.0 111.787 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.34 -41.47 93.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.325 -1.761 . . . . 0.0 107.178 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -156.6 156.64 33.91 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.247 1.819 . . . . 0.0 107.191 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.98 -58.99 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.193 1.797 . . . . 0.0 114.796 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.33 -9.22 85.85 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.233 -0.759 . . . . 0.0 114.008 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.49 154.48 50.44 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -55.87 103.48 0.37 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 108.177 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 23.2 Cg_exo -50.51 143.97 26.27 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.942 3.095 . . . . 0.0 118.2 -171.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.7 p -132.99 -12.68 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -178.83 162.77 1.34 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.167 0.984 . . . . 0.0 113.427 -175.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -107.65 114.12 27.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.437 1.895 . . . . 0.0 108.582 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.0 166.26 12.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.499 1.119 . . . . 0.0 110.216 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.47 126.27 3.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.931 1.292 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.36 -2.73 80.94 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.316 -1.269 . . . . 0.0 114.648 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.26 121.56 29.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.437 2.119 . . . . 0.0 108.179 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -83.94 159.99 21.16 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.833 -1.167 . . . . 0.0 111.595 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.06 155.21 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.332 1.453 . . . . 0.0 107.753 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -101.96 153.73 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.07 0.948 . . . . 0.0 109.385 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -161.83 126.82 3.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.879 1.672 . . . . 0.0 107.34 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt 30.52 83.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.936 2.095 . . . . 0.0 112.951 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.63 -35.86 0.27 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -94.34 154.14 17.64 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.917 1.859 . . . . 0.0 112.867 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -107.03 124.7 50.02 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.327 2.651 . . . . 0.0 105.861 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.74 161.64 26.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.889 0.876 . . . . 0.0 110.114 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 m -136.93 144.54 43.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.21 150.32 26.28 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 122.057 0.932 . . . . 0.0 111.079 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.48 -34.05 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.858 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -140.39 -72.15 0.37 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.774 0.321 . . . . 0.0 111.64 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -159.31 133.15 7.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.836 1.655 . . . . 0.0 108.562 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 t -166.38 151.69 8.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.96 40.05 1.5 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.082 1.353 . . . . 0.0 107.55 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.5 t -130.49 156.4 44.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.388 1.075 . . . . 0.0 108.199 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -36.76 110.9 0.48 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.418 2.287 . . . . 0.0 113.098 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 134.62 62.41 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.286 2.657 . . . . 0.0 113.189 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.03 -53.06 3.38 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 m -81.13 47.76 1.05 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.966 0.906 . . . . 0.0 110.586 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -164.92 -117.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 m -163.93 168.85 18.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.996 1.719 . . . . 0.0 107.589 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 66.67 14.77 9.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.658 1.183 . . . . 0.0 112.501 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.64 155.69 24.01 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.694 1.598 . . . . 0.0 109.042 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 m -152.17 125.46 8.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.57 137.53 54.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.119 0.567 . . . . 0.0 110.495 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.85 -15.13 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.289 1.436 . . . . 0.0 110.739 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.17 -161.81 35.63 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -153.98 163.04 40.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.1 t -88.22 -17.13 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.13 2.172 . . . . 0.0 111.367 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.432 0 C-N-CA 126.569 1.948 . . . . 0.0 105.83 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 . . . . . 0 C--O 1.223 -0.326 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 80.8 m 45.68 27.7 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.236 2.214 . . . . 0.0 114.136 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.33 -21.34 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.111 2.564 . . . . 0.0 114.037 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -57.29 -37.41 72.38 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.28 0.632 . . . . 0.0 109.944 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.06 176.19 5.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.957 0.903 . . . . 0.0 109.635 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.76 98.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.782 0.833 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.41 128.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.928 1.291 . . . . 0.0 108.898 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -43.08 134.47 3.09 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.818 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -91.7 31.93 10.7 Favored 'Cis proline' 0 C--N 1.348 0.528 0 CA-C-N 120.239 1.121 . . . . 0.0 114.433 0.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -75.57 61.88 1.37 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.179 1.354 . . . . 0.0 109.311 177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 12.2 m95 -49.91 164.03 0.12 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.026 1.731 . . . . 0.0 113.578 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -79.82 -37.51 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.232 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -156.46 -171.64 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.278 0.945 . . . . 0.0 112.311 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.289 55.2 tttm -107.15 -45.63 4.09 Favored 'General case' 0 N--CA 1.412 -2.363 1 C-N-CA 132.942 4.497 . . . . 0.0 110.215 178.646 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 168.26 -44.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 131.603 3.961 . . . . 0.0 104.751 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -58.08 178.3 0.1 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 130.912 3.685 . . . . 0.0 116.923 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.12 37.44 4.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.878 2.871 . . . . 0.0 106.47 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.17 46.53 0.02 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.043 1.306 . . . . 0.0 111.473 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.76 152.63 18.57 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.91 119.4 51.3 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 50.2 Cg_exo -53.85 154.71 16.18 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 117.708 2.157 . . . . 0.0 117.708 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -151.09 4.52 0.46 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.34 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -175.79 168.73 3.05 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 121.356 1.889 . . . . 0.0 116.094 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.82 125.6 50.85 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -87.29 167.96 13.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.786 1.234 . . . . 0.0 111.192 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.08 127.13 8.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.985 1.314 . . . . 0.0 110.409 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -15.31 22.26 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.419 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -77.37 132.08 38.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.816 1.808 . . . . 0.0 108.929 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -94.66 162.38 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.664 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.4 tt -161.74 154.57 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.208 1.003 . . . . 0.0 108.315 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -95.3 156.38 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.233 . . . . 0.0 107.797 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -172.1 141.93 1.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.581 1.953 . . . . 0.0 106.942 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mttp 24.64 73.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.831 2.052 . . . . 0.0 113.034 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.51 38.07 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 128.955 3.169 . . . . 0.0 114.474 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -144.22 158.23 43.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.83 127.82 44.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 127.747 2.419 . . . . 0.0 107.867 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -126.26 166.76 16.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.799 1.239 . . . . 0.0 108.856 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -150.32 148.3 28.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.269 1.028 . . . . 0.0 108.366 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.56 148.32 25.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.684 1.194 . . . . 0.0 111.53 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -90.47 -32.73 16.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.569 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.9 p90 -142.57 -74.18 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.069 0.462 . . . . 0.0 112.223 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -160.21 119.58 2.78 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 127.597 2.359 . . . . 0.0 105.003 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -158.54 152.36 23.53 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.047 1.294 . . . . 0.0 112.096 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 8.84 5.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 109.578 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 m -77.58 155.03 31.79 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.31 139.02 80.48 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 119.667 1.121 . . . . 0.0 109.7 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.21 116.85 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.198 1.932 . . . . 0.0 112.724 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.1 25.88 70.08 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.279 -0.734 . . . . 0.0 112.1 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.6 p -59.99 -56.71 18.33 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.479 1.139 . . . . 0.0 110.191 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.07 -43.41 0.23 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.093 1.357 . . . . 0.0 111.325 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -166.75 -171.65 1.9 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 124.484 1.113 . . . . 0.0 109.142 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 p 65.67 5.9 3.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 130.854 3.662 . . . . 0.0 113.663 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.72 159.58 33.3 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 125.01 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -148.22 132.85 17.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -78.58 130.6 36.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.67 -13.54 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.637 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.12 -171.68 35.7 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 119.674 1.125 . . . . 0.0 112.339 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -107.83 87.54 2.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -32.69 -55.88 0.36 Allowed 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 127.257 2.223 . . . . 0.0 114.179 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.006 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.442 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.6 m -87.64 97.96 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.46 10.82 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.446 2.298 . . . . 0.0 111.828 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.16 -3.69 28.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.28 170.67 15.36 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.47 1.032 . . . . 0.0 110.356 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -59.7 121.3 11.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.45 131.39 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.034 0.934 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -43.12 134.02 3.16 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.766 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.81 30.2 14.29 Favored 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.595 1.248 . . . . 0.0 112.755 -0.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -76.14 62.94 1.77 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -49.69 159.36 0.38 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.945 0.878 . . . . 0.0 113.245 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.58 -43.16 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.467 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -90.46 139.08 31.03 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.417 1.103 . . . . 0.0 111.385 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -110.83 166.97 10.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.617 1.967 . . . . 0.0 109.958 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -67.42 -34.8 77.98 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.1 163.54 39.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.097 1.759 . . . . 0.0 106.909 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.93 -55.87 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.503 1.521 . . . . 0.0 114.082 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.79 5.38 79.46 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.485 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.86 171.16 55.06 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.516 1.158 . . . . 0.0 111.2 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.83 165.66 51.44 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.22 145.15 71.47 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.607 1.538 . . . . 0.0 108.669 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 m -141.66 -7.62 0.97 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.191 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 176.0 170.77 0.39 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.1 0.952 . . . . 0.0 111.775 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -112.67 111.16 21.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.742 1.617 . . . . 0.0 107.279 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -83.71 162.81 20.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 109.721 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.4 128.2 1.41 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.993 1.717 . . . . 0.0 112.593 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.31 -7.99 49.47 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.567 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.15 136.05 35.2 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.534 2.167 . . . . 0.0 106.825 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -98.87 159.24 15.09 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.64 -0.662 . . . . 0.0 112.002 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 tt -159.75 163.72 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.894 1.278 . . . . 0.0 108.784 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 4' ' ' CYS . 1.6 t -121.4 165.75 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.12 -62.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -156.1 125.6 6.28 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.15 -42.8 0.17 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.123 2.773 . . . . 0.0 115.507 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -109.75 146.05 35.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.524 1.13 . . . . 0.0 112.253 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tp -97.35 127.53 43.4 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 129.057 2.943 . . . . 0.0 105.682 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.92 161.78 28.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.87 0.868 . . . . 0.0 110.759 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.5 m -138.99 145.52 39.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.83 147.99 26.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.991 0.9 . . . . 0.0 111.442 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -85.06 -36.08 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.097 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -142.52 -70.05 0.34 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.917 0.487 . . . . 0.0 111.389 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -158.53 138.47 12.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.524 1.53 . . . . 0.0 108.908 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -173.32 147.78 1.56 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.499 0.666 . . . . 0.0 109.96 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.87 26.37 4.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 153.07 19.63 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.626 1.571 . . . . 0.0 108.137 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -49.24 117.19 6.42 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.48 0.712 . . . . 0.0 110.012 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.36 120.52 4.49 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.294 2.663 . . . . 0.0 112.261 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.44 -23.78 29.21 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.394 -0.67 . . . . 0.0 111.794 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 t -77.11 59.37 1.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.604 1.202 . . . . 0.0 110.416 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 41.47 -109.06 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.474 1.909 . . . . 0.0 109.734 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t 58.27 -82.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.73 1.612 . . . . 0.0 111.038 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -150.77 28.32 0.7 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.372 1.469 . . . . 0.0 110.425 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.44 171.5 7.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.339 1.066 . . . . 0.0 112.784 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -162.98 130.75 3.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.954 2.102 . . . . 0.0 105.519 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -78.94 139.68 38.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.83 -16.87 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.911 1.284 . . . . 0.0 111.256 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.84 -167.3 39.79 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -144.78 156.6 44.13 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.687 1.195 . . . . 0.0 108.121 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.9 m -114.83 -68.59 0.91 Allowed 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 123.828 0.705 . . . . 0.0 111.093 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 CA-C-O 115.337 -2.268 . . . . 0.0 106.971 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 t -59.51 -52.56 65.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.231 1.015 . . . . 0.0 109.631 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 166.65 -63.79 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 131.161 3.784 . . . . 0.0 103.903 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -157.91 28.11 0.27 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.223 1.009 . . . . 0.0 111.314 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 179.34 5.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.312 0.506 . . . . 0.0 109.992 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.63 98.03 0.17 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.988 0.423 . . . . 0.0 109.9 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -105.88 137.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -46.51 135.57 7.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.092 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -94.33 31.42 12.37 Favored 'Cis proline' 0 C--N 1.349 0.567 0 N-CA-C 115.354 1.251 . . . . 0.0 115.354 1.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -77.67 59.77 2.06 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 121.272 1.851 . . . . 0.0 108.741 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -55.29 157.72 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.787 0.835 . . . . 0.0 112.893 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.39 -49.12 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.347 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -84.33 154.24 23.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.503 1.144 . . . . 0.0 109.541 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -126.01 168.14 14.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.944 2.098 . . . . 0.0 109.762 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.64 -31.29 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -160.57 160.15 31.45 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.388 1.475 . . . . 0.0 107.708 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.01 -61.79 0.62 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.141 1.776 . . . . 0.0 114.151 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.65 14.31 61.83 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.511 -0.605 . . . . 0.0 113.354 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 -169.38 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.365 1.083 . . . . 0.0 111.478 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.19 160.8 28.12 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -51.84 145.75 30.81 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.826 2.351 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 m -134.22 -29.95 1.21 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.274 0.63 . . . . 0.0 112.428 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 173.62 171.83 0.17 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.243 0.474 . . . . 0.0 111.057 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -111.17 140.32 45.82 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.61 167.72 9.94 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.574 1.15 . . . . 0.0 109.267 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.55 121.07 1.6 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.596 1.159 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.89 -11.59 70.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.155 1.36 . . . . 0.0 113.785 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -81.42 123.83 28.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.036 1.418 . . . . 0.0 109.26 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -89.14 162.56 15.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.962 1.705 . . . . 0.0 112.268 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.7 tt -168.07 165.94 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.849 1.26 . . . . 0.0 108.375 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.4 t -118.53 163.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.416 . . . . 0.0 108.011 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.97 -60.84 0.9 Allowed 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.47 106.73 3.15 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.22 -46.67 0.49 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.773 1.654 . . . . 0.0 114.204 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -87.64 145.26 26.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 112.039 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 58' ' ' VAL . 7.0 tp -99.18 133.23 43.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 130.31 3.444 . . . . 0.0 107.737 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -134.18 153.95 51.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.169 0.987 . . . . 0.0 109.243 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 m -125.76 135.62 52.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.845 0.858 . . . . 0.0 109.742 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.78 136.98 47.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.818 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -87.8 -36.29 17.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.451 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 11.5 p90 -138.61 -70.85 0.42 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.314 0.646 . . . . 0.0 110.127 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -159.61 130.34 5.82 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 128.146 2.579 . . . . 0.0 106.353 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -165.41 151.42 9.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.676 1.126 . . . . 0.0 111.32 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.9 19.43 2.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.369 1.868 . . . . 0.0 108.765 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -85.18 164.83 17.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.59 119.53 33.67 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.71 125.51 11.27 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.19 2.593 . . . . 0.0 112.02 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.27 -11.81 65.33 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.011 -0.883 . . . . 0.0 112.314 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 t -76.22 69.5 2.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.072 1.436 . . . . 0.0 109.102 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 43.11 -125.78 0.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.376 1.87 . . . . 0.0 109.285 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t 53.38 -132.25 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.146 0.578 . . . . 0.0 109.769 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -69.49 -80.56 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 129.59 3.156 . . . . 0.0 109.401 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -7.95 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.979 2.912 . . . . 0.0 116.538 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -89.31 114.58 25.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.16 -1.837 . . . . 0.0 107.264 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -67.74 132.82 48.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.48 10.5 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.855 0.862 . . . . 0.0 112.693 -177.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.16 -155.59 16.33 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 p -85.01 167.05 16.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -50.5 -42.04 54.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.917 0.865 . . . . 0.0 111.577 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -1.012 0 C-N-CA 128.92 2.888 . . . . 0.0 104.486 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m 53.61 20.68 2.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.113 1.765 . . . . 0.0 113.232 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.17 -25.94 1.02 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.774 2.43 . . . . 0.0 114.321 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -58.37 -36.52 73.63 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.63 0.772 . . . . 0.0 110.889 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -171.96 3.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.592 0.757 . . . . 0.0 110.422 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.35 94.97 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.455 -0.778 . . . . 0.0 109.91 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.91 135.85 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 126.196 1.798 . . . . 0.0 108.234 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -44.28 132.18 4.54 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.71 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -95.54 32.59 10.88 Favored 'Cis proline' 0 C--N 1.35 0.649 0 CA-C-N 120.75 1.304 . . . . 0.0 114.931 1.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -76.45 57.24 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.095 1.316 . . . . 0.0 109.309 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 28.3 m95 -51.36 141.19 15.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.047 1.339 . . . . 0.0 112.899 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 t -77.61 -29.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 112.287 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.4 m -67.05 -18.4 65.34 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.34 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.991 1.716 . . . . 0.0 111.62 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t0 149.06 -45.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 1 C-N-CA 132.867 4.467 . . . . 0.0 105.361 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.1 p-90 -149.71 171.91 15.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 108.229 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.56 -53.89 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.441 1.896 . . . . 0.0 114.395 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.8 18.27 24.54 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.325 0.964 . . . . 0.0 112.239 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.94 145.7 35.51 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.865 0.833 . . . . 0.0 112.695 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -72.84 136.0 80.36 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 53.4 Cg_exo -39.67 138.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 1 C-N-CA 125.406 4.071 . . . . 0.0 116.254 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -123.61 -30.63 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 172.87 164.81 0.13 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.555 1.07 . . . . 0.0 110.847 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -97.35 133.81 41.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 107.777 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.26 163.5 12.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.929 1.292 . . . . 0.0 110.305 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.92 122.66 1.78 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.898 1.279 . . . . 0.0 111.944 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.2 -3.69 70.71 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.667 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -83.01 118.18 23.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.499 2.149 . . . . 0.0 106.542 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -78.39 164.83 24.46 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.286 -0.884 . . . . 0.0 110.058 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.0 tt -161.51 159.39 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.689 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.59 155.18 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.502 1.521 . . . . 0.0 108.704 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -176.6 135.27 0.23 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.61 2.364 . . . . 0.0 107.357 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? 44.75 33.0 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.132 2.173 . . . . 0.0 115.128 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.54 77.75 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.798 1.189 . . . . 0.0 112.923 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.13 154.61 37.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -97.99 120.87 39.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.277 1.831 . . . . 0.0 108.191 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -123.56 159.43 29.21 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.828 0.851 . . . . 0.0 108.971 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -144.9 143.2 30.45 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.14 149.0 25.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.154 0.978 . . . . 0.0 109.788 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.57 -31.15 22.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.903 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.71 -72.94 0.28 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.628 0.728 . . . . 0.0 110.191 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -165.99 136.54 3.54 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.287 1.435 . . . . 0.0 109.982 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -176.31 155.38 1.46 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 119.157 0.89 . . . . 0.0 111.4 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.02 18.98 5.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.988 1.715 . . . . 0.0 108.09 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -84.42 171.22 12.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.05 121.4 35.76 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 51.2 Cg_exo -53.77 115.76 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.624 2.216 . . . . 0.0 110.833 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 1.54 33.37 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.101 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -75.94 49.99 0.57 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.984 1.892 . . . . 0.0 111.314 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 42.98 -140.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.152 1.781 . . . . 0.0 109.216 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.2 t 44.11 -106.91 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 112.879 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 p -75.44 -5.99 47.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.931 2.092 . . . . 0.0 114.801 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.411 ' CE2' ' HA ' ' A' ' 49' ' ' PRO . 99.3 m95 -107.07 174.23 5.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.636 1.107 . . . . 0.0 112.87 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -163.42 135.36 5.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.908 2.083 . . . . 0.0 105.788 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -88.5 128.25 35.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.68 -15.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.184 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.16 -155.86 26.44 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 119.39 0.995 . . . . 0.0 111.696 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -89.9 135.71 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.03 99.44 6.1 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.512 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.5 m -91.0 87.61 6.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -49.29 -34.53 15.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.7 1.6 . . . . 0.0 113.091 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.1 -18.4 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.336 1.054 . . . . 0.0 112.825 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.67 -175.81 2.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.91 102.44 0.6 Allowed 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.954 -0.467 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.54 125.62 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -47.73 138.19 9.55 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.603 -0.685 . . . . 0.0 110.79 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.82 35.43 7.7 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 N-CA-C 114.925 1.087 . . . . 0.0 114.925 1.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -75.33 65.19 1.61 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 121.532 1.969 . . . . 0.0 109.897 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -50.38 154.77 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.841 0.856 . . . . 0.0 112.465 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -84.03 -41.55 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.783 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.4 m -106.03 155.04 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.457 1.122 . . . . 0.0 113.371 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -103.58 150.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.034 2.134 . . . . 0.0 106.752 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.56 -34.35 77.69 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.648 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -141.04 158.31 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.417 1.087 . . . . 0.0 108.672 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.67 -61.29 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.288 1.835 . . . . 0.0 114.071 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.53 10.74 72.34 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.458 -0.634 . . . . 0.0 113.309 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.59 171.17 52.66 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 118.57 1.185 . . . . 0.0 110.885 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 168.39 19.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.36 133.02 55.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 108.348 -1.443 . . . . 0.0 108.348 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -128.05 -13.16 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.825 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 177.36 167.97 0.62 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.45 1.023 . . . . 0.0 113.292 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.61 139.5 42.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.62 168.59 8.98 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.233 1.013 . . . . 0.0 109.051 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.01 121.58 2.15 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.827 1.251 . . . . 0.0 111.487 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.15 -15.7 54.98 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.017 0.818 . . . . 0.0 113.75 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -76.57 121.77 23.65 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.108 1.454 . . . . 0.0 108.737 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -87.7 164.03 16.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.272 1.429 . . . . 0.0 112.313 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 tt -164.6 154.52 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.912 1.685 . . . . 0.0 106.992 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.519 HG11 ' H ' ' A' ' 4' ' ' CYS . 2.0 t -108.41 156.34 9.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -152.13 -108.24 0.05 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -73.7 87.79 1.71 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.973 0.806 . . . . 0.0 108.994 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.24 -40.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 130.332 3.825 . . . . 0.0 117.045 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -102.37 164.06 11.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.919 0.888 . . . . 0.0 111.478 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.2 tp -80.76 131.48 35.43 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.694 2.398 . . . . 0.0 107.739 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.04 153.31 46.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.085 1.354 . . . . 0.0 108.453 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 58' ' ' VAL . 53.9 m -137.77 146.27 43.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.282 0.633 . . . . 0.0 109.632 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.14 144.24 33.22 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.891 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -92.74 -30.04 15.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.904 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -141.73 -73.88 0.31 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 111.998 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.49 119.39 2.65 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.791 2.836 . . . . 0.0 106.117 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 t -163.01 150.89 13.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 120.111 1.323 . . . . 0.0 112.115 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.28 12.99 6.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.932 2.093 . . . . 0.0 107.941 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 t -74.93 172.64 11.92 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.07 118.38 42.22 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 109.987 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.61 140.26 36.93 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.668 2.246 . . . . 0.0 111.829 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.27 -10.8 60.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.598 -1.112 . . . . 0.0 112.157 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -79.02 54.97 1.7 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.795 1.798 . . . . 0.0 110.513 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 42.34 -146.32 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.116 2.166 . . . . 0.0 112.038 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 m 40.78 -100.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.508 2.323 . . . . 0.0 113.762 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.4 p -78.21 -4.13 46.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.05 139.08 51.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 119.117 0.871 . . . . 0.0 110.692 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -133.17 122.82 24.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 113.476 -1.693 . . . . 0.0 106.955 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -69.33 138.6 53.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.486 HG21 ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -121.16 -12.02 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.93 -159.27 32.01 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 120.248 1.385 . . . . 0.0 110.819 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -149.98 -176.67 5.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.424 1.09 . . . . 0.0 108.304 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.2 m -122.68 -69.71 0.81 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.948 0.899 . . . . 0.0 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.997 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.87 -57.35 3.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.341 1.067 . . . . 0.0 108.36 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 163.89 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 130.455 3.502 . . . . 0.0 105.083 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.14 4.09 0.45 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 113.04 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.85 178.92 7.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.165 0.893 . . . . 0.0 111.926 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.57 100.84 0.07 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.339 1.056 . . . . 0.0 110.747 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.97 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -45.57 133.96 6.17 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.334 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.8 32.86 10.5 Favored 'Cis proline' 0 C--N 1.353 0.777 0 CA-C-N 121.198 1.464 . . . . 0.0 114.375 0.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.84 66.58 2.13 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 120.276 1.398 . . . . 0.0 107.306 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -60.38 161.25 7.54 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.433 1.493 . . . . 0.0 112.145 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -81.99 -26.02 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.839 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.5 m -153.09 175.81 12.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 112.297 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.288 88.5 tttt -111.4 -47.08 3.21 Favored 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 130.475 3.51 . . . . 0.0 109.936 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 159.98 -45.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.195 1 C-N-CA 131.954 4.102 . . . . 0.0 103.768 -172.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -61.63 169.66 2.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.0 2.52 . . . . 0.0 113.526 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.33 39.26 2.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.227 2.211 . . . . 0.0 107.06 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.7 48.08 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.057 1.313 . . . . 0.0 110.806 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.91 156.58 21.52 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -57.44 124.89 69.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.767 1.284 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -55.32 146.13 63.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.151 1.901 . . . . 0.0 113.311 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.19 2.87 0.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.019 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -175.29 166.95 3.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.005 1.383 . . . . 0.0 114.624 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -115.72 123.11 47.48 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.561 1.544 . . . . 0.0 107.784 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -95.55 157.87 15.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.344 1.458 . . . . 0.0 110.518 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.69 123.96 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.119 1.767 . . . . 0.0 112.397 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.58 -13.61 51.21 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 117.523 -1.71 . . . . 0.0 114.644 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -80.68 143.71 32.82 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 121.229 2.514 . . . . 0.0 107.758 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 m -103.28 157.62 16.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.74 165.81 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.32 151.36 23.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.676 0.671 . . . . 0.0 109.888 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -154.58 124.96 6.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? 35.87 73.9 0.08 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.124 1.77 . . . . 0.0 111.918 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 -46.32 0.54 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.028 1.775 . . . . 0.0 114.07 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -68.49 141.53 55.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.563 1.182 . . . . 0.0 111.763 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 tp -98.58 123.97 43.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 128.882 2.873 . . . . 0.0 106.474 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.93 169.19 11.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.457 1.103 . . . . 0.0 109.735 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -149.79 150.09 31.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 148.89 25.68 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 122.022 0.915 . . . . 0.0 112.207 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -92.21 -35.37 13.85 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 110.011 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -144.87 -72.82 0.26 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.409 0.684 . . . . 0.0 110.726 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -156.45 133.78 10.69 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.807 1.643 . . . . 0.0 109.12 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -168.92 151.78 5.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.886 0.766 . . . . 0.0 111.35 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.79 17.66 3.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.317 1.847 . . . . 0.0 107.47 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.2 t -85.47 166.71 16.11 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.99 119.78 33.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.21 117.44 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.192 2.594 . . . . 0.0 112.189 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 -25.95 14.16 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.632 1.11 . . . . 0.0 111.331 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.9 t -76.08 61.45 1.55 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.491 1.146 . . . . 0.0 111.153 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 45.18 -119.44 0.77 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.436 1.494 . . . . 0.0 108.766 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t 66.43 -63.91 0.24 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.58 1.952 . . . . 0.0 113.017 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -178.51 32.64 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 129.665 3.186 . . . . 0.0 107.083 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -109.7 149.08 30.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.693 1.133 . . . . 0.0 110.776 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -144.79 127.97 16.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -77.37 137.45 38.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.75 -17.15 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.678 1.191 . . . . 0.0 111.001 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.63 -151.55 19.13 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.354 0.979 . . . . 0.0 111.359 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -141.26 138.57 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.14 1.776 . . . . 0.0 107.786 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.3 m -74.71 98.21 3.4 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 173.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.257 1.456 0 O-C-N 125.328 1.642 . . . . 0.0 109.382 175.877 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 121.248 0.547 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 33' ' ' VAL 0.294 1.5 m 15.25 69.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 131.546 3.938 . . . . 0.0 114.558 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.25 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.394 2.278 . . . . 0.0 113.549 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -56.33 -32.52 64.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.51 0.724 . . . . 0.0 111.059 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.84 169.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.616 1.166 . . . . 0.0 109.949 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -48.33 120.34 3.57 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.33 1.052 . . . . 0.0 109.975 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -105.99 126.71 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -48.33 135.84 12.3 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.703 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.46 28.47 16.51 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 119.989 1.032 . . . . 0.0 114.208 -0.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -74.64 67.79 1.59 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.873 1.215 . . . . 0.0 108.677 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 30.5 m95 -48.34 160.35 0.16 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.927 0.891 . . . . 0.0 111.609 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -34.17 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.909 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -170.37 -167.91 0.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.336 1.065 . . . . 0.0 113.152 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.261 41.4 mtpt -101.2 -33.01 10.26 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 131.375 3.87 . . . . 0.0 108.457 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 159.23 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 129.426 3.09 . . . . 0.0 106.28 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -117.73 153.86 32.68 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.425 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.73 -63.58 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.228 1.811 . . . . 0.0 114.152 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.52 0.66 54.77 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.384 -0.675 . . . . 0.0 113.144 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.6 128.03 10.1 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -58.87 115.6 12.45 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 35.6 Cg_exo -42.57 130.88 5.27 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.733 2.289 . . . . 0.0 114.074 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -128.54 -15.18 4.56 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.164 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 177.68 164.08 0.61 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.503 1.047 . . . . 0.0 111.221 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -98.23 125.77 43.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -92.96 169.91 10.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.646 1.179 . . . . 0.0 109.184 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.83 127.46 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.065 0.946 . . . . 0.0 111.387 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.2 -11.65 54.02 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.61 -1.106 . . . . 0.0 113.474 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -81.39 136.84 35.73 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.685 1.743 . . . . 0.0 109.954 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.0 m -104.89 163.39 12.56 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.364 1.066 . . . . 0.0 112.786 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.53 155.63 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.175 0.99 . . . . 0.0 109.004 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' A' ' 4' ' ' CYS . 18.2 t -102.29 150.63 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -138.65 -138.28 0.13 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.27 84.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.932 1.696 . . . . 0.0 111.336 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.83 -27.48 0.18 Allowed Glycine 0 CA--C 1.538 1.486 0 C-N-CA 128.716 3.055 . . . . 0.0 114.729 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -87.14 151.35 23.27 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.984 1.714 . . . . 0.0 111.591 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -104.76 128.16 52.79 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.189 2.995 . . . . 0.0 107.362 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -129.29 157.56 41.52 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.279 1.032 . . . . 0.0 110.365 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -131.7 140.51 49.32 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.606 1.163 . . . . 0.0 109.425 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.47 140.87 34.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 109.8 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -90.34 -32.58 16.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.348 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -139.35 -70.75 0.4 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.094 0.473 . . . . 0.0 111.734 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -161.47 123.89 3.03 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 126.269 1.828 . . . . 0.0 107.219 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -163.61 143.91 8.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.737 1.153 . . . . 0.0 111.731 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.15 13.79 9.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.793 2.037 . . . . 0.0 106.823 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -73.89 162.34 29.19 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.484 1.113 . . . . 0.0 108.503 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.84 121.26 67.2 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.07 131.27 21.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.843 2.362 . . . . 0.0 112.393 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.53 65.95 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.734 -1.036 . . . . 0.0 112.957 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.3 t -76.95 62.03 2.05 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.648 1.724 . . . . 0.0 110.381 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 51.98 -138.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.31 . . . . 0.0 108.667 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.4 t 57.33 -139.55 0.87 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.121 0.873 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -62.41 -74.97 0.08 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.678 2.791 . . . . 0.0 110.095 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -19.54 114.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.738 2.415 . . . . 0.0 114.508 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.255 23.4 m -118.47 125.3 49.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 113.197 -1.819 . . . . 0.0 107.034 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -68.6 140.06 55.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.711 0.232 . . . . 0.0 110.462 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 -16.07 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 111.292 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.6 -154.45 24.23 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.223 0.92 . . . . 0.0 111.053 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 p -160.27 167.68 27.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.455 1.902 . . . . 0.0 107.125 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.1 m -50.63 -65.48 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 127.401 2.28 . . . . 0.0 105.051 -172.619 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.415 ' HB2' HG11 ' A' ' 33' ' ' VAL . 5.3 t -71.48 -60.97 1.95 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 150.53 -60.69 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 130.027 3.331 . . . . 0.0 106.278 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -151.59 32.01 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.75 178.82 4.44 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.033 0.833 . . . . 0.0 110.603 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -61.19 98.26 0.08 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -109.26 124.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 124.538 1.135 . . . . 0.0 109.945 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -39.67 132.97 1.36 Allowed Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.003 1.321 . . . . 0.0 110.833 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -85.93 18.31 30.47 Favored 'Cis proline' 0 CA--C 1.535 0.559 0 CA-C-N 120.465 1.202 . . . . 0.0 114.881 0.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -74.6 64.47 1.21 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.217 1.371 . . . . 0.0 109.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -54.16 152.61 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.643 0.777 . . . . 0.0 111.685 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -70.54 -42.99 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.209 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.5 t -100.02 149.87 23.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.942 1.353 . . . . 0.0 110.985 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -101.62 169.17 9.01 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.943 2.097 . . . . 0.0 107.687 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -39.84 86.29 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -146.42 162.04 39.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.702 1.601 . . . . 0.0 107.688 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.8 -60.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.562 1.545 . . . . 0.0 113.702 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.27 60.89 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.124 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.17 -159.67 23.23 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.135 0.967 . . . . 0.0 111.564 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -118.66 159.29 44.74 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.362 1.465 . . . . 0.0 107.521 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.58 136.2 21.02 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.359 2.04 . . . . 0.0 110.943 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.5 m -136.4 -18.47 1.48 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.81 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 178.86 156.71 0.48 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -84.79 124.02 31.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.29 153.77 40.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -54.62 133.69 46.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.64 -2.02 49.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.035 -1.425 . . . . 0.0 113.401 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -90.19 147.68 23.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.29 2.045 . . . . 0.0 107.953 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 m -90.85 160.91 15.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.237 -0.289 . . . . 0.0 111.334 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.24 138.09 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 4' ' ' CYS . 55.7 t -106.36 157.81 6.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -151.54 -92.94 0.06 Allowed 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -76.53 52.94 0.83 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.313 1.845 . . . . 0.0 110.739 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.83 -36.01 1.23 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.833 2.635 . . . . 0.0 111.663 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -71.42 141.94 50.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.086 0.954 . . . . 0.0 110.491 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.25 115.68 28.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 129.385 3.074 . . . . 0.0 106.136 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -113.94 171.47 7.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.064 0.946 . . . . 0.0 109.213 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 m -151.14 146.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.68 137.73 39.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.399 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' ND2' ' CZ3' ' A' ' 43' ' ' TRP . 30.5 p-10 -60.4 -36.89 79.17 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.783 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 1.9 p90 -146.66 -140.66 0.11 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.368 2.267 . . . . 0.0 112.942 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -79.18 115.15 18.67 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 130.17 3.388 . . . . 0.0 113.38 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.95 143.63 6.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.166 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.61 30.68 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.873 2.069 . . . . 0.0 106.746 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.8 t -83.39 -133.93 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.889 0.876 . . . . 0.0 108.955 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.49 110.09 55.68 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.72 113.92 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.401 2.734 . . . . 0.0 111.815 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.28 -0.32 37.78 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.6 p -77.02 44.37 0.39 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.461 2.13 . . . . 0.0 112.153 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 t70 42.13 -149.66 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.07 2.148 . . . . 0.0 111.579 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m 50.59 -76.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.145 2.578 . . . . 0.0 114.267 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -83.84 -53.59 5.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.967 1.707 . . . . 0.0 109.991 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.62 164.49 21.36 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.694 1.997 . . . . 0.0 112.749 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -159.1 138.37 11.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -88.27 138.47 31.41 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 109.705 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -14.65 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.621 1.169 . . . . 0.0 111.66 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 -152.17 20.91 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.04 140.01 20.1 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.07 1.348 . . . . 0.0 108.769 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' HG21 ' A' ' 33' ' ' VAL . 6.9 m -74.35 -53.34 9.85 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.808 0.813 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.068 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -173.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -69.99 -55.59 9.18 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 121.671 0.748 . . . . 0.0 109.895 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.35 -67.23 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 130.571 3.548 . . . . 0.0 104.428 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -156.51 26.15 0.34 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.979 0.912 . . . . 0.0 111.631 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.44 -165.96 1.47 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.575 0.625 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -71.83 85.09 0.94 Allowed 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.23 124.43 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.202 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -38.07 131.04 0.97 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.771 1.229 . . . . 0.0 111.85 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -90.21 23.77 24.23 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 120.445 1.195 . . . . 0.0 114.244 0.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.71 66.1 1.42 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.896 1.225 . . . . 0.0 109.53 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -51.95 156.91 1.38 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.964 0.888 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.29 -31.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.834 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.7 m -151.56 167.24 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.262 11.4 tmtt? -82.6 -38.99 22.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.449 2.299 . . . . 0.0 113.535 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.4 t70 167.56 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 1 C-N-CA 132.529 4.332 . . . . 0.0 102.713 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -111.51 175.41 5.44 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 128.194 2.598 . . . . 0.0 107.375 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.21 -55.8 5.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.43 66.95 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.308 0.883 . . . . 0.0 115.308 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.5 163.93 38.72 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.004 1.402 . . . . 0.0 111.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 164.9 51.4 Favored Pre-proline 0 C--O 1.217 -0.606 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.81 156.53 56.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.066 2.488 . . . . 0.0 114.352 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 m -141.07 -28.24 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 0.0 111.849 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -178.59 170.4 1.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 111.249 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -105.75 126.66 52.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.08 160.97 13.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.054 1.342 . . . . 0.0 109.435 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.76 125.88 2.92 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 111.715 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.59 -13.09 54.04 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.882 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.35 144.83 32.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 120.406 2.103 . . . . 0.0 107.781 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -98.71 158.74 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.756 0.422 . . . . 0.0 110.997 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.41 144.33 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.05 150.92 12.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.057 0.543 . . . . 0.0 110.594 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -156.91 133.48 10.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 46.35 33.79 2.01 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.457 1.903 . . . . 0.0 113.165 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.52 9.71 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.986 2.231 . . . . 0.0 112.576 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -78.11 139.94 39.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.629 1.214 . . . . 0.0 110.008 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.51 128.05 36.42 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 129.126 2.97 . . . . 0.0 107.615 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -128.26 167.61 16.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.519 1.127 . . . . 0.0 108.631 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -148.77 147.12 28.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.97 148.97 21.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.72 1.247 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -89.89 -36.42 15.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -132.09 -79.37 0.51 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.05 0.453 . . . . 0.0 111.852 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -157.44 132.62 8.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.777 2.031 . . . . 0.0 107.913 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -167.49 153.65 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.236 0.926 . . . . 0.0 110.107 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.29 34.24 0.65 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.675 1.59 . . . . 0.0 108.943 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 p -88.64 -100.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.189 0.596 . . . . 0.0 111.294 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.55 110.34 4.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.6 111.44 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.948 3.099 . . . . 0.0 113.586 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.71 -27.81 10.08 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.909 1.243 . . . . 0.0 111.867 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.1 t -76.47 65.47 2.34 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.323 1.062 . . . . 0.0 110.959 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 50.94 -128.21 2.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 t 72.45 -47.99 0.68 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.722 1.609 . . . . 0.0 112.813 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 -64.33 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.998 2.919 . . . . 0.0 105.906 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -11.91 121.54 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 129.074 2.95 . . . . 0.0 116.932 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 m -120.24 118.83 31.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 112.597 -2.092 . . . . 0.0 106.206 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -71.3 140.51 50.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -2.37 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.03 -152.53 24.24 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -147.64 142.14 26.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.779 1.232 . . . . 0.0 109.096 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 m -67.68 -46.51 72.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.726 0.774 . . . . 0.0 109.642 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--O 1.257 1.454 0 CA-C-O 115.559 -2.162 . . . . 0.0 105.25 -174.899 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.1 t -67.95 -52.63 33.87 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 121.215 0.531 . . . . 0.0 111.825 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 157.01 -57.6 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 130.517 3.527 . . . . 0.0 105.88 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -149.74 -5.6 0.36 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.393 1.077 . . . . 0.0 113.319 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.52 174.39 11.62 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.201 0.909 . . . . 0.0 112.024 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -54.31 103.85 0.09 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.524 1.13 . . . . 0.0 110.126 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.32 135.82 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 108.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -43.66 132.18 3.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.196 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -98.25 36.29 7.05 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 121.135 1.441 . . . . 0.0 113.593 -0.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -76.26 62.49 1.78 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.538 1.063 . . . . 0.0 108.738 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -52.55 150.89 4.61 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.458 1.103 . . . . 0.0 112.992 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -95.25 -29.52 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.231 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -64.33 -41.31 96.86 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.565 1.075 . . . . 0.0 111.407 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 mttt 57.29 -178.84 0.05 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.458 1.503 . . . . 0.0 112.79 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.54 -17.44 61.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.088 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -158.21 -74.33 0.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.743 0.701 . . . . 0.0 110.902 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.88 -52.6 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.11 0.564 . . . . 0.0 110.645 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.77 -11.86 54.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.705 0.669 . . . . 0.0 111.74 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.22 -177.05 32.84 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 122.11 0.839 . . . . 0.0 113.958 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -62.55 158.85 46.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.267 1.027 . . . . 0.0 110.338 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -64.49 168.26 13.35 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.114 1.876 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -154.2 -29.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.408 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 164.59 169.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.705 1.202 . . . . 0.0 110.418 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -107.02 128.15 54.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.09 162.59 13.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.728 1.211 . . . . 0.0 109.123 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -38.08 122.4 1.03 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.865 1.666 . . . . 0.0 112.012 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -15.27 45.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.475 -1.181 . . . . 0.0 114.384 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -76.19 138.53 40.72 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.534 2.167 . . . . 0.0 106.482 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -108.12 152.67 24.23 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.071 -0.393 . . . . 0.0 111.431 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -148.83 162.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.071 1.348 . . . . 0.0 107.659 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -116.02 151.37 17.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -157.07 119.47 3.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 40.36 76.21 0.07 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.726 2.011 . . . . 0.0 111.283 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.36 -47.11 0.68 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.913 1.72 . . . . 0.0 114.201 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -73.81 142.13 46.18 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.982 0.913 . . . . 0.0 113.122 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.9 tp -97.35 129.49 44.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 130.161 3.384 . . . . 0.0 107.236 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -133.19 156.29 47.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.83 0.852 . . . . 0.0 109.845 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.5 m -130.42 144.7 51.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.224 1.41 . . . . 0.0 107.701 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.9 149.92 24.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.058 0.932 . . . . 0.0 110.302 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.42 -33.42 17.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.942 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 17.7 p90 -143.46 -70.68 0.31 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.786 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -156.94 138.16 13.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.162 2.185 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -171.67 147.46 2.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.73 36.39 2.0 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.559 1.544 . . . . 0.0 107.616 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 m -126.56 153.0 45.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.667 1.187 . . . . 0.0 109.24 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.5 t -36.31 110.58 0.46 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.589 1.956 . . . . 0.0 112.787 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.01 138.16 43.68 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.073 3.182 . . . . 0.0 114.126 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.45 -43.67 1.59 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.997 0.808 . . . . 0.0 112.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.9 t -73.37 -41.89 62.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.619 0.767 . . . . 0.0 111.597 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.85 -111.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -161.26 171.36 18.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.144 1.378 . . . . 0.0 108.554 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 64.73 18.36 11.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -112.61 157.52 21.11 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.116 1.766 . . . . 0.0 109.351 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 m -152.03 119.86 6.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -68.7 142.03 55.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 109.784 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.39 -6.97 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.3 1.04 . . . . 0.0 112.352 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.42 -155.44 26.4 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 p -154.04 150.06 27.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.935 1.294 . . . . 0.0 108.302 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -86.08 -47.09 9.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 122.266 1.031 . . . . 0.0 109.412 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 129.885 3.274 . . . . 0.0 105.024 -175.0 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 33' ' ' VAL . 3.3 m -98.58 -23.94 15.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.704 1.138 . . . . 0.0 109.925 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.59 20.61 12.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.916 1.287 . . . . 0.0 112.138 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -162.47 -45.21 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.928 1.291 . . . . 0.0 110.024 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.97 173.41 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -70.45 122.78 20.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.2 136.89 30.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 125.556 1.543 . . . . 0.0 109.71 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -46.08 133.22 7.17 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.045 1.293 . . . . 0.0 111.802 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -95.54 36.82 6.64 Favored 'Cis proline' 0 C--N 1.353 0.81 0 CA-C-N 121.563 1.594 . . . . 0.0 113.52 -0.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.76 66.04 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -59.82 147.69 37.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.403 0.62 . . . . 0.0 110.305 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.6 -43.76 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.544 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -91.48 146.72 23.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 122.626 1.203 . . . . 0.0 109.553 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -115.72 166.65 11.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.154 2.182 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -58.0 -34.83 70.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.393 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -158.49 170.26 22.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.607 1.963 . . . . 0.0 106.848 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.38 -60.69 0.48 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.781 1.632 . . . . 0.0 113.808 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.81 24.07 29.38 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.849 0.738 . . . . 0.0 112.062 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 -174.81 49.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 121.829 0.683 . . . . 0.0 113.19 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.82 154.45 75.64 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.58 154.28 31.46 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.214 1.943 . . . . 0.0 110.011 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.73 -4.89 0.31 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.81 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 165.59 167.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.22 1.008 . . . . 0.0 113.705 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -114.62 137.52 51.79 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.577 1.551 . . . . 0.0 107.099 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.21 168.65 9.22 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.366 1.066 . . . . 0.0 109.28 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.14 124.34 2.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 111.85 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.53 -14.43 55.29 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.701 1.143 . . . . 0.0 113.501 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -78.65 126.63 31.0 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.172 1.486 . . . . 0.0 109.204 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 p -91.5 164.13 13.91 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.886 1.674 . . . . 0.0 112.285 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.56 153.95 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG21 ' SG ' ' A' ' 4' ' ' CYS . 2.8 t -111.55 153.4 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 118.48 0.582 . . . . 0.0 109.521 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -161.38 129.17 4.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 33.16 74.2 0.06 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.136 1.774 . . . . 0.0 112.247 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.07 -40.7 0.33 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.677 2.084 . . . . 0.0 115.089 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -78.37 145.5 35.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.607 1.194 . . . . 0.0 112.716 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.4 tp -101.82 126.8 48.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 129.837 3.255 . . . . 0.0 106.923 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.75 152.76 49.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.443 0.697 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.1 m -128.63 140.04 51.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 109.203 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 141.76 40.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.865 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.41 -39.51 13.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.428 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -133.5 -71.47 0.51 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -159.28 135.75 9.18 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 127.732 2.413 . . . . 0.0 106.561 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -168.19 157.05 9.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.236 0.926 . . . . 0.0 110.507 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.56 21.12 0.92 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.848 1.659 . . . . 0.0 109.277 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.5 p -91.25 164.23 13.96 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.7 t -52.14 111.81 2.8 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.388 0.675 . . . . 0.0 109.326 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.21 122.69 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.337 3.358 . . . . 0.0 113.445 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.84 -23.15 34.71 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.468 1.032 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 m -76.24 66.92 2.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.284 1.042 . . . . 0.0 110.666 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 47.2 -126.7 1.65 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.996 1.319 . . . . 0.0 108.847 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m 65.07 -40.87 0.29 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.467 2.307 . . . . 0.0 115.94 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p 179.34 -69.82 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.264 2.626 . . . . 0.0 106.224 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -8.91 112.98 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.723 3.209 . . . . 0.0 116.124 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.4 m -108.88 113.16 25.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 112.805 -1.998 . . . . 0.0 106.264 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -66.79 134.34 51.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -111.13 -9.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.686 0.794 . . . . 0.0 111.185 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.68 -167.64 32.63 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.103 0.865 . . . . 0.0 111.593 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -122.79 123.22 40.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -31.44 68.15 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 . . . . . 0 C--O 1.258 1.518 0 CA-C-O 114.84 -2.505 . . . . 0.0 107.05 -175.039 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.8 t -64.75 -47.21 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.476 0.655 . . . . 0.0 111.951 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 155.98 -61.04 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 130.705 3.602 . . . . 0.0 104.849 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.1 0.85 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.463 1.105 . . . . 0.0 113.259 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.72 -175.29 5.2 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.092 0.86 . . . . 0.0 111.838 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.52 94.0 0.04 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.814 0.845 . . . . 0.0 111.003 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 p -96.6 131.81 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.0 135.73 11.33 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.856 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -93.87 33.47 9.62 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.636 1.263 . . . . 0.0 114.706 0.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -74.5 66.95 1.44 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.999 1.272 . . . . 0.0 108.336 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 9.6 m95 -50.86 160.86 0.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.989 1.316 . . . . 0.0 113.251 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.21 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.938 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -110.9 147.78 33.87 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.773 2.829 . . . . 0.0 107.728 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -66.68 -29.11 69.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -152.63 157.87 41.6 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.624 1.17 . . . . 0.0 108.243 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.78 -60.73 0.69 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.363 1.865 . . . . 0.0 114.615 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.38 5.71 84.61 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.863 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.62 150.71 27.12 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.922 1.361 . . . . 0.0 110.677 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -68.67 151.59 97.16 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 50.6 Cg_exo -57.43 157.96 20.67 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 CA-C-N 119.655 0.912 . . . . 0.0 112.729 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 t -157.74 9.74 0.17 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.333 -1.318 . . . . 0.0 110.804 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -178.14 170.49 1.8 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-O 122.647 1.213 . . . . 0.0 113.843 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -115.06 98.56 6.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.874 2.07 . . . . 0.0 105.77 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.29 165.57 13.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.887 -0.508 . . . . 0.0 111.872 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.86 132.07 11.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.324 1.05 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 -10.06 34.93 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.338 -1.257 . . . . 0.0 113.339 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 40' ' ' THR . 0.5 OUTLIER -78.99 156.41 28.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 120.062 1.931 . . . . 0.0 106.479 178.18 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -117.94 166.26 12.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.534 0.734 . . . . 0.0 110.524 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 tt -162.38 160.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -116.62 151.37 18.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.71 0.687 . . . . 0.0 109.729 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -162.62 134.85 5.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt 49.59 32.22 4.79 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.84 1.656 . . . . 0.0 112.686 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.09 -19.24 23.2 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.71 2.1 . . . . 0.0 112.874 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -85.53 145.1 27.55 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.702 1.251 . . . . 0.0 109.591 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tp -93.45 129.47 39.61 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.313 2.645 . . . . 0.0 107.178 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -127.62 164.78 21.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.346 1.058 . . . . 0.0 108.381 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' GLN . 57.7 m -146.24 145.6 30.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.36 144.5 26.36 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 111.108 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -93.45 -36.54 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.378 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -132.91 -78.01 0.49 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.281 0.563 . . . . 0.0 112.112 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -157.55 132.95 9.01 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -167.07 147.84 5.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.45 1.023 . . . . 0.0 111.022 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.3 15.72 4.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.158 1.383 . . . . 0.0 107.921 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -77.46 163.31 26.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.56 127.9 90.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -45.33 122.4 4.58 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.528 2.818 . . . . 0.0 112.844 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.09 -24.95 27.76 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.167 0.889 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -76.92 75.58 3.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.333 1.066 . . . . 0.0 109.558 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.81 -131.43 0.74 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 110.051 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t 67.7 -54.77 0.49 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.394 2.277 . . . . 0.0 113.979 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 p -172.45 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.548 1.139 . . . . 0.0 109.886 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -18.68 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.427 3.091 . . . . 0.0 116.715 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 m -143.43 130.99 21.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 112.583 -2.099 . . . . 0.0 107.057 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -74.0 141.21 45.86 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.6 -6.23 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.268 1.027 . . . . 0.0 113.027 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.7 -151.42 22.82 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -153.85 154.22 33.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.448 1.099 . . . . 0.0 109.324 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 m -87.27 -53.81 4.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 110.029 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 p -9.95 84.98 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 130.568 3.547 . . . . 0.0 117.037 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.22 -23.8 9.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.009 2.524 . . . . 0.0 112.892 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -54.5 -38.06 66.05 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.21 152.65 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -46.84 122.43 4.3 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.468 0.707 . . . . 0.0 109.967 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.18 130.77 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 119.173 0.897 . . . . 0.0 109.096 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.412 ' HA ' HD11 ' A' ' 32' ' ' ILE . 30.6 t80 -47.98 136.48 11.04 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.523 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -91.49 24.03 24.98 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.944 1.016 . . . . 0.0 113.876 0.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -73.17 68.75 1.01 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 119.859 1.209 . . . . 0.0 109.807 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -52.22 157.05 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.741 0.782 . . . . 0.0 112.043 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.24 -21.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -145.15 166.83 24.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.063 0.935 . . . . 0.0 113.16 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.271 51.0 tttp -96.9 -40.1 9.07 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 128.543 2.737 . . . . 0.0 110.313 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 174.75 -40.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 1 C-N-CA 133.217 4.607 . . . . 0.0 102.926 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -113.57 166.52 11.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.76 -68.08 0.39 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.45 11.38 1.15 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.42 155.74 27.4 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.258 1.529 . . . . 0.0 110.187 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.9 121.05 42.79 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -50.94 152.95 9.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.449 2.1 . . . . 0.0 116.654 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 m -152.37 -17.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.081 0.952 . . . . 0.0 112.23 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 179.38 164.19 0.96 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.752 1.16 . . . . 0.0 110.973 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -100.09 141.49 32.85 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.72 169.76 8.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.735 1.214 . . . . 0.0 109.404 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.97 122.03 2.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.622 1.169 . . . . 0.0 111.358 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 -19.06 48.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.863 1.221 . . . . 0.0 113.215 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -76.92 131.98 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.257 1.528 . . . . 0.0 110.503 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.93 163.5 12.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.2 1.8 . . . . 0.0 112.087 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 10' ' ' TYR . 12.5 tt -167.02 149.42 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.176 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.92 153.61 3.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.407 1.003 . . . . 0.0 108.554 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -158.21 115.49 2.91 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 39.45 78.58 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.041 1.736 . . . . 0.0 112.132 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.27 -42.86 0.53 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.017 1.294 . . . . 0.0 115.825 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -81.57 145.39 30.67 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 122.041 0.924 . . . . 0.0 111.996 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tp -99.44 125.47 45.17 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 129.143 2.977 . . . . 0.0 106.317 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.06 167.35 13.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.31 1.044 . . . . 0.0 108.749 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -148.59 142.88 26.17 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.72 144.21 29.51 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.148 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -95.73 -35.29 11.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.097 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -131.38 -75.42 0.52 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.382 0.426 . . . . 0.0 111.53 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -159.96 125.61 4.12 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.939 2.096 . . . . 0.0 107.921 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 t -167.41 150.57 6.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.979 1.263 . . . . 0.0 111.863 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.21 5.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.783 2.033 . . . . 0.0 108.061 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -71.26 162.99 28.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.39 120.6 53.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.89 122.98 9.04 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.211 2.608 . . . . 0.0 112.615 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.5 -30.44 9.62 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.4 m -75.94 73.38 2.84 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.534 1.167 . . . . 0.0 110.44 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 55.94 -133.2 1.54 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.806 1.242 . . . . 0.0 108.948 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t 59.52 -152.88 0.39 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -54.41 13.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.909 -0.494 . . . . 0.0 109.899 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -13.5 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.953 2.901 . . . . 0.0 117.505 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 m -117.97 126.89 53.2 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.44 2.296 . . . . 0.0 106.399 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.02 141.91 47.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -15.9 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.583 1.153 . . . . 0.0 111.873 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.92 -177.56 47.58 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.0 1.273 . . . . 0.0 112.213 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.5 p -137.03 110.86 8.15 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.932 1.693 . . . . 0.0 107.285 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.8 m -74.04 -37.89 64.16 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HB2' HG21 ' A' ' 33' ' ' VAL . 5.6 t -82.75 -48.75 10.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.261 1.024 . . . . 0.0 110.241 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.85 -55.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.845 3.258 . . . . 0.0 105.146 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -152.16 -2.68 0.27 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.615 1.166 . . . . 0.0 112.736 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.59 157.98 30.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.569 1.077 . . . . 0.0 111.07 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -39.5 106.85 0.06 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 126.509 1.924 . . . . 0.0 112.742 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.3 132.02 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.545 1.138 . . . . 0.0 108.762 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.61 133.77 6.27 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.597 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.27 34.42 8.57 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 120.982 1.386 . . . . 0.0 114.422 0.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -76.71 59.53 1.57 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.164 1.347 . . . . 0.0 108.118 176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . 0.267 7.2 m95 -55.66 156.83 4.5 Favored 'General case' 0 N--CA 1.412 -2.352 0 C-N-CA 129.356 3.062 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.38 -26.82 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.652 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 t -156.05 173.67 16.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 124.345 2.022 . . . . 0.0 116.0 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.38 -172.01 2.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 130.42 3.488 . . . . 0.0 106.499 171.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.44 -30.56 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.937 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -131.66 152.46 50.84 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 110.156 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.72 -63.35 0.52 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.89 2.076 . . . . 0.0 115.108 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 3.37 69.92 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.962 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.92 147.26 34.78 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 120.199 2.0 . . . . 0.0 111.069 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.35 120.16 80.06 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -38.74 159.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.838 3.692 . . . . 0.0 121.153 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 2.93 0.43 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 112.134 -2.303 . . . . 0.0 109.515 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 178.16 172.24 0.68 Allowed 'General case' 0 C--N 1.349 0.552 0 CA-C-N 120.307 1.412 . . . . 0.0 113.657 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -110.09 139.02 45.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.97 169.29 8.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.353 1.461 . . . . 0.0 109.281 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -42.26 123.86 2.62 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.922 1.289 . . . . 0.0 112.052 -177.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.17 -17.24 18.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.761 0.696 . . . . 0.0 113.751 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -75.03 128.22 35.05 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -100.76 164.67 11.75 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.3 tt -161.59 173.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.215 1.406 . . . . 0.0 108.233 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 4' ' ' CYS . 70.9 t -121.89 153.24 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.032 1.333 . . . . 0.0 110.452 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -158.05 114.19 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 41.18 81.74 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.617 2.367 . . . . 0.0 112.231 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.4 -44.05 0.58 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.57 1.557 . . . . 0.0 114.755 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.61 146.67 40.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.895 0.878 . . . . 0.0 111.739 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.0 tp -106.11 129.17 54.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 130.45 3.5 . . . . 0.0 106.993 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -132.33 162.46 30.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.267 1.027 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.0 m -134.53 144.58 48.09 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.335 1.454 . . . . 0.0 109.096 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.69 145.85 27.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.124 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' HB3' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-80 -86.8 -32.59 20.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.443 1.497 . . . . 0.0 111.492 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 17.9 p90 -148.96 -65.16 0.23 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 111.101 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -159.86 134.88 7.98 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 127.564 2.346 . . . . 0.0 107.629 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -174.32 144.29 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.057 0.844 . . . . 0.0 111.573 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.81 14.64 9.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.715 2.006 . . . . 0.0 107.932 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.52 165.81 23.86 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.3 t -57.24 118.69 26.18 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.493 -0.765 . . . . 0.0 108.954 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.05 119.17 5.67 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.551 2.168 . . . . 0.0 110.75 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.55 -26.72 9.36 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.3 t -73.43 80.14 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -41.17 139.67 0.93 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.777 1.631 . . . . 0.0 111.413 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t 163.57 -49.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.795 2.438 . . . . 0.0 106.301 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 t -146.56 11.06 1.11 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.979 1.712 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -113.54 156.41 23.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.26 1.024 . . . . 0.0 108.903 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -153.32 126.02 8.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -72.85 140.56 47.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.23 0.468 . . . . 0.0 110.004 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -17.13 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.901 1.281 . . . . 0.0 111.053 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.37 -157.35 29.78 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -154.27 140.72 18.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.886 1.674 . . . . 0.0 106.77 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.58 -44.28 11.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.553 0.615 . . . . 0.0 111.136 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 110.768 -0.086 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.9 t -74.76 -58.59 3.19 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 122.198 0.999 . . . . 0.0 108.558 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.24 -58.02 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 129.747 3.219 . . . . 0.0 104.803 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -152.15 32.32 0.53 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.943 0.897 . . . . 0.0 112.117 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.03 155.63 24.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -32.54 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.587 1.955 . . . . 0.0 113.87 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -88.76 122.97 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -48.66 137.92 12.33 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 120.92 1.691 . . . . 0.0 109.998 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -92.21 36.12 6.64 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 120.612 1.254 . . . . 0.0 114.708 0.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -74.3 66.57 1.32 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.068 1.303 . . . . 0.0 107.86 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 6.3 m95 -50.55 164.44 0.13 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.533 1.533 . . . . 0.0 113.025 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.94 -33.0 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.139 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -144.57 172.63 12.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.266 86.8 tttt -99.49 -57.73 2.09 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.816 3.246 . . . . 0.0 109.582 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -158.07 -50.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.905 5.682 . . . . 0.0 101.913 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -113.28 175.26 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -58.88 3.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.06 -21.13 63.41 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.22 153.43 48.44 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -59.93 131.88 89.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 37.7 Cg_exo -60.89 160.34 25.8 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 N-CA-C 117.944 2.248 . . . . 0.0 117.944 -173.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -151.86 -7.92 0.22 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 112.448 -2.16 . . . . 0.0 110.4 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -174.41 173.29 3.0 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.58 123.3 41.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.745 2.418 . . . . 0.0 105.941 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.6 169.2 11.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.192 0.997 . . . . 0.0 111.669 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.77 128.16 20.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.7 66.6 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.061 -1.411 . . . . 0.0 113.977 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.66 136.74 33.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.582 2.191 . . . . 0.0 106.252 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.1 m -98.36 157.51 16.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.224 0.535 . . . . 0.0 112.208 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 tt -152.05 162.9 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 t -121.86 145.4 28.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.655 0.661 . . . . 0.0 109.519 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -167.34 167.77 13.72 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 40.33 39.68 0.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.957 1.253 . . . . 0.0 112.933 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.39 36.79 54.18 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.963 1.744 . . . . 0.0 112.413 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -150.82 157.22 42.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.939 1.296 . . . . 0.0 110.194 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.3 tp -87.73 132.12 34.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.984 2.514 . . . . 0.0 109.392 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.74 156.79 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.515 1.126 . . . . 0.0 108.59 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 m -137.2 145.2 43.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.58 153.93 21.43 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.35 1.071 . . . . 0.0 110.584 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.08 -32.84 15.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.715 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -138.89 -146.0 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.483 1.513 . . . . 0.0 109.551 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.15 115.9 28.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.751 2.421 . . . . 0.0 106.038 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -157.46 156.57 32.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.131 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.79 20.06 4.19 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.418 1.887 . . . . 0.0 108.049 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -79.9 -179.35 6.92 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.23 120.47 73.4 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 55' ' ' TRP . 52.4 Cg_exo -54.51 127.37 25.73 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.572 2.848 . . . . 0.0 115.551 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.62 -38.41 1.05 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 123.688 0.661 . . . . 0.0 112.759 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -65.72 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.414 0.607 . . . . 0.0 110.814 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.88 179.89 6.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.551 0.691 . . . . 0.0 110.948 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -47.24 164.92 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.838 3.255 . . . . 0.0 115.508 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.2 p 71.95 4.72 5.12 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.637 2.775 . . . . 0.0 114.649 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 49' ' ' PRO . 98.6 m95 -117.2 149.23 40.73 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.779 1.231 . . . . 0.0 110.85 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 m -136.69 118.51 15.14 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.95 139.59 48.76 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -121.57 12.19 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.076 0.55 . . . . 0.0 112.257 -179.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.33 -150.86 17.91 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t -89.42 176.78 6.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -73.47 96.1 2.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 O-C-N 125.017 1.448 . . . . 0.0 109.724 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -37.12 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 129.243 3.017 . . . . 0.0 116.45 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.63 -27.17 10.56 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.789 2.436 . . . . 0.0 111.342 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -54.3 -33.37 58.59 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.82 176.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.31 1.444 . . . . 0.0 109.067 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -60.37 118.41 6.41 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.84 137.06 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -55.52 135.24 70.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 120.704 1.593 . . . . 0.0 110.824 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -99.37 31.17 11.47 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 121.382 1.529 . . . . 0.0 113.319 -1.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -74.76 65.06 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 39.4 m95 -48.59 152.41 0.96 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.88 0.848 . . . . 0.0 112.316 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.97 -25.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.137 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 m -153.19 169.99 21.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.527 1.632 . . . . 0.0 115.037 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.48 -166.5 1.09 Allowed 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 129.439 3.096 . . . . 0.0 108.305 173.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -53.97 -44.57 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.621 -2.081 . . . . 0.0 107.823 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -128.49 153.36 47.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.392 1.877 . . . . 0.0 109.728 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.44 -63.48 0.44 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.493 1.917 . . . . 0.0 115.174 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 4.73 79.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.677 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.76 154.0 46.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-N 120.487 2.144 . . . . 0.0 110.988 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.0 113.31 8.86 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 51.5 Cg_exo -37.79 147.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 1 C-N-CA 125.746 4.297 . . . . 0.0 117.412 -173.2 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 p -139.74 -8.01 1.25 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -178.52 158.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 119.152 0.887 . . . . 0.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -99.21 113.77 26.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 3.4 tt0 -82.15 164.27 21.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.238 1.815 . . . . 0.0 110.615 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -47.63 127.51 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 120.804 -1.185 . . . . 0.0 112.603 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 -14.37 48.92 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.956 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -81.06 139.9 35.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.688 2.744 . . . . 0.0 107.216 178.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 p -94.25 164.65 12.95 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.262 -0.899 . . . . 0.0 111.919 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 tt -156.86 151.35 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -98.8 150.1 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -159.93 116.47 2.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 38.23 77.3 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.971 2.109 . . . . 0.0 112.541 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.63 -42.09 0.55 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.59 1.567 . . . . 0.0 113.981 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -78.24 151.08 33.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.083 0.944 . . . . 0.0 112.14 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -105.3 124.13 49.02 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 128.94 2.896 . . . . 0.0 106.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.55 168.92 11.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.6 m -150.82 148.84 28.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.76 146.92 25.42 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.921 0.867 . . . . 0.0 112.166 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -87.56 -36.4 17.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 29.3 p90 -139.14 -71.97 0.4 Allowed 'General case' 0 C--N 1.339 0.122 0 CA-C-O 120.889 0.376 . . . . 0.0 111.623 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -159.73 128.94 5.21 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.353 1.461 . . . . 0.0 108.454 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 t -166.55 150.98 7.53 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 119.134 0.879 . . . . 0.0 111.307 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.89 15.28 4.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.907 1.683 . . . . 0.0 107.996 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 p -87.9 172.02 9.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.41 123.82 83.93 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 111.607 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.26 140.25 72.38 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.513 2.808 . . . . 0.0 114.671 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.38 -45.73 2.11 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.655 1.121 . . . . 0.0 111.699 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -73.23 -45.14 57.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.503 0.721 . . . . 0.0 112.646 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.5 -167.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.583 1.182 . . . . 0.0 114.152 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -57.76 140.92 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.758 3.223 . . . . 0.0 117.459 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t 62.39 23.41 13.88 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 128.142 2.577 . . . . 0.0 113.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -107.58 152.08 24.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.286 1.041 . . . . 0.0 111.116 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 m -153.63 134.09 13.55 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.62 138.47 37.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.579 0.752 . . . . 0.0 109.801 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.98 -4.37 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.084 0.954 . . . . 0.0 111.218 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.05 -151.65 23.77 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -145.77 156.37 43.55 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 107.491 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.9 t -67.44 -34.09 76.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.836 0.827 . . . . 0.0 111.047 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.514 0 CA-C-O 115.006 -2.426 . . . . 0.0 107.022 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.783 0.325 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.277 0.1 OUTLIER -7.66 85.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 130.041 3.336 . . . . 0.0 115.844 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.72 64.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.434 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -57.99 -32.9 68.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.995 0.918 . . . . 0.0 110.467 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.01 171.17 7.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.727 1.211 . . . . 0.0 108.636 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -64.21 129.8 41.4 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.72 130.84 55.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 C-N-CA 124.454 1.101 . . . . 0.0 110.326 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -43.13 133.89 3.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.704 1.138 . . . . 0.0 110.975 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.48 31.08 11.68 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.613 1.255 . . . . 0.0 114.36 0.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -73.4 67.7 1.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.033 1.288 . . . . 0.0 108.252 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -54.82 151.73 8.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.751 -0.593 . . . . 0.0 111.383 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.62 -43.7 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -105.16 160.53 15.0 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 122.811 1.291 . . . . 0.0 112.733 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -116.67 162.21 18.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.126 2.57 . . . . 0.0 108.596 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.76 -30.67 70.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -157.03 156.59 33.14 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 108.89 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 73.7 0.05 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.039 1.736 . . . . 0.0 111.852 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.95 -20.1 0.76 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.316 1.436 . . . . 0.0 111.512 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.11 175.41 48.22 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.321 1.06 . . . . 0.0 110.895 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.36 151.2 87.59 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.71 139.6 23.94 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.132 1.888 . . . . 0.0 109.497 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.05 -7.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.625 -1.179 . . . . 0.0 112.922 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 176.4 164.76 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -111.38 140.37 46.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -108.48 173.4 6.33 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.849 1.26 . . . . 0.0 108.679 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.75 129.31 26.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.692 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.47 68.15 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.606 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -84.62 127.14 33.92 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.54 1.67 . . . . 0.0 109.611 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -89.47 166.41 13.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.374 1.07 . . . . 0.0 113.838 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 tt -170.91 154.25 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.665 1.586 . . . . 0.0 108.575 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.1 t -107.59 159.41 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -155.32 -66.64 0.12 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -117.32 96.35 5.38 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.838 1.655 . . . . 0.0 109.625 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.01 15.24 0.01 OUTLIER Glycine 0 CA--C 1.531 1.056 1 C-N-CA 131.005 4.145 . . . . 0.0 117.64 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -143.71 160.68 40.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.142 -1.211 . . . . 0.0 109.012 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.1 tp -89.4 124.14 34.19 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 127.208 2.203 . . . . 0.0 106.643 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -121.54 152.36 39.29 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.156 0.982 . . . . 0.0 108.628 178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 58' ' ' VAL . 77.4 m -134.18 145.31 49.1 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.26 146.41 28.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.539 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -90.41 -32.17 16.54 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.792 1.637 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -148.7 -140.76 0.1 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.221 2.208 . . . . 0.0 107.601 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -87.02 126.4 34.72 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 127.849 2.46 . . . . 0.0 108.48 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.8 143.54 8.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.34 43.17 1.77 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.863 1.265 . . . . 0.0 108.637 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -138.8 161.36 37.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -31.32 105.02 0.22 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 128.938 2.895 . . . . 0.0 113.769 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -51.06 138.4 43.91 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 124.379 3.386 . . . . 0.0 113.889 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.65 -36.83 0.59 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.158 1.361 . . . . 0.0 113.446 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.0 m -76.08 -45.58 33.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 112.382 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -97.37 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.982 0.355 . . . . 0.0 111.486 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -168.23 175.46 6.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t 63.99 21.05 12.47 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.448 1.099 . . . . 0.0 109.834 -177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -123.09 140.43 53.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 124.236 1.014 . . . . 0.0 109.702 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -136.27 120.93 18.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.793 1.637 . . . . 0.0 106.677 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -70.73 134.05 47.13 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.431 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -110.08 -15.56 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.997 1.319 . . . . 0.0 111.802 -178.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.33 160.8 29.62 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -112.01 144.98 40.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 m -117.93 -48.72 2.54 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.281 0.632 . . . . 0.0 111.598 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.933 -172.208 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' H ' HG11 ' A' ' 33' ' ' VAL . 1.3 p -71.55 82.7 0.83 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.391 1.091 . . . . 0.0 111.194 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -39.8 -39.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.995 3.318 . . . . 0.0 113.866 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.03 -35.24 64.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.075 0.95 . . . . 0.0 111.029 179.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.94 153.87 18.06 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.505 1.122 . . . . 0.0 108.01 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -43.56 118.62 1.42 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.523 1.129 . . . . 0.0 111.476 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.69 127.68 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -49.7 135.07 19.58 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.335 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -93.07 25.15 23.26 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 121.321 1.507 . . . . 0.0 115.337 0.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -72.98 66.8 0.82 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.82 1.191 . . . . 0.0 108.119 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -53.58 154.79 3.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.38 -45.85 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.545 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -94.04 153.77 17.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 122.691 1.234 . . . . 0.0 110.179 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -112.72 166.8 11.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.39 2.276 . . . . 0.0 108.915 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.74 -32.66 74.23 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -157.35 158.65 36.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.993 1.317 . . . . 0.0 108.202 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.95 -61.21 0.67 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.262 1.825 . . . . 0.0 114.376 -177.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.47 12.88 65.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.541 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.17 -166.1 41.75 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.42 1.11 . . . . 0.0 111.625 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.24 160.68 26.41 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.923 1.289 . . . . 0.0 107.819 177.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.56 149.13 10.45 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.392 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.7 m -146.02 -19.35 0.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.308 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 177.85 166.05 0.69 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.365 0.984 . . . . 0.0 113.006 -175.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.66 113.41 26.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.57 167.97 16.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.662 0.785 . . . . 0.0 109.633 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -42.35 126.88 3.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.977 1.311 . . . . 0.0 111.877 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -8.18 57.98 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.153 178.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.37 126.45 32.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.661 1.73 . . . . 0.0 108.703 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -86.49 162.58 18.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.127 1.771 . . . . 0.0 112.518 -178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -163.95 150.15 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.085 1.354 . . . . 0.0 108.224 177.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' H ' ' A' ' 4' ' ' CYS . 2.2 t -102.52 155.52 5.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -167.21 125.18 1.28 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 108.363 175.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 43.4 55.99 4.54 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 123.682 1.706 . . . . 0.0 111.44 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -36.06 1.11 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.704 2.573 . . . . 0.0 114.256 177.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -70.87 145.39 50.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.275 1.036 . . . . 0.0 110.443 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -101.95 119.66 39.14 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 129.088 2.955 . . . . 0.0 106.287 178.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -123.84 156.27 36.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.398 0.679 . . . . 0.0 110.051 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.8 m -132.58 143.01 49.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.583 1.153 . . . . 0.0 108.312 177.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.77 144.89 34.73 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.882 0.873 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.411 ' HB3' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-20 -86.65 -37.68 17.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.334 -177.377 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 18.1 p90 -144.69 -67.46 0.32 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.561 0.696 . . . . 0.0 110.368 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -155.42 142.05 18.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.821 2.448 . . . . 0.0 107.614 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -176.36 145.42 0.58 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 45.55 0.92 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.326 1.851 . . . . 0.0 106.516 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 56.2 p -106.96 -105.56 0.33 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.377 1.071 . . . . 0.0 113.106 -174.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.3 t -145.39 117.28 5.17 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.81 130.94 23.96 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.064 2.509 . . . . 0.0 115.885 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.79 -42.27 1.29 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.545 1.545 . . . . 0.0 113.025 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.8 m -59.33 -57.14 14.32 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.58 -25.43 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p 89.0 179.28 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.773 2.829 . . . . 0.0 110.48 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t 78.76 28.34 0.43 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 -170.211 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -136.39 157.34 47.04 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 129.772 3.229 . . . . 0.0 106.591 -175.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -155.25 120.19 4.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.73 128.71 36.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.32 -13.04 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.369 1.068 . . . . 0.0 110.423 178.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.59 -156.64 28.38 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.63 134.8 14.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 88.5 m -91.21 -42.49 10.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.319 0.509 . . . . 0.0 111.921 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.921 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -171.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 t -53.44 -53.59 49.18 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.53 1.059 . . . . 0.0 111.566 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 151.88 -61.17 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.373 3.469 . . . . 0.0 106.467 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -151.68 2.8 0.39 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -82.2 -171.27 3.33 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.421 1.01 . . . . 0.0 111.098 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -69.65 97.76 1.09 Allowed 'General case' 0 C--N 1.338 0.096 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 7' ' ' ALA . 2.4 t -102.66 124.89 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.046 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -42.14 132.79 2.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 119.487 1.04 . . . . 0.0 111.15 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.72 27.29 15.01 Favored 'Cis proline' 0 C--N 1.35 0.638 0 N-CA-C 115.888 1.457 . . . . 0.0 115.888 1.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -74.71 66.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.153 1.342 . . . . 0.0 107.617 175.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -58.1 176.14 0.18 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 112.388 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.83 -33.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.12 -66.85 0.84 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -171.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' CG ' ' H ' ' A' ' 17' ' ' ASP . 3.5 tttm 53.51 -167.26 0.07 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 123.611 1.672 . . . . 0.0 112.487 -170.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.403 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 10.5 m-20 -82.0 -40.3 22.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.3 2.64 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -79.81 174.61 11.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.842 2.057 . . . . 0.0 114.566 -175.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.41 39.91 3.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.198 2.199 . . . . 0.0 106.923 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.09 47.58 0.04 OUTLIER Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.374 1.464 . . . . 0.0 110.623 -177.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.25 -157.49 9.78 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -78.09 -174.78 0.47 Allowed Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -110.12 158.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.909 1.739 . . . . 0.0 113.373 178.316 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -150.92 -12.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.39 0.676 . . . . 0.0 112.049 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 178.6 164.07 0.77 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.342 0.974 . . . . 0.0 111.02 -177.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -112.37 149.65 32.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.654 1.182 . . . . 0.0 108.078 177.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.18 172.71 8.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.66 0.784 . . . . 0.0 110.471 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.22 123.25 2.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.485 1.514 . . . . 0.0 112.088 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -14.37 40.7 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.463 1.03 . . . . 0.0 113.779 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.49 118.06 21.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.295 1.547 . . . . 0.0 109.633 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -80.76 166.69 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 111.928 179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 tt -165.9 151.83 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.003 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.434 HG21 ' SG ' ' A' ' 61' ' ' CYS . 41.0 t -109.22 156.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -138.98 -126.56 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.36 84.19 1.44 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.277 1.399 . . . . 0.0 108.933 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.84 -45.28 0.87 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 127.993 2.711 . . . . 0.0 113.022 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -68.93 143.43 54.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.79 0.836 . . . . 0.0 111.675 -176.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.42 122.53 43.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 129.96 3.304 . . . . 0.0 106.621 177.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -122.84 170.79 9.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.824 1.25 . . . . 0.0 109.242 178.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -148.75 144.63 27.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.81 145.9 27.01 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.41 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -95.47 -31.39 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.221 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -134.18 -73.77 0.48 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 111.307 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -158.4 135.95 10.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.441 2.296 . . . . 0.0 108.441 -177.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -168.9 149.99 4.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.21 0.914 . . . . 0.0 109.677 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.97 37.0 0.86 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.131 1.772 . . . . 0.0 108.038 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.3 p -94.7 -103.93 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.018 0.927 . . . . 0.0 111.888 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.4 112.92 4.73 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.66 1.984 . . . . 0.0 106.056 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.1 121.02 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.421 2.747 . . . . 0.0 113.128 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.88 -17.59 57.7 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.995 0.807 . . . . 0.0 113.05 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -77.31 74.66 3.87 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.993 1.396 . . . . 0.0 109.453 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 t70 51.69 -132.19 1.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.362 1.065 . . . . 0.0 108.691 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t 57.7 -150.58 0.44 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.267 0.94 . . . . 0.0 109.136 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.45 -51.83 39.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.815 0.846 . . . . 0.0 109.702 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -20.06 130.66 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.156 2.582 . . . . 0.0 116.22 -175.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -136.77 128.76 29.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -75.3 141.03 43.48 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -14.06 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.87 1.268 . . . . 0.0 111.635 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.82 -148.12 13.31 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.553 1.069 . . . . 0.0 110.693 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -157.98 135.83 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.279 1.431 . . . . 0.0 108.827 178.194 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.434 ' SG ' HG21 ' A' ' 33' ' ' VAL . 2.7 m -68.11 -49.52 60.65 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.675 0.75 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 -175.067 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 7' ' ' ALA . 40.4 t -54.34 -48.81 70.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.859 0.754 . . . . 0.0 112.907 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 104.87 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.25 3.02 . . . . 0.0 108.458 -175.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.61 40.82 1.11 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . -162.45 173.7 13.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.701 1.137 . . . . 0.0 109.093 174.161 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -48.83 107.3 0.13 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 125.189 1.396 . . . . 0.0 112.187 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.9 131.01 48.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.206 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -44.2 133.04 4.42 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.926 1.239 . . . . 0.0 110.404 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.9 35.97 7.43 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 121.202 1.465 . . . . 0.0 113.908 0.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.22 61.44 1.16 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.764 1.165 . . . . 0.0 108.237 176.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -55.38 156.02 4.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.775 0.798 . . . . 0.0 112.819 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -76.12 -53.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.608 178.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -80.82 143.31 32.9 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -124.61 165.91 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 112.069 -176.269 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -45.21 95.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.331 -1.758 . . . . 0.0 109.904 177.072 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.283 1.7 m95 21.24 166.4 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 136.471 5.908 . . . . 0.0 124.845 -177.365 . . . . . . . . 3 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 120.69 57.3 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 2 C-N-CA 136.595 5.958 . . . . 0.0 100.825 -173.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.28 59.34 3.37 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.647 2.546 . . . . 0.0 107.295 -173.631 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.35 -148.15 7.35 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 123.483 0.563 . . . . 0.0 111.949 -178.099 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -131.09 163.8 46.71 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.635 1.174 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.38 150.26 26.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.836 3.024 . . . . 0.0 110.477 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.91 -17.79 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.219 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -179.68 168.41 1.37 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -178.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -114.91 131.11 56.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.629 1.972 . . . . 0.0 107.567 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.58 165.05 11.32 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.968 0.907 . . . . 0.0 109.626 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.23 123.68 2.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.666 1.186 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.79 -12.43 57.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.157 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.77 139.31 39.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.263 2.031 . . . . 0.0 105.795 177.344 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -105.93 156.83 17.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.918 0.487 . . . . 0.0 111.079 -178.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -157.52 168.77 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.389 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.15 149.38 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.385 0.674 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.04 134.3 16.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.037 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 50.74 27.69 3.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.958 1.703 . . . . 0.0 113.915 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.0 -22.13 27.21 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 126.477 1.989 . . . . 0.0 112.231 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.97 138.08 36.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.424 1.112 . . . . 0.0 109.247 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.8 tp -91.54 131.19 37.15 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 128.45 2.7 . . . . 0.0 108.435 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -135.52 159.45 41.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 109.666 178.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -132.95 142.42 48.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.446 1.498 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.22 150.21 27.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.163 0.983 . . . . 0.0 111.077 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.776 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -139.91 -75.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -161.25 125.98 3.54 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.27 2.228 . . . . 0.0 106.506 -176.741 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 t -168.1 154.47 7.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.835 1.198 . . . . 0.0 111.608 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.42 20.69 4.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.238 1.815 . . . . 0.0 106.737 174.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -82.21 146.96 29.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.3 t -46.88 121.98 7.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.788 0.835 . . . . 0.0 109.192 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.44 127.69 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.171 2.581 . . . . 0.0 113.831 -179.188 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.47 22.77 73.36 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.521 178.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 p -66.36 -71.57 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.307 1.053 . . . . 0.0 110.616 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -146.14 -32.67 0.34 Allowed 'General case' 0 C--O 1.23 0.069 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m -156.48 168.1 28.42 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.214 -0.929 . . . . 0.0 112.039 -174.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 p 70.53 0.39 3.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 130.303 3.441 . . . . 0.0 114.412 177.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.66 171.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.908 1.283 . . . . 0.0 112.573 -178.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -158.92 124.07 4.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.48 144.5 42.02 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.92 -6.52 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.873 0.869 . . . . 0.0 112.927 -178.974 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.49 -152.15 23.66 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 p -156.51 152.36 27.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.448 1.099 . . . . 0.0 109.029 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.93 -46.22 14.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.323 1.058 . . . . 0.0 108.91 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 129.86 3.264 . . . . 0.0 104.482 -174.988 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.4 159.73 53.91 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.1 m-20 -51.9 -30.79 25.62 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.545 1.138 . . . . 0.0 113.362 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -125.58 -60.12 1.33 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.237 1.015 . . . . 0.0 110.249 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.64 -66.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.251 3.02 . . . . 0.0 104.948 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -154.11 25.42 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.092 0.957 . . . . 0.0 111.61 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.94 -165.03 1.27 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.583 0.629 . . . . 0.0 109.688 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.04 89.2 1.93 Allowed 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.353 -0.842 . . . . 0.0 109.472 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 3' ' ' ASP . 98.6 t -83.64 118.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 108.239 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -45.17 135.29 5.28 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 120.767 1.621 . . . . 0.0 110.944 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -89.93 33.82 7.62 Favored 'Cis proline' 0 C--N 1.349 0.58 0 N-CA-C 115.685 1.379 . . . . 0.0 115.685 1.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -74.3 62.63 0.97 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.257 1.39 . . . . 0.0 108.867 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 7.1 m95 -51.68 160.82 0.59 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.098 1.359 . . . . 0.0 111.791 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.48 -31.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.345 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.7 t -153.36 167.53 29.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.315 0.9 OUTLIER -91.35 -30.55 16.48 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 131.177 3.791 . . . . 0.0 111.342 175.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 154.47 -43.06 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.549 3.94 . . . . 0.0 103.714 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -118.57 172.86 7.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.951 1.7 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.13 -57.5 5.31 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.98 -27.77 71.81 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.063 0.785 . . . . 0.0 115.063 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.08 142.44 43.12 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 119.215 1.507 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -60.33 132.94 90.64 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 72.8 Cg_exo -53.58 166.86 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 119.119 2.699 . . . . 0.0 119.119 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 m -150.46 -12.38 0.25 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.017 -1.902 . . . . 0.0 110.837 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 179.06 174.29 0.72 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 120.182 1.356 . . . . 0.0 112.982 -175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -112.1 132.12 55.04 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.71 169.58 9.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.819 1.248 . . . . 0.0 110.093 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -44.72 125.09 4.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.084 1.354 . . . . 0.0 111.386 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.07 -9.62 56.44 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.002 -0.888 . . . . 0.0 113.815 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -84.31 124.78 31.62 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.289 1.545 . . . . 0.0 108.032 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -92.29 165.36 13.14 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.899 0.88 . . . . 0.0 113.24 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.4 tt -161.22 163.47 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.024 1.33 . . . . 0.0 107.834 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.31 146.32 19.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -148.31 108.81 4.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.1 mttp 39.09 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.766 2.026 . . . . 0.0 112.432 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 -50.63 1.5 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.148 1.356 . . . . 0.0 112.805 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.0 142.25 47.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.338 1.069 . . . . 0.0 111.957 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 58' ' ' VAL . 5.1 tp -102.17 131.88 48.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 129.029 2.932 . . . . 0.0 107.284 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -132.94 164.78 26.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.944 0.898 . . . . 0.0 109.902 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.0 m -134.02 143.36 48.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.806 1.242 . . . . 0.0 108.024 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 142.44 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.797 0.808 . . . . 0.0 109.176 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -84.39 -34.24 23.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.202 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 19.0 p90 -143.07 -69.85 0.33 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -161.34 125.61 3.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.916 1.687 . . . . 0.0 108.125 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -166.99 154.74 9.36 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.767 1.167 . . . . 0.0 111.435 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HA ' ' CH2' ' A' ' 13' ' ' TRP . . . -143.01 32.01 1.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.879 1.671 . . . . 0.0 109.676 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -84.02 -103.86 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.059 0.457 . . . . 0.0 111.429 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.7 t -144.74 115.26 5.18 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HA ' ' CD2' ' A' ' 55' ' ' TRP . 45.3 Cg_exo -53.16 112.33 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.698 2.265 . . . . 0.0 112.542 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.82 -26.88 9.63 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.084 1.326 . . . . 0.0 111.721 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -78.37 70.28 4.69 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.359 1.08 . . . . 0.0 109.631 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 42.51 -111.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.805 1.642 . . . . 0.0 108.889 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t 59.65 -72.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.772 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.4 t -173.65 38.65 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.095 2.558 . . . . 0.0 107.146 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD2' ' HA ' ' A' ' 49' ' ' PRO . 89.9 m95 -112.08 154.49 25.33 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.615 1.198 . . . . 0.0 111.377 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -153.41 120.97 5.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -71.0 124.28 24.0 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.296 0.638 . . . . 0.0 109.933 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -101.86 -13.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.084 0.554 . . . . 0.0 112.134 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.29 -149.45 17.65 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -154.33 135.21 13.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 109.812 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.5 m -71.97 -46.87 55.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.994 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.311 -1.804 . . . . 0.0 106.509 -173.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.73 -149.5 46.59 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -156.29 139.89 15.96 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.1 m -77.28 75.15 3.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.281 1.038 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -20.59 -51.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 131.363 3.865 . . . . 0.0 115.304 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -62.13 -8.6 5.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.315 1.446 . . . . 0.0 114.351 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.84 141.59 49.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.099 0.96 . . . . 0.0 108.924 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -29.51 105.13 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 128.086 2.554 . . . . 0.0 113.631 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.1 134.05 27.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -45.39 132.74 5.99 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 119.783 1.174 . . . . 0.0 111.425 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.61 43.25 3.11 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 121.593 1.605 . . . . 0.0 113.904 -0.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -76.39 64.28 2.1 Favored 'General case' 0 N--CA 1.428 -1.572 0 O-C-N 119.324 -2.11 . . . . 0.0 107.429 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -56.05 156.21 5.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.977 0.894 . . . . 0.0 110.888 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.91 -21.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.304 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.9 t -145.08 165.89 26.94 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.752 1.263 . . . . 0.0 112.63 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.298 85.8 tttt -97.14 -34.07 11.27 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 131.241 3.816 . . . . 0.0 109.363 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 162.92 -42.97 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 1 C-N-CA 132.896 4.478 . . . . 0.0 102.641 -172.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -117.56 155.06 30.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.462 1.505 . . . . 0.0 107.593 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.67 -60.43 3.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.696 1.598 . . . . 0.0 115.231 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.7 -4.22 61.07 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.842 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.31 152.4 43.31 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 119.426 1.613 . . . . 0.0 109.923 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.28 144.74 94.68 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.06 158.33 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 116.571 1.72 . . . . 0.0 116.571 -169.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 m -152.23 -17.43 0.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.067 0.947 . . . . 0.0 112.599 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 177.31 150.48 0.18 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.318 0.963 . . . . 0.0 110.516 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.73 141.32 32.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.6 166.19 13.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.378 1.071 . . . . 0.0 108.696 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -56.68 130.67 46.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.761 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.68 -6.5 69.39 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.386 -1.23 . . . . 0.0 113.273 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -85.61 143.24 28.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.911 1.855 . . . . 0.0 109.613 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -103.01 164.52 11.56 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 tt -161.74 156.73 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.876 1.27 . . . . 0.0 109.7 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.87 159.3 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 126.515 1.926 . . . . 0.0 109.78 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.5 t80 174.66 147.18 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.32 2.648 . . . . 0.0 107.13 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 40.94 44.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 113.326 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.46 24.85 25.33 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.494 2.473 . . . . 0.0 113.218 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -119.7 156.61 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.679 1.592 . . . . 0.0 107.211 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.598 ' CD2' HG13 ' A' ' 58' ' ' VAL . 12.8 tp -110.29 122.02 46.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.596 1.958 . . . . 0.0 107.863 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -125.77 150.28 47.88 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.673 0.67 . . . . 0.0 110.001 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 m -117.13 138.97 51.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.876 1.27 . . . . 0.0 108.359 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.96 142.37 36.73 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.172 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -87.47 -30.81 20.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.603 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 33.0 p90 -145.13 -141.27 0.12 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.838 1.655 . . . . 0.0 108.325 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -92.37 116.21 28.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.823 2.849 . . . . 0.0 106.165 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 t -163.83 148.35 10.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.492 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.63 13.04 9.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.326 1.85 . . . . 0.0 107.997 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.6 t -70.51 162.46 28.76 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.14 118.52 62.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.121 0.568 . . . . 0.0 110.289 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -41.1 122.37 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.941 3.761 . . . . 0.0 114.45 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.46 22.51 3.82 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.697 1.618 . . . . 0.0 114.471 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -123.88 26.67 7.53 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.514 1.157 . . . . 0.0 110.416 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -170.19 -79.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -174.56 177.67 2.09 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.7 1.2 . . . . 0.0 108.239 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.3 p 64.12 15.31 9.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.674 2.79 . . . . 0.0 112.903 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -126.21 142.6 51.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.954 1.302 . . . . 0.0 110.512 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -136.48 114.64 11.54 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.734 1.614 . . . . 0.0 107.556 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -62.91 140.68 58.85 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.395 0.617 . . . . 0.0 109.832 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.598 HG13 ' CD2' ' A' ' 38' ' ' LEU 0.278 0.3 OUTLIER -131.77 3.79 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.593 1.157 . . . . 0.0 112.439 -174.886 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.23 -170.55 34.45 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.5 p -161.37 167.76 25.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 m -57.58 -40.02 78.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.415 1.086 . . . . 0.0 110.885 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.598 0 CA-C-O 114.77 -2.538 . . . . 0.0 106.861 -173.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 53.62 35.24 51.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.451 1.024 . . . . 0.0 112.727 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.97 140.72 40.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.224 1.41 . . . . 0.0 111.088 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.71 80.97 0.28 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.776 1.274 . . . . 0.0 111.07 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.46 30.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.056 2.142 . . . . 0.0 111.8 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -58.09 -30.59 66.36 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.92 1.288 . . . . 0.0 111.212 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.49 161.92 14.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.316 1.046 . . . . 0.0 108.673 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.42 121.25 5.43 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.391 0.677 . . . . 0.0 110.1 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.15 135.11 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 117.624 -1.179 . . . . 0.0 108.541 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -46.07 133.59 7.1 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 120.057 1.299 . . . . 0.0 111.008 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -97.03 33.11 10.15 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 121.414 1.541 . . . . 0.0 113.875 -0.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.23 68.06 1.44 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 32.3 m95 -51.07 168.21 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.642 0.777 . . . . 0.0 112.328 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.78 -19.03 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.81 -72.17 0.59 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -171.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 tttt 48.83 -157.03 0.07 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 122.371 1.081 . . . . 0.0 111.787 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.34 -41.47 93.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.325 -1.761 . . . . 0.0 107.178 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -156.6 156.64 33.91 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.247 1.819 . . . . 0.0 107.191 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.98 -58.99 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.193 1.797 . . . . 0.0 114.796 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.33 -9.22 85.85 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.233 -0.759 . . . . 0.0 114.008 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.49 154.48 50.44 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -55.87 103.48 0.37 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 108.177 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 23.2 Cg_exo -50.51 143.97 26.27 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.942 3.095 . . . . 0.0 118.2 -171.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.7 p -132.99 -12.68 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -178.83 162.77 1.34 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.167 0.984 . . . . 0.0 113.427 -175.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -107.65 114.12 27.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.437 1.895 . . . . 0.0 108.582 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.0 166.26 12.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.499 1.119 . . . . 0.0 110.216 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.47 126.27 3.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.931 1.292 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.36 -2.73 80.94 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.316 -1.269 . . . . 0.0 114.648 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.26 121.56 29.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.437 2.119 . . . . 0.0 108.179 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -83.94 159.99 21.16 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.833 -1.167 . . . . 0.0 111.595 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.06 155.21 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.332 1.453 . . . . 0.0 107.753 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -101.96 153.73 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.07 0.948 . . . . 0.0 109.385 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -161.83 126.82 3.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.879 1.672 . . . . 0.0 107.34 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt 30.52 83.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.936 2.095 . . . . 0.0 112.951 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.63 -35.86 0.27 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -94.34 154.14 17.64 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.917 1.859 . . . . 0.0 112.867 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -107.03 124.7 50.02 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.327 2.651 . . . . 0.0 105.861 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.74 161.64 26.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.889 0.876 . . . . 0.0 110.114 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 m -136.93 144.54 43.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.21 150.32 26.28 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 122.057 0.932 . . . . 0.0 111.079 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.48 -34.05 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.858 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -140.39 -72.15 0.37 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.774 0.321 . . . . 0.0 111.64 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -159.31 133.15 7.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.836 1.655 . . . . 0.0 108.562 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 t -166.38 151.69 8.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.96 40.05 1.5 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.082 1.353 . . . . 0.0 107.55 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.5 t -130.49 156.4 44.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.388 1.075 . . . . 0.0 108.199 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -36.76 110.9 0.48 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.418 2.287 . . . . 0.0 113.098 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 134.62 62.41 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.286 2.657 . . . . 0.0 113.189 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.03 -53.06 3.38 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 m -81.13 47.76 1.05 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.966 0.906 . . . . 0.0 110.586 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -164.92 -117.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 m -163.93 168.85 18.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.996 1.719 . . . . 0.0 107.589 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 66.67 14.77 9.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.658 1.183 . . . . 0.0 112.501 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.64 155.69 24.01 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.694 1.598 . . . . 0.0 109.042 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 m -152.17 125.46 8.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.57 137.53 54.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.119 0.567 . . . . 0.0 110.495 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.85 -15.13 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.289 1.436 . . . . 0.0 110.739 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.17 -161.81 35.63 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -153.98 163.04 40.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.1 t -88.22 -17.13 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.13 2.172 . . . . 0.0 111.367 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.432 0 C-N-CA 126.569 1.948 . . . . 0.0 105.83 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.053 0.454 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.22 37.25 93.68 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -75.67 63.78 1.63 Allowed 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 125.207 1.403 . . . . 0.0 109.299 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 80.8 m 45.68 27.7 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.236 2.214 . . . . 0.0 114.136 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.33 -21.34 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.111 2.564 . . . . 0.0 114.037 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -57.29 -37.41 72.38 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.28 0.632 . . . . 0.0 109.944 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.06 176.19 5.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.957 0.903 . . . . 0.0 109.635 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.76 98.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.782 0.833 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.41 128.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.928 1.291 . . . . 0.0 108.898 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -43.08 134.47 3.09 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.818 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -91.7 31.93 10.7 Favored 'Cis proline' 0 C--N 1.348 0.528 0 CA-C-N 120.239 1.121 . . . . 0.0 114.433 0.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -75.57 61.88 1.37 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.179 1.354 . . . . 0.0 109.311 177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 12.2 m95 -49.91 164.03 0.12 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.026 1.731 . . . . 0.0 113.578 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -79.82 -37.51 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.232 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -156.46 -171.64 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.278 0.945 . . . . 0.0 112.311 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.289 55.2 tttm -107.15 -45.63 4.09 Favored 'General case' 0 N--CA 1.412 -2.363 1 C-N-CA 132.942 4.497 . . . . 0.0 110.215 178.646 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 168.26 -44.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 131.603 3.961 . . . . 0.0 104.751 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -58.08 178.3 0.1 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 130.912 3.685 . . . . 0.0 116.923 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.12 37.44 4.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.878 2.871 . . . . 0.0 106.47 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.17 46.53 0.02 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.043 1.306 . . . . 0.0 111.473 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.76 152.63 18.57 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.91 119.4 51.3 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 50.2 Cg_exo -53.85 154.71 16.18 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 117.708 2.157 . . . . 0.0 117.708 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -151.09 4.52 0.46 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.34 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -175.79 168.73 3.05 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 121.356 1.889 . . . . 0.0 116.094 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.82 125.6 50.85 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -87.29 167.96 13.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.786 1.234 . . . . 0.0 111.192 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.08 127.13 8.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.985 1.314 . . . . 0.0 110.409 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -15.31 22.26 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.419 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -77.37 132.08 38.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.816 1.808 . . . . 0.0 108.929 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -94.66 162.38 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.664 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.4 tt -161.74 154.57 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.208 1.003 . . . . 0.0 108.315 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -95.3 156.38 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.233 . . . . 0.0 107.797 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -172.1 141.93 1.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.581 1.953 . . . . 0.0 106.942 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mttp 24.64 73.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.831 2.052 . . . . 0.0 113.034 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.51 38.07 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 128.955 3.169 . . . . 0.0 114.474 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -144.22 158.23 43.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.83 127.82 44.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 127.747 2.419 . . . . 0.0 107.867 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -126.26 166.76 16.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.799 1.239 . . . . 0.0 108.856 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -150.32 148.3 28.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.269 1.028 . . . . 0.0 108.366 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.56 148.32 25.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.684 1.194 . . . . 0.0 111.53 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -90.47 -32.73 16.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.569 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.9 p90 -142.57 -74.18 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.069 0.462 . . . . 0.0 112.223 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -160.21 119.58 2.78 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 127.597 2.359 . . . . 0.0 105.003 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -158.54 152.36 23.53 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.047 1.294 . . . . 0.0 112.096 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 8.84 5.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 109.578 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 m -77.58 155.03 31.79 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.31 139.02 80.48 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 119.667 1.121 . . . . 0.0 109.7 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.21 116.85 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.198 1.932 . . . . 0.0 112.724 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.1 25.88 70.08 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.279 -0.734 . . . . 0.0 112.1 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.6 p -59.99 -56.71 18.33 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.479 1.139 . . . . 0.0 110.191 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.07 -43.41 0.23 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.093 1.357 . . . . 0.0 111.325 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -166.75 -171.65 1.9 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 124.484 1.113 . . . . 0.0 109.142 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 p 65.67 5.9 3.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 130.854 3.662 . . . . 0.0 113.663 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.72 159.58 33.3 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 125.01 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -148.22 132.85 17.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -78.58 130.6 36.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.67 -13.54 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.637 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.12 -171.68 35.7 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 119.674 1.125 . . . . 0.0 112.339 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -107.83 87.54 2.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -32.69 -55.88 0.36 Allowed 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 127.257 2.223 . . . . 0.0 114.179 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.006 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.29 151.44 17.17 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.33 158.52 20.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.522 -0.987 . . . . 0.0 109.223 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.442 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.6 m -87.64 97.96 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.46 10.82 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.446 2.298 . . . . 0.0 111.828 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.16 -3.69 28.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.28 170.67 15.36 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.47 1.032 . . . . 0.0 110.356 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -59.7 121.3 11.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.45 131.39 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.034 0.934 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -43.12 134.02 3.16 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.766 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.81 30.2 14.29 Favored 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.595 1.248 . . . . 0.0 112.755 -0.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -76.14 62.94 1.77 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -49.69 159.36 0.38 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.945 0.878 . . . . 0.0 113.245 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.58 -43.16 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.467 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -90.46 139.08 31.03 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.417 1.103 . . . . 0.0 111.385 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -110.83 166.97 10.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.617 1.967 . . . . 0.0 109.958 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -67.42 -34.8 77.98 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.1 163.54 39.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.097 1.759 . . . . 0.0 106.909 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.93 -55.87 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.503 1.521 . . . . 0.0 114.082 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.79 5.38 79.46 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.485 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.86 171.16 55.06 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.516 1.158 . . . . 0.0 111.2 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.83 165.66 51.44 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.22 145.15 71.47 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.607 1.538 . . . . 0.0 108.669 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 m -141.66 -7.62 0.97 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.191 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 176.0 170.77 0.39 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.1 0.952 . . . . 0.0 111.775 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -112.67 111.16 21.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.742 1.617 . . . . 0.0 107.279 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -83.71 162.81 20.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 109.721 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.4 128.2 1.41 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.993 1.717 . . . . 0.0 112.593 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.31 -7.99 49.47 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.567 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.15 136.05 35.2 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.534 2.167 . . . . 0.0 106.825 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -98.87 159.24 15.09 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.64 -0.662 . . . . 0.0 112.002 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 tt -159.75 163.72 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.894 1.278 . . . . 0.0 108.784 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 4' ' ' CYS . 1.6 t -121.4 165.75 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.12 -62.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -156.1 125.6 6.28 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.15 -42.8 0.17 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.123 2.773 . . . . 0.0 115.507 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -109.75 146.05 35.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.524 1.13 . . . . 0.0 112.253 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tp -97.35 127.53 43.4 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 129.057 2.943 . . . . 0.0 105.682 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.92 161.78 28.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.87 0.868 . . . . 0.0 110.759 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.5 m -138.99 145.52 39.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.83 147.99 26.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.991 0.9 . . . . 0.0 111.442 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -85.06 -36.08 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.097 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -142.52 -70.05 0.34 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.917 0.487 . . . . 0.0 111.389 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -158.53 138.47 12.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.524 1.53 . . . . 0.0 108.908 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -173.32 147.78 1.56 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.499 0.666 . . . . 0.0 109.96 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.87 26.37 4.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 153.07 19.63 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.626 1.571 . . . . 0.0 108.137 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -49.24 117.19 6.42 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.48 0.712 . . . . 0.0 110.012 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.36 120.52 4.49 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.294 2.663 . . . . 0.0 112.261 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.44 -23.78 29.21 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.394 -0.67 . . . . 0.0 111.794 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 t -77.11 59.37 1.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.604 1.202 . . . . 0.0 110.416 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 41.47 -109.06 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.474 1.909 . . . . 0.0 109.734 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t 58.27 -82.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.73 1.612 . . . . 0.0 111.038 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -150.77 28.32 0.7 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.372 1.469 . . . . 0.0 110.425 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.44 171.5 7.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.339 1.066 . . . . 0.0 112.784 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -162.98 130.75 3.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.954 2.102 . . . . 0.0 105.519 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -78.94 139.68 38.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.83 -16.87 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.911 1.284 . . . . 0.0 111.256 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.84 -167.3 39.79 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -144.78 156.6 44.13 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.687 1.195 . . . . 0.0 108.121 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.9 m -114.83 -68.59 0.91 Allowed 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 123.828 0.705 . . . . 0.0 111.093 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 CA-C-O 115.337 -2.268 . . . . 0.0 106.971 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.45 163.94 37.6 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.8 -30.59 14.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.417 1.109 . . . . 0.0 112.447 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 t -59.51 -52.56 65.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.231 1.015 . . . . 0.0 109.631 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 166.65 -63.79 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 131.161 3.784 . . . . 0.0 103.903 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -157.91 28.11 0.27 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.223 1.009 . . . . 0.0 111.314 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 179.34 5.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.312 0.506 . . . . 0.0 109.992 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.63 98.03 0.17 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.988 0.423 . . . . 0.0 109.9 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -105.88 137.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -46.51 135.57 7.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.092 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -94.33 31.42 12.37 Favored 'Cis proline' 0 C--N 1.349 0.567 0 N-CA-C 115.354 1.251 . . . . 0.0 115.354 1.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -77.67 59.77 2.06 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 121.272 1.851 . . . . 0.0 108.741 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -55.29 157.72 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.787 0.835 . . . . 0.0 112.893 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.39 -49.12 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.347 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -84.33 154.24 23.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.503 1.144 . . . . 0.0 109.541 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -126.01 168.14 14.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.944 2.098 . . . . 0.0 109.762 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.64 -31.29 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -160.57 160.15 31.45 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.388 1.475 . . . . 0.0 107.708 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.01 -61.79 0.62 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.141 1.776 . . . . 0.0 114.151 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.65 14.31 61.83 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.511 -0.605 . . . . 0.0 113.354 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 -169.38 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.365 1.083 . . . . 0.0 111.478 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.19 160.8 28.12 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -51.84 145.75 30.81 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.826 2.351 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 m -134.22 -29.95 1.21 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.274 0.63 . . . . 0.0 112.428 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 173.62 171.83 0.17 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.243 0.474 . . . . 0.0 111.057 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -111.17 140.32 45.82 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.61 167.72 9.94 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.574 1.15 . . . . 0.0 109.267 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.55 121.07 1.6 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.596 1.159 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.89 -11.59 70.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.155 1.36 . . . . 0.0 113.785 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -81.42 123.83 28.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.036 1.418 . . . . 0.0 109.26 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -89.14 162.56 15.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.962 1.705 . . . . 0.0 112.268 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.7 tt -168.07 165.94 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.849 1.26 . . . . 0.0 108.375 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.4 t -118.53 163.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.416 . . . . 0.0 108.011 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.97 -60.84 0.9 Allowed 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.47 106.73 3.15 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.22 -46.67 0.49 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.773 1.654 . . . . 0.0 114.204 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -87.64 145.26 26.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 112.039 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 58' ' ' VAL . 7.0 tp -99.18 133.23 43.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 130.31 3.444 . . . . 0.0 107.737 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -134.18 153.95 51.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.169 0.987 . . . . 0.0 109.243 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 m -125.76 135.62 52.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.845 0.858 . . . . 0.0 109.742 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.78 136.98 47.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.818 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -87.8 -36.29 17.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.451 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 11.5 p90 -138.61 -70.85 0.42 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.314 0.646 . . . . 0.0 110.127 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -159.61 130.34 5.82 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 128.146 2.579 . . . . 0.0 106.353 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -165.41 151.42 9.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.676 1.126 . . . . 0.0 111.32 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.9 19.43 2.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.369 1.868 . . . . 0.0 108.765 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -85.18 164.83 17.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.59 119.53 33.67 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.71 125.51 11.27 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.19 2.593 . . . . 0.0 112.02 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.27 -11.81 65.33 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.011 -0.883 . . . . 0.0 112.314 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 t -76.22 69.5 2.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.072 1.436 . . . . 0.0 109.102 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 43.11 -125.78 0.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.376 1.87 . . . . 0.0 109.285 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t 53.38 -132.25 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.146 0.578 . . . . 0.0 109.769 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -69.49 -80.56 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 129.59 3.156 . . . . 0.0 109.401 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -7.95 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.979 2.912 . . . . 0.0 116.538 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -89.31 114.58 25.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.16 -1.837 . . . . 0.0 107.264 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -67.74 132.82 48.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.48 10.5 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.855 0.862 . . . . 0.0 112.693 -177.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.16 -155.59 16.33 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 p -85.01 167.05 16.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -50.5 -42.04 54.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.917 0.865 . . . . 0.0 111.577 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -1.012 0 C-N-CA 128.92 2.888 . . . . 0.0 104.486 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.0 114.28 0.61 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -75.37 52.07 0.59 Allowed 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.715 1.206 . . . . 0.0 110.337 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m 53.61 20.68 2.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.113 1.765 . . . . 0.0 113.232 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.17 -25.94 1.02 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.774 2.43 . . . . 0.0 114.321 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -58.37 -36.52 73.63 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.63 0.772 . . . . 0.0 110.889 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -171.96 3.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.592 0.757 . . . . 0.0 110.422 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.35 94.97 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.455 -0.778 . . . . 0.0 109.91 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.91 135.85 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 126.196 1.798 . . . . 0.0 108.234 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -44.28 132.18 4.54 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.71 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -95.54 32.59 10.88 Favored 'Cis proline' 0 C--N 1.35 0.649 0 CA-C-N 120.75 1.304 . . . . 0.0 114.931 1.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -76.45 57.24 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.095 1.316 . . . . 0.0 109.309 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 28.3 m95 -51.36 141.19 15.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.047 1.339 . . . . 0.0 112.899 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 t -77.61 -29.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 112.287 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.4 m -67.05 -18.4 65.34 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.34 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.991 1.716 . . . . 0.0 111.62 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t0 149.06 -45.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 1 C-N-CA 132.867 4.467 . . . . 0.0 105.361 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.1 p-90 -149.71 171.91 15.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 108.229 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.56 -53.89 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.441 1.896 . . . . 0.0 114.395 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.8 18.27 24.54 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.325 0.964 . . . . 0.0 112.239 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.94 145.7 35.51 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.865 0.833 . . . . 0.0 112.695 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -72.84 136.0 80.36 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 53.4 Cg_exo -39.67 138.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 1 C-N-CA 125.406 4.071 . . . . 0.0 116.254 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -123.61 -30.63 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 172.87 164.81 0.13 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.555 1.07 . . . . 0.0 110.847 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -97.35 133.81 41.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 107.777 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.26 163.5 12.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.929 1.292 . . . . 0.0 110.305 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.92 122.66 1.78 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.898 1.279 . . . . 0.0 111.944 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.2 -3.69 70.71 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.667 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -83.01 118.18 23.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.499 2.149 . . . . 0.0 106.542 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -78.39 164.83 24.46 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.286 -0.884 . . . . 0.0 110.058 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.0 tt -161.51 159.39 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.689 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.59 155.18 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.502 1.521 . . . . 0.0 108.704 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -176.6 135.27 0.23 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.61 2.364 . . . . 0.0 107.357 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? 44.75 33.0 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.132 2.173 . . . . 0.0 115.128 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.54 77.75 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.798 1.189 . . . . 0.0 112.923 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.13 154.61 37.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -97.99 120.87 39.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.277 1.831 . . . . 0.0 108.191 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -123.56 159.43 29.21 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.828 0.851 . . . . 0.0 108.971 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -144.9 143.2 30.45 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.14 149.0 25.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.154 0.978 . . . . 0.0 109.788 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.57 -31.15 22.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.903 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.71 -72.94 0.28 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.628 0.728 . . . . 0.0 110.191 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -165.99 136.54 3.54 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.287 1.435 . . . . 0.0 109.982 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -176.31 155.38 1.46 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 119.157 0.89 . . . . 0.0 111.4 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.02 18.98 5.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.988 1.715 . . . . 0.0 108.09 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -84.42 171.22 12.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.05 121.4 35.76 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 51.2 Cg_exo -53.77 115.76 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.624 2.216 . . . . 0.0 110.833 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 1.54 33.37 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.101 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -75.94 49.99 0.57 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.984 1.892 . . . . 0.0 111.314 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 42.98 -140.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.152 1.781 . . . . 0.0 109.216 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.2 t 44.11 -106.91 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 112.879 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 p -75.44 -5.99 47.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.931 2.092 . . . . 0.0 114.801 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.411 ' CE2' ' HA ' ' A' ' 49' ' ' PRO . 99.3 m95 -107.07 174.23 5.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.636 1.107 . . . . 0.0 112.87 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -163.42 135.36 5.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.908 2.083 . . . . 0.0 105.788 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -88.5 128.25 35.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.68 -15.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.184 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.16 -155.86 26.44 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 119.39 0.995 . . . . 0.0 111.696 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -89.9 135.71 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.03 99.44 6.1 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.512 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 121.375 0.607 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.69 51.23 0.4 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 105.759 -2.936 . . . . 0.0 105.759 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -167.13 175.75 7.28 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 129.278 3.031 . . . . 0.0 106.092 -173.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.5 m -91.0 87.61 6.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -49.29 -34.53 15.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.7 1.6 . . . . 0.0 113.091 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.1 -18.4 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.336 1.054 . . . . 0.0 112.825 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.67 -175.81 2.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.91 102.44 0.6 Allowed 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.954 -0.467 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.54 125.62 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -47.73 138.19 9.55 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.603 -0.685 . . . . 0.0 110.79 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.82 35.43 7.7 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 N-CA-C 114.925 1.087 . . . . 0.0 114.925 1.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -75.33 65.19 1.61 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 121.532 1.969 . . . . 0.0 109.897 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -50.38 154.77 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.841 0.856 . . . . 0.0 112.465 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -84.03 -41.55 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.783 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.4 m -106.03 155.04 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.457 1.122 . . . . 0.0 113.371 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -103.58 150.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.034 2.134 . . . . 0.0 106.752 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.56 -34.35 77.69 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.648 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -141.04 158.31 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.417 1.087 . . . . 0.0 108.672 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.67 -61.29 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.288 1.835 . . . . 0.0 114.071 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.53 10.74 72.34 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.458 -0.634 . . . . 0.0 113.309 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.59 171.17 52.66 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 118.57 1.185 . . . . 0.0 110.885 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 168.39 19.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.36 133.02 55.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 108.348 -1.443 . . . . 0.0 108.348 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -128.05 -13.16 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.825 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 177.36 167.97 0.62 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.45 1.023 . . . . 0.0 113.292 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.61 139.5 42.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.62 168.59 8.98 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.233 1.013 . . . . 0.0 109.051 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.01 121.58 2.15 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.827 1.251 . . . . 0.0 111.487 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.15 -15.7 54.98 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.017 0.818 . . . . 0.0 113.75 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -76.57 121.77 23.65 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.108 1.454 . . . . 0.0 108.737 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -87.7 164.03 16.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.272 1.429 . . . . 0.0 112.313 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 tt -164.6 154.52 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.912 1.685 . . . . 0.0 106.992 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.519 HG11 ' H ' ' A' ' 4' ' ' CYS . 2.0 t -108.41 156.34 9.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -152.13 -108.24 0.05 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -73.7 87.79 1.71 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.973 0.806 . . . . 0.0 108.994 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.24 -40.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 130.332 3.825 . . . . 0.0 117.045 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -102.37 164.06 11.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.919 0.888 . . . . 0.0 111.478 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.2 tp -80.76 131.48 35.43 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.694 2.398 . . . . 0.0 107.739 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.04 153.31 46.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.085 1.354 . . . . 0.0 108.453 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 58' ' ' VAL . 53.9 m -137.77 146.27 43.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.282 0.633 . . . . 0.0 109.632 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.14 144.24 33.22 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.891 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -92.74 -30.04 15.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.904 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -141.73 -73.88 0.31 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 111.998 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.49 119.39 2.65 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.791 2.836 . . . . 0.0 106.117 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 t -163.01 150.89 13.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 120.111 1.323 . . . . 0.0 112.115 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.28 12.99 6.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.932 2.093 . . . . 0.0 107.941 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 t -74.93 172.64 11.92 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.07 118.38 42.22 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 109.987 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.61 140.26 36.93 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.668 2.246 . . . . 0.0 111.829 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.27 -10.8 60.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.598 -1.112 . . . . 0.0 112.157 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -79.02 54.97 1.7 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.795 1.798 . . . . 0.0 110.513 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 42.34 -146.32 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.116 2.166 . . . . 0.0 112.038 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 m 40.78 -100.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.508 2.323 . . . . 0.0 113.762 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.4 p -78.21 -4.13 46.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.05 139.08 51.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 119.117 0.871 . . . . 0.0 110.692 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -133.17 122.82 24.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 113.476 -1.693 . . . . 0.0 106.955 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -69.33 138.6 53.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.486 HG21 ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -121.16 -12.02 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.93 -159.27 32.01 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 120.248 1.385 . . . . 0.0 110.819 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -149.98 -176.67 5.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.424 1.09 . . . . 0.0 108.304 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.2 m -122.68 -69.71 0.81 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.948 0.899 . . . . 0.0 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.997 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 121.16 0.505 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.39 44.28 85.0 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -54.34 -42.77 70.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.108 0.963 . . . . 0.0 110.055 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.87 -57.35 3.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.341 1.067 . . . . 0.0 108.36 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 163.89 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 130.455 3.502 . . . . 0.0 105.083 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.14 4.09 0.45 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 113.04 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.85 178.92 7.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.165 0.893 . . . . 0.0 111.926 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.57 100.84 0.07 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.339 1.056 . . . . 0.0 110.747 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.97 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -45.57 133.96 6.17 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.334 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.8 32.86 10.5 Favored 'Cis proline' 0 C--N 1.353 0.777 0 CA-C-N 121.198 1.464 . . . . 0.0 114.375 0.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.84 66.58 2.13 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 120.276 1.398 . . . . 0.0 107.306 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -60.38 161.25 7.54 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.433 1.493 . . . . 0.0 112.145 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -81.99 -26.02 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.839 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.5 m -153.09 175.81 12.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 112.297 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.288 88.5 tttt -111.4 -47.08 3.21 Favored 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 130.475 3.51 . . . . 0.0 109.936 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 159.98 -45.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.195 1 C-N-CA 131.954 4.102 . . . . 0.0 103.768 -172.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -61.63 169.66 2.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.0 2.52 . . . . 0.0 113.526 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.33 39.26 2.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.227 2.211 . . . . 0.0 107.06 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.7 48.08 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.057 1.313 . . . . 0.0 110.806 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.91 156.58 21.52 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -57.44 124.89 69.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.767 1.284 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -55.32 146.13 63.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.151 1.901 . . . . 0.0 113.311 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.19 2.87 0.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.019 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -175.29 166.95 3.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.005 1.383 . . . . 0.0 114.624 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -115.72 123.11 47.48 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.561 1.544 . . . . 0.0 107.784 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -95.55 157.87 15.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.344 1.458 . . . . 0.0 110.518 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.69 123.96 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.119 1.767 . . . . 0.0 112.397 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.58 -13.61 51.21 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 117.523 -1.71 . . . . 0.0 114.644 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -80.68 143.71 32.82 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 121.229 2.514 . . . . 0.0 107.758 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 m -103.28 157.62 16.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.74 165.81 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.32 151.36 23.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.676 0.671 . . . . 0.0 109.888 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -154.58 124.96 6.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? 35.87 73.9 0.08 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.124 1.77 . . . . 0.0 111.918 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 -46.32 0.54 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.028 1.775 . . . . 0.0 114.07 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -68.49 141.53 55.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.563 1.182 . . . . 0.0 111.763 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 tp -98.58 123.97 43.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 128.882 2.873 . . . . 0.0 106.474 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.93 169.19 11.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.457 1.103 . . . . 0.0 109.735 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -149.79 150.09 31.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 148.89 25.68 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 122.022 0.915 . . . . 0.0 112.207 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -92.21 -35.37 13.85 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 110.011 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -144.87 -72.82 0.26 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.409 0.684 . . . . 0.0 110.726 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -156.45 133.78 10.69 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.807 1.643 . . . . 0.0 109.12 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -168.92 151.78 5.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.886 0.766 . . . . 0.0 111.35 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.79 17.66 3.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.317 1.847 . . . . 0.0 107.47 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.2 t -85.47 166.71 16.11 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.99 119.78 33.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.21 117.44 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.192 2.594 . . . . 0.0 112.189 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 -25.95 14.16 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.632 1.11 . . . . 0.0 111.331 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.9 t -76.08 61.45 1.55 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.491 1.146 . . . . 0.0 111.153 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 45.18 -119.44 0.77 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.436 1.494 . . . . 0.0 108.766 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t 66.43 -63.91 0.24 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.58 1.952 . . . . 0.0 113.017 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -178.51 32.64 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 129.665 3.186 . . . . 0.0 107.083 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -109.7 149.08 30.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.693 1.133 . . . . 0.0 110.776 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -144.79 127.97 16.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -77.37 137.45 38.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.75 -17.15 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.678 1.191 . . . . 0.0 111.001 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.63 -151.55 19.13 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.354 0.979 . . . . 0.0 111.359 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -141.26 138.57 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.14 1.776 . . . . 0.0 107.786 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.3 m -74.71 98.21 3.4 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 173.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.257 1.456 0 O-C-N 125.328 1.642 . . . . 0.0 109.382 175.877 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.04 171.37 39.28 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -75.61 71.93 2.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.804 0.842 . . . . 0.0 109.551 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 33' ' ' VAL 0.294 1.5 m 15.25 69.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 131.546 3.938 . . . . 0.0 114.558 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.25 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.394 2.278 . . . . 0.0 113.549 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -56.33 -32.52 64.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.51 0.724 . . . . 0.0 111.059 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.84 169.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.616 1.166 . . . . 0.0 109.949 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -48.33 120.34 3.57 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.33 1.052 . . . . 0.0 109.975 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -105.99 126.71 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -48.33 135.84 12.3 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.703 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.46 28.47 16.51 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 119.989 1.032 . . . . 0.0 114.208 -0.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -74.64 67.79 1.59 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.873 1.215 . . . . 0.0 108.677 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 30.5 m95 -48.34 160.35 0.16 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.927 0.891 . . . . 0.0 111.609 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -34.17 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.909 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -170.37 -167.91 0.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.336 1.065 . . . . 0.0 113.152 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.261 41.4 mtpt -101.2 -33.01 10.26 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 131.375 3.87 . . . . 0.0 108.457 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 159.23 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 129.426 3.09 . . . . 0.0 106.28 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -117.73 153.86 32.68 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.425 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.73 -63.58 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.228 1.811 . . . . 0.0 114.152 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.52 0.66 54.77 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.384 -0.675 . . . . 0.0 113.144 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.6 128.03 10.1 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -58.87 115.6 12.45 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 35.6 Cg_exo -42.57 130.88 5.27 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.733 2.289 . . . . 0.0 114.074 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -128.54 -15.18 4.56 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.164 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 177.68 164.08 0.61 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.503 1.047 . . . . 0.0 111.221 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -98.23 125.77 43.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -92.96 169.91 10.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.646 1.179 . . . . 0.0 109.184 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.83 127.46 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.065 0.946 . . . . 0.0 111.387 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.2 -11.65 54.02 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.61 -1.106 . . . . 0.0 113.474 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -81.39 136.84 35.73 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.685 1.743 . . . . 0.0 109.954 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.0 m -104.89 163.39 12.56 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.364 1.066 . . . . 0.0 112.786 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.53 155.63 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.175 0.99 . . . . 0.0 109.004 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' A' ' 4' ' ' CYS . 18.2 t -102.29 150.63 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -138.65 -138.28 0.13 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.27 84.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.932 1.696 . . . . 0.0 111.336 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.83 -27.48 0.18 Allowed Glycine 0 CA--C 1.538 1.486 0 C-N-CA 128.716 3.055 . . . . 0.0 114.729 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -87.14 151.35 23.27 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.984 1.714 . . . . 0.0 111.591 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -104.76 128.16 52.79 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.189 2.995 . . . . 0.0 107.362 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -129.29 157.56 41.52 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.279 1.032 . . . . 0.0 110.365 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -131.7 140.51 49.32 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.606 1.163 . . . . 0.0 109.425 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.47 140.87 34.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 109.8 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -90.34 -32.58 16.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.348 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -139.35 -70.75 0.4 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.094 0.473 . . . . 0.0 111.734 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -161.47 123.89 3.03 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 126.269 1.828 . . . . 0.0 107.219 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -163.61 143.91 8.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.737 1.153 . . . . 0.0 111.731 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.15 13.79 9.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.793 2.037 . . . . 0.0 106.823 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -73.89 162.34 29.19 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.484 1.113 . . . . 0.0 108.503 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.84 121.26 67.2 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.07 131.27 21.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.843 2.362 . . . . 0.0 112.393 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.53 65.95 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.734 -1.036 . . . . 0.0 112.957 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.3 t -76.95 62.03 2.05 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.648 1.724 . . . . 0.0 110.381 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 51.98 -138.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.31 . . . . 0.0 108.667 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.4 t 57.33 -139.55 0.87 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.121 0.873 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -62.41 -74.97 0.08 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.678 2.791 . . . . 0.0 110.095 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -19.54 114.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.738 2.415 . . . . 0.0 114.508 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.255 23.4 m -118.47 125.3 49.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 113.197 -1.819 . . . . 0.0 107.034 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -68.6 140.06 55.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.711 0.232 . . . . 0.0 110.462 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 -16.07 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 111.292 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.6 -154.45 24.23 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.223 0.92 . . . . 0.0 111.053 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 p -160.27 167.68 27.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.455 1.902 . . . . 0.0 107.125 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.1 m -50.63 -65.48 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 127.401 2.28 . . . . 0.0 105.051 -172.619 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.48 174.56 46.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -37.36 61.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.826 0.851 . . . . 0.0 110.587 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.415 ' HB2' HG11 ' A' ' 33' ' ' VAL . 5.3 t -71.48 -60.97 1.95 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 150.53 -60.69 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 130.027 3.331 . . . . 0.0 106.278 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -151.59 32.01 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.75 178.82 4.44 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.033 0.833 . . . . 0.0 110.603 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -61.19 98.26 0.08 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -109.26 124.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 124.538 1.135 . . . . 0.0 109.945 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -39.67 132.97 1.36 Allowed Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.003 1.321 . . . . 0.0 110.833 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -85.93 18.31 30.47 Favored 'Cis proline' 0 CA--C 1.535 0.559 0 CA-C-N 120.465 1.202 . . . . 0.0 114.881 0.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -74.6 64.47 1.21 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.217 1.371 . . . . 0.0 109.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -54.16 152.61 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.643 0.777 . . . . 0.0 111.685 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -70.54 -42.99 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.209 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.5 t -100.02 149.87 23.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.942 1.353 . . . . 0.0 110.985 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -101.62 169.17 9.01 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.943 2.097 . . . . 0.0 107.687 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -39.84 86.29 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -146.42 162.04 39.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.702 1.601 . . . . 0.0 107.688 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.8 -60.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.562 1.545 . . . . 0.0 113.702 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.27 60.89 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.124 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.17 -159.67 23.23 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.135 0.967 . . . . 0.0 111.564 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -118.66 159.29 44.74 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.362 1.465 . . . . 0.0 107.521 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.58 136.2 21.02 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.359 2.04 . . . . 0.0 110.943 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.5 m -136.4 -18.47 1.48 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.81 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 178.86 156.71 0.48 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -84.79 124.02 31.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.29 153.77 40.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -54.62 133.69 46.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.64 -2.02 49.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.035 -1.425 . . . . 0.0 113.401 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -90.19 147.68 23.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.29 2.045 . . . . 0.0 107.953 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 m -90.85 160.91 15.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.237 -0.289 . . . . 0.0 111.334 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.24 138.09 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 4' ' ' CYS . 55.7 t -106.36 157.81 6.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -151.54 -92.94 0.06 Allowed 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -76.53 52.94 0.83 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.313 1.845 . . . . 0.0 110.739 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.83 -36.01 1.23 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.833 2.635 . . . . 0.0 111.663 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -71.42 141.94 50.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.086 0.954 . . . . 0.0 110.491 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.25 115.68 28.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 129.385 3.074 . . . . 0.0 106.136 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -113.94 171.47 7.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.064 0.946 . . . . 0.0 109.213 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 m -151.14 146.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.68 137.73 39.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.399 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' ND2' ' CZ3' ' A' ' 43' ' ' TRP . 30.5 p-10 -60.4 -36.89 79.17 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.783 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 1.9 p90 -146.66 -140.66 0.11 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.368 2.267 . . . . 0.0 112.942 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -79.18 115.15 18.67 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 130.17 3.388 . . . . 0.0 113.38 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.95 143.63 6.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.166 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.61 30.68 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.873 2.069 . . . . 0.0 106.746 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.8 t -83.39 -133.93 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.889 0.876 . . . . 0.0 108.955 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.49 110.09 55.68 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.72 113.92 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.401 2.734 . . . . 0.0 111.815 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.28 -0.32 37.78 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.6 p -77.02 44.37 0.39 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.461 2.13 . . . . 0.0 112.153 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 t70 42.13 -149.66 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.07 2.148 . . . . 0.0 111.579 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m 50.59 -76.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.145 2.578 . . . . 0.0 114.267 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -83.84 -53.59 5.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.967 1.707 . . . . 0.0 109.991 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.62 164.49 21.36 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.694 1.997 . . . . 0.0 112.749 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -159.1 138.37 11.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -88.27 138.47 31.41 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 109.705 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -14.65 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.621 1.169 . . . . 0.0 111.66 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 -152.17 20.91 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.04 140.01 20.1 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.07 1.348 . . . . 0.0 108.769 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' HG21 ' A' ' 33' ' ' VAL . 6.9 m -74.35 -53.34 9.85 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.808 0.813 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.068 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -173.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ptt? . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.205 0.526 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.46 36.46 2.04 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.65 -49.98 55.7 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.228 1.811 . . . . 0.0 110.426 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -69.99 -55.59 9.18 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 121.671 0.748 . . . . 0.0 109.895 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.35 -67.23 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 130.571 3.548 . . . . 0.0 104.428 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -156.51 26.15 0.34 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.979 0.912 . . . . 0.0 111.631 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.44 -165.96 1.47 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.575 0.625 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -71.83 85.09 0.94 Allowed 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.23 124.43 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.202 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -38.07 131.04 0.97 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.771 1.229 . . . . 0.0 111.85 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -90.21 23.77 24.23 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 120.445 1.195 . . . . 0.0 114.244 0.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.71 66.1 1.42 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.896 1.225 . . . . 0.0 109.53 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -51.95 156.91 1.38 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.964 0.888 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.29 -31.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.834 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.7 m -151.56 167.24 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.262 11.4 tmtt? -82.6 -38.99 22.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.449 2.299 . . . . 0.0 113.535 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.4 t70 167.56 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 1 C-N-CA 132.529 4.332 . . . . 0.0 102.713 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -111.51 175.41 5.44 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 128.194 2.598 . . . . 0.0 107.375 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.21 -55.8 5.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.43 66.95 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.308 0.883 . . . . 0.0 115.308 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.5 163.93 38.72 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.004 1.402 . . . . 0.0 111.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 164.9 51.4 Favored Pre-proline 0 C--O 1.217 -0.606 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.81 156.53 56.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.066 2.488 . . . . 0.0 114.352 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 m -141.07 -28.24 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 0.0 111.849 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -178.59 170.4 1.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 111.249 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -105.75 126.66 52.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.08 160.97 13.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.054 1.342 . . . . 0.0 109.435 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.76 125.88 2.92 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 111.715 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.59 -13.09 54.04 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.882 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.35 144.83 32.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 120.406 2.103 . . . . 0.0 107.781 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -98.71 158.74 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.756 0.422 . . . . 0.0 110.997 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.41 144.33 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.05 150.92 12.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.057 0.543 . . . . 0.0 110.594 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -156.91 133.48 10.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 46.35 33.79 2.01 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.457 1.903 . . . . 0.0 113.165 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.52 9.71 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.986 2.231 . . . . 0.0 112.576 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -78.11 139.94 39.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.629 1.214 . . . . 0.0 110.008 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.51 128.05 36.42 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 129.126 2.97 . . . . 0.0 107.615 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -128.26 167.61 16.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.519 1.127 . . . . 0.0 108.631 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -148.77 147.12 28.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.97 148.97 21.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.72 1.247 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -89.89 -36.42 15.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -132.09 -79.37 0.51 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.05 0.453 . . . . 0.0 111.852 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -157.44 132.62 8.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.777 2.031 . . . . 0.0 107.913 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -167.49 153.65 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.236 0.926 . . . . 0.0 110.107 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.29 34.24 0.65 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.675 1.59 . . . . 0.0 108.943 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 p -88.64 -100.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.189 0.596 . . . . 0.0 111.294 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.55 110.34 4.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.6 111.44 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.948 3.099 . . . . 0.0 113.586 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.71 -27.81 10.08 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.909 1.243 . . . . 0.0 111.867 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.1 t -76.47 65.47 2.34 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.323 1.062 . . . . 0.0 110.959 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 50.94 -128.21 2.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 t 72.45 -47.99 0.68 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.722 1.609 . . . . 0.0 112.813 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 -64.33 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.998 2.919 . . . . 0.0 105.906 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -11.91 121.54 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 129.074 2.95 . . . . 0.0 116.932 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 m -120.24 118.83 31.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 112.597 -2.092 . . . . 0.0 106.206 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -71.3 140.51 50.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -2.37 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.03 -152.53 24.24 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -147.64 142.14 26.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.779 1.232 . . . . 0.0 109.096 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 m -67.68 -46.51 72.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.726 0.774 . . . . 0.0 109.642 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--O 1.257 1.454 0 CA-C-O 115.559 -2.162 . . . . 0.0 105.25 -174.899 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 121.278 0.561 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.98 37.11 93.31 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -31.96 -45.77 0.11 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 129.31 3.044 . . . . 0.0 113.721 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.1 t -67.95 -52.63 33.87 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 121.215 0.531 . . . . 0.0 111.825 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 157.01 -57.6 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 130.517 3.527 . . . . 0.0 105.88 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -149.74 -5.6 0.36 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.393 1.077 . . . . 0.0 113.319 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.52 174.39 11.62 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.201 0.909 . . . . 0.0 112.024 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -54.31 103.85 0.09 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.524 1.13 . . . . 0.0 110.126 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.32 135.82 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 108.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -43.66 132.18 3.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.196 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -98.25 36.29 7.05 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 121.135 1.441 . . . . 0.0 113.593 -0.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -76.26 62.49 1.78 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.538 1.063 . . . . 0.0 108.738 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -52.55 150.89 4.61 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.458 1.103 . . . . 0.0 112.992 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -95.25 -29.52 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.231 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -64.33 -41.31 96.86 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.565 1.075 . . . . 0.0 111.407 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 mttt 57.29 -178.84 0.05 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.458 1.503 . . . . 0.0 112.79 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.54 -17.44 61.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.088 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -158.21 -74.33 0.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.743 0.701 . . . . 0.0 110.902 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.88 -52.6 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.11 0.564 . . . . 0.0 110.645 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.77 -11.86 54.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.705 0.669 . . . . 0.0 111.74 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.22 -177.05 32.84 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 122.11 0.839 . . . . 0.0 113.958 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -62.55 158.85 46.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.267 1.027 . . . . 0.0 110.338 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -64.49 168.26 13.35 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.114 1.876 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -154.2 -29.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.408 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 164.59 169.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.705 1.202 . . . . 0.0 110.418 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -107.02 128.15 54.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.09 162.59 13.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.728 1.211 . . . . 0.0 109.123 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -38.08 122.4 1.03 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.865 1.666 . . . . 0.0 112.012 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -15.27 45.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.475 -1.181 . . . . 0.0 114.384 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -76.19 138.53 40.72 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.534 2.167 . . . . 0.0 106.482 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -108.12 152.67 24.23 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.071 -0.393 . . . . 0.0 111.431 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -148.83 162.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.071 1.348 . . . . 0.0 107.659 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -116.02 151.37 17.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -157.07 119.47 3.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 40.36 76.21 0.07 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.726 2.011 . . . . 0.0 111.283 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.36 -47.11 0.68 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.913 1.72 . . . . 0.0 114.201 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -73.81 142.13 46.18 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.982 0.913 . . . . 0.0 113.122 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.9 tp -97.35 129.49 44.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 130.161 3.384 . . . . 0.0 107.236 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -133.19 156.29 47.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.83 0.852 . . . . 0.0 109.845 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.5 m -130.42 144.7 51.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.224 1.41 . . . . 0.0 107.701 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.9 149.92 24.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.058 0.932 . . . . 0.0 110.302 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.42 -33.42 17.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.942 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 17.7 p90 -143.46 -70.68 0.31 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.786 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -156.94 138.16 13.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.162 2.185 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -171.67 147.46 2.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.73 36.39 2.0 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.559 1.544 . . . . 0.0 107.616 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 m -126.56 153.0 45.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.667 1.187 . . . . 0.0 109.24 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.5 t -36.31 110.58 0.46 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.589 1.956 . . . . 0.0 112.787 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.01 138.16 43.68 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.073 3.182 . . . . 0.0 114.126 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.45 -43.67 1.59 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.997 0.808 . . . . 0.0 112.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.9 t -73.37 -41.89 62.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.619 0.767 . . . . 0.0 111.597 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.85 -111.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -161.26 171.36 18.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.144 1.378 . . . . 0.0 108.554 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 64.73 18.36 11.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -112.61 157.52 21.11 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.116 1.766 . . . . 0.0 109.351 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 m -152.03 119.86 6.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -68.7 142.03 55.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 109.784 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.39 -6.97 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.3 1.04 . . . . 0.0 112.352 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.42 -155.44 26.4 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 p -154.04 150.06 27.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.935 1.294 . . . . 0.0 108.302 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -86.08 -47.09 9.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 122.266 1.031 . . . . 0.0 109.412 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 129.885 3.274 . . . . 0.0 105.024 -175.0 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -132.82 52.32 0.83 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p30 39.2 -126.29 0.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.516 1.526 . . . . 0.0 110.165 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 33' ' ' VAL . 3.3 m -98.58 -23.94 15.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.704 1.138 . . . . 0.0 109.925 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.59 20.61 12.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.916 1.287 . . . . 0.0 112.138 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -162.47 -45.21 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.928 1.291 . . . . 0.0 110.024 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.97 173.41 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -70.45 122.78 20.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.2 136.89 30.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 125.556 1.543 . . . . 0.0 109.71 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -46.08 133.22 7.17 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.045 1.293 . . . . 0.0 111.802 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -95.54 36.82 6.64 Favored 'Cis proline' 0 C--N 1.353 0.81 0 CA-C-N 121.563 1.594 . . . . 0.0 113.52 -0.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.76 66.04 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -59.82 147.69 37.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.403 0.62 . . . . 0.0 110.305 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.6 -43.76 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.544 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -91.48 146.72 23.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 122.626 1.203 . . . . 0.0 109.553 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -115.72 166.65 11.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.154 2.182 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -58.0 -34.83 70.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.393 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -158.49 170.26 22.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.607 1.963 . . . . 0.0 106.848 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.38 -60.69 0.48 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.781 1.632 . . . . 0.0 113.808 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.81 24.07 29.38 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.849 0.738 . . . . 0.0 112.062 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 -174.81 49.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 121.829 0.683 . . . . 0.0 113.19 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.82 154.45 75.64 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.58 154.28 31.46 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.214 1.943 . . . . 0.0 110.011 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.73 -4.89 0.31 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.81 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 165.59 167.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.22 1.008 . . . . 0.0 113.705 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -114.62 137.52 51.79 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.577 1.551 . . . . 0.0 107.099 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.21 168.65 9.22 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.366 1.066 . . . . 0.0 109.28 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.14 124.34 2.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 111.85 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.53 -14.43 55.29 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.701 1.143 . . . . 0.0 113.501 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -78.65 126.63 31.0 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.172 1.486 . . . . 0.0 109.204 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 p -91.5 164.13 13.91 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.886 1.674 . . . . 0.0 112.285 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.56 153.95 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG21 ' SG ' ' A' ' 4' ' ' CYS . 2.8 t -111.55 153.4 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 118.48 0.582 . . . . 0.0 109.521 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -161.38 129.17 4.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 33.16 74.2 0.06 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.136 1.774 . . . . 0.0 112.247 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.07 -40.7 0.33 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.677 2.084 . . . . 0.0 115.089 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -78.37 145.5 35.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.607 1.194 . . . . 0.0 112.716 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.4 tp -101.82 126.8 48.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 129.837 3.255 . . . . 0.0 106.923 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.75 152.76 49.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.443 0.697 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.1 m -128.63 140.04 51.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 109.203 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 141.76 40.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.865 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.41 -39.51 13.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.428 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -133.5 -71.47 0.51 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -159.28 135.75 9.18 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 127.732 2.413 . . . . 0.0 106.561 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -168.19 157.05 9.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.236 0.926 . . . . 0.0 110.507 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.56 21.12 0.92 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.848 1.659 . . . . 0.0 109.277 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.5 p -91.25 164.23 13.96 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.7 t -52.14 111.81 2.8 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.388 0.675 . . . . 0.0 109.326 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.21 122.69 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.337 3.358 . . . . 0.0 113.445 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.84 -23.15 34.71 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.468 1.032 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 m -76.24 66.92 2.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.284 1.042 . . . . 0.0 110.666 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 47.2 -126.7 1.65 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.996 1.319 . . . . 0.0 108.847 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m 65.07 -40.87 0.29 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.467 2.307 . . . . 0.0 115.94 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p 179.34 -69.82 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.264 2.626 . . . . 0.0 106.224 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -8.91 112.98 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.723 3.209 . . . . 0.0 116.124 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.4 m -108.88 113.16 25.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 112.805 -1.998 . . . . 0.0 106.264 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -66.79 134.34 51.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -111.13 -9.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.686 0.794 . . . . 0.0 111.185 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.68 -167.64 32.63 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.103 0.865 . . . . 0.0 111.593 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -122.79 123.22 40.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -31.44 68.15 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.518 0 CA-C-O 114.84 -2.505 . . . . 0.0 107.05 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.56 139.69 6.25 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -33.55 -47.25 0.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.923 2.489 . . . . 0.0 113.734 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.8 t -64.75 -47.21 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.476 0.655 . . . . 0.0 111.951 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 155.98 -61.04 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 130.705 3.602 . . . . 0.0 104.849 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.1 0.85 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.463 1.105 . . . . 0.0 113.259 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.72 -175.29 5.2 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.092 0.86 . . . . 0.0 111.838 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.52 94.0 0.04 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.814 0.845 . . . . 0.0 111.003 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 p -96.6 131.81 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.0 135.73 11.33 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.856 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -93.87 33.47 9.62 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.636 1.263 . . . . 0.0 114.706 0.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -74.5 66.95 1.44 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.999 1.272 . . . . 0.0 108.336 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 9.6 m95 -50.86 160.86 0.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.989 1.316 . . . . 0.0 113.251 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.21 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.938 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -110.9 147.78 33.87 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.773 2.829 . . . . 0.0 107.728 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -66.68 -29.11 69.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -152.63 157.87 41.6 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.624 1.17 . . . . 0.0 108.243 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.78 -60.73 0.69 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.363 1.865 . . . . 0.0 114.615 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.38 5.71 84.61 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.863 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.62 150.71 27.12 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.922 1.361 . . . . 0.0 110.677 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -68.67 151.59 97.16 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 50.6 Cg_exo -57.43 157.96 20.67 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 CA-C-N 119.655 0.912 . . . . 0.0 112.729 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 t -157.74 9.74 0.17 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.333 -1.318 . . . . 0.0 110.804 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -178.14 170.49 1.8 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-O 122.647 1.213 . . . . 0.0 113.843 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -115.06 98.56 6.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.874 2.07 . . . . 0.0 105.77 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.29 165.57 13.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.887 -0.508 . . . . 0.0 111.872 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.86 132.07 11.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.324 1.05 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 -10.06 34.93 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.338 -1.257 . . . . 0.0 113.339 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 40' ' ' THR . 0.5 OUTLIER -78.99 156.41 28.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 120.062 1.931 . . . . 0.0 106.479 178.18 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -117.94 166.26 12.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.534 0.734 . . . . 0.0 110.524 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 tt -162.38 160.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -116.62 151.37 18.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.71 0.687 . . . . 0.0 109.729 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -162.62 134.85 5.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt 49.59 32.22 4.79 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.84 1.656 . . . . 0.0 112.686 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.09 -19.24 23.2 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.71 2.1 . . . . 0.0 112.874 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -85.53 145.1 27.55 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.702 1.251 . . . . 0.0 109.591 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tp -93.45 129.47 39.61 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.313 2.645 . . . . 0.0 107.178 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -127.62 164.78 21.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.346 1.058 . . . . 0.0 108.381 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' GLN . 57.7 m -146.24 145.6 30.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.36 144.5 26.36 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 111.108 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -93.45 -36.54 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.378 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -132.91 -78.01 0.49 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.281 0.563 . . . . 0.0 112.112 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -157.55 132.95 9.01 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -167.07 147.84 5.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.45 1.023 . . . . 0.0 111.022 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.3 15.72 4.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.158 1.383 . . . . 0.0 107.921 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -77.46 163.31 26.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.56 127.9 90.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -45.33 122.4 4.58 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.528 2.818 . . . . 0.0 112.844 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.09 -24.95 27.76 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.167 0.889 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -76.92 75.58 3.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.333 1.066 . . . . 0.0 109.558 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.81 -131.43 0.74 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 110.051 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t 67.7 -54.77 0.49 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.394 2.277 . . . . 0.0 113.979 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 p -172.45 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.548 1.139 . . . . 0.0 109.886 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -18.68 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.427 3.091 . . . . 0.0 116.715 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 m -143.43 130.99 21.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 112.583 -2.099 . . . . 0.0 107.057 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -74.0 141.21 45.86 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.6 -6.23 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.268 1.027 . . . . 0.0 113.027 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.7 -151.42 22.82 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -153.85 154.22 33.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.448 1.099 . . . . 0.0 109.324 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 m -87.27 -53.81 4.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 110.029 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtt . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.4 31.14 79.75 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.892 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -80.99 68.05 7.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.161 1.385 . . . . 0.0 108.015 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 p -9.95 84.98 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 130.568 3.547 . . . . 0.0 117.037 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.22 -23.8 9.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.009 2.524 . . . . 0.0 112.892 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -54.5 -38.06 66.05 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.21 152.65 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -46.84 122.43 4.3 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.468 0.707 . . . . 0.0 109.967 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.18 130.77 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 119.173 0.897 . . . . 0.0 109.096 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' HA ' HD11 ' A' ' 32' ' ' ILE . 30.6 t80 -47.98 136.48 11.04 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.523 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -91.49 24.03 24.98 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.944 1.016 . . . . 0.0 113.876 0.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -73.17 68.75 1.01 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 119.859 1.209 . . . . 0.0 109.807 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -52.22 157.05 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.741 0.782 . . . . 0.0 112.043 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.24 -21.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -145.15 166.83 24.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.063 0.935 . . . . 0.0 113.16 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.271 51.0 tttp -96.9 -40.1 9.07 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 128.543 2.737 . . . . 0.0 110.313 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 174.75 -40.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 1 C-N-CA 133.217 4.607 . . . . 0.0 102.926 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -113.57 166.52 11.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.76 -68.08 0.39 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.45 11.38 1.15 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.42 155.74 27.4 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.258 1.529 . . . . 0.0 110.187 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.9 121.05 42.79 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -50.94 152.95 9.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.449 2.1 . . . . 0.0 116.654 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 m -152.37 -17.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.081 0.952 . . . . 0.0 112.23 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 179.38 164.19 0.96 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.752 1.16 . . . . 0.0 110.973 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -100.09 141.49 32.85 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.72 169.76 8.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.735 1.214 . . . . 0.0 109.404 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.97 122.03 2.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.622 1.169 . . . . 0.0 111.358 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 -19.06 48.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.863 1.221 . . . . 0.0 113.215 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -76.92 131.98 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.257 1.528 . . . . 0.0 110.503 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.93 163.5 12.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.2 1.8 . . . . 0.0 112.087 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 10' ' ' TYR . 12.5 tt -167.02 149.42 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.176 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.92 153.61 3.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.407 1.003 . . . . 0.0 108.554 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -158.21 115.49 2.91 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 39.45 78.58 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.041 1.736 . . . . 0.0 112.132 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.27 -42.86 0.53 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.017 1.294 . . . . 0.0 115.825 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -81.57 145.39 30.67 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 122.041 0.924 . . . . 0.0 111.996 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tp -99.44 125.47 45.17 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 129.143 2.977 . . . . 0.0 106.317 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.06 167.35 13.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.31 1.044 . . . . 0.0 108.749 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -148.59 142.88 26.17 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.72 144.21 29.51 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.148 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -95.73 -35.29 11.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.097 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -131.38 -75.42 0.52 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.382 0.426 . . . . 0.0 111.53 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -159.96 125.61 4.12 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.939 2.096 . . . . 0.0 107.921 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 t -167.41 150.57 6.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.979 1.263 . . . . 0.0 111.863 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.21 5.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.783 2.033 . . . . 0.0 108.061 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -71.26 162.99 28.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.39 120.6 53.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.89 122.98 9.04 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.211 2.608 . . . . 0.0 112.615 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.5 -30.44 9.62 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.4 m -75.94 73.38 2.84 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.534 1.167 . . . . 0.0 110.44 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 55.94 -133.2 1.54 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.806 1.242 . . . . 0.0 108.948 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t 59.52 -152.88 0.39 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -54.41 13.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.909 -0.494 . . . . 0.0 109.899 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -13.5 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.953 2.901 . . . . 0.0 117.505 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 m -117.97 126.89 53.2 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.44 2.296 . . . . 0.0 106.399 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.02 141.91 47.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -15.9 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.583 1.153 . . . . 0.0 111.873 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.92 -177.56 47.58 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.0 1.273 . . . . 0.0 112.213 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.5 p -137.03 110.86 8.15 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.932 1.693 . . . . 0.0 107.285 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.8 m -74.04 -37.89 64.16 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.269 0.557 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.83 41.59 94.15 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -43.95 -35.81 2.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.997 2.119 . . . . 0.0 113.586 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HB2' HG21 ' A' ' 33' ' ' VAL . 5.6 t -82.75 -48.75 10.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.261 1.024 . . . . 0.0 110.241 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.85 -55.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.845 3.258 . . . . 0.0 105.146 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -152.16 -2.68 0.27 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.615 1.166 . . . . 0.0 112.736 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.59 157.98 30.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.569 1.077 . . . . 0.0 111.07 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -39.5 106.85 0.06 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 126.509 1.924 . . . . 0.0 112.742 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.3 132.02 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.545 1.138 . . . . 0.0 108.762 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.61 133.77 6.27 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.597 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.27 34.42 8.57 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 120.982 1.386 . . . . 0.0 114.422 0.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -76.71 59.53 1.57 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.164 1.347 . . . . 0.0 108.118 176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . 0.267 7.2 m95 -55.66 156.83 4.5 Favored 'General case' 0 N--CA 1.412 -2.352 0 C-N-CA 129.356 3.062 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.38 -26.82 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.652 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 t -156.05 173.67 16.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 124.345 2.022 . . . . 0.0 116.0 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.38 -172.01 2.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 130.42 3.488 . . . . 0.0 106.499 171.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.44 -30.56 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.937 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -131.66 152.46 50.84 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 110.156 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.72 -63.35 0.52 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.89 2.076 . . . . 0.0 115.108 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 3.37 69.92 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.962 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.92 147.26 34.78 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 120.199 2.0 . . . . 0.0 111.069 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.35 120.16 80.06 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -38.74 159.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.838 3.692 . . . . 0.0 121.153 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 2.93 0.43 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 112.134 -2.303 . . . . 0.0 109.515 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 178.16 172.24 0.68 Allowed 'General case' 0 C--N 1.349 0.552 0 CA-C-N 120.307 1.412 . . . . 0.0 113.657 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -110.09 139.02 45.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.97 169.29 8.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.353 1.461 . . . . 0.0 109.281 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -42.26 123.86 2.62 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.922 1.289 . . . . 0.0 112.052 -177.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.17 -17.24 18.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.761 0.696 . . . . 0.0 113.751 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -75.03 128.22 35.05 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -100.76 164.67 11.75 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.3 tt -161.59 173.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.215 1.406 . . . . 0.0 108.233 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 4' ' ' CYS . 70.9 t -121.89 153.24 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.032 1.333 . . . . 0.0 110.452 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -158.05 114.19 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 41.18 81.74 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.617 2.367 . . . . 0.0 112.231 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.4 -44.05 0.58 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.57 1.557 . . . . 0.0 114.755 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.61 146.67 40.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.895 0.878 . . . . 0.0 111.739 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.0 tp -106.11 129.17 54.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 130.45 3.5 . . . . 0.0 106.993 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -132.33 162.46 30.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.267 1.027 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.0 m -134.53 144.58 48.09 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.335 1.454 . . . . 0.0 109.096 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.69 145.85 27.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.124 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' HB3' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-80 -86.8 -32.59 20.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.443 1.497 . . . . 0.0 111.492 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 17.9 p90 -148.96 -65.16 0.23 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 111.101 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -159.86 134.88 7.98 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 127.564 2.346 . . . . 0.0 107.629 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -174.32 144.29 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.057 0.844 . . . . 0.0 111.573 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.81 14.64 9.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.715 2.006 . . . . 0.0 107.932 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.52 165.81 23.86 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.3 t -57.24 118.69 26.18 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.493 -0.765 . . . . 0.0 108.954 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.05 119.17 5.67 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.551 2.168 . . . . 0.0 110.75 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.55 -26.72 9.36 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.3 t -73.43 80.14 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -41.17 139.67 0.93 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.777 1.631 . . . . 0.0 111.413 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t 163.57 -49.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.795 2.438 . . . . 0.0 106.301 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 t -146.56 11.06 1.11 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.979 1.712 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -113.54 156.41 23.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.26 1.024 . . . . 0.0 108.903 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -153.32 126.02 8.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -72.85 140.56 47.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.23 0.468 . . . . 0.0 110.004 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -17.13 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.901 1.281 . . . . 0.0 111.053 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.37 -157.35 29.78 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -154.27 140.72 18.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.886 1.674 . . . . 0.0 106.77 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.58 -44.28 11.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.553 0.615 . . . . 0.0 111.136 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.7 168.55 54.62 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.81 -42.57 36.5 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.628 0.771 . . . . 0.0 110.768 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.9 t -74.76 -58.59 3.19 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 122.198 0.999 . . . . 0.0 108.558 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.24 -58.02 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 129.747 3.219 . . . . 0.0 104.803 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -152.15 32.32 0.53 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.943 0.897 . . . . 0.0 112.117 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.03 155.63 24.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -32.54 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.587 1.955 . . . . 0.0 113.87 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -88.76 122.97 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -48.66 137.92 12.33 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 120.92 1.691 . . . . 0.0 109.998 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -92.21 36.12 6.64 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 120.612 1.254 . . . . 0.0 114.708 0.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -74.3 66.57 1.32 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.068 1.303 . . . . 0.0 107.86 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 6.3 m95 -50.55 164.44 0.13 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.533 1.533 . . . . 0.0 113.025 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.94 -33.0 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.139 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -144.57 172.63 12.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.266 86.8 tttt -99.49 -57.73 2.09 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.816 3.246 . . . . 0.0 109.582 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -158.07 -50.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.905 5.682 . . . . 0.0 101.913 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -113.28 175.26 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -58.88 3.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.06 -21.13 63.41 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.22 153.43 48.44 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -59.93 131.88 89.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 37.7 Cg_exo -60.89 160.34 25.8 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 N-CA-C 117.944 2.248 . . . . 0.0 117.944 -173.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -151.86 -7.92 0.22 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 112.448 -2.16 . . . . 0.0 110.4 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -174.41 173.29 3.0 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.58 123.3 41.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.745 2.418 . . . . 0.0 105.941 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.6 169.2 11.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.192 0.997 . . . . 0.0 111.669 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.77 128.16 20.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.7 66.6 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.061 -1.411 . . . . 0.0 113.977 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.66 136.74 33.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.582 2.191 . . . . 0.0 106.252 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.1 m -98.36 157.51 16.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.224 0.535 . . . . 0.0 112.208 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 tt -152.05 162.9 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 t -121.86 145.4 28.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.655 0.661 . . . . 0.0 109.519 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -167.34 167.77 13.72 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 40.33 39.68 0.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.957 1.253 . . . . 0.0 112.933 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.39 36.79 54.18 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.963 1.744 . . . . 0.0 112.413 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -150.82 157.22 42.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.939 1.296 . . . . 0.0 110.194 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.3 tp -87.73 132.12 34.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.984 2.514 . . . . 0.0 109.392 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.74 156.79 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.515 1.126 . . . . 0.0 108.59 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 m -137.2 145.2 43.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.58 153.93 21.43 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.35 1.071 . . . . 0.0 110.584 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.08 -32.84 15.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.715 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -138.89 -146.0 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.483 1.513 . . . . 0.0 109.551 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.15 115.9 28.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.751 2.421 . . . . 0.0 106.038 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -157.46 156.57 32.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.131 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.79 20.06 4.19 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.418 1.887 . . . . 0.0 108.049 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -79.9 -179.35 6.92 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.23 120.47 73.4 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 55' ' ' TRP . 52.4 Cg_exo -54.51 127.37 25.73 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.572 2.848 . . . . 0.0 115.551 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.62 -38.41 1.05 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 123.688 0.661 . . . . 0.0 112.759 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -65.72 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.414 0.607 . . . . 0.0 110.814 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.88 179.89 6.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.551 0.691 . . . . 0.0 110.948 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -47.24 164.92 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.838 3.255 . . . . 0.0 115.508 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.2 p 71.95 4.72 5.12 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.637 2.775 . . . . 0.0 114.649 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 49' ' ' PRO . 98.6 m95 -117.2 149.23 40.73 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.779 1.231 . . . . 0.0 110.85 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 m -136.69 118.51 15.14 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.95 139.59 48.76 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -121.57 12.19 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.076 0.55 . . . . 0.0 112.257 -179.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.33 -150.86 17.91 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t -89.42 176.78 6.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -73.47 96.1 2.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 O-C-N 125.017 1.448 . . . . 0.0 109.724 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 ttp . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.72 46.77 0.02 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.07 69.72 2.68 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.849 1.66 . . . . 0.0 108.204 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -37.12 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 129.243 3.017 . . . . 0.0 116.45 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.63 -27.17 10.56 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.789 2.436 . . . . 0.0 111.342 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -54.3 -33.37 58.59 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.82 176.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.31 1.444 . . . . 0.0 109.067 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -60.37 118.41 6.41 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.84 137.06 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -55.52 135.24 70.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 120.704 1.593 . . . . 0.0 110.824 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -99.37 31.17 11.47 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 121.382 1.529 . . . . 0.0 113.319 -1.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -74.76 65.06 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 39.4 m95 -48.59 152.41 0.96 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.88 0.848 . . . . 0.0 112.316 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.97 -25.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.137 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 m -153.19 169.99 21.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.527 1.632 . . . . 0.0 115.037 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.48 -166.5 1.09 Allowed 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 129.439 3.096 . . . . 0.0 108.305 173.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -53.97 -44.57 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.621 -2.081 . . . . 0.0 107.823 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -128.49 153.36 47.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.392 1.877 . . . . 0.0 109.728 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.44 -63.48 0.44 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.493 1.917 . . . . 0.0 115.174 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 4.73 79.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.677 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.76 154.0 46.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-N 120.487 2.144 . . . . 0.0 110.988 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.0 113.31 8.86 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 51.5 Cg_exo -37.79 147.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 1 C-N-CA 125.746 4.297 . . . . 0.0 117.412 -173.2 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 p -139.74 -8.01 1.25 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -178.52 158.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 119.152 0.887 . . . . 0.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -99.21 113.77 26.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 3.4 tt0 -82.15 164.27 21.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.238 1.815 . . . . 0.0 110.615 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -47.63 127.51 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 120.804 -1.185 . . . . 0.0 112.603 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 -14.37 48.92 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.956 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -81.06 139.9 35.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.688 2.744 . . . . 0.0 107.216 178.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 p -94.25 164.65 12.95 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.262 -0.899 . . . . 0.0 111.919 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 tt -156.86 151.35 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -98.8 150.1 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -159.93 116.47 2.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 38.23 77.3 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.971 2.109 . . . . 0.0 112.541 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.63 -42.09 0.55 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.59 1.567 . . . . 0.0 113.981 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -78.24 151.08 33.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.083 0.944 . . . . 0.0 112.14 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -105.3 124.13 49.02 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 128.94 2.896 . . . . 0.0 106.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.55 168.92 11.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.6 m -150.82 148.84 28.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.76 146.92 25.42 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.921 0.867 . . . . 0.0 112.166 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -87.56 -36.4 17.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 29.3 p90 -139.14 -71.97 0.4 Allowed 'General case' 0 C--N 1.339 0.122 0 CA-C-O 120.889 0.376 . . . . 0.0 111.623 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -159.73 128.94 5.21 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.353 1.461 . . . . 0.0 108.454 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 t -166.55 150.98 7.53 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 119.134 0.879 . . . . 0.0 111.307 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.89 15.28 4.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.907 1.683 . . . . 0.0 107.996 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 p -87.9 172.02 9.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.41 123.82 83.93 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 111.607 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.26 140.25 72.38 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.513 2.808 . . . . 0.0 114.671 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.38 -45.73 2.11 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.655 1.121 . . . . 0.0 111.699 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -73.23 -45.14 57.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.503 0.721 . . . . 0.0 112.646 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.5 -167.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.583 1.182 . . . . 0.0 114.152 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -57.76 140.92 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.758 3.223 . . . . 0.0 117.459 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t 62.39 23.41 13.88 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 128.142 2.577 . . . . 0.0 113.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -107.58 152.08 24.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.286 1.041 . . . . 0.0 111.116 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 m -153.63 134.09 13.55 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.62 138.47 37.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.579 0.752 . . . . 0.0 109.801 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.98 -4.37 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.084 0.954 . . . . 0.0 111.218 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.05 -151.65 23.77 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -145.77 156.37 43.55 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 107.491 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.9 t -67.44 -34.09 76.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.836 0.827 . . . . 0.0 111.047 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.514 0 CA-C-O 115.006 -2.426 . . . . 0.0 107.022 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.18 -152.94 12.12 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 119.524 1.057 . . . . 0.0 112.685 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -66.91 80.79 0.11 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.261 1.424 . . . . 0.0 110.363 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.277 0.1 OUTLIER -7.66 85.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 130.041 3.336 . . . . 0.0 115.844 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.72 64.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.434 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -57.99 -32.9 68.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.995 0.918 . . . . 0.0 110.467 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.01 171.17 7.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.727 1.211 . . . . 0.0 108.636 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -64.21 129.8 41.4 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.72 130.84 55.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 C-N-CA 124.454 1.101 . . . . 0.0 110.326 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -43.13 133.89 3.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.704 1.138 . . . . 0.0 110.975 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.48 31.08 11.68 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.613 1.255 . . . . 0.0 114.36 0.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -73.4 67.7 1.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.033 1.288 . . . . 0.0 108.252 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -54.82 151.73 8.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.751 -0.593 . . . . 0.0 111.383 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.62 -43.7 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -105.16 160.53 15.0 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 122.811 1.291 . . . . 0.0 112.733 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -116.67 162.21 18.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.126 2.57 . . . . 0.0 108.596 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.76 -30.67 70.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -157.03 156.59 33.14 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 108.89 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 73.7 0.05 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.039 1.736 . . . . 0.0 111.852 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.95 -20.1 0.76 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.316 1.436 . . . . 0.0 111.512 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.11 175.41 48.22 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.321 1.06 . . . . 0.0 110.895 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.36 151.2 87.59 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.71 139.6 23.94 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.132 1.888 . . . . 0.0 109.497 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.05 -7.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.625 -1.179 . . . . 0.0 112.922 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 176.4 164.76 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -111.38 140.37 46.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -108.48 173.4 6.33 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.849 1.26 . . . . 0.0 108.679 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.75 129.31 26.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.692 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.47 68.15 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.606 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -84.62 127.14 33.92 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.54 1.67 . . . . 0.0 109.611 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -89.47 166.41 13.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.374 1.07 . . . . 0.0 113.838 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 tt -170.91 154.25 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.665 1.586 . . . . 0.0 108.575 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.1 t -107.59 159.41 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -155.32 -66.64 0.12 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -117.32 96.35 5.38 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.838 1.655 . . . . 0.0 109.625 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.01 15.24 0.01 OUTLIER Glycine 0 CA--C 1.531 1.056 1 C-N-CA 131.005 4.145 . . . . 0.0 117.64 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -143.71 160.68 40.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.142 -1.211 . . . . 0.0 109.012 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.1 tp -89.4 124.14 34.19 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 127.208 2.203 . . . . 0.0 106.643 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -121.54 152.36 39.29 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.156 0.982 . . . . 0.0 108.628 178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 58' ' ' VAL . 77.4 m -134.18 145.31 49.1 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.26 146.41 28.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.539 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -90.41 -32.17 16.54 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.792 1.637 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -148.7 -140.76 0.1 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.221 2.208 . . . . 0.0 107.601 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -87.02 126.4 34.72 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 127.849 2.46 . . . . 0.0 108.48 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.8 143.54 8.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.34 43.17 1.77 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.863 1.265 . . . . 0.0 108.637 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -138.8 161.36 37.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -31.32 105.02 0.22 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 128.938 2.895 . . . . 0.0 113.769 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -51.06 138.4 43.91 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 124.379 3.386 . . . . 0.0 113.889 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.65 -36.83 0.59 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.158 1.361 . . . . 0.0 113.446 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.0 m -76.08 -45.58 33.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 112.382 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -97.37 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.982 0.355 . . . . 0.0 111.486 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -168.23 175.46 6.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t 63.99 21.05 12.47 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.448 1.099 . . . . 0.0 109.834 -177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -123.09 140.43 53.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 124.236 1.014 . . . . 0.0 109.702 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -136.27 120.93 18.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.793 1.637 . . . . 0.0 106.677 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -70.73 134.05 47.13 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.431 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -110.08 -15.56 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.997 1.319 . . . . 0.0 111.802 -178.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.33 160.8 29.62 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -112.01 144.98 40.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 m -117.93 -48.72 2.54 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.281 0.632 . . . . 0.0 111.598 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.933 -172.208 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.432 0.635 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.46 150.52 13.64 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 107.303 -2.319 . . . . 0.0 107.303 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.29 149.29 0.4 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.278 1.031 . . . . 0.0 108.509 -177.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.492 ' H ' HG11 ' A' ' 33' ' ' VAL . 1.3 p -71.55 82.7 0.83 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.391 1.091 . . . . 0.0 111.194 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -39.8 -39.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.995 3.318 . . . . 0.0 113.866 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.03 -35.24 64.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.075 0.95 . . . . 0.0 111.029 179.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.94 153.87 18.06 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.505 1.122 . . . . 0.0 108.01 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -43.56 118.62 1.42 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.523 1.129 . . . . 0.0 111.476 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.69 127.68 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -49.7 135.07 19.58 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.335 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -93.07 25.15 23.26 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 121.321 1.507 . . . . 0.0 115.337 0.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -72.98 66.8 0.82 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.82 1.191 . . . . 0.0 108.119 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -53.58 154.79 3.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.38 -45.85 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.545 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -94.04 153.77 17.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 122.691 1.234 . . . . 0.0 110.179 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -112.72 166.8 11.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.39 2.276 . . . . 0.0 108.915 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.74 -32.66 74.23 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -157.35 158.65 36.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.993 1.317 . . . . 0.0 108.202 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.95 -61.21 0.67 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.262 1.825 . . . . 0.0 114.376 -177.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.47 12.88 65.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.541 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.17 -166.1 41.75 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.42 1.11 . . . . 0.0 111.625 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.24 160.68 26.41 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.923 1.289 . . . . 0.0 107.819 177.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.56 149.13 10.45 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.392 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.7 m -146.02 -19.35 0.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.308 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 177.85 166.05 0.69 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.365 0.984 . . . . 0.0 113.006 -175.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.66 113.41 26.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.57 167.97 16.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.662 0.785 . . . . 0.0 109.633 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -42.35 126.88 3.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.977 1.311 . . . . 0.0 111.877 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -8.18 57.98 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.153 178.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.37 126.45 32.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.661 1.73 . . . . 0.0 108.703 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -86.49 162.58 18.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.127 1.771 . . . . 0.0 112.518 -178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -163.95 150.15 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.085 1.354 . . . . 0.0 108.224 177.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' H ' ' A' ' 4' ' ' CYS . 2.2 t -102.52 155.52 5.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -167.21 125.18 1.28 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 108.363 175.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 43.4 55.99 4.54 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 123.682 1.706 . . . . 0.0 111.44 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -36.06 1.11 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.704 2.573 . . . . 0.0 114.256 177.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -70.87 145.39 50.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.275 1.036 . . . . 0.0 110.443 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -101.95 119.66 39.14 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 129.088 2.955 . . . . 0.0 106.287 178.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -123.84 156.27 36.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.398 0.679 . . . . 0.0 110.051 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.8 m -132.58 143.01 49.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.583 1.153 . . . . 0.0 108.312 177.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.77 144.89 34.73 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.882 0.873 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.411 ' HB3' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-20 -86.65 -37.68 17.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.334 -177.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 18.1 p90 -144.69 -67.46 0.32 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.561 0.696 . . . . 0.0 110.368 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -155.42 142.05 18.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.821 2.448 . . . . 0.0 107.614 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -176.36 145.42 0.58 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 45.55 0.92 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.326 1.851 . . . . 0.0 106.516 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 56.2 p -106.96 -105.56 0.33 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.377 1.071 . . . . 0.0 113.106 -174.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.3 t -145.39 117.28 5.17 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.81 130.94 23.96 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.064 2.509 . . . . 0.0 115.885 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.79 -42.27 1.29 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.545 1.545 . . . . 0.0 113.025 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.8 m -59.33 -57.14 14.32 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.58 -25.43 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p 89.0 179.28 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.773 2.829 . . . . 0.0 110.48 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t 78.76 28.34 0.43 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 -170.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -136.39 157.34 47.04 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 129.772 3.229 . . . . 0.0 106.591 -175.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -155.25 120.19 4.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.73 128.71 36.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.32 -13.04 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.369 1.068 . . . . 0.0 110.423 178.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.59 -156.64 28.38 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.63 134.8 14.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 88.5 m -91.21 -42.49 10.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.319 0.509 . . . . 0.0 111.921 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.246 0.921 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -171.976 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 121.313 0.578 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.11 112.71 5.22 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -26.51 -49.67 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.562 2.745 . . . . 0.0 114.966 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 t -53.44 -53.59 49.18 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.53 1.059 . . . . 0.0 111.566 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 151.88 -61.17 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.373 3.469 . . . . 0.0 106.467 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -151.68 2.8 0.39 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -82.2 -171.27 3.33 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.421 1.01 . . . . 0.0 111.098 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -69.65 97.76 1.09 Allowed 'General case' 0 C--N 1.338 0.096 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 7' ' ' ALA . 2.4 t -102.66 124.89 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.046 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -42.14 132.79 2.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 119.487 1.04 . . . . 0.0 111.15 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.72 27.29 15.01 Favored 'Cis proline' 0 C--N 1.35 0.638 0 N-CA-C 115.888 1.457 . . . . 0.0 115.888 1.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -74.71 66.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.153 1.342 . . . . 0.0 107.617 175.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -58.1 176.14 0.18 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 112.388 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.83 -33.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.12 -66.85 0.84 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -171.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' CG ' ' H ' ' A' ' 17' ' ' ASP . 3.5 tttm 53.51 -167.26 0.07 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 123.611 1.672 . . . . 0.0 112.487 -170.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.403 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 10.5 m-20 -82.0 -40.3 22.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.3 2.64 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -79.81 174.61 11.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.842 2.057 . . . . 0.0 114.566 -175.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.41 39.91 3.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.198 2.199 . . . . 0.0 106.923 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.09 47.58 0.04 OUTLIER Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.374 1.464 . . . . 0.0 110.623 -177.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.25 -157.49 9.78 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -78.09 -174.78 0.47 Allowed Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -110.12 158.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.909 1.739 . . . . 0.0 113.373 178.316 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -150.92 -12.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.39 0.676 . . . . 0.0 112.049 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 178.6 164.07 0.77 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.342 0.974 . . . . 0.0 111.02 -177.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -112.37 149.65 32.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.654 1.182 . . . . 0.0 108.078 177.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.18 172.71 8.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.66 0.784 . . . . 0.0 110.471 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.22 123.25 2.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.485 1.514 . . . . 0.0 112.088 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -14.37 40.7 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.463 1.03 . . . . 0.0 113.779 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.49 118.06 21.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.295 1.547 . . . . 0.0 109.633 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -80.76 166.69 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 111.928 179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 tt -165.9 151.83 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.003 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.434 HG21 ' SG ' ' A' ' 61' ' ' CYS . 41.0 t -109.22 156.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -138.98 -126.56 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.36 84.19 1.44 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.277 1.399 . . . . 0.0 108.933 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.84 -45.28 0.87 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 127.993 2.711 . . . . 0.0 113.022 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -68.93 143.43 54.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.79 0.836 . . . . 0.0 111.675 -176.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.42 122.53 43.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 129.96 3.304 . . . . 0.0 106.621 177.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -122.84 170.79 9.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.824 1.25 . . . . 0.0 109.242 178.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -148.75 144.63 27.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.81 145.9 27.01 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.41 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -95.47 -31.39 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.221 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -134.18 -73.77 0.48 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 111.307 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -158.4 135.95 10.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.441 2.296 . . . . 0.0 108.441 -177.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -168.9 149.99 4.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.21 0.914 . . . . 0.0 109.677 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.97 37.0 0.86 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.131 1.772 . . . . 0.0 108.038 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.3 p -94.7 -103.93 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.018 0.927 . . . . 0.0 111.888 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.4 112.92 4.73 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.66 1.984 . . . . 0.0 106.056 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.1 121.02 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.421 2.747 . . . . 0.0 113.128 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.88 -17.59 57.7 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.995 0.807 . . . . 0.0 113.05 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -77.31 74.66 3.87 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.993 1.396 . . . . 0.0 109.453 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 t70 51.69 -132.19 1.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.362 1.065 . . . . 0.0 108.691 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t 57.7 -150.58 0.44 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.267 0.94 . . . . 0.0 109.136 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.45 -51.83 39.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.815 0.846 . . . . 0.0 109.702 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -20.06 130.66 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.156 2.582 . . . . 0.0 116.22 -175.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -136.77 128.76 29.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -75.3 141.03 43.48 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -14.06 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.87 1.268 . . . . 0.0 111.635 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.82 -148.12 13.31 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.553 1.069 . . . . 0.0 110.693 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -157.98 135.83 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.279 1.431 . . . . 0.0 108.827 178.194 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.434 ' SG ' HG21 ' A' ' 33' ' ' VAL . 2.7 m -68.11 -49.52 60.65 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.675 0.75 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 -175.067 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptm . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.705 0.764 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.23 66.41 2.9 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -16.44 -57.45 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.413 3.085 . . . . 0.0 115.853 -176.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 7' ' ' ALA . 40.4 t -54.34 -48.81 70.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.859 0.754 . . . . 0.0 112.907 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 104.87 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.25 3.02 . . . . 0.0 108.458 -175.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.61 40.82 1.11 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . -162.45 173.7 13.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.701 1.137 . . . . 0.0 109.093 174.161 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -48.83 107.3 0.13 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 125.189 1.396 . . . . 0.0 112.187 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.9 131.01 48.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.206 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -44.2 133.04 4.42 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.926 1.239 . . . . 0.0 110.404 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.9 35.97 7.43 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 121.202 1.465 . . . . 0.0 113.908 0.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.22 61.44 1.16 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.764 1.165 . . . . 0.0 108.237 176.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -55.38 156.02 4.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.775 0.798 . . . . 0.0 112.819 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -76.12 -53.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.608 178.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -80.82 143.31 32.9 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -124.61 165.91 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 112.069 -176.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -45.21 95.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.331 -1.758 . . . . 0.0 109.904 177.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.283 1.7 m95 21.24 166.4 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 136.471 5.908 . . . . 0.0 124.845 -177.365 . . . . . . . . 3 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 120.69 57.3 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 2 C-N-CA 136.595 5.958 . . . . 0.0 100.825 -173.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.28 59.34 3.37 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.647 2.546 . . . . 0.0 107.295 -173.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.35 -148.15 7.35 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 123.483 0.563 . . . . 0.0 111.949 -178.099 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -131.09 163.8 46.71 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.635 1.174 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.38 150.26 26.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.836 3.024 . . . . 0.0 110.477 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.91 -17.79 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.219 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -179.68 168.41 1.37 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -178.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -114.91 131.11 56.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.629 1.972 . . . . 0.0 107.567 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.58 165.05 11.32 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.968 0.907 . . . . 0.0 109.626 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.23 123.68 2.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.666 1.186 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.79 -12.43 57.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.157 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.77 139.31 39.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.263 2.031 . . . . 0.0 105.795 177.344 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -105.93 156.83 17.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.918 0.487 . . . . 0.0 111.079 -178.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -157.52 168.77 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.389 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.15 149.38 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.385 0.674 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.04 134.3 16.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.037 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 50.74 27.69 3.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.958 1.703 . . . . 0.0 113.915 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.0 -22.13 27.21 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 126.477 1.989 . . . . 0.0 112.231 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.97 138.08 36.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.424 1.112 . . . . 0.0 109.247 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.8 tp -91.54 131.19 37.15 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 128.45 2.7 . . . . 0.0 108.435 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -135.52 159.45 41.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 109.666 178.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -132.95 142.42 48.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.446 1.498 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.22 150.21 27.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.163 0.983 . . . . 0.0 111.077 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.776 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -139.91 -75.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -161.25 125.98 3.54 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.27 2.228 . . . . 0.0 106.506 -176.741 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 t -168.1 154.47 7.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.835 1.198 . . . . 0.0 111.608 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.42 20.69 4.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.238 1.815 . . . . 0.0 106.737 174.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -82.21 146.96 29.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.3 t -46.88 121.98 7.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.788 0.835 . . . . 0.0 109.192 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.44 127.69 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.171 2.581 . . . . 0.0 113.831 -179.188 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.47 22.77 73.36 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.521 178.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 p -66.36 -71.57 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.307 1.053 . . . . 0.0 110.616 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -146.14 -32.67 0.34 Allowed 'General case' 0 C--O 1.23 0.069 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m -156.48 168.1 28.42 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.214 -0.929 . . . . 0.0 112.039 -174.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 p 70.53 0.39 3.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 130.303 3.441 . . . . 0.0 114.412 177.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.66 171.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.908 1.283 . . . . 0.0 112.573 -178.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -158.92 124.07 4.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.48 144.5 42.02 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.92 -6.52 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.873 0.869 . . . . 0.0 112.927 -178.974 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.49 -152.15 23.66 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 p -156.51 152.36 27.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.448 1.099 . . . . 0.0 109.029 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.93 -46.22 14.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.323 1.058 . . . . 0.0 108.91 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 129.86 3.264 . . . . 0.0 104.482 -174.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.1 m-20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 118.136 -0.935 . . . . 0.0 113.362 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -125.58 -60.12 1.33 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.237 1.015 . . . . 0.0 110.249 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.64 -66.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.251 3.02 . . . . 0.0 104.948 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -154.11 25.42 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.092 0.957 . . . . 0.0 111.61 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.94 -165.03 1.27 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.583 0.629 . . . . 0.0 109.688 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.04 89.2 1.93 Allowed 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.353 -0.842 . . . . 0.0 109.472 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 3' ' ' ASP . 98.6 t -83.64 118.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 108.239 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -45.17 135.29 5.28 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 120.767 1.621 . . . . 0.0 110.944 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -89.93 33.82 7.62 Favored 'Cis proline' 0 C--N 1.349 0.58 0 N-CA-C 115.685 1.379 . . . . 0.0 115.685 1.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -74.3 62.63 0.97 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.257 1.39 . . . . 0.0 108.867 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 7.1 m95 -51.68 160.82 0.59 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.098 1.359 . . . . 0.0 111.791 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.48 -31.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.345 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.7 t -153.36 167.53 29.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.315 0.9 OUTLIER -91.35 -30.55 16.48 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 131.177 3.791 . . . . 0.0 111.342 175.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 154.47 -43.06 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.549 3.94 . . . . 0.0 103.714 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -118.57 172.86 7.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.951 1.7 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.13 -57.5 5.31 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.98 -27.77 71.81 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.063 0.785 . . . . 0.0 115.063 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.08 142.44 43.12 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 119.215 1.507 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -60.33 132.94 90.64 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 72.8 Cg_exo -53.58 166.86 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 119.119 2.699 . . . . 0.0 119.119 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 m -150.46 -12.38 0.25 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.017 -1.902 . . . . 0.0 110.837 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 179.06 174.29 0.72 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 120.182 1.356 . . . . 0.0 112.982 -175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -112.1 132.12 55.04 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.71 169.58 9.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.819 1.248 . . . . 0.0 110.093 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -44.72 125.09 4.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.084 1.354 . . . . 0.0 111.386 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.07 -9.62 56.44 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.002 -0.888 . . . . 0.0 113.815 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -84.31 124.78 31.62 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.289 1.545 . . . . 0.0 108.032 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -92.29 165.36 13.14 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.899 0.88 . . . . 0.0 113.24 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.4 tt -161.22 163.47 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.024 1.33 . . . . 0.0 107.834 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.31 146.32 19.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -148.31 108.81 4.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.1 mttp 39.09 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.766 2.026 . . . . 0.0 112.432 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 -50.63 1.5 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.148 1.356 . . . . 0.0 112.805 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.0 142.25 47.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.338 1.069 . . . . 0.0 111.957 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 58' ' ' VAL . 5.1 tp -102.17 131.88 48.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 129.029 2.932 . . . . 0.0 107.284 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -132.94 164.78 26.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.944 0.898 . . . . 0.0 109.902 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.0 m -134.02 143.36 48.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.806 1.242 . . . . 0.0 108.024 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 142.44 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.797 0.808 . . . . 0.0 109.176 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -84.39 -34.24 23.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.202 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 19.0 p90 -143.07 -69.85 0.33 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -161.34 125.61 3.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.916 1.687 . . . . 0.0 108.125 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -166.99 154.74 9.36 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.767 1.167 . . . . 0.0 111.435 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HA ' ' CH2' ' A' ' 13' ' ' TRP . . . -143.01 32.01 1.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.879 1.671 . . . . 0.0 109.676 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -84.02 -103.86 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.059 0.457 . . . . 0.0 111.429 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.7 t -144.74 115.26 5.18 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HA ' ' CD2' ' A' ' 55' ' ' TRP . 45.3 Cg_exo -53.16 112.33 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.698 2.265 . . . . 0.0 112.542 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.82 -26.88 9.63 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.084 1.326 . . . . 0.0 111.721 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -78.37 70.28 4.69 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.359 1.08 . . . . 0.0 109.631 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 42.51 -111.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.805 1.642 . . . . 0.0 108.889 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t 59.65 -72.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.772 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.4 t -173.65 38.65 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.095 2.558 . . . . 0.0 107.146 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD2' ' HA ' ' A' ' 49' ' ' PRO . 89.9 m95 -112.08 154.49 25.33 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.615 1.198 . . . . 0.0 111.377 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -153.41 120.97 5.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -71.0 124.28 24.0 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.296 0.638 . . . . 0.0 109.933 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -101.86 -13.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.084 0.554 . . . . 0.0 112.134 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.29 -149.45 17.65 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -154.33 135.21 13.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 109.812 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.5 m -71.97 -46.87 55.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.994 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.311 -1.804 . . . . 0.0 106.509 -173.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.1 m -77.28 75.15 3.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.281 1.038 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -20.59 -51.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 131.363 3.865 . . . . 0.0 115.304 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -8.6 5.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.315 1.446 . . . . 0.0 114.351 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.84 141.59 49.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.099 0.96 . . . . 0.0 108.924 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -29.51 105.13 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 128.086 2.554 . . . . 0.0 113.631 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.1 134.05 27.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -45.39 132.74 5.99 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 119.783 1.174 . . . . 0.0 111.425 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.61 43.25 3.11 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 121.593 1.605 . . . . 0.0 113.904 -0.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -76.39 64.28 2.1 Favored 'General case' 0 N--CA 1.428 -1.572 0 O-C-N 119.324 -2.11 . . . . 0.0 107.429 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -56.05 156.21 5.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.977 0.894 . . . . 0.0 110.888 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.91 -21.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.304 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.9 t -145.08 165.89 26.94 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.752 1.263 . . . . 0.0 112.63 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.298 85.8 tttt -97.14 -34.07 11.27 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 131.241 3.816 . . . . 0.0 109.363 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 162.92 -42.97 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 1 C-N-CA 132.896 4.478 . . . . 0.0 102.641 -172.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -117.56 155.06 30.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.462 1.505 . . . . 0.0 107.593 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.67 -60.43 3.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.696 1.598 . . . . 0.0 115.231 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.7 -4.22 61.07 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.842 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.31 152.4 43.31 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 119.426 1.613 . . . . 0.0 109.923 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.28 144.74 94.68 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.06 158.33 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 116.571 1.72 . . . . 0.0 116.571 -169.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 m -152.23 -17.43 0.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.067 0.947 . . . . 0.0 112.599 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 177.31 150.48 0.18 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.318 0.963 . . . . 0.0 110.516 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.73 141.32 32.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.6 166.19 13.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.378 1.071 . . . . 0.0 108.696 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -56.68 130.67 46.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.761 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.68 -6.5 69.39 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.386 -1.23 . . . . 0.0 113.273 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -85.61 143.24 28.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.911 1.855 . . . . 0.0 109.613 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -103.01 164.52 11.56 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 tt -161.74 156.73 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.876 1.27 . . . . 0.0 109.7 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.87 159.3 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 126.515 1.926 . . . . 0.0 109.78 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.5 t80 174.66 147.18 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.32 2.648 . . . . 0.0 107.13 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 40.94 44.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 113.326 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.46 24.85 25.33 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.494 2.473 . . . . 0.0 113.218 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -119.7 156.61 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.679 1.592 . . . . 0.0 107.211 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.598 ' CD2' HG13 ' A' ' 58' ' ' VAL . 12.8 tp -110.29 122.02 46.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.596 1.958 . . . . 0.0 107.863 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -125.77 150.28 47.88 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.673 0.67 . . . . 0.0 110.001 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 m -117.13 138.97 51.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.876 1.27 . . . . 0.0 108.359 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.96 142.37 36.73 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.172 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.47 -30.81 20.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.603 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 33.0 p90 -145.13 -141.27 0.12 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.838 1.655 . . . . 0.0 108.325 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -92.37 116.21 28.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.823 2.849 . . . . 0.0 106.165 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 t -163.83 148.35 10.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.492 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.63 13.04 9.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.326 1.85 . . . . 0.0 107.997 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.6 t -70.51 162.46 28.76 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.14 118.52 62.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.121 0.568 . . . . 0.0 110.289 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -41.1 122.37 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.941 3.761 . . . . 0.0 114.45 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.46 22.51 3.82 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.697 1.618 . . . . 0.0 114.471 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -123.88 26.67 7.53 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.514 1.157 . . . . 0.0 110.416 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -170.19 -79.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -174.56 177.67 2.09 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.7 1.2 . . . . 0.0 108.239 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.3 p 64.12 15.31 9.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.674 2.79 . . . . 0.0 112.903 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -126.21 142.6 51.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.954 1.302 . . . . 0.0 110.512 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -136.48 114.64 11.54 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.734 1.614 . . . . 0.0 107.556 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -62.91 140.68 58.85 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.395 0.617 . . . . 0.0 109.832 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.598 HG13 ' CD2' ' A' ' 38' ' ' LEU 0.278 0.3 OUTLIER -131.77 3.79 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.593 1.157 . . . . 0.0 112.439 -174.886 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.23 -170.55 34.45 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.5 p -161.37 167.76 25.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 m -57.58 -40.02 78.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.415 1.086 . . . . 0.0 110.885 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.598 0 CA-C-O 114.77 -2.538 . . . . 0.0 106.861 -173.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.042 0.448 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.71 80.97 0.28 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.776 1.274 . . . . 0.0 111.07 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.46 30.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.056 2.142 . . . . 0.0 111.8 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -58.09 -30.59 66.36 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.92 1.288 . . . . 0.0 111.212 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.49 161.92 14.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.316 1.046 . . . . 0.0 108.673 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.42 121.25 5.43 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.391 0.677 . . . . 0.0 110.1 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.15 135.11 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 117.624 -1.179 . . . . 0.0 108.541 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -46.07 133.59 7.1 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 120.057 1.299 . . . . 0.0 111.008 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -97.03 33.11 10.15 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 121.414 1.541 . . . . 0.0 113.875 -0.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.23 68.06 1.44 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 32.3 m95 -51.07 168.21 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.642 0.777 . . . . 0.0 112.328 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.78 -19.03 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.81 -72.17 0.59 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -171.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 tttt 48.83 -157.03 0.07 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 122.371 1.081 . . . . 0.0 111.787 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.34 -41.47 93.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.325 -1.761 . . . . 0.0 107.178 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -156.6 156.64 33.91 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.247 1.819 . . . . 0.0 107.191 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.98 -58.99 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.193 1.797 . . . . 0.0 114.796 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.33 -9.22 85.85 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.233 -0.759 . . . . 0.0 114.008 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.49 154.48 50.44 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -55.87 103.48 0.37 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 108.177 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 23.2 Cg_exo -50.51 143.97 26.27 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.942 3.095 . . . . 0.0 118.2 -171.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.7 p -132.99 -12.68 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -178.83 162.77 1.34 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.167 0.984 . . . . 0.0 113.427 -175.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -107.65 114.12 27.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.437 1.895 . . . . 0.0 108.582 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.0 166.26 12.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.499 1.119 . . . . 0.0 110.216 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.47 126.27 3.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.931 1.292 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.36 -2.73 80.94 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.316 -1.269 . . . . 0.0 114.648 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.26 121.56 29.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.437 2.119 . . . . 0.0 108.179 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -83.94 159.99 21.16 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.833 -1.167 . . . . 0.0 111.595 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.06 155.21 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.332 1.453 . . . . 0.0 107.753 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -101.96 153.73 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.07 0.948 . . . . 0.0 109.385 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -161.83 126.82 3.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.879 1.672 . . . . 0.0 107.34 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt 30.52 83.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.936 2.095 . . . . 0.0 112.951 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.63 -35.86 0.27 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -94.34 154.14 17.64 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.917 1.859 . . . . 0.0 112.867 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -107.03 124.7 50.02 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.327 2.651 . . . . 0.0 105.861 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.74 161.64 26.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.889 0.876 . . . . 0.0 110.114 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 m -136.93 144.54 43.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.21 150.32 26.28 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 122.057 0.932 . . . . 0.0 111.079 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.48 -34.05 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.858 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -140.39 -72.15 0.37 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.774 0.321 . . . . 0.0 111.64 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -159.31 133.15 7.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.836 1.655 . . . . 0.0 108.562 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 t -166.38 151.69 8.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.96 40.05 1.5 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.082 1.353 . . . . 0.0 107.55 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.5 t -130.49 156.4 44.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.388 1.075 . . . . 0.0 108.199 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -36.76 110.9 0.48 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.418 2.287 . . . . 0.0 113.098 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 134.62 62.41 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.286 2.657 . . . . 0.0 113.189 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.03 -53.06 3.38 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 m -81.13 47.76 1.05 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.966 0.906 . . . . 0.0 110.586 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -164.92 -117.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 m -163.93 168.85 18.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.996 1.719 . . . . 0.0 107.589 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 66.67 14.77 9.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.658 1.183 . . . . 0.0 112.501 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.64 155.69 24.01 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.694 1.598 . . . . 0.0 109.042 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 m -152.17 125.46 8.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.57 137.53 54.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.119 0.567 . . . . 0.0 110.495 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.85 -15.13 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.289 1.436 . . . . 0.0 110.739 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.17 -161.81 35.63 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -153.98 163.04 40.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.1 t -88.22 -17.13 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.13 2.172 . . . . 0.0 111.367 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.432 0 C-N-CA 126.569 1.948 . . . . 0.0 105.83 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 . . . . . 0 C--O 1.223 -0.326 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 80.8 m 45.68 27.7 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.236 2.214 . . . . 0.0 114.136 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.33 -21.34 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.111 2.564 . . . . 0.0 114.037 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -57.29 -37.41 72.38 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.28 0.632 . . . . 0.0 109.944 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.06 176.19 5.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.957 0.903 . . . . 0.0 109.635 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.76 98.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.782 0.833 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.41 128.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.928 1.291 . . . . 0.0 108.898 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -43.08 134.47 3.09 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.818 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -91.7 31.93 10.7 Favored 'Cis proline' 0 C--N 1.348 0.528 0 CA-C-N 120.239 1.121 . . . . 0.0 114.433 0.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -75.57 61.88 1.37 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.179 1.354 . . . . 0.0 109.311 177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 12.2 m95 -49.91 164.03 0.12 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.026 1.731 . . . . 0.0 113.578 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -79.82 -37.51 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.232 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -156.46 -171.64 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.278 0.945 . . . . 0.0 112.311 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.289 55.2 tttm -107.15 -45.63 4.09 Favored 'General case' 0 N--CA 1.412 -2.363 1 C-N-CA 132.942 4.497 . . . . 0.0 110.215 178.646 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 168.26 -44.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 131.603 3.961 . . . . 0.0 104.751 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -58.08 178.3 0.1 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 130.912 3.685 . . . . 0.0 116.923 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.12 37.44 4.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.878 2.871 . . . . 0.0 106.47 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.17 46.53 0.02 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.043 1.306 . . . . 0.0 111.473 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.76 152.63 18.57 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.91 119.4 51.3 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 50.2 Cg_exo -53.85 154.71 16.18 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 117.708 2.157 . . . . 0.0 117.708 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -151.09 4.52 0.46 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.34 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -175.79 168.73 3.05 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 121.356 1.889 . . . . 0.0 116.094 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.82 125.6 50.85 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -87.29 167.96 13.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.786 1.234 . . . . 0.0 111.192 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.08 127.13 8.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.985 1.314 . . . . 0.0 110.409 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -15.31 22.26 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.419 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -77.37 132.08 38.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.816 1.808 . . . . 0.0 108.929 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -94.66 162.38 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.664 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.4 tt -161.74 154.57 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.208 1.003 . . . . 0.0 108.315 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -95.3 156.38 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.233 . . . . 0.0 107.797 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -172.1 141.93 1.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.581 1.953 . . . . 0.0 106.942 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mttp 24.64 73.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.831 2.052 . . . . 0.0 113.034 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.51 38.07 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 128.955 3.169 . . . . 0.0 114.474 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -144.22 158.23 43.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.83 127.82 44.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 127.747 2.419 . . . . 0.0 107.867 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -126.26 166.76 16.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.799 1.239 . . . . 0.0 108.856 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -150.32 148.3 28.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.269 1.028 . . . . 0.0 108.366 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.56 148.32 25.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.684 1.194 . . . . 0.0 111.53 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -90.47 -32.73 16.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.569 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.9 p90 -142.57 -74.18 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.069 0.462 . . . . 0.0 112.223 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -160.21 119.58 2.78 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 127.597 2.359 . . . . 0.0 105.003 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -158.54 152.36 23.53 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.047 1.294 . . . . 0.0 112.096 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 8.84 5.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 109.578 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 m -77.58 155.03 31.79 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.31 139.02 80.48 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 119.667 1.121 . . . . 0.0 109.7 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.21 116.85 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.198 1.932 . . . . 0.0 112.724 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.1 25.88 70.08 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.279 -0.734 . . . . 0.0 112.1 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.6 p -59.99 -56.71 18.33 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.479 1.139 . . . . 0.0 110.191 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.07 -43.41 0.23 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.093 1.357 . . . . 0.0 111.325 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -166.75 -171.65 1.9 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 124.484 1.113 . . . . 0.0 109.142 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 p 65.67 5.9 3.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 130.854 3.662 . . . . 0.0 113.663 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.72 159.58 33.3 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 125.01 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -148.22 132.85 17.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.58 130.6 36.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.67 -13.54 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.637 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.12 -171.68 35.7 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 119.674 1.125 . . . . 0.0 112.339 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -107.83 87.54 2.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -32.69 -55.88 0.36 Allowed 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 127.257 2.223 . . . . 0.0 114.179 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.006 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.442 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.6 m -87.64 97.96 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.46 10.82 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.446 2.298 . . . . 0.0 111.828 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.16 -3.69 28.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.28 170.67 15.36 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.47 1.032 . . . . 0.0 110.356 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -59.7 121.3 11.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.45 131.39 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.034 0.934 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -43.12 134.02 3.16 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.766 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.81 30.2 14.29 Favored 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.595 1.248 . . . . 0.0 112.755 -0.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -76.14 62.94 1.77 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -49.69 159.36 0.38 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.945 0.878 . . . . 0.0 113.245 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.58 -43.16 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.467 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -90.46 139.08 31.03 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.417 1.103 . . . . 0.0 111.385 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -110.83 166.97 10.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.617 1.967 . . . . 0.0 109.958 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -67.42 -34.8 77.98 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.1 163.54 39.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.097 1.759 . . . . 0.0 106.909 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.93 -55.87 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.503 1.521 . . . . 0.0 114.082 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.79 5.38 79.46 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.485 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.86 171.16 55.06 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.516 1.158 . . . . 0.0 111.2 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.83 165.66 51.44 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.22 145.15 71.47 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.607 1.538 . . . . 0.0 108.669 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 m -141.66 -7.62 0.97 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.191 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 176.0 170.77 0.39 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.1 0.952 . . . . 0.0 111.775 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -112.67 111.16 21.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.742 1.617 . . . . 0.0 107.279 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -83.71 162.81 20.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 109.721 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.4 128.2 1.41 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.993 1.717 . . . . 0.0 112.593 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.31 -7.99 49.47 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.567 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.15 136.05 35.2 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.534 2.167 . . . . 0.0 106.825 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -98.87 159.24 15.09 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.64 -0.662 . . . . 0.0 112.002 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 tt -159.75 163.72 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.894 1.278 . . . . 0.0 108.784 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 4' ' ' CYS . 1.6 t -121.4 165.75 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.12 -62.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -156.1 125.6 6.28 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.15 -42.8 0.17 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.123 2.773 . . . . 0.0 115.507 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -109.75 146.05 35.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.524 1.13 . . . . 0.0 112.253 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tp -97.35 127.53 43.4 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 129.057 2.943 . . . . 0.0 105.682 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.92 161.78 28.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.87 0.868 . . . . 0.0 110.759 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.5 m -138.99 145.52 39.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.83 147.99 26.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.991 0.9 . . . . 0.0 111.442 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -85.06 -36.08 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.097 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -142.52 -70.05 0.34 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.917 0.487 . . . . 0.0 111.389 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -158.53 138.47 12.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.524 1.53 . . . . 0.0 108.908 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -173.32 147.78 1.56 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.499 0.666 . . . . 0.0 109.96 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.87 26.37 4.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 153.07 19.63 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.626 1.571 . . . . 0.0 108.137 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -49.24 117.19 6.42 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.48 0.712 . . . . 0.0 110.012 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.36 120.52 4.49 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.294 2.663 . . . . 0.0 112.261 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.44 -23.78 29.21 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.394 -0.67 . . . . 0.0 111.794 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 t -77.11 59.37 1.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.604 1.202 . . . . 0.0 110.416 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 41.47 -109.06 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.474 1.909 . . . . 0.0 109.734 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t 58.27 -82.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.73 1.612 . . . . 0.0 111.038 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -150.77 28.32 0.7 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.372 1.469 . . . . 0.0 110.425 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.44 171.5 7.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.339 1.066 . . . . 0.0 112.784 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -162.98 130.75 3.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.954 2.102 . . . . 0.0 105.519 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -78.94 139.68 38.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.83 -16.87 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.911 1.284 . . . . 0.0 111.256 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.84 -167.3 39.79 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -144.78 156.6 44.13 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.687 1.195 . . . . 0.0 108.121 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.9 m -114.83 -68.59 0.91 Allowed 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 123.828 0.705 . . . . 0.0 111.093 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 CA-C-O 115.337 -2.268 . . . . 0.0 106.971 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 t -59.51 -52.56 65.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.231 1.015 . . . . 0.0 109.631 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 166.65 -63.79 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 131.161 3.784 . . . . 0.0 103.903 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -157.91 28.11 0.27 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.223 1.009 . . . . 0.0 111.314 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 179.34 5.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.312 0.506 . . . . 0.0 109.992 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.63 98.03 0.17 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.988 0.423 . . . . 0.0 109.9 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -105.88 137.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -46.51 135.57 7.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.092 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -94.33 31.42 12.37 Favored 'Cis proline' 0 C--N 1.349 0.567 0 N-CA-C 115.354 1.251 . . . . 0.0 115.354 1.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -77.67 59.77 2.06 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 121.272 1.851 . . . . 0.0 108.741 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -55.29 157.72 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.787 0.835 . . . . 0.0 112.893 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.39 -49.12 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.347 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -84.33 154.24 23.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.503 1.144 . . . . 0.0 109.541 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -126.01 168.14 14.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.944 2.098 . . . . 0.0 109.762 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.64 -31.29 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -160.57 160.15 31.45 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.388 1.475 . . . . 0.0 107.708 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.01 -61.79 0.62 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.141 1.776 . . . . 0.0 114.151 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.65 14.31 61.83 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.511 -0.605 . . . . 0.0 113.354 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 -169.38 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.365 1.083 . . . . 0.0 111.478 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.19 160.8 28.12 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -51.84 145.75 30.81 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.826 2.351 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 m -134.22 -29.95 1.21 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.274 0.63 . . . . 0.0 112.428 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 173.62 171.83 0.17 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.243 0.474 . . . . 0.0 111.057 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -111.17 140.32 45.82 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.61 167.72 9.94 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.574 1.15 . . . . 0.0 109.267 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.55 121.07 1.6 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.596 1.159 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.89 -11.59 70.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.155 1.36 . . . . 0.0 113.785 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -81.42 123.83 28.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.036 1.418 . . . . 0.0 109.26 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -89.14 162.56 15.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.962 1.705 . . . . 0.0 112.268 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.7 tt -168.07 165.94 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.849 1.26 . . . . 0.0 108.375 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.4 t -118.53 163.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.416 . . . . 0.0 108.011 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.97 -60.84 0.9 Allowed 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.47 106.73 3.15 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.22 -46.67 0.49 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.773 1.654 . . . . 0.0 114.204 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -87.64 145.26 26.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 112.039 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 58' ' ' VAL . 7.0 tp -99.18 133.23 43.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 130.31 3.444 . . . . 0.0 107.737 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -134.18 153.95 51.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.169 0.987 . . . . 0.0 109.243 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 m -125.76 135.62 52.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.845 0.858 . . . . 0.0 109.742 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.78 136.98 47.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.818 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' N ' HD22 ' A' ' 42' ' ' ASN . 1.0 OUTLIER -87.8 -36.29 17.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.451 -177.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 11.5 p90 -138.61 -70.85 0.42 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.314 0.646 . . . . 0.0 110.127 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -159.61 130.34 5.82 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 128.146 2.579 . . . . 0.0 106.353 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -165.41 151.42 9.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.676 1.126 . . . . 0.0 111.32 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.9 19.43 2.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.369 1.868 . . . . 0.0 108.765 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -85.18 164.83 17.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.59 119.53 33.67 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.71 125.51 11.27 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.19 2.593 . . . . 0.0 112.02 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.27 -11.81 65.33 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.011 -0.883 . . . . 0.0 112.314 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 t -76.22 69.5 2.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.072 1.436 . . . . 0.0 109.102 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 43.11 -125.78 0.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.376 1.87 . . . . 0.0 109.285 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t 53.38 -132.25 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.146 0.578 . . . . 0.0 109.769 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -69.49 -80.56 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 129.59 3.156 . . . . 0.0 109.401 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -7.95 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.979 2.912 . . . . 0.0 116.538 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -89.31 114.58 25.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.16 -1.837 . . . . 0.0 107.264 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -67.74 132.82 48.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.48 10.5 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.855 0.862 . . . . 0.0 112.693 -177.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.16 -155.59 16.33 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 p -85.01 167.05 16.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -50.5 -42.04 54.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.917 0.865 . . . . 0.0 111.577 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -1.012 0 C-N-CA 128.92 2.888 . . . . 0.0 104.486 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m 53.61 20.68 2.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.113 1.765 . . . . 0.0 113.232 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.17 -25.94 1.02 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.774 2.43 . . . . 0.0 114.321 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -58.37 -36.52 73.63 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.63 0.772 . . . . 0.0 110.889 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -171.96 3.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.592 0.757 . . . . 0.0 110.422 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.35 94.97 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.455 -0.778 . . . . 0.0 109.91 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.91 135.85 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 126.196 1.798 . . . . 0.0 108.234 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -44.28 132.18 4.54 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.71 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -95.54 32.59 10.88 Favored 'Cis proline' 0 C--N 1.35 0.649 0 CA-C-N 120.75 1.304 . . . . 0.0 114.931 1.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -76.45 57.24 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.095 1.316 . . . . 0.0 109.309 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 28.3 m95 -51.36 141.19 15.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.047 1.339 . . . . 0.0 112.899 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 t -77.61 -29.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 112.287 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.4 m -67.05 -18.4 65.34 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.34 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.991 1.716 . . . . 0.0 111.62 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t0 149.06 -45.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 1 C-N-CA 132.867 4.467 . . . . 0.0 105.361 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.1 p-90 -149.71 171.91 15.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 108.229 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.56 -53.89 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.441 1.896 . . . . 0.0 114.395 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.8 18.27 24.54 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.325 0.964 . . . . 0.0 112.239 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.94 145.7 35.51 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.865 0.833 . . . . 0.0 112.695 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -72.84 136.0 80.36 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 53.4 Cg_exo -39.67 138.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 1 C-N-CA 125.406 4.071 . . . . 0.0 116.254 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -123.61 -30.63 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 172.87 164.81 0.13 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.555 1.07 . . . . 0.0 110.847 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -97.35 133.81 41.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 107.777 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.26 163.5 12.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.929 1.292 . . . . 0.0 110.305 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.92 122.66 1.78 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.898 1.279 . . . . 0.0 111.944 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.2 -3.69 70.71 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.667 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -83.01 118.18 23.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.499 2.149 . . . . 0.0 106.542 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -78.39 164.83 24.46 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.286 -0.884 . . . . 0.0 110.058 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.0 tt -161.51 159.39 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.689 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.59 155.18 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.502 1.521 . . . . 0.0 108.704 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -176.6 135.27 0.23 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.61 2.364 . . . . 0.0 107.357 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? 44.75 33.0 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.132 2.173 . . . . 0.0 115.128 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.54 77.75 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.798 1.189 . . . . 0.0 112.923 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.13 154.61 37.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -97.99 120.87 39.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.277 1.831 . . . . 0.0 108.191 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -123.56 159.43 29.21 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.828 0.851 . . . . 0.0 108.971 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -144.9 143.2 30.45 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.14 149.0 25.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.154 0.978 . . . . 0.0 109.788 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.57 -31.15 22.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.903 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.71 -72.94 0.28 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.628 0.728 . . . . 0.0 110.191 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -165.99 136.54 3.54 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.287 1.435 . . . . 0.0 109.982 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -176.31 155.38 1.46 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 119.157 0.89 . . . . 0.0 111.4 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.02 18.98 5.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.988 1.715 . . . . 0.0 108.09 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -84.42 171.22 12.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.05 121.4 35.76 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 51.2 Cg_exo -53.77 115.76 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.624 2.216 . . . . 0.0 110.833 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 1.54 33.37 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.101 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -75.94 49.99 0.57 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.984 1.892 . . . . 0.0 111.314 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 42.98 -140.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.152 1.781 . . . . 0.0 109.216 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.2 t 44.11 -106.91 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 112.879 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 p -75.44 -5.99 47.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.931 2.092 . . . . 0.0 114.801 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.411 ' CE2' ' HA ' ' A' ' 49' ' ' PRO . 99.3 m95 -107.07 174.23 5.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.636 1.107 . . . . 0.0 112.87 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -163.42 135.36 5.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.908 2.083 . . . . 0.0 105.788 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -88.5 128.25 35.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.68 -15.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.184 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.16 -155.86 26.44 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 119.39 0.995 . . . . 0.0 111.696 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -89.9 135.71 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.03 99.44 6.1 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.512 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.5 m -91.0 87.61 6.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -49.29 -34.53 15.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.7 1.6 . . . . 0.0 113.091 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.1 -18.4 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.336 1.054 . . . . 0.0 112.825 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.67 -175.81 2.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.91 102.44 0.6 Allowed 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.954 -0.467 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.54 125.62 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -47.73 138.19 9.55 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.603 -0.685 . . . . 0.0 110.79 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.82 35.43 7.7 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 N-CA-C 114.925 1.087 . . . . 0.0 114.925 1.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -75.33 65.19 1.61 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 121.532 1.969 . . . . 0.0 109.897 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -50.38 154.77 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.841 0.856 . . . . 0.0 112.465 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -84.03 -41.55 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.783 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.4 m -106.03 155.04 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.457 1.122 . . . . 0.0 113.371 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -103.58 150.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.034 2.134 . . . . 0.0 106.752 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.56 -34.35 77.69 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.648 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -141.04 158.31 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.417 1.087 . . . . 0.0 108.672 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.67 -61.29 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.288 1.835 . . . . 0.0 114.071 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.53 10.74 72.34 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.458 -0.634 . . . . 0.0 113.309 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.59 171.17 52.66 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 118.57 1.185 . . . . 0.0 110.885 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 168.39 19.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.36 133.02 55.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 108.348 -1.443 . . . . 0.0 108.348 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -128.05 -13.16 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.825 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 177.36 167.97 0.62 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.45 1.023 . . . . 0.0 113.292 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.61 139.5 42.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.62 168.59 8.98 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.233 1.013 . . . . 0.0 109.051 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.01 121.58 2.15 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.827 1.251 . . . . 0.0 111.487 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.15 -15.7 54.98 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.017 0.818 . . . . 0.0 113.75 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -76.57 121.77 23.65 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.108 1.454 . . . . 0.0 108.737 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -87.7 164.03 16.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.272 1.429 . . . . 0.0 112.313 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 tt -164.6 154.52 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.912 1.685 . . . . 0.0 106.992 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.519 HG11 ' H ' ' A' ' 4' ' ' CYS . 2.0 t -108.41 156.34 9.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -152.13 -108.24 0.05 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -73.7 87.79 1.71 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.973 0.806 . . . . 0.0 108.994 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.24 -40.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 130.332 3.825 . . . . 0.0 117.045 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -102.37 164.06 11.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.919 0.888 . . . . 0.0 111.478 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.2 tp -80.76 131.48 35.43 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.694 2.398 . . . . 0.0 107.739 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.04 153.31 46.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.085 1.354 . . . . 0.0 108.453 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 58' ' ' VAL . 53.9 m -137.77 146.27 43.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.282 0.633 . . . . 0.0 109.632 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.14 144.24 33.22 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.891 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -92.74 -30.04 15.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.904 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -141.73 -73.88 0.31 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 111.998 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.49 119.39 2.65 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.791 2.836 . . . . 0.0 106.117 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 t -163.01 150.89 13.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 120.111 1.323 . . . . 0.0 112.115 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.28 12.99 6.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.932 2.093 . . . . 0.0 107.941 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 t -74.93 172.64 11.92 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.07 118.38 42.22 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 109.987 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.61 140.26 36.93 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.668 2.246 . . . . 0.0 111.829 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.27 -10.8 60.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.598 -1.112 . . . . 0.0 112.157 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -79.02 54.97 1.7 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.795 1.798 . . . . 0.0 110.513 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 42.34 -146.32 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.116 2.166 . . . . 0.0 112.038 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 m 40.78 -100.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.508 2.323 . . . . 0.0 113.762 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.4 p -78.21 -4.13 46.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.05 139.08 51.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 119.117 0.871 . . . . 0.0 110.692 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -133.17 122.82 24.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 113.476 -1.693 . . . . 0.0 106.955 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -69.33 138.6 53.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.486 HG21 ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -121.16 -12.02 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.93 -159.27 32.01 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 120.248 1.385 . . . . 0.0 110.819 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -149.98 -176.67 5.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.424 1.09 . . . . 0.0 108.304 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.2 m -122.68 -69.71 0.81 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.948 0.899 . . . . 0.0 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.997 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.87 -57.35 3.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.341 1.067 . . . . 0.0 108.36 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 163.89 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 130.455 3.502 . . . . 0.0 105.083 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.14 4.09 0.45 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 113.04 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.85 178.92 7.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.165 0.893 . . . . 0.0 111.926 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.57 100.84 0.07 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.339 1.056 . . . . 0.0 110.747 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.97 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -45.57 133.96 6.17 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.334 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.8 32.86 10.5 Favored 'Cis proline' 0 C--N 1.353 0.777 0 CA-C-N 121.198 1.464 . . . . 0.0 114.375 0.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.84 66.58 2.13 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 120.276 1.398 . . . . 0.0 107.306 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -60.38 161.25 7.54 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.433 1.493 . . . . 0.0 112.145 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -81.99 -26.02 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.839 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.5 m -153.09 175.81 12.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 112.297 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.288 88.5 tttt -111.4 -47.08 3.21 Favored 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 130.475 3.51 . . . . 0.0 109.936 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 159.98 -45.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.195 1 C-N-CA 131.954 4.102 . . . . 0.0 103.768 -172.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -61.63 169.66 2.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.0 2.52 . . . . 0.0 113.526 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.33 39.26 2.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.227 2.211 . . . . 0.0 107.06 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.7 48.08 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.057 1.313 . . . . 0.0 110.806 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.91 156.58 21.52 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -57.44 124.89 69.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.767 1.284 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -55.32 146.13 63.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.151 1.901 . . . . 0.0 113.311 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.19 2.87 0.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.019 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -175.29 166.95 3.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.005 1.383 . . . . 0.0 114.624 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -115.72 123.11 47.48 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.561 1.544 . . . . 0.0 107.784 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -95.55 157.87 15.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.344 1.458 . . . . 0.0 110.518 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.69 123.96 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.119 1.767 . . . . 0.0 112.397 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.58 -13.61 51.21 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 117.523 -1.71 . . . . 0.0 114.644 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -80.68 143.71 32.82 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 121.229 2.514 . . . . 0.0 107.758 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 m -103.28 157.62 16.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.74 165.81 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.32 151.36 23.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.676 0.671 . . . . 0.0 109.888 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -154.58 124.96 6.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? 35.87 73.9 0.08 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.124 1.77 . . . . 0.0 111.918 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 -46.32 0.54 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.028 1.775 . . . . 0.0 114.07 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -68.49 141.53 55.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.563 1.182 . . . . 0.0 111.763 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 tp -98.58 123.97 43.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 128.882 2.873 . . . . 0.0 106.474 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.93 169.19 11.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.457 1.103 . . . . 0.0 109.735 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -149.79 150.09 31.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 148.89 25.68 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 122.022 0.915 . . . . 0.0 112.207 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -92.21 -35.37 13.85 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 110.011 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -144.87 -72.82 0.26 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.409 0.684 . . . . 0.0 110.726 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -156.45 133.78 10.69 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.807 1.643 . . . . 0.0 109.12 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -168.92 151.78 5.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.886 0.766 . . . . 0.0 111.35 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.79 17.66 3.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.317 1.847 . . . . 0.0 107.47 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.2 t -85.47 166.71 16.11 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.99 119.78 33.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.21 117.44 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.192 2.594 . . . . 0.0 112.189 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 -25.95 14.16 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.632 1.11 . . . . 0.0 111.331 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.9 t -76.08 61.45 1.55 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.491 1.146 . . . . 0.0 111.153 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 45.18 -119.44 0.77 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.436 1.494 . . . . 0.0 108.766 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t 66.43 -63.91 0.24 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.58 1.952 . . . . 0.0 113.017 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -178.51 32.64 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 129.665 3.186 . . . . 0.0 107.083 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -109.7 149.08 30.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.693 1.133 . . . . 0.0 110.776 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -144.79 127.97 16.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -77.37 137.45 38.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.75 -17.15 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.678 1.191 . . . . 0.0 111.001 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.63 -151.55 19.13 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.354 0.979 . . . . 0.0 111.359 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -141.26 138.57 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.14 1.776 . . . . 0.0 107.786 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.3 m -74.71 98.21 3.4 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 173.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.257 1.456 0 O-C-N 125.328 1.642 . . . . 0.0 109.382 175.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 121.248 0.547 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 33' ' ' VAL 0.294 1.5 m 15.25 69.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 131.546 3.938 . . . . 0.0 114.558 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.25 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.394 2.278 . . . . 0.0 113.549 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -56.33 -32.52 64.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.51 0.724 . . . . 0.0 111.059 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.84 169.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.616 1.166 . . . . 0.0 109.949 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -48.33 120.34 3.57 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.33 1.052 . . . . 0.0 109.975 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -105.99 126.71 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -48.33 135.84 12.3 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.703 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.46 28.47 16.51 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 119.989 1.032 . . . . 0.0 114.208 -0.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -74.64 67.79 1.59 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.873 1.215 . . . . 0.0 108.677 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 30.5 m95 -48.34 160.35 0.16 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.927 0.891 . . . . 0.0 111.609 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -34.17 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.909 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -170.37 -167.91 0.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.336 1.065 . . . . 0.0 113.152 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.261 41.4 mtpt -101.2 -33.01 10.26 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 131.375 3.87 . . . . 0.0 108.457 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 159.23 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 129.426 3.09 . . . . 0.0 106.28 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -117.73 153.86 32.68 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.425 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.73 -63.58 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.228 1.811 . . . . 0.0 114.152 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.52 0.66 54.77 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.384 -0.675 . . . . 0.0 113.144 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.6 128.03 10.1 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -58.87 115.6 12.45 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 35.6 Cg_exo -42.57 130.88 5.27 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.733 2.289 . . . . 0.0 114.074 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -128.54 -15.18 4.56 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.164 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 177.68 164.08 0.61 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.503 1.047 . . . . 0.0 111.221 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -98.23 125.77 43.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -92.96 169.91 10.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.646 1.179 . . . . 0.0 109.184 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.83 127.46 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.065 0.946 . . . . 0.0 111.387 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.2 -11.65 54.02 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.61 -1.106 . . . . 0.0 113.474 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -81.39 136.84 35.73 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.685 1.743 . . . . 0.0 109.954 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.0 m -104.89 163.39 12.56 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.364 1.066 . . . . 0.0 112.786 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.53 155.63 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.175 0.99 . . . . 0.0 109.004 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' A' ' 4' ' ' CYS . 18.2 t -102.29 150.63 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -138.65 -138.28 0.13 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.27 84.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.932 1.696 . . . . 0.0 111.336 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.83 -27.48 0.18 Allowed Glycine 0 CA--C 1.538 1.486 0 C-N-CA 128.716 3.055 . . . . 0.0 114.729 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -87.14 151.35 23.27 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.984 1.714 . . . . 0.0 111.591 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -104.76 128.16 52.79 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.189 2.995 . . . . 0.0 107.362 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -129.29 157.56 41.52 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.279 1.032 . . . . 0.0 110.365 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -131.7 140.51 49.32 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.606 1.163 . . . . 0.0 109.425 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.47 140.87 34.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 109.8 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -90.34 -32.58 16.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.348 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -139.35 -70.75 0.4 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.094 0.473 . . . . 0.0 111.734 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -161.47 123.89 3.03 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 126.269 1.828 . . . . 0.0 107.219 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -163.61 143.91 8.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.737 1.153 . . . . 0.0 111.731 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.15 13.79 9.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.793 2.037 . . . . 0.0 106.823 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -73.89 162.34 29.19 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.484 1.113 . . . . 0.0 108.503 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.84 121.26 67.2 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.07 131.27 21.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.843 2.362 . . . . 0.0 112.393 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.53 65.95 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.734 -1.036 . . . . 0.0 112.957 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.3 t -76.95 62.03 2.05 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.648 1.724 . . . . 0.0 110.381 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 51.98 -138.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.31 . . . . 0.0 108.667 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.4 t 57.33 -139.55 0.87 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.121 0.873 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -62.41 -74.97 0.08 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.678 2.791 . . . . 0.0 110.095 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -19.54 114.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.738 2.415 . . . . 0.0 114.508 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.255 23.4 m -118.47 125.3 49.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 113.197 -1.819 . . . . 0.0 107.034 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -68.6 140.06 55.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.711 0.232 . . . . 0.0 110.462 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 -16.07 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 111.292 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.6 -154.45 24.23 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.223 0.92 . . . . 0.0 111.053 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 p -160.27 167.68 27.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.455 1.902 . . . . 0.0 107.125 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.1 m -50.63 -65.48 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 127.401 2.28 . . . . 0.0 105.051 -172.619 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.415 ' HB2' HG11 ' A' ' 33' ' ' VAL . 5.3 t -71.48 -60.97 1.95 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 150.53 -60.69 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 130.027 3.331 . . . . 0.0 106.278 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -151.59 32.01 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.75 178.82 4.44 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.033 0.833 . . . . 0.0 110.603 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -61.19 98.26 0.08 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -109.26 124.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 124.538 1.135 . . . . 0.0 109.945 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -39.67 132.97 1.36 Allowed Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.003 1.321 . . . . 0.0 110.833 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -85.93 18.31 30.47 Favored 'Cis proline' 0 CA--C 1.535 0.559 0 CA-C-N 120.465 1.202 . . . . 0.0 114.881 0.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -74.6 64.47 1.21 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.217 1.371 . . . . 0.0 109.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -54.16 152.61 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.643 0.777 . . . . 0.0 111.685 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -70.54 -42.99 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.209 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.5 t -100.02 149.87 23.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.942 1.353 . . . . 0.0 110.985 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -101.62 169.17 9.01 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.943 2.097 . . . . 0.0 107.687 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -39.84 86.29 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -146.42 162.04 39.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.702 1.601 . . . . 0.0 107.688 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.8 -60.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.562 1.545 . . . . 0.0 113.702 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.27 60.89 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.124 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.17 -159.67 23.23 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.135 0.967 . . . . 0.0 111.564 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -118.66 159.29 44.74 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.362 1.465 . . . . 0.0 107.521 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.58 136.2 21.02 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.359 2.04 . . . . 0.0 110.943 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.5 m -136.4 -18.47 1.48 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.81 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 178.86 156.71 0.48 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -84.79 124.02 31.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.29 153.77 40.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -54.62 133.69 46.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.64 -2.02 49.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.035 -1.425 . . . . 0.0 113.401 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -90.19 147.68 23.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.29 2.045 . . . . 0.0 107.953 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 m -90.85 160.91 15.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.237 -0.289 . . . . 0.0 111.334 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.24 138.09 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 4' ' ' CYS . 55.7 t -106.36 157.81 6.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -151.54 -92.94 0.06 Allowed 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -76.53 52.94 0.83 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.313 1.845 . . . . 0.0 110.739 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.83 -36.01 1.23 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.833 2.635 . . . . 0.0 111.663 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -71.42 141.94 50.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.086 0.954 . . . . 0.0 110.491 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.25 115.68 28.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 129.385 3.074 . . . . 0.0 106.136 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -113.94 171.47 7.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.064 0.946 . . . . 0.0 109.213 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 m -151.14 146.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.68 137.73 39.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.399 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.89 79.17 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.783 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 1.9 p90 -146.66 -140.66 0.11 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.368 2.267 . . . . 0.0 112.942 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -79.18 115.15 18.67 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 130.17 3.388 . . . . 0.0 113.38 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.95 143.63 6.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.166 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.61 30.68 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.873 2.069 . . . . 0.0 106.746 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.8 t -83.39 -133.93 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.889 0.876 . . . . 0.0 108.955 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.49 110.09 55.68 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.72 113.92 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.401 2.734 . . . . 0.0 111.815 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.28 -0.32 37.78 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.6 p -77.02 44.37 0.39 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.461 2.13 . . . . 0.0 112.153 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 t70 42.13 -149.66 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.07 2.148 . . . . 0.0 111.579 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m 50.59 -76.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.145 2.578 . . . . 0.0 114.267 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -83.84 -53.59 5.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.967 1.707 . . . . 0.0 109.991 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.62 164.49 21.36 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.694 1.997 . . . . 0.0 112.749 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -159.1 138.37 11.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -88.27 138.47 31.41 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 109.705 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -14.65 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.621 1.169 . . . . 0.0 111.66 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 -152.17 20.91 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.04 140.01 20.1 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.07 1.348 . . . . 0.0 108.769 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' HG21 ' A' ' 33' ' ' VAL . 6.9 m -74.35 -53.34 9.85 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.808 0.813 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.068 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -173.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -69.99 -55.59 9.18 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 121.671 0.748 . . . . 0.0 109.895 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.35 -67.23 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 130.571 3.548 . . . . 0.0 104.428 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -156.51 26.15 0.34 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.979 0.912 . . . . 0.0 111.631 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.44 -165.96 1.47 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.575 0.625 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -71.83 85.09 0.94 Allowed 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.23 124.43 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.202 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -38.07 131.04 0.97 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.771 1.229 . . . . 0.0 111.85 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -90.21 23.77 24.23 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 120.445 1.195 . . . . 0.0 114.244 0.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.71 66.1 1.42 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.896 1.225 . . . . 0.0 109.53 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -51.95 156.91 1.38 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.964 0.888 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.29 -31.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.834 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.7 m -151.56 167.24 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.262 11.4 tmtt? -82.6 -38.99 22.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.449 2.299 . . . . 0.0 113.535 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.4 t70 167.56 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 1 C-N-CA 132.529 4.332 . . . . 0.0 102.713 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -111.51 175.41 5.44 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 128.194 2.598 . . . . 0.0 107.375 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.21 -55.8 5.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.43 66.95 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.308 0.883 . . . . 0.0 115.308 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.5 163.93 38.72 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.004 1.402 . . . . 0.0 111.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 164.9 51.4 Favored Pre-proline 0 C--O 1.217 -0.606 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.81 156.53 56.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.066 2.488 . . . . 0.0 114.352 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 m -141.07 -28.24 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 0.0 111.849 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -178.59 170.4 1.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 111.249 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -105.75 126.66 52.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.08 160.97 13.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.054 1.342 . . . . 0.0 109.435 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.76 125.88 2.92 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 111.715 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.59 -13.09 54.04 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.882 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.35 144.83 32.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 120.406 2.103 . . . . 0.0 107.781 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -98.71 158.74 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.756 0.422 . . . . 0.0 110.997 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.41 144.33 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.05 150.92 12.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.057 0.543 . . . . 0.0 110.594 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -156.91 133.48 10.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 46.35 33.79 2.01 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.457 1.903 . . . . 0.0 113.165 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.52 9.71 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.986 2.231 . . . . 0.0 112.576 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -78.11 139.94 39.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.629 1.214 . . . . 0.0 110.008 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.51 128.05 36.42 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 129.126 2.97 . . . . 0.0 107.615 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -128.26 167.61 16.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.519 1.127 . . . . 0.0 108.631 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -148.77 147.12 28.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.97 148.97 21.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.72 1.247 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -89.89 -36.42 15.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -132.09 -79.37 0.51 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.05 0.453 . . . . 0.0 111.852 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -157.44 132.62 8.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.777 2.031 . . . . 0.0 107.913 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -167.49 153.65 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.236 0.926 . . . . 0.0 110.107 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.29 34.24 0.65 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.675 1.59 . . . . 0.0 108.943 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 p -88.64 -100.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.189 0.596 . . . . 0.0 111.294 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.55 110.34 4.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.6 111.44 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.948 3.099 . . . . 0.0 113.586 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.71 -27.81 10.08 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.909 1.243 . . . . 0.0 111.867 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.1 t -76.47 65.47 2.34 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.323 1.062 . . . . 0.0 110.959 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 50.94 -128.21 2.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 t 72.45 -47.99 0.68 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.722 1.609 . . . . 0.0 112.813 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 -64.33 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.998 2.919 . . . . 0.0 105.906 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -11.91 121.54 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 129.074 2.95 . . . . 0.0 116.932 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 m -120.24 118.83 31.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 112.597 -2.092 . . . . 0.0 106.206 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -71.3 140.51 50.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -2.37 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.03 -152.53 24.24 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -147.64 142.14 26.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.779 1.232 . . . . 0.0 109.096 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 m -67.68 -46.51 72.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.726 0.774 . . . . 0.0 109.642 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--O 1.257 1.454 0 CA-C-O 115.559 -2.162 . . . . 0.0 105.25 -174.899 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.1 t -67.95 -52.63 33.87 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 121.215 0.531 . . . . 0.0 111.825 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 157.01 -57.6 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 130.517 3.527 . . . . 0.0 105.88 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -149.74 -5.6 0.36 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.393 1.077 . . . . 0.0 113.319 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.52 174.39 11.62 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.201 0.909 . . . . 0.0 112.024 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -54.31 103.85 0.09 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.524 1.13 . . . . 0.0 110.126 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.32 135.82 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 108.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -43.66 132.18 3.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.196 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -98.25 36.29 7.05 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 121.135 1.441 . . . . 0.0 113.593 -0.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -76.26 62.49 1.78 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.538 1.063 . . . . 0.0 108.738 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -52.55 150.89 4.61 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.458 1.103 . . . . 0.0 112.992 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -95.25 -29.52 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.231 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -64.33 -41.31 96.86 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.565 1.075 . . . . 0.0 111.407 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 mttt 57.29 -178.84 0.05 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.458 1.503 . . . . 0.0 112.79 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.54 -17.44 61.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.088 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -158.21 -74.33 0.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.743 0.701 . . . . 0.0 110.902 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.88 -52.6 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.11 0.564 . . . . 0.0 110.645 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.77 -11.86 54.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.705 0.669 . . . . 0.0 111.74 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.22 -177.05 32.84 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 122.11 0.839 . . . . 0.0 113.958 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -62.55 158.85 46.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.267 1.027 . . . . 0.0 110.338 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -64.49 168.26 13.35 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.114 1.876 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -154.2 -29.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.408 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 164.59 169.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.705 1.202 . . . . 0.0 110.418 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -107.02 128.15 54.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.09 162.59 13.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.728 1.211 . . . . 0.0 109.123 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -38.08 122.4 1.03 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.865 1.666 . . . . 0.0 112.012 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -15.27 45.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.475 -1.181 . . . . 0.0 114.384 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -76.19 138.53 40.72 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.534 2.167 . . . . 0.0 106.482 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -108.12 152.67 24.23 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.071 -0.393 . . . . 0.0 111.431 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -148.83 162.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.071 1.348 . . . . 0.0 107.659 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -116.02 151.37 17.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -157.07 119.47 3.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 40.36 76.21 0.07 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.726 2.011 . . . . 0.0 111.283 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.36 -47.11 0.68 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.913 1.72 . . . . 0.0 114.201 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -73.81 142.13 46.18 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.982 0.913 . . . . 0.0 113.122 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.9 tp -97.35 129.49 44.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 130.161 3.384 . . . . 0.0 107.236 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -133.19 156.29 47.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.83 0.852 . . . . 0.0 109.845 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.5 m -130.42 144.7 51.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.224 1.41 . . . . 0.0 107.701 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.9 149.92 24.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.058 0.932 . . . . 0.0 110.302 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.42 -33.42 17.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.942 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 17.7 p90 -143.46 -70.68 0.31 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.786 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -156.94 138.16 13.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.162 2.185 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -171.67 147.46 2.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.73 36.39 2.0 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.559 1.544 . . . . 0.0 107.616 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 m -126.56 153.0 45.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.667 1.187 . . . . 0.0 109.24 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.5 t -36.31 110.58 0.46 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.589 1.956 . . . . 0.0 112.787 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.01 138.16 43.68 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.073 3.182 . . . . 0.0 114.126 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.45 -43.67 1.59 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.997 0.808 . . . . 0.0 112.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.9 t -73.37 -41.89 62.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.619 0.767 . . . . 0.0 111.597 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.85 -111.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -161.26 171.36 18.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.144 1.378 . . . . 0.0 108.554 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 64.73 18.36 11.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -112.61 157.52 21.11 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.116 1.766 . . . . 0.0 109.351 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 m -152.03 119.86 6.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -68.7 142.03 55.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 109.784 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.39 -6.97 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.3 1.04 . . . . 0.0 112.352 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.42 -155.44 26.4 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 p -154.04 150.06 27.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.935 1.294 . . . . 0.0 108.302 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -86.08 -47.09 9.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 122.266 1.031 . . . . 0.0 109.412 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 129.885 3.274 . . . . 0.0 105.024 -175.0 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 33' ' ' VAL . 3.3 m -98.58 -23.94 15.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.704 1.138 . . . . 0.0 109.925 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.59 20.61 12.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.916 1.287 . . . . 0.0 112.138 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -162.47 -45.21 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.928 1.291 . . . . 0.0 110.024 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.97 173.41 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -70.45 122.78 20.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.2 136.89 30.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 125.556 1.543 . . . . 0.0 109.71 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -46.08 133.22 7.17 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.045 1.293 . . . . 0.0 111.802 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -95.54 36.82 6.64 Favored 'Cis proline' 0 C--N 1.353 0.81 0 CA-C-N 121.563 1.594 . . . . 0.0 113.52 -0.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.76 66.04 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -59.82 147.69 37.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.403 0.62 . . . . 0.0 110.305 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.6 -43.76 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.544 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -91.48 146.72 23.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 122.626 1.203 . . . . 0.0 109.553 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -115.72 166.65 11.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.154 2.182 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -58.0 -34.83 70.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.393 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -158.49 170.26 22.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.607 1.963 . . . . 0.0 106.848 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.38 -60.69 0.48 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.781 1.632 . . . . 0.0 113.808 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.81 24.07 29.38 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.849 0.738 . . . . 0.0 112.062 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 -174.81 49.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 121.829 0.683 . . . . 0.0 113.19 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.82 154.45 75.64 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.58 154.28 31.46 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.214 1.943 . . . . 0.0 110.011 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.73 -4.89 0.31 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.81 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 165.59 167.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.22 1.008 . . . . 0.0 113.705 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -114.62 137.52 51.79 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.577 1.551 . . . . 0.0 107.099 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.21 168.65 9.22 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.366 1.066 . . . . 0.0 109.28 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.14 124.34 2.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 111.85 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.53 -14.43 55.29 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.701 1.143 . . . . 0.0 113.501 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -78.65 126.63 31.0 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.172 1.486 . . . . 0.0 109.204 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 p -91.5 164.13 13.91 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.886 1.674 . . . . 0.0 112.285 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.56 153.95 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG21 ' SG ' ' A' ' 4' ' ' CYS . 2.8 t -111.55 153.4 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 118.48 0.582 . . . . 0.0 109.521 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -161.38 129.17 4.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 33.16 74.2 0.06 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.136 1.774 . . . . 0.0 112.247 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.07 -40.7 0.33 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.677 2.084 . . . . 0.0 115.089 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -78.37 145.5 35.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.607 1.194 . . . . 0.0 112.716 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.4 tp -101.82 126.8 48.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 129.837 3.255 . . . . 0.0 106.923 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.75 152.76 49.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.443 0.697 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.1 m -128.63 140.04 51.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 109.203 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 141.76 40.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.865 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' N ' HD22 ' A' ' 42' ' ' ASN . 0.8 OUTLIER -89.41 -39.51 13.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.428 -178.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -133.5 -71.47 0.51 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -159.28 135.75 9.18 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 127.732 2.413 . . . . 0.0 106.561 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -168.19 157.05 9.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.236 0.926 . . . . 0.0 110.507 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.56 21.12 0.92 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.848 1.659 . . . . 0.0 109.277 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.5 p -91.25 164.23 13.96 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.7 t -52.14 111.81 2.8 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.388 0.675 . . . . 0.0 109.326 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.21 122.69 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.337 3.358 . . . . 0.0 113.445 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.84 -23.15 34.71 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.468 1.032 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 m -76.24 66.92 2.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.284 1.042 . . . . 0.0 110.666 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 47.2 -126.7 1.65 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.996 1.319 . . . . 0.0 108.847 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m 65.07 -40.87 0.29 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.467 2.307 . . . . 0.0 115.94 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p 179.34 -69.82 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.264 2.626 . . . . 0.0 106.224 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -8.91 112.98 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.723 3.209 . . . . 0.0 116.124 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.4 m -108.88 113.16 25.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 112.805 -1.998 . . . . 0.0 106.264 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -66.79 134.34 51.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -111.13 -9.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.686 0.794 . . . . 0.0 111.185 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.68 -167.64 32.63 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.103 0.865 . . . . 0.0 111.593 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -122.79 123.22 40.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -31.44 68.15 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.518 0 CA-C-O 114.84 -2.505 . . . . 0.0 107.05 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.8 t -64.75 -47.21 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.476 0.655 . . . . 0.0 111.951 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 155.98 -61.04 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 130.705 3.602 . . . . 0.0 104.849 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.1 0.85 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.463 1.105 . . . . 0.0 113.259 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.72 -175.29 5.2 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.092 0.86 . . . . 0.0 111.838 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.52 94.0 0.04 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.814 0.845 . . . . 0.0 111.003 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 p -96.6 131.81 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.0 135.73 11.33 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.856 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -93.87 33.47 9.62 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.636 1.263 . . . . 0.0 114.706 0.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -74.5 66.95 1.44 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.999 1.272 . . . . 0.0 108.336 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 9.6 m95 -50.86 160.86 0.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.989 1.316 . . . . 0.0 113.251 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.21 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.938 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -110.9 147.78 33.87 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.773 2.829 . . . . 0.0 107.728 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -66.68 -29.11 69.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -152.63 157.87 41.6 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.624 1.17 . . . . 0.0 108.243 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.78 -60.73 0.69 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.363 1.865 . . . . 0.0 114.615 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.38 5.71 84.61 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.863 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.62 150.71 27.12 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.922 1.361 . . . . 0.0 110.677 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -68.67 151.59 97.16 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 50.6 Cg_exo -57.43 157.96 20.67 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 CA-C-N 119.655 0.912 . . . . 0.0 112.729 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 t -157.74 9.74 0.17 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.333 -1.318 . . . . 0.0 110.804 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -178.14 170.49 1.8 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-O 122.647 1.213 . . . . 0.0 113.843 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -115.06 98.56 6.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.874 2.07 . . . . 0.0 105.77 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.29 165.57 13.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.887 -0.508 . . . . 0.0 111.872 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.86 132.07 11.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.324 1.05 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 -10.06 34.93 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.338 -1.257 . . . . 0.0 113.339 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 40' ' ' THR . 8.6 mm-40 -78.99 156.41 28.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 120.062 1.931 . . . . 0.0 106.479 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -117.94 166.26 12.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.534 0.734 . . . . 0.0 110.524 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 tt -162.38 160.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -116.62 151.37 18.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.71 0.687 . . . . 0.0 109.729 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -162.62 134.85 5.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt 49.59 32.22 4.79 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.84 1.656 . . . . 0.0 112.686 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.09 -19.24 23.2 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.71 2.1 . . . . 0.0 112.874 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -85.53 145.1 27.55 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.702 1.251 . . . . 0.0 109.591 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tp -93.45 129.47 39.61 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.313 2.645 . . . . 0.0 107.178 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -127.62 164.78 21.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.346 1.058 . . . . 0.0 108.381 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' GLN . 57.7 m -146.24 145.6 30.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.36 144.5 26.36 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 111.108 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -93.45 -36.54 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.378 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -132.91 -78.01 0.49 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.281 0.563 . . . . 0.0 112.112 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -157.55 132.95 9.01 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -167.07 147.84 5.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.45 1.023 . . . . 0.0 111.022 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.3 15.72 4.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.158 1.383 . . . . 0.0 107.921 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -77.46 163.31 26.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.56 127.9 90.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -45.33 122.4 4.58 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.528 2.818 . . . . 0.0 112.844 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.09 -24.95 27.76 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.167 0.889 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -76.92 75.58 3.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.333 1.066 . . . . 0.0 109.558 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.81 -131.43 0.74 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 110.051 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t 67.7 -54.77 0.49 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.394 2.277 . . . . 0.0 113.979 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 p -172.45 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.548 1.139 . . . . 0.0 109.886 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -18.68 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.427 3.091 . . . . 0.0 116.715 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 m -143.43 130.99 21.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 112.583 -2.099 . . . . 0.0 107.057 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -74.0 141.21 45.86 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.6 -6.23 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.268 1.027 . . . . 0.0 113.027 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.7 -151.42 22.82 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -153.85 154.22 33.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.448 1.099 . . . . 0.0 109.324 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 m -87.27 -53.81 4.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 110.029 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 p -9.95 84.98 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 130.568 3.547 . . . . 0.0 117.037 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.22 -23.8 9.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.009 2.524 . . . . 0.0 112.892 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -54.5 -38.06 66.05 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.21 152.65 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -46.84 122.43 4.3 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.468 0.707 . . . . 0.0 109.967 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.18 130.77 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 119.173 0.897 . . . . 0.0 109.096 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.412 ' HA ' HD11 ' A' ' 32' ' ' ILE . 30.6 t80 -47.98 136.48 11.04 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.523 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -91.49 24.03 24.98 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.944 1.016 . . . . 0.0 113.876 0.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -73.17 68.75 1.01 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 119.859 1.209 . . . . 0.0 109.807 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -52.22 157.05 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.741 0.782 . . . . 0.0 112.043 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.24 -21.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -145.15 166.83 24.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.063 0.935 . . . . 0.0 113.16 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.271 51.0 tttp -96.9 -40.1 9.07 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 128.543 2.737 . . . . 0.0 110.313 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 174.75 -40.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 1 C-N-CA 133.217 4.607 . . . . 0.0 102.926 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -113.57 166.52 11.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.76 -68.08 0.39 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.45 11.38 1.15 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.42 155.74 27.4 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.258 1.529 . . . . 0.0 110.187 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.9 121.05 42.79 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -50.94 152.95 9.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.449 2.1 . . . . 0.0 116.654 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 m -152.37 -17.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.081 0.952 . . . . 0.0 112.23 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 179.38 164.19 0.96 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.752 1.16 . . . . 0.0 110.973 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -100.09 141.49 32.85 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.72 169.76 8.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.735 1.214 . . . . 0.0 109.404 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.97 122.03 2.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.622 1.169 . . . . 0.0 111.358 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 -19.06 48.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.863 1.221 . . . . 0.0 113.215 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -76.92 131.98 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.257 1.528 . . . . 0.0 110.503 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.93 163.5 12.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.2 1.8 . . . . 0.0 112.087 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 10' ' ' TYR . 12.5 tt -167.02 149.42 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.176 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.92 153.61 3.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.407 1.003 . . . . 0.0 108.554 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -158.21 115.49 2.91 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 39.45 78.58 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.041 1.736 . . . . 0.0 112.132 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.27 -42.86 0.53 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.017 1.294 . . . . 0.0 115.825 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -81.57 145.39 30.67 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 122.041 0.924 . . . . 0.0 111.996 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tp -99.44 125.47 45.17 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 129.143 2.977 . . . . 0.0 106.317 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.06 167.35 13.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.31 1.044 . . . . 0.0 108.749 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -148.59 142.88 26.17 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.72 144.21 29.51 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.148 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -95.73 -35.29 11.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.097 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -131.38 -75.42 0.52 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.382 0.426 . . . . 0.0 111.53 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -159.96 125.61 4.12 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.939 2.096 . . . . 0.0 107.921 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 t -167.41 150.57 6.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.979 1.263 . . . . 0.0 111.863 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.21 5.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.783 2.033 . . . . 0.0 108.061 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -71.26 162.99 28.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.39 120.6 53.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.89 122.98 9.04 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.211 2.608 . . . . 0.0 112.615 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.5 -30.44 9.62 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.4 m -75.94 73.38 2.84 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.534 1.167 . . . . 0.0 110.44 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 55.94 -133.2 1.54 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.806 1.242 . . . . 0.0 108.948 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t 59.52 -152.88 0.39 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -54.41 13.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.909 -0.494 . . . . 0.0 109.899 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -13.5 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.953 2.901 . . . . 0.0 117.505 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 m -117.97 126.89 53.2 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.44 2.296 . . . . 0.0 106.399 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.02 141.91 47.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -15.9 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.583 1.153 . . . . 0.0 111.873 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.92 -177.56 47.58 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.0 1.273 . . . . 0.0 112.213 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.5 p -137.03 110.86 8.15 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.932 1.693 . . . . 0.0 107.285 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.8 m -74.04 -37.89 64.16 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HB2' HG21 ' A' ' 33' ' ' VAL . 5.6 t -82.75 -48.75 10.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.261 1.024 . . . . 0.0 110.241 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.85 -55.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.845 3.258 . . . . 0.0 105.146 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -152.16 -2.68 0.27 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.615 1.166 . . . . 0.0 112.736 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.59 157.98 30.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.569 1.077 . . . . 0.0 111.07 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -39.5 106.85 0.06 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 126.509 1.924 . . . . 0.0 112.742 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.3 132.02 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.545 1.138 . . . . 0.0 108.762 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.61 133.77 6.27 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.597 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.27 34.42 8.57 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 120.982 1.386 . . . . 0.0 114.422 0.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -76.71 59.53 1.57 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.164 1.347 . . . . 0.0 108.118 176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . 0.267 7.2 m95 -55.66 156.83 4.5 Favored 'General case' 0 N--CA 1.412 -2.352 0 C-N-CA 129.356 3.062 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.38 -26.82 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.652 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 t -156.05 173.67 16.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 124.345 2.022 . . . . 0.0 116.0 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.38 -172.01 2.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 130.42 3.488 . . . . 0.0 106.499 171.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.44 -30.56 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.937 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -131.66 152.46 50.84 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 110.156 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.72 -63.35 0.52 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.89 2.076 . . . . 0.0 115.108 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 3.37 69.92 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.962 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.92 147.26 34.78 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 120.199 2.0 . . . . 0.0 111.069 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.35 120.16 80.06 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -38.74 159.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.838 3.692 . . . . 0.0 121.153 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 2.93 0.43 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 112.134 -2.303 . . . . 0.0 109.515 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 178.16 172.24 0.68 Allowed 'General case' 0 C--N 1.349 0.552 0 CA-C-N 120.307 1.412 . . . . 0.0 113.657 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -110.09 139.02 45.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.97 169.29 8.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.353 1.461 . . . . 0.0 109.281 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -42.26 123.86 2.62 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.922 1.289 . . . . 0.0 112.052 -177.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.17 -17.24 18.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.761 0.696 . . . . 0.0 113.751 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -75.03 128.22 35.05 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -100.76 164.67 11.75 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.3 tt -161.59 173.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.215 1.406 . . . . 0.0 108.233 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 4' ' ' CYS . 70.9 t -121.89 153.24 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.032 1.333 . . . . 0.0 110.452 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -158.05 114.19 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 41.18 81.74 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.617 2.367 . . . . 0.0 112.231 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.4 -44.05 0.58 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.57 1.557 . . . . 0.0 114.755 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.61 146.67 40.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.895 0.878 . . . . 0.0 111.739 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.0 tp -106.11 129.17 54.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 130.45 3.5 . . . . 0.0 106.993 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -132.33 162.46 30.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.267 1.027 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.0 m -134.53 144.58 48.09 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.335 1.454 . . . . 0.0 109.096 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.69 145.85 27.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.124 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' HB3' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-80 -86.8 -32.59 20.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.443 1.497 . . . . 0.0 111.492 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 17.9 p90 -148.96 -65.16 0.23 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 111.101 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -159.86 134.88 7.98 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 127.564 2.346 . . . . 0.0 107.629 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -174.32 144.29 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.057 0.844 . . . . 0.0 111.573 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.81 14.64 9.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.715 2.006 . . . . 0.0 107.932 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.52 165.81 23.86 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.3 t -57.24 118.69 26.18 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.493 -0.765 . . . . 0.0 108.954 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.05 119.17 5.67 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.551 2.168 . . . . 0.0 110.75 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.55 -26.72 9.36 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.3 t -73.43 80.14 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -41.17 139.67 0.93 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.777 1.631 . . . . 0.0 111.413 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t 163.57 -49.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.795 2.438 . . . . 0.0 106.301 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 t -146.56 11.06 1.11 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.979 1.712 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -113.54 156.41 23.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.26 1.024 . . . . 0.0 108.903 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -153.32 126.02 8.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -72.85 140.56 47.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.23 0.468 . . . . 0.0 110.004 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -17.13 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.901 1.281 . . . . 0.0 111.053 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.37 -157.35 29.78 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -154.27 140.72 18.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.886 1.674 . . . . 0.0 106.77 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.58 -44.28 11.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.553 0.615 . . . . 0.0 111.136 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 110.768 -0.086 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.9 t -74.76 -58.59 3.19 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 122.198 0.999 . . . . 0.0 108.558 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.24 -58.02 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 129.747 3.219 . . . . 0.0 104.803 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -152.15 32.32 0.53 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.943 0.897 . . . . 0.0 112.117 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.03 155.63 24.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -32.54 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.587 1.955 . . . . 0.0 113.87 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -88.76 122.97 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -48.66 137.92 12.33 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 120.92 1.691 . . . . 0.0 109.998 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -92.21 36.12 6.64 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 120.612 1.254 . . . . 0.0 114.708 0.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -74.3 66.57 1.32 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.068 1.303 . . . . 0.0 107.86 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 6.3 m95 -50.55 164.44 0.13 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.533 1.533 . . . . 0.0 113.025 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.94 -33.0 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.139 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -144.57 172.63 12.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.266 86.8 tttt -99.49 -57.73 2.09 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.816 3.246 . . . . 0.0 109.582 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -158.07 -50.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.905 5.682 . . . . 0.0 101.913 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -113.28 175.26 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -58.88 3.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.06 -21.13 63.41 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.22 153.43 48.44 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -59.93 131.88 89.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 37.7 Cg_exo -60.89 160.34 25.8 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 N-CA-C 117.944 2.248 . . . . 0.0 117.944 -173.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -151.86 -7.92 0.22 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 112.448 -2.16 . . . . 0.0 110.4 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -174.41 173.29 3.0 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.58 123.3 41.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.745 2.418 . . . . 0.0 105.941 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.6 169.2 11.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.192 0.997 . . . . 0.0 111.669 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.77 128.16 20.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.7 66.6 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.061 -1.411 . . . . 0.0 113.977 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.66 136.74 33.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.582 2.191 . . . . 0.0 106.252 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.1 m -98.36 157.51 16.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.224 0.535 . . . . 0.0 112.208 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 tt -152.05 162.9 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 t -121.86 145.4 28.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.655 0.661 . . . . 0.0 109.519 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -167.34 167.77 13.72 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 40.33 39.68 0.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.957 1.253 . . . . 0.0 112.933 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.39 36.79 54.18 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.963 1.744 . . . . 0.0 112.413 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -150.82 157.22 42.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.939 1.296 . . . . 0.0 110.194 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.3 tp -87.73 132.12 34.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.984 2.514 . . . . 0.0 109.392 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.74 156.79 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.515 1.126 . . . . 0.0 108.59 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 m -137.2 145.2 43.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.58 153.93 21.43 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.35 1.071 . . . . 0.0 110.584 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -91.08 -32.84 15.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.715 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -138.89 -146.0 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.483 1.513 . . . . 0.0 109.551 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.15 115.9 28.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.751 2.421 . . . . 0.0 106.038 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -157.46 156.57 32.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.131 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.79 20.06 4.19 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.418 1.887 . . . . 0.0 108.049 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -79.9 -179.35 6.92 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.23 120.47 73.4 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 55' ' ' TRP . 52.4 Cg_exo -54.51 127.37 25.73 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.572 2.848 . . . . 0.0 115.551 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.62 -38.41 1.05 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 123.688 0.661 . . . . 0.0 112.759 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -65.72 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.414 0.607 . . . . 0.0 110.814 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.88 179.89 6.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.551 0.691 . . . . 0.0 110.948 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -47.24 164.92 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.838 3.255 . . . . 0.0 115.508 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.2 p 71.95 4.72 5.12 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.637 2.775 . . . . 0.0 114.649 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 49' ' ' PRO . 98.6 m95 -117.2 149.23 40.73 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.779 1.231 . . . . 0.0 110.85 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 m -136.69 118.51 15.14 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.95 139.59 48.76 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -121.57 12.19 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.076 0.55 . . . . 0.0 112.257 -179.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.33 -150.86 17.91 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t -89.42 176.78 6.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -73.47 96.1 2.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 O-C-N 125.017 1.448 . . . . 0.0 109.724 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -37.12 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 129.243 3.017 . . . . 0.0 116.45 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.63 -27.17 10.56 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.789 2.436 . . . . 0.0 111.342 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -54.3 -33.37 58.59 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.82 176.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.31 1.444 . . . . 0.0 109.067 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -60.37 118.41 6.41 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.84 137.06 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -55.52 135.24 70.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 120.704 1.593 . . . . 0.0 110.824 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -99.37 31.17 11.47 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 121.382 1.529 . . . . 0.0 113.319 -1.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -74.76 65.06 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 39.4 m95 -48.59 152.41 0.96 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.88 0.848 . . . . 0.0 112.316 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.97 -25.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.137 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 m -153.19 169.99 21.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.527 1.632 . . . . 0.0 115.037 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.48 -166.5 1.09 Allowed 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 129.439 3.096 . . . . 0.0 108.305 173.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -53.97 -44.57 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.621 -2.081 . . . . 0.0 107.823 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -128.49 153.36 47.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.392 1.877 . . . . 0.0 109.728 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.44 -63.48 0.44 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.493 1.917 . . . . 0.0 115.174 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 4.73 79.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.677 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.76 154.0 46.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-N 120.487 2.144 . . . . 0.0 110.988 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.0 113.31 8.86 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 51.5 Cg_exo -37.79 147.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 1 C-N-CA 125.746 4.297 . . . . 0.0 117.412 -173.2 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 p -139.74 -8.01 1.25 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -178.52 158.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 119.152 0.887 . . . . 0.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -99.21 113.77 26.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 3.4 tt0 -82.15 164.27 21.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.238 1.815 . . . . 0.0 110.615 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -47.63 127.51 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 120.804 -1.185 . . . . 0.0 112.603 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 -14.37 48.92 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.956 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -81.06 139.9 35.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.688 2.744 . . . . 0.0 107.216 178.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 p -94.25 164.65 12.95 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.262 -0.899 . . . . 0.0 111.919 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 tt -156.86 151.35 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -98.8 150.1 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -159.93 116.47 2.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 38.23 77.3 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.971 2.109 . . . . 0.0 112.541 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.63 -42.09 0.55 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.59 1.567 . . . . 0.0 113.981 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -78.24 151.08 33.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.083 0.944 . . . . 0.0 112.14 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -105.3 124.13 49.02 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 128.94 2.896 . . . . 0.0 106.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.55 168.92 11.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.6 m -150.82 148.84 28.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.76 146.92 25.42 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.921 0.867 . . . . 0.0 112.166 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -87.56 -36.4 17.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 29.3 p90 -139.14 -71.97 0.4 Allowed 'General case' 0 C--N 1.339 0.122 0 CA-C-O 120.889 0.376 . . . . 0.0 111.623 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -159.73 128.94 5.21 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.353 1.461 . . . . 0.0 108.454 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 t -166.55 150.98 7.53 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 119.134 0.879 . . . . 0.0 111.307 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.89 15.28 4.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.907 1.683 . . . . 0.0 107.996 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 p -87.9 172.02 9.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.41 123.82 83.93 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 111.607 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.26 140.25 72.38 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.513 2.808 . . . . 0.0 114.671 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.38 -45.73 2.11 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.655 1.121 . . . . 0.0 111.699 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -73.23 -45.14 57.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.503 0.721 . . . . 0.0 112.646 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.5 -167.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.583 1.182 . . . . 0.0 114.152 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -57.76 140.92 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.758 3.223 . . . . 0.0 117.459 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t 62.39 23.41 13.88 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 128.142 2.577 . . . . 0.0 113.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -107.58 152.08 24.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.286 1.041 . . . . 0.0 111.116 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 m -153.63 134.09 13.55 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.62 138.47 37.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.579 0.752 . . . . 0.0 109.801 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.98 -4.37 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.084 0.954 . . . . 0.0 111.218 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.05 -151.65 23.77 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -145.77 156.37 43.55 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 107.491 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.9 t -67.44 -34.09 76.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.836 0.827 . . . . 0.0 111.047 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.514 0 CA-C-O 115.006 -2.426 . . . . 0.0 107.022 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.783 0.325 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.277 0.1 OUTLIER -7.66 85.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 130.041 3.336 . . . . 0.0 115.844 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.72 64.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.434 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -57.99 -32.9 68.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.995 0.918 . . . . 0.0 110.467 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.01 171.17 7.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.727 1.211 . . . . 0.0 108.636 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -64.21 129.8 41.4 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.72 130.84 55.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 C-N-CA 124.454 1.101 . . . . 0.0 110.326 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -43.13 133.89 3.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.704 1.138 . . . . 0.0 110.975 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.48 31.08 11.68 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.613 1.255 . . . . 0.0 114.36 0.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -73.4 67.7 1.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.033 1.288 . . . . 0.0 108.252 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -54.82 151.73 8.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.751 -0.593 . . . . 0.0 111.383 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.62 -43.7 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -105.16 160.53 15.0 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 122.811 1.291 . . . . 0.0 112.733 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -116.67 162.21 18.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.126 2.57 . . . . 0.0 108.596 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.76 -30.67 70.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -157.03 156.59 33.14 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 108.89 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 73.7 0.05 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.039 1.736 . . . . 0.0 111.852 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.95 -20.1 0.76 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.316 1.436 . . . . 0.0 111.512 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.11 175.41 48.22 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.321 1.06 . . . . 0.0 110.895 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.36 151.2 87.59 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.71 139.6 23.94 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.132 1.888 . . . . 0.0 109.497 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.05 -7.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.625 -1.179 . . . . 0.0 112.922 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 176.4 164.76 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -111.38 140.37 46.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -108.48 173.4 6.33 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.849 1.26 . . . . 0.0 108.679 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.75 129.31 26.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.692 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.47 68.15 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.606 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -84.62 127.14 33.92 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.54 1.67 . . . . 0.0 109.611 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -89.47 166.41 13.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.374 1.07 . . . . 0.0 113.838 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 tt -170.91 154.25 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.665 1.586 . . . . 0.0 108.575 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.1 t -107.59 159.41 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -155.32 -66.64 0.12 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -117.32 96.35 5.38 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.838 1.655 . . . . 0.0 109.625 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.01 15.24 0.01 OUTLIER Glycine 0 CA--C 1.531 1.056 1 C-N-CA 131.005 4.145 . . . . 0.0 117.64 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -143.71 160.68 40.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.142 -1.211 . . . . 0.0 109.012 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.1 tp -89.4 124.14 34.19 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 127.208 2.203 . . . . 0.0 106.643 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -121.54 152.36 39.29 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.156 0.982 . . . . 0.0 108.628 178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 58' ' ' VAL . 77.4 m -134.18 145.31 49.1 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.26 146.41 28.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.539 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -90.41 -32.17 16.54 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.792 1.637 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -148.7 -140.76 0.1 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.221 2.208 . . . . 0.0 107.601 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -87.02 126.4 34.72 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 127.849 2.46 . . . . 0.0 108.48 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.8 143.54 8.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.34 43.17 1.77 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.863 1.265 . . . . 0.0 108.637 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -138.8 161.36 37.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -31.32 105.02 0.22 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 128.938 2.895 . . . . 0.0 113.769 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -51.06 138.4 43.91 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 124.379 3.386 . . . . 0.0 113.889 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.65 -36.83 0.59 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.158 1.361 . . . . 0.0 113.446 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.0 m -76.08 -45.58 33.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 112.382 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -97.37 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.982 0.355 . . . . 0.0 111.486 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -168.23 175.46 6.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t 63.99 21.05 12.47 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.448 1.099 . . . . 0.0 109.834 -177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -123.09 140.43 53.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 124.236 1.014 . . . . 0.0 109.702 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -136.27 120.93 18.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.793 1.637 . . . . 0.0 106.677 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -70.73 134.05 47.13 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.431 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -110.08 -15.56 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.997 1.319 . . . . 0.0 111.802 -178.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.33 160.8 29.62 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -112.01 144.98 40.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 m -117.93 -48.72 2.54 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.281 0.632 . . . . 0.0 111.598 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.933 -172.208 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' H ' HG11 ' A' ' 33' ' ' VAL . 1.3 p -71.55 82.7 0.83 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.391 1.091 . . . . 0.0 111.194 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -39.8 -39.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.995 3.318 . . . . 0.0 113.866 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.03 -35.24 64.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.075 0.95 . . . . 0.0 111.029 179.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.94 153.87 18.06 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.505 1.122 . . . . 0.0 108.01 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -43.56 118.62 1.42 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.523 1.129 . . . . 0.0 111.476 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.69 127.68 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -49.7 135.07 19.58 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.335 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -93.07 25.15 23.26 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 121.321 1.507 . . . . 0.0 115.337 0.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -72.98 66.8 0.82 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.82 1.191 . . . . 0.0 108.119 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -53.58 154.79 3.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.38 -45.85 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.545 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -94.04 153.77 17.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 122.691 1.234 . . . . 0.0 110.179 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -112.72 166.8 11.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.39 2.276 . . . . 0.0 108.915 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.74 -32.66 74.23 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -157.35 158.65 36.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.993 1.317 . . . . 0.0 108.202 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.95 -61.21 0.67 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.262 1.825 . . . . 0.0 114.376 -177.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.47 12.88 65.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.541 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.17 -166.1 41.75 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.42 1.11 . . . . 0.0 111.625 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.24 160.68 26.41 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.923 1.289 . . . . 0.0 107.819 177.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.56 149.13 10.45 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.392 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.7 m -146.02 -19.35 0.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.308 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 177.85 166.05 0.69 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.365 0.984 . . . . 0.0 113.006 -175.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.66 113.41 26.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.57 167.97 16.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.662 0.785 . . . . 0.0 109.633 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -42.35 126.88 3.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.977 1.311 . . . . 0.0 111.877 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -8.18 57.98 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.153 178.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.37 126.45 32.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.661 1.73 . . . . 0.0 108.703 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -86.49 162.58 18.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.127 1.771 . . . . 0.0 112.518 -178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -163.95 150.15 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.085 1.354 . . . . 0.0 108.224 177.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' H ' ' A' ' 4' ' ' CYS . 2.2 t -102.52 155.52 5.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -167.21 125.18 1.28 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 108.363 175.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 43.4 55.99 4.54 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 123.682 1.706 . . . . 0.0 111.44 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -36.06 1.11 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.704 2.573 . . . . 0.0 114.256 177.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -70.87 145.39 50.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.275 1.036 . . . . 0.0 110.443 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -101.95 119.66 39.14 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 129.088 2.955 . . . . 0.0 106.287 178.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -123.84 156.27 36.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.398 0.679 . . . . 0.0 110.051 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.8 m -132.58 143.01 49.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.583 1.153 . . . . 0.0 108.312 177.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.77 144.89 34.73 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.882 0.873 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.444 ' N ' HD22 ' A' ' 42' ' ' ASN . 0.8 OUTLIER -86.65 -37.68 17.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.334 -177.377 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 18.1 p90 -144.69 -67.46 0.32 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.561 0.696 . . . . 0.0 110.368 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -155.42 142.05 18.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.821 2.448 . . . . 0.0 107.614 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -176.36 145.42 0.58 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 45.55 0.92 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.326 1.851 . . . . 0.0 106.516 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 56.2 p -106.96 -105.56 0.33 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.377 1.071 . . . . 0.0 113.106 -174.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.3 t -145.39 117.28 5.17 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.81 130.94 23.96 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.064 2.509 . . . . 0.0 115.885 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.79 -42.27 1.29 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.545 1.545 . . . . 0.0 113.025 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.8 m -59.33 -57.14 14.32 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.58 -25.43 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p 89.0 179.28 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.773 2.829 . . . . 0.0 110.48 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t 78.76 28.34 0.43 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 -170.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -136.39 157.34 47.04 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 129.772 3.229 . . . . 0.0 106.591 -175.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -155.25 120.19 4.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.73 128.71 36.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.32 -13.04 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.369 1.068 . . . . 0.0 110.423 178.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.59 -156.64 28.38 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.63 134.8 14.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 88.5 m -91.21 -42.49 10.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.319 0.509 . . . . 0.0 111.921 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.921 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -171.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 t -53.44 -53.59 49.18 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.53 1.059 . . . . 0.0 111.566 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 151.88 -61.17 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.373 3.469 . . . . 0.0 106.467 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -151.68 2.8 0.39 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -82.2 -171.27 3.33 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.421 1.01 . . . . 0.0 111.098 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -69.65 97.76 1.09 Allowed 'General case' 0 C--N 1.338 0.096 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 7' ' ' ALA . 2.4 t -102.66 124.89 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.046 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -42.14 132.79 2.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 119.487 1.04 . . . . 0.0 111.15 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.72 27.29 15.01 Favored 'Cis proline' 0 C--N 1.35 0.638 0 N-CA-C 115.888 1.457 . . . . 0.0 115.888 1.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -74.71 66.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.153 1.342 . . . . 0.0 107.617 175.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -58.1 176.14 0.18 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 112.388 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.83 -33.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.12 -66.85 0.84 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -171.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' CG ' ' H ' ' A' ' 17' ' ' ASP . 3.5 tttm 53.51 -167.26 0.07 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 123.611 1.672 . . . . 0.0 112.487 -170.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.403 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 10.5 m-20 -82.0 -40.3 22.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.3 2.64 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -79.81 174.61 11.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.842 2.057 . . . . 0.0 114.566 -175.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.41 39.91 3.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.198 2.199 . . . . 0.0 106.923 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.09 47.58 0.04 OUTLIER Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.374 1.464 . . . . 0.0 110.623 -177.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.25 -157.49 9.78 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -78.09 -174.78 0.47 Allowed Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -110.12 158.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.909 1.739 . . . . 0.0 113.373 178.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -150.92 -12.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.39 0.676 . . . . 0.0 112.049 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 178.6 164.07 0.77 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.342 0.974 . . . . 0.0 111.02 -177.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -112.37 149.65 32.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.654 1.182 . . . . 0.0 108.078 177.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.18 172.71 8.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.66 0.784 . . . . 0.0 110.471 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.22 123.25 2.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.485 1.514 . . . . 0.0 112.088 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -14.37 40.7 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.463 1.03 . . . . 0.0 113.779 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.49 118.06 21.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.295 1.547 . . . . 0.0 109.633 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -80.76 166.69 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 111.928 179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 tt -165.9 151.83 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.434 HG21 ' SG ' ' A' ' 61' ' ' CYS . 41.0 t -109.22 156.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -138.98 -126.56 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.36 84.19 1.44 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.277 1.399 . . . . 0.0 108.933 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.84 -45.28 0.87 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 127.993 2.711 . . . . 0.0 113.022 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -68.93 143.43 54.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.79 0.836 . . . . 0.0 111.675 -176.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.42 122.53 43.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 129.96 3.304 . . . . 0.0 106.621 177.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -122.84 170.79 9.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.824 1.25 . . . . 0.0 109.242 178.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -148.75 144.63 27.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.81 145.9 27.01 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.41 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -95.47 -31.39 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.221 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -134.18 -73.77 0.48 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 111.307 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -158.4 135.95 10.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.441 2.296 . . . . 0.0 108.441 -177.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -168.9 149.99 4.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.21 0.914 . . . . 0.0 109.677 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.97 37.0 0.86 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.131 1.772 . . . . 0.0 108.038 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.3 p -94.7 -103.93 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.018 0.927 . . . . 0.0 111.888 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.4 112.92 4.73 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.66 1.984 . . . . 0.0 106.056 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.1 121.02 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.421 2.747 . . . . 0.0 113.128 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.88 -17.59 57.7 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.995 0.807 . . . . 0.0 113.05 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -77.31 74.66 3.87 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.993 1.396 . . . . 0.0 109.453 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 t70 51.69 -132.19 1.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.362 1.065 . . . . 0.0 108.691 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t 57.7 -150.58 0.44 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.267 0.94 . . . . 0.0 109.136 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.45 -51.83 39.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.815 0.846 . . . . 0.0 109.702 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -20.06 130.66 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.156 2.582 . . . . 0.0 116.22 -175.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -136.77 128.76 29.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -75.3 141.03 43.48 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -14.06 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.87 1.268 . . . . 0.0 111.635 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.82 -148.12 13.31 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.553 1.069 . . . . 0.0 110.693 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -157.98 135.83 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.279 1.431 . . . . 0.0 108.827 178.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.434 ' SG ' HG21 ' A' ' 33' ' ' VAL . 2.7 m -68.11 -49.52 60.65 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.675 0.75 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 -175.067 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 7' ' ' ALA . 40.4 t -54.34 -48.81 70.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.859 0.754 . . . . 0.0 112.907 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 104.87 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.25 3.02 . . . . 0.0 108.458 -175.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.61 40.82 1.11 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . -162.45 173.7 13.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.701 1.137 . . . . 0.0 109.093 174.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -48.83 107.3 0.13 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 125.189 1.396 . . . . 0.0 112.187 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.9 131.01 48.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.206 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -44.2 133.04 4.42 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.926 1.239 . . . . 0.0 110.404 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.9 35.97 7.43 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 121.202 1.465 . . . . 0.0 113.908 0.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.22 61.44 1.16 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.764 1.165 . . . . 0.0 108.237 176.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -55.38 156.02 4.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.775 0.798 . . . . 0.0 112.819 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -76.12 -53.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.608 178.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -80.82 143.31 32.9 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -124.61 165.91 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 112.069 -176.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -45.21 95.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.331 -1.758 . . . . 0.0 109.904 177.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.283 1.7 m95 21.24 166.4 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 136.471 5.908 . . . . 0.0 124.845 -177.365 . . . . . . . . 3 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 120.69 57.3 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 2 C-N-CA 136.595 5.958 . . . . 0.0 100.825 -173.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.28 59.34 3.37 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.647 2.546 . . . . 0.0 107.295 -173.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.35 -148.15 7.35 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 123.483 0.563 . . . . 0.0 111.949 -178.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -131.09 163.8 46.71 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.635 1.174 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.38 150.26 26.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.836 3.024 . . . . 0.0 110.477 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.91 -17.79 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.219 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -179.68 168.41 1.37 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -178.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -114.91 131.11 56.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.629 1.972 . . . . 0.0 107.567 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.58 165.05 11.32 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.968 0.907 . . . . 0.0 109.626 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.23 123.68 2.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.666 1.186 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.79 -12.43 57.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.157 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.77 139.31 39.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.263 2.031 . . . . 0.0 105.795 177.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -105.93 156.83 17.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.918 0.487 . . . . 0.0 111.079 -178.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -157.52 168.77 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.15 149.38 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.385 0.674 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.04 134.3 16.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.037 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 50.74 27.69 3.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.958 1.703 . . . . 0.0 113.915 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.0 -22.13 27.21 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 126.477 1.989 . . . . 0.0 112.231 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.97 138.08 36.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.424 1.112 . . . . 0.0 109.247 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.8 tp -91.54 131.19 37.15 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 128.45 2.7 . . . . 0.0 108.435 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -135.52 159.45 41.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 109.666 178.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -132.95 142.42 48.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.446 1.498 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.22 150.21 27.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.163 0.983 . . . . 0.0 111.077 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.776 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -139.91 -75.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -161.25 125.98 3.54 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.27 2.228 . . . . 0.0 106.506 -176.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 t -168.1 154.47 7.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.835 1.198 . . . . 0.0 111.608 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.42 20.69 4.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.238 1.815 . . . . 0.0 106.737 174.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -82.21 146.96 29.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.3 t -46.88 121.98 7.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.788 0.835 . . . . 0.0 109.192 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.44 127.69 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.171 2.581 . . . . 0.0 113.831 -179.188 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.47 22.77 73.36 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.521 178.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 p -66.36 -71.57 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.307 1.053 . . . . 0.0 110.616 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -146.14 -32.67 0.34 Allowed 'General case' 0 C--O 1.23 0.069 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m -156.48 168.1 28.42 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.214 -0.929 . . . . 0.0 112.039 -174.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 p 70.53 0.39 3.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 130.303 3.441 . . . . 0.0 114.412 177.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.66 171.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.908 1.283 . . . . 0.0 112.573 -178.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -158.92 124.07 4.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.48 144.5 42.02 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.92 -6.52 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.873 0.869 . . . . 0.0 112.927 -178.974 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.49 -152.15 23.66 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 p -156.51 152.36 27.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.448 1.099 . . . . 0.0 109.029 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.93 -46.22 14.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.323 1.058 . . . . 0.0 108.91 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 129.86 3.264 . . . . 0.0 104.482 -174.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.4 159.73 53.91 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.1 m-20 -51.9 -30.79 25.62 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.545 1.138 . . . . 0.0 113.362 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -125.58 -60.12 1.33 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.237 1.015 . . . . 0.0 110.249 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.64 -66.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.251 3.02 . . . . 0.0 104.948 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -154.11 25.42 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.092 0.957 . . . . 0.0 111.61 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.94 -165.03 1.27 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.583 0.629 . . . . 0.0 109.688 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.04 89.2 1.93 Allowed 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.353 -0.842 . . . . 0.0 109.472 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 3' ' ' ASP . 98.6 t -83.64 118.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 108.239 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -45.17 135.29 5.28 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 120.767 1.621 . . . . 0.0 110.944 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -89.93 33.82 7.62 Favored 'Cis proline' 0 C--N 1.349 0.58 0 N-CA-C 115.685 1.379 . . . . 0.0 115.685 1.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -74.3 62.63 0.97 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.257 1.39 . . . . 0.0 108.867 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 7.1 m95 -51.68 160.82 0.59 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.098 1.359 . . . . 0.0 111.791 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.48 -31.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.345 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.7 t -153.36 167.53 29.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.315 0.9 OUTLIER -91.35 -30.55 16.48 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 131.177 3.791 . . . . 0.0 111.342 175.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 154.47 -43.06 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.549 3.94 . . . . 0.0 103.714 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -118.57 172.86 7.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.951 1.7 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.13 -57.5 5.31 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.98 -27.77 71.81 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 115.063 0.785 . . . . 0.0 115.063 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.08 142.44 43.12 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 119.215 1.507 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -60.33 132.94 90.64 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 72.8 Cg_exo -53.58 166.86 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 119.119 2.699 . . . . 0.0 119.119 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 m -150.46 -12.38 0.25 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.017 -1.902 . . . . 0.0 110.837 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 179.06 174.29 0.72 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 120.182 1.356 . . . . 0.0 112.982 -175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -112.1 132.12 55.04 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.71 169.58 9.16 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.819 1.248 . . . . 0.0 110.093 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -44.72 125.09 4.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.084 1.354 . . . . 0.0 111.386 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.07 -9.62 56.44 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.002 -0.888 . . . . 0.0 113.815 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -84.31 124.78 31.62 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.289 1.545 . . . . 0.0 108.032 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -92.29 165.36 13.14 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.899 0.88 . . . . 0.0 113.24 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.4 tt -161.22 163.47 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.024 1.33 . . . . 0.0 107.834 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.31 146.32 19.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -148.31 108.81 4.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.1 mttp 39.09 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.766 2.026 . . . . 0.0 112.432 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 -50.63 1.5 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.148 1.356 . . . . 0.0 112.805 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.0 142.25 47.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.338 1.069 . . . . 0.0 111.957 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 58' ' ' VAL . 5.1 tp -102.17 131.88 48.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 129.029 2.932 . . . . 0.0 107.284 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -132.94 164.78 26.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.944 0.898 . . . . 0.0 109.902 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.0 m -134.02 143.36 48.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.806 1.242 . . . . 0.0 108.024 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 142.44 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.797 0.808 . . . . 0.0 109.176 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -84.39 -34.24 23.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.202 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 19.0 p90 -143.07 -69.85 0.33 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -161.34 125.61 3.42 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.916 1.687 . . . . 0.0 108.125 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 t -166.99 154.74 9.36 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.767 1.167 . . . . 0.0 111.435 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HA ' ' CH2' ' A' ' 13' ' ' TRP . . . -143.01 32.01 1.39 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.879 1.671 . . . . 0.0 109.676 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -84.02 -103.86 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.059 0.457 . . . . 0.0 111.429 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.7 t -144.74 115.26 5.18 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HA ' ' CD2' ' A' ' 55' ' ' TRP . 45.3 Cg_exo -53.16 112.33 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.698 2.265 . . . . 0.0 112.542 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.82 -26.88 9.63 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.084 1.326 . . . . 0.0 111.721 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -78.37 70.28 4.69 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.359 1.08 . . . . 0.0 109.631 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 42.51 -111.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.805 1.642 . . . . 0.0 108.889 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.7 t 59.65 -72.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.772 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.4 t -173.65 38.65 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.095 2.558 . . . . 0.0 107.146 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD2' ' HA ' ' A' ' 49' ' ' PRO . 89.9 m95 -112.08 154.49 25.33 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.615 1.198 . . . . 0.0 111.377 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -153.41 120.97 5.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -71.0 124.28 24.0 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.296 0.638 . . . . 0.0 109.933 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -101.86 -13.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.084 0.554 . . . . 0.0 112.134 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.29 -149.45 17.65 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -154.33 135.21 13.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 109.812 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.5 m -71.97 -46.87 55.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.994 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.311 -1.804 . . . . 0.0 106.509 -173.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.73 -149.5 46.59 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -156.29 139.89 15.96 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.1 m -77.28 75.15 3.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.281 1.038 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -20.59 -51.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 131.363 3.865 . . . . 0.0 115.304 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -8.6 5.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.315 1.446 . . . . 0.0 114.351 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.84 141.59 49.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.099 0.96 . . . . 0.0 108.924 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -29.51 105.13 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 128.086 2.554 . . . . 0.0 113.631 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.1 134.05 27.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -45.39 132.74 5.99 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 119.783 1.174 . . . . 0.0 111.425 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.61 43.25 3.11 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 121.593 1.605 . . . . 0.0 113.904 -0.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -76.39 64.28 2.1 Favored 'General case' 0 N--CA 1.428 -1.572 0 O-C-N 119.324 -2.11 . . . . 0.0 107.429 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -56.05 156.21 5.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.977 0.894 . . . . 0.0 110.888 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.91 -21.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.304 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.9 t -145.08 165.89 26.94 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.752 1.263 . . . . 0.0 112.63 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.298 85.8 tttt -97.14 -34.07 11.27 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 131.241 3.816 . . . . 0.0 109.363 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 162.92 -42.97 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 1 C-N-CA 132.896 4.478 . . . . 0.0 102.641 -172.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -117.56 155.06 30.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.462 1.505 . . . . 0.0 107.593 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.67 -60.43 3.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.696 1.598 . . . . 0.0 115.231 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.7 -4.22 61.07 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.842 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.31 152.4 43.31 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 119.426 1.613 . . . . 0.0 109.923 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.28 144.74 94.68 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.06 158.33 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 116.571 1.72 . . . . 0.0 116.571 -169.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.4 m -152.23 -17.43 0.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.067 0.947 . . . . 0.0 112.599 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 177.31 150.48 0.18 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.318 0.963 . . . . 0.0 110.516 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -82.73 141.32 32.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.6 166.19 13.78 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.378 1.071 . . . . 0.0 108.696 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -56.68 130.67 46.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.761 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.68 -6.5 69.39 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.386 -1.23 . . . . 0.0 113.273 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -85.61 143.24 28.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.911 1.855 . . . . 0.0 109.613 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -103.01 164.52 11.56 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 tt -161.74 156.73 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.876 1.27 . . . . 0.0 109.7 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -101.87 159.3 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 126.515 1.926 . . . . 0.0 109.78 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.5 t80 174.66 147.18 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.32 2.648 . . . . 0.0 107.13 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 40.94 44.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 113.326 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.46 24.85 25.33 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.494 2.473 . . . . 0.0 113.218 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -119.7 156.61 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.679 1.592 . . . . 0.0 107.211 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.598 ' CD2' HG13 ' A' ' 58' ' ' VAL . 12.8 tp -110.29 122.02 46.68 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.596 1.958 . . . . 0.0 107.863 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -125.77 150.28 47.88 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.673 0.67 . . . . 0.0 110.001 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 m -117.13 138.97 51.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.876 1.27 . . . . 0.0 108.359 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.96 142.37 36.73 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.172 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.47 -30.81 20.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.603 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 33.0 p90 -145.13 -141.27 0.12 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.838 1.655 . . . . 0.0 108.325 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -92.37 116.21 28.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.823 2.849 . . . . 0.0 106.165 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 t -163.83 148.35 10.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.492 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.63 13.04 9.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.326 1.85 . . . . 0.0 107.997 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.6 t -70.51 162.46 28.76 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.14 118.52 62.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.121 0.568 . . . . 0.0 110.289 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -41.1 122.37 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.941 3.761 . . . . 0.0 114.45 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.46 22.51 3.82 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.697 1.618 . . . . 0.0 114.471 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -123.88 26.67 7.53 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.514 1.157 . . . . 0.0 110.416 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -170.19 -79.88 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -174.56 177.67 2.09 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.7 1.2 . . . . 0.0 108.239 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.3 p 64.12 15.31 9.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.674 2.79 . . . . 0.0 112.903 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -126.21 142.6 51.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.954 1.302 . . . . 0.0 110.512 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -136.48 114.64 11.54 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.734 1.614 . . . . 0.0 107.556 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -62.91 140.68 58.85 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.395 0.617 . . . . 0.0 109.832 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.598 HG13 ' CD2' ' A' ' 38' ' ' LEU 0.278 0.3 OUTLIER -131.77 3.79 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 124.593 1.157 . . . . 0.0 112.439 -174.886 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.23 -170.55 34.45 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.5 p -161.37 167.76 25.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 m -57.58 -40.02 78.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.415 1.086 . . . . 0.0 110.885 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.598 0 CA-C-O 114.77 -2.538 . . . . 0.0 106.861 -173.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 53.62 35.24 51.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.451 1.024 . . . . 0.0 112.727 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.97 140.72 40.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.224 1.41 . . . . 0.0 111.088 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.71 80.97 0.28 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.776 1.274 . . . . 0.0 111.07 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.46 30.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.056 2.142 . . . . 0.0 111.8 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -58.09 -30.59 66.36 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.92 1.288 . . . . 0.0 111.212 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.49 161.92 14.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.316 1.046 . . . . 0.0 108.673 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.42 121.25 5.43 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.391 0.677 . . . . 0.0 110.1 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.15 135.11 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 117.624 -1.179 . . . . 0.0 108.541 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -46.07 133.59 7.1 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 120.057 1.299 . . . . 0.0 111.008 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -97.03 33.11 10.15 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 121.414 1.541 . . . . 0.0 113.875 -0.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.23 68.06 1.44 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 32.3 m95 -51.07 168.21 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.642 0.777 . . . . 0.0 112.328 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.78 -19.03 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.81 -72.17 0.59 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -171.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 tttt 48.83 -157.03 0.07 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 122.371 1.081 . . . . 0.0 111.787 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.34 -41.47 93.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.325 -1.761 . . . . 0.0 107.178 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -156.6 156.64 33.91 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.247 1.819 . . . . 0.0 107.191 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.98 -58.99 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.193 1.797 . . . . 0.0 114.796 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.33 -9.22 85.85 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.233 -0.759 . . . . 0.0 114.008 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.49 154.48 50.44 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -55.87 103.48 0.37 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 108.177 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 23.2 Cg_exo -50.51 143.97 26.27 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.942 3.095 . . . . 0.0 118.2 -171.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.7 p -132.99 -12.68 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -178.83 162.77 1.34 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.167 0.984 . . . . 0.0 113.427 -175.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -107.65 114.12 27.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.437 1.895 . . . . 0.0 108.582 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.0 166.26 12.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.499 1.119 . . . . 0.0 110.216 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.47 126.27 3.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.931 1.292 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.36 -2.73 80.94 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.316 -1.269 . . . . 0.0 114.648 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.26 121.56 29.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.437 2.119 . . . . 0.0 108.179 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -83.94 159.99 21.16 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.833 -1.167 . . . . 0.0 111.595 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.06 155.21 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.332 1.453 . . . . 0.0 107.753 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -101.96 153.73 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.07 0.948 . . . . 0.0 109.385 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -161.83 126.82 3.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.879 1.672 . . . . 0.0 107.34 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt 30.52 83.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.936 2.095 . . . . 0.0 112.951 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.63 -35.86 0.27 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -94.34 154.14 17.64 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.917 1.859 . . . . 0.0 112.867 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tp -107.03 124.7 50.02 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.327 2.651 . . . . 0.0 105.861 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.74 161.64 26.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.889 0.876 . . . . 0.0 110.114 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 m -136.93 144.54 43.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.21 150.32 26.28 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 122.057 0.932 . . . . 0.0 111.079 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.48 -34.05 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.858 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -140.39 -72.15 0.37 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.774 0.321 . . . . 0.0 111.64 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -159.31 133.15 7.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.836 1.655 . . . . 0.0 108.562 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 t -166.38 151.69 8.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.96 40.05 1.5 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.082 1.353 . . . . 0.0 107.55 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.5 t -130.49 156.4 44.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.388 1.075 . . . . 0.0 108.199 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 t -36.76 110.9 0.48 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.418 2.287 . . . . 0.0 113.098 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 134.62 62.41 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.286 2.657 . . . . 0.0 113.189 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.03 -53.06 3.38 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 m -81.13 47.76 1.05 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.966 0.906 . . . . 0.0 110.586 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -164.92 -117.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 m -163.93 168.85 18.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.996 1.719 . . . . 0.0 107.589 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 66.67 14.77 9.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.658 1.183 . . . . 0.0 112.501 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.64 155.69 24.01 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.694 1.598 . . . . 0.0 109.042 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 m -152.17 125.46 8.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.57 137.53 54.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.119 0.567 . . . . 0.0 110.495 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.85 -15.13 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.289 1.436 . . . . 0.0 110.739 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.17 -161.81 35.63 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -153.98 163.04 40.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.1 t -88.22 -17.13 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.13 2.172 . . . . 0.0 111.367 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.432 0 C-N-CA 126.569 1.948 . . . . 0.0 105.83 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.053 0.454 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.22 37.25 93.68 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -75.67 63.78 1.63 Allowed 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 125.207 1.403 . . . . 0.0 109.299 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 80.8 m 45.68 27.7 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.236 2.214 . . . . 0.0 114.136 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.33 -21.34 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.111 2.564 . . . . 0.0 114.037 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -57.29 -37.41 72.38 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.28 0.632 . . . . 0.0 109.944 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.06 176.19 5.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.957 0.903 . . . . 0.0 109.635 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.76 98.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.782 0.833 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.41 128.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.928 1.291 . . . . 0.0 108.898 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -43.08 134.47 3.09 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.818 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -91.7 31.93 10.7 Favored 'Cis proline' 0 C--N 1.348 0.528 0 CA-C-N 120.239 1.121 . . . . 0.0 114.433 0.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -75.57 61.88 1.37 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.179 1.354 . . . . 0.0 109.311 177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 12.2 m95 -49.91 164.03 0.12 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.026 1.731 . . . . 0.0 113.578 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -79.82 -37.51 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.232 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -156.46 -171.64 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.278 0.945 . . . . 0.0 112.311 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.289 55.2 tttm -107.15 -45.63 4.09 Favored 'General case' 0 N--CA 1.412 -2.363 1 C-N-CA 132.942 4.497 . . . . 0.0 110.215 178.646 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 168.26 -44.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 131.603 3.961 . . . . 0.0 104.751 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -58.08 178.3 0.1 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 130.912 3.685 . . . . 0.0 116.923 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.12 37.44 4.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.878 2.871 . . . . 0.0 106.47 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.17 46.53 0.02 OUTLIER Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.043 1.306 . . . . 0.0 111.473 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.76 152.63 18.57 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.91 119.4 51.3 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 50.2 Cg_exo -53.85 154.71 16.18 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 117.708 2.157 . . . . 0.0 117.708 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -151.09 4.52 0.46 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.34 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -175.79 168.73 3.05 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 121.356 1.889 . . . . 0.0 116.094 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.82 125.6 50.85 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -87.29 167.96 13.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.786 1.234 . . . . 0.0 111.192 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.08 127.13 8.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.985 1.314 . . . . 0.0 110.409 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -15.31 22.26 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.419 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -77.37 132.08 38.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.816 1.808 . . . . 0.0 108.929 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.5 m -94.66 162.38 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.664 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.4 tt -161.74 154.57 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.208 1.003 . . . . 0.0 108.315 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -95.3 156.38 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.233 . . . . 0.0 107.797 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -172.1 141.93 1.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.581 1.953 . . . . 0.0 106.942 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mttp 24.64 73.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.831 2.052 . . . . 0.0 113.034 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.51 38.07 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 128.955 3.169 . . . . 0.0 114.474 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -144.22 158.23 43.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.83 127.82 44.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 127.747 2.419 . . . . 0.0 107.867 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -126.26 166.76 16.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.799 1.239 . . . . 0.0 108.856 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -150.32 148.3 28.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.269 1.028 . . . . 0.0 108.366 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.56 148.32 25.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.684 1.194 . . . . 0.0 111.53 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -90.47 -32.73 16.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.569 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.9 p90 -142.57 -74.18 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.069 0.462 . . . . 0.0 112.223 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -160.21 119.58 2.78 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 127.597 2.359 . . . . 0.0 105.003 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 t -158.54 152.36 23.53 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.047 1.294 . . . . 0.0 112.096 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 8.84 5.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 109.578 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 m -77.58 155.03 31.79 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.31 139.02 80.48 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 119.667 1.121 . . . . 0.0 109.7 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.21 116.85 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.198 1.932 . . . . 0.0 112.724 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.1 25.88 70.08 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.279 -0.734 . . . . 0.0 112.1 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.6 p -59.99 -56.71 18.33 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.479 1.139 . . . . 0.0 110.191 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.07 -43.41 0.23 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.093 1.357 . . . . 0.0 111.325 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.8 t -166.75 -171.65 1.9 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 124.484 1.113 . . . . 0.0 109.142 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 p 65.67 5.9 3.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 130.854 3.662 . . . . 0.0 113.663 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.72 159.58 33.3 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 125.01 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -148.22 132.85 17.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.58 130.6 36.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.67 -13.54 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.637 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.12 -171.68 35.7 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 119.674 1.125 . . . . 0.0 112.339 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -107.83 87.54 2.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -32.69 -55.88 0.36 Allowed 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 127.257 2.223 . . . . 0.0 114.179 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.006 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.29 151.44 17.17 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.33 158.52 20.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.522 -0.987 . . . . 0.0 109.223 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.442 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.6 m -87.64 97.96 11.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.46 10.82 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.446 2.298 . . . . 0.0 111.828 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.16 -3.69 28.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.28 170.67 15.36 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.47 1.032 . . . . 0.0 110.356 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -59.7 121.3 11.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.45 131.39 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.034 0.934 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -43.12 134.02 3.16 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.766 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.81 30.2 14.29 Favored 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.595 1.248 . . . . 0.0 112.755 -0.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -76.14 62.94 1.77 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -49.69 159.36 0.38 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.945 0.878 . . . . 0.0 113.245 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.58 -43.16 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.467 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -90.46 139.08 31.03 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.417 1.103 . . . . 0.0 111.385 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -110.83 166.97 10.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.617 1.967 . . . . 0.0 109.958 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -67.42 -34.8 77.98 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -153.1 163.54 39.67 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.097 1.759 . . . . 0.0 106.909 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.93 -55.87 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.503 1.521 . . . . 0.0 114.082 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.79 5.38 79.46 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.485 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.86 171.16 55.06 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.516 1.158 . . . . 0.0 111.2 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.83 165.66 51.44 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.22 145.15 71.47 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.607 1.538 . . . . 0.0 108.669 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 m -141.66 -7.62 0.97 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.191 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 176.0 170.77 0.39 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.1 0.952 . . . . 0.0 111.775 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -112.67 111.16 21.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.742 1.617 . . . . 0.0 107.279 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -83.71 162.81 20.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 109.721 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.4 128.2 1.41 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.993 1.717 . . . . 0.0 112.593 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.31 -7.99 49.47 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.147 -1.363 . . . . 0.0 114.567 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.15 136.05 35.2 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.534 2.167 . . . . 0.0 106.825 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -98.87 159.24 15.09 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.64 -0.662 . . . . 0.0 112.002 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 tt -159.75 163.72 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.894 1.278 . . . . 0.0 108.784 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 4' ' ' CYS . 1.6 t -121.4 165.75 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.12 -62.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -156.1 125.6 6.28 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.15 -42.8 0.17 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.123 2.773 . . . . 0.0 115.507 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -109.75 146.05 35.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.524 1.13 . . . . 0.0 112.253 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tp -97.35 127.53 43.4 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 129.057 2.943 . . . . 0.0 105.682 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.92 161.78 28.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.87 0.868 . . . . 0.0 110.759 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.5 m -138.99 145.52 39.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.83 147.99 26.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.991 0.9 . . . . 0.0 111.442 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -85.06 -36.08 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.097 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -142.52 -70.05 0.34 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.917 0.487 . . . . 0.0 111.389 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -158.53 138.47 12.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.524 1.53 . . . . 0.0 108.908 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -173.32 147.78 1.56 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.499 0.666 . . . . 0.0 109.96 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.87 26.37 4.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 153.07 19.63 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.626 1.571 . . . . 0.0 108.137 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -49.24 117.19 6.42 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.48 0.712 . . . . 0.0 110.012 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.36 120.52 4.49 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.294 2.663 . . . . 0.0 112.261 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.44 -23.78 29.21 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.394 -0.67 . . . . 0.0 111.794 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 t -77.11 59.37 1.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.604 1.202 . . . . 0.0 110.416 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 41.47 -109.06 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.474 1.909 . . . . 0.0 109.734 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t 58.27 -82.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.73 1.612 . . . . 0.0 111.038 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -150.77 28.32 0.7 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.372 1.469 . . . . 0.0 110.425 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.44 171.5 7.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.339 1.066 . . . . 0.0 112.784 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -162.98 130.75 3.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.954 2.102 . . . . 0.0 105.519 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -78.94 139.68 38.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.83 -16.87 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.911 1.284 . . . . 0.0 111.256 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.84 -167.3 39.79 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -144.78 156.6 44.13 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.687 1.195 . . . . 0.0 108.121 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.9 m -114.83 -68.59 0.91 Allowed 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 123.828 0.705 . . . . 0.0 111.093 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 CA-C-O 115.337 -2.268 . . . . 0.0 106.971 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.45 163.94 37.6 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.8 -30.59 14.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.417 1.109 . . . . 0.0 112.447 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 t -59.51 -52.56 65.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.231 1.015 . . . . 0.0 109.631 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 166.65 -63.79 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 131.161 3.784 . . . . 0.0 103.903 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -157.91 28.11 0.27 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.223 1.009 . . . . 0.0 111.314 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 179.34 5.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.312 0.506 . . . . 0.0 109.992 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.63 98.03 0.17 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.988 0.423 . . . . 0.0 109.9 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -105.88 137.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -46.51 135.57 7.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.092 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -94.33 31.42 12.37 Favored 'Cis proline' 0 C--N 1.349 0.567 0 N-CA-C 115.354 1.251 . . . . 0.0 115.354 1.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -77.67 59.77 2.06 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 121.272 1.851 . . . . 0.0 108.741 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -55.29 157.72 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.787 0.835 . . . . 0.0 112.893 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.39 -49.12 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.347 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -84.33 154.24 23.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.503 1.144 . . . . 0.0 109.541 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -126.01 168.14 14.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.944 2.098 . . . . 0.0 109.762 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.64 -31.29 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -160.57 160.15 31.45 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.388 1.475 . . . . 0.0 107.708 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.01 -61.79 0.62 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.141 1.776 . . . . 0.0 114.151 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.65 14.31 61.83 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.511 -0.605 . . . . 0.0 113.354 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 -169.38 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.365 1.083 . . . . 0.0 111.478 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.19 160.8 28.12 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -51.84 145.75 30.81 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.826 2.351 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 m -134.22 -29.95 1.21 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.274 0.63 . . . . 0.0 112.428 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 173.62 171.83 0.17 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.243 0.474 . . . . 0.0 111.057 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -111.17 140.32 45.82 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.61 167.72 9.94 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.574 1.15 . . . . 0.0 109.267 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.55 121.07 1.6 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.596 1.159 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.89 -11.59 70.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.155 1.36 . . . . 0.0 113.785 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -81.42 123.83 28.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.036 1.418 . . . . 0.0 109.26 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -89.14 162.56 15.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.962 1.705 . . . . 0.0 112.268 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.7 tt -168.07 165.94 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.849 1.26 . . . . 0.0 108.375 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.4 t -118.53 163.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.416 . . . . 0.0 108.011 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.97 -60.84 0.9 Allowed 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.47 106.73 3.15 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.22 -46.67 0.49 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.773 1.654 . . . . 0.0 114.204 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -87.64 145.26 26.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 112.039 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 58' ' ' VAL . 7.0 tp -99.18 133.23 43.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 130.31 3.444 . . . . 0.0 107.737 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -134.18 153.95 51.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.169 0.987 . . . . 0.0 109.243 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 m -125.76 135.62 52.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.845 0.858 . . . . 0.0 109.742 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.78 136.98 47.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.818 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' N ' HD22 ' A' ' 42' ' ' ASN . 1.0 OUTLIER -87.8 -36.29 17.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.451 -177.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 11.5 p90 -138.61 -70.85 0.42 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.314 0.646 . . . . 0.0 110.127 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -159.61 130.34 5.82 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 128.146 2.579 . . . . 0.0 106.353 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -165.41 151.42 9.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.676 1.126 . . . . 0.0 111.32 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.9 19.43 2.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.369 1.868 . . . . 0.0 108.765 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -85.18 164.83 17.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.59 119.53 33.67 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.71 125.51 11.27 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.19 2.593 . . . . 0.0 112.02 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.27 -11.81 65.33 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 119.011 -0.883 . . . . 0.0 112.314 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 t -76.22 69.5 2.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.072 1.436 . . . . 0.0 109.102 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 43.11 -125.78 0.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.376 1.87 . . . . 0.0 109.285 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t 53.38 -132.25 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.146 0.578 . . . . 0.0 109.769 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -69.49 -80.56 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 129.59 3.156 . . . . 0.0 109.401 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -7.95 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.979 2.912 . . . . 0.0 116.538 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -89.31 114.58 25.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.16 -1.837 . . . . 0.0 107.264 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -67.74 132.82 48.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.48 10.5 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.855 0.862 . . . . 0.0 112.693 -177.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.16 -155.59 16.33 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 p -85.01 167.05 16.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -50.5 -42.04 54.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.917 0.865 . . . . 0.0 111.577 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -1.012 0 C-N-CA 128.92 2.888 . . . . 0.0 104.486 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.0 114.28 0.61 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -75.37 52.07 0.59 Allowed 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.715 1.206 . . . . 0.0 110.337 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m 53.61 20.68 2.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.113 1.765 . . . . 0.0 113.232 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.17 -25.94 1.02 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.774 2.43 . . . . 0.0 114.321 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -58.37 -36.52 73.63 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.63 0.772 . . . . 0.0 110.889 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -171.96 3.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.592 0.757 . . . . 0.0 110.422 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.35 94.97 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.455 -0.778 . . . . 0.0 109.91 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.91 135.85 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 126.196 1.798 . . . . 0.0 108.234 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -44.28 132.18 4.54 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.71 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -95.54 32.59 10.88 Favored 'Cis proline' 0 C--N 1.35 0.649 0 CA-C-N 120.75 1.304 . . . . 0.0 114.931 1.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -76.45 57.24 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.095 1.316 . . . . 0.0 109.309 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 28.3 m95 -51.36 141.19 15.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.047 1.339 . . . . 0.0 112.899 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 t -77.61 -29.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 112.287 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.4 m -67.05 -18.4 65.34 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.34 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.991 1.716 . . . . 0.0 111.62 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t0 149.06 -45.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 1 C-N-CA 132.867 4.467 . . . . 0.0 105.361 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.1 p-90 -149.71 171.91 15.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 108.229 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.56 -53.89 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.441 1.896 . . . . 0.0 114.395 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.8 18.27 24.54 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.325 0.964 . . . . 0.0 112.239 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.94 145.7 35.51 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.865 0.833 . . . . 0.0 112.695 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -72.84 136.0 80.36 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 53.4 Cg_exo -39.67 138.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 1 C-N-CA 125.406 4.071 . . . . 0.0 116.254 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -123.61 -30.63 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 172.87 164.81 0.13 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.555 1.07 . . . . 0.0 110.847 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -97.35 133.81 41.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 107.777 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.26 163.5 12.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.929 1.292 . . . . 0.0 110.305 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.92 122.66 1.78 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.898 1.279 . . . . 0.0 111.944 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.2 -3.69 70.71 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.667 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -83.01 118.18 23.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.499 2.149 . . . . 0.0 106.542 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -78.39 164.83 24.46 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.286 -0.884 . . . . 0.0 110.058 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.0 tt -161.51 159.39 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.689 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.59 155.18 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.502 1.521 . . . . 0.0 108.704 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -176.6 135.27 0.23 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.61 2.364 . . . . 0.0 107.357 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? 44.75 33.0 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.132 2.173 . . . . 0.0 115.128 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.54 77.75 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.798 1.189 . . . . 0.0 112.923 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.13 154.61 37.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -97.99 120.87 39.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.277 1.831 . . . . 0.0 108.191 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -123.56 159.43 29.21 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.828 0.851 . . . . 0.0 108.971 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -144.9 143.2 30.45 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.14 149.0 25.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.154 0.978 . . . . 0.0 109.788 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.57 -31.15 22.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.903 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.71 -72.94 0.28 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.628 0.728 . . . . 0.0 110.191 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -165.99 136.54 3.54 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.287 1.435 . . . . 0.0 109.982 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -176.31 155.38 1.46 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 119.157 0.89 . . . . 0.0 111.4 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.02 18.98 5.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.988 1.715 . . . . 0.0 108.09 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -84.42 171.22 12.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.05 121.4 35.76 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 51.2 Cg_exo -53.77 115.76 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.624 2.216 . . . . 0.0 110.833 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 1.54 33.37 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.101 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -75.94 49.99 0.57 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.984 1.892 . . . . 0.0 111.314 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 42.98 -140.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.152 1.781 . . . . 0.0 109.216 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.2 t 44.11 -106.91 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 112.879 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 p -75.44 -5.99 47.8 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.931 2.092 . . . . 0.0 114.801 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.411 ' CE2' ' HA ' ' A' ' 49' ' ' PRO . 99.3 m95 -107.07 174.23 5.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.636 1.107 . . . . 0.0 112.87 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -163.42 135.36 5.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.908 2.083 . . . . 0.0 105.788 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -88.5 128.25 35.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.68 -15.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.184 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.16 -155.86 26.44 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 119.39 0.995 . . . . 0.0 111.696 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -89.9 135.71 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.03 99.44 6.1 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.512 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 121.375 0.607 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.69 51.23 0.4 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 105.759 -2.936 . . . . 0.0 105.759 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -167.13 175.75 7.28 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 129.278 3.031 . . . . 0.0 106.092 -173.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.5 m -91.0 87.61 6.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -49.29 -34.53 15.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.7 1.6 . . . . 0.0 113.091 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.1 -18.4 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.336 1.054 . . . . 0.0 112.825 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.67 -175.81 2.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.621 1.168 . . . . 0.0 109.97 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.91 102.44 0.6 Allowed 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.954 -0.467 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.54 125.62 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -47.73 138.19 9.55 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.603 -0.685 . . . . 0.0 110.79 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.82 35.43 7.7 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 N-CA-C 114.925 1.087 . . . . 0.0 114.925 1.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -75.33 65.19 1.61 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 121.532 1.969 . . . . 0.0 109.897 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -50.38 154.77 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.841 0.856 . . . . 0.0 112.465 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -84.03 -41.55 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.783 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.4 m -106.03 155.04 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.457 1.122 . . . . 0.0 113.371 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -103.58 150.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.034 2.134 . . . . 0.0 106.752 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.56 -34.35 77.69 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.648 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -141.04 158.31 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.417 1.087 . . . . 0.0 108.672 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.67 -61.29 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.288 1.835 . . . . 0.0 114.071 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.53 10.74 72.34 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.458 -0.634 . . . . 0.0 113.309 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.59 171.17 52.66 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 118.57 1.185 . . . . 0.0 110.885 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 168.39 19.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.36 133.02 55.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 108.348 -1.443 . . . . 0.0 108.348 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -128.05 -13.16 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.825 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 177.36 167.97 0.62 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.45 1.023 . . . . 0.0 113.292 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.61 139.5 42.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.62 168.59 8.98 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.233 1.013 . . . . 0.0 109.051 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.01 121.58 2.15 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.827 1.251 . . . . 0.0 111.487 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.15 -15.7 54.98 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.017 0.818 . . . . 0.0 113.75 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -76.57 121.77 23.65 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.108 1.454 . . . . 0.0 108.737 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -87.7 164.03 16.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.272 1.429 . . . . 0.0 112.313 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 tt -164.6 154.52 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.912 1.685 . . . . 0.0 106.992 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.519 HG11 ' H ' ' A' ' 4' ' ' CYS . 2.0 t -108.41 156.34 9.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -152.13 -108.24 0.05 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -73.7 87.79 1.71 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.973 0.806 . . . . 0.0 108.994 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.24 -40.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 130.332 3.825 . . . . 0.0 117.045 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -102.37 164.06 11.88 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.919 0.888 . . . . 0.0 111.478 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.2 tp -80.76 131.48 35.43 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.694 2.398 . . . . 0.0 107.739 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.04 153.31 46.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.085 1.354 . . . . 0.0 108.453 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 58' ' ' VAL . 53.9 m -137.77 146.27 43.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.282 0.633 . . . . 0.0 109.632 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.14 144.24 33.22 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.891 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -92.74 -30.04 15.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.904 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -141.73 -73.88 0.31 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 111.998 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.49 119.39 2.65 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.791 2.836 . . . . 0.0 106.117 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 t -163.01 150.89 13.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 120.111 1.323 . . . . 0.0 112.115 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.28 12.99 6.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.932 2.093 . . . . 0.0 107.941 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 t -74.93 172.64 11.92 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.07 118.38 42.22 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 109.987 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.61 140.26 36.93 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.668 2.246 . . . . 0.0 111.829 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.27 -10.8 60.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.598 -1.112 . . . . 0.0 112.157 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -79.02 54.97 1.7 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.795 1.798 . . . . 0.0 110.513 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 42.34 -146.32 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.116 2.166 . . . . 0.0 112.038 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 m 40.78 -100.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.508 2.323 . . . . 0.0 113.762 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.4 p -78.21 -4.13 46.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.05 139.08 51.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 119.117 0.871 . . . . 0.0 110.692 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -133.17 122.82 24.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 113.476 -1.693 . . . . 0.0 106.955 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -69.33 138.6 53.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.486 HG21 ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -121.16 -12.02 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.93 -159.27 32.01 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 120.248 1.385 . . . . 0.0 110.819 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -149.98 -176.67 5.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.424 1.09 . . . . 0.0 108.304 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.2 m -122.68 -69.71 0.81 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.948 0.899 . . . . 0.0 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.997 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 121.16 0.505 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.39 44.28 85.0 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -54.34 -42.77 70.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.108 0.963 . . . . 0.0 110.055 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.87 -57.35 3.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.341 1.067 . . . . 0.0 108.36 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 163.89 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 130.455 3.502 . . . . 0.0 105.083 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -151.14 4.09 0.45 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 113.04 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.85 178.92 7.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.165 0.893 . . . . 0.0 111.926 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -58.57 100.84 0.07 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.339 1.056 . . . . 0.0 110.747 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.97 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -45.57 133.96 6.17 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.334 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.8 32.86 10.5 Favored 'Cis proline' 0 C--N 1.353 0.777 0 CA-C-N 121.198 1.464 . . . . 0.0 114.375 0.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.84 66.58 2.13 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 120.276 1.398 . . . . 0.0 107.306 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -60.38 161.25 7.54 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.433 1.493 . . . . 0.0 112.145 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -81.99 -26.02 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.839 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.5 m -153.09 175.81 12.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 112.297 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.288 88.5 tttt -111.4 -47.08 3.21 Favored 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 130.475 3.51 . . . . 0.0 109.936 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 159.98 -45.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.195 1 C-N-CA 131.954 4.102 . . . . 0.0 103.768 -172.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -61.63 169.66 2.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.0 2.52 . . . . 0.0 113.526 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.33 39.26 2.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.227 2.211 . . . . 0.0 107.06 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.7 48.08 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.057 1.313 . . . . 0.0 110.806 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.91 156.58 21.52 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -57.44 124.89 69.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.767 1.284 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -55.32 146.13 63.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.151 1.901 . . . . 0.0 113.311 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.19 2.87 0.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.019 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -175.29 166.95 3.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.005 1.383 . . . . 0.0 114.624 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -115.72 123.11 47.48 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.561 1.544 . . . . 0.0 107.784 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -95.55 157.87 15.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.344 1.458 . . . . 0.0 110.518 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.69 123.96 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.119 1.767 . . . . 0.0 112.397 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.58 -13.61 51.21 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 117.523 -1.71 . . . . 0.0 114.644 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -80.68 143.71 32.82 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 121.229 2.514 . . . . 0.0 107.758 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 m -103.28 157.62 16.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.74 165.81 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.32 151.36 23.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.676 0.671 . . . . 0.0 109.888 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -154.58 124.96 6.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? 35.87 73.9 0.08 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.124 1.77 . . . . 0.0 111.918 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 -46.32 0.54 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.028 1.775 . . . . 0.0 114.07 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -68.49 141.53 55.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.563 1.182 . . . . 0.0 111.763 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 tp -98.58 123.97 43.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 128.882 2.873 . . . . 0.0 106.474 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.93 169.19 11.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.457 1.103 . . . . 0.0 109.735 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -149.79 150.09 31.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 148.89 25.68 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 122.022 0.915 . . . . 0.0 112.207 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -92.21 -35.37 13.85 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 110.011 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -144.87 -72.82 0.26 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.409 0.684 . . . . 0.0 110.726 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -156.45 133.78 10.69 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.807 1.643 . . . . 0.0 109.12 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -168.92 151.78 5.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.886 0.766 . . . . 0.0 111.35 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.79 17.66 3.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.317 1.847 . . . . 0.0 107.47 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.2 t -85.47 166.71 16.11 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.99 119.78 33.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.21 117.44 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.192 2.594 . . . . 0.0 112.189 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 -25.95 14.16 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.632 1.11 . . . . 0.0 111.331 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.9 t -76.08 61.45 1.55 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.491 1.146 . . . . 0.0 111.153 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 45.18 -119.44 0.77 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.436 1.494 . . . . 0.0 108.766 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t 66.43 -63.91 0.24 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.58 1.952 . . . . 0.0 113.017 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -178.51 32.64 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 129.665 3.186 . . . . 0.0 107.083 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -109.7 149.08 30.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.693 1.133 . . . . 0.0 110.776 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -144.79 127.97 16.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -77.37 137.45 38.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.75 -17.15 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.678 1.191 . . . . 0.0 111.001 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.63 -151.55 19.13 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.354 0.979 . . . . 0.0 111.359 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -141.26 138.57 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.14 1.776 . . . . 0.0 107.786 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.3 m -74.71 98.21 3.4 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 173.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--O 1.257 1.456 0 O-C-N 125.328 1.642 . . . . 0.0 109.382 175.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.04 171.37 39.28 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -75.61 71.93 2.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.804 0.842 . . . . 0.0 109.551 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 33' ' ' VAL 0.294 1.5 m 15.25 69.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 131.546 3.938 . . . . 0.0 114.558 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.25 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.394 2.278 . . . . 0.0 113.549 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -56.33 -32.52 64.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.51 0.724 . . . . 0.0 111.059 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.84 169.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.616 1.166 . . . . 0.0 109.949 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -48.33 120.34 3.57 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.33 1.052 . . . . 0.0 109.975 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -105.99 126.71 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -48.33 135.84 12.3 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.703 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.46 28.47 16.51 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 119.989 1.032 . . . . 0.0 114.208 -0.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -74.64 67.79 1.59 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.873 1.215 . . . . 0.0 108.677 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 30.5 m95 -48.34 160.35 0.16 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.927 0.891 . . . . 0.0 111.609 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -34.17 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.909 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -170.37 -167.91 0.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.336 1.065 . . . . 0.0 113.152 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.261 41.4 mtpt -101.2 -33.01 10.26 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 131.375 3.87 . . . . 0.0 108.457 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 159.23 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 129.426 3.09 . . . . 0.0 106.28 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -117.73 153.86 32.68 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.425 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.73 -63.58 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.228 1.811 . . . . 0.0 114.152 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.52 0.66 54.77 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.384 -0.675 . . . . 0.0 113.144 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.6 128.03 10.1 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -58.87 115.6 12.45 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 35.6 Cg_exo -42.57 130.88 5.27 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.733 2.289 . . . . 0.0 114.074 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -128.54 -15.18 4.56 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.164 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 177.68 164.08 0.61 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.503 1.047 . . . . 0.0 111.221 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -98.23 125.77 43.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -92.96 169.91 10.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.646 1.179 . . . . 0.0 109.184 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.83 127.46 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.065 0.946 . . . . 0.0 111.387 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.2 -11.65 54.02 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.61 -1.106 . . . . 0.0 113.474 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -81.39 136.84 35.73 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.685 1.743 . . . . 0.0 109.954 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.0 m -104.89 163.39 12.56 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.364 1.066 . . . . 0.0 112.786 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.53 155.63 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.175 0.99 . . . . 0.0 109.004 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' A' ' 4' ' ' CYS . 18.2 t -102.29 150.63 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -138.65 -138.28 0.13 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.27 84.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.932 1.696 . . . . 0.0 111.336 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.83 -27.48 0.18 Allowed Glycine 0 CA--C 1.538 1.486 0 C-N-CA 128.716 3.055 . . . . 0.0 114.729 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -87.14 151.35 23.27 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.984 1.714 . . . . 0.0 111.591 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -104.76 128.16 52.79 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.189 2.995 . . . . 0.0 107.362 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -129.29 157.56 41.52 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.279 1.032 . . . . 0.0 110.365 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -131.7 140.51 49.32 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.606 1.163 . . . . 0.0 109.425 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.47 140.87 34.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 109.8 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -90.34 -32.58 16.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.348 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -139.35 -70.75 0.4 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.094 0.473 . . . . 0.0 111.734 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -161.47 123.89 3.03 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 126.269 1.828 . . . . 0.0 107.219 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -163.61 143.91 8.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.737 1.153 . . . . 0.0 111.731 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.15 13.79 9.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.793 2.037 . . . . 0.0 106.823 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -73.89 162.34 29.19 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.484 1.113 . . . . 0.0 108.503 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.84 121.26 67.2 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.07 131.27 21.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.843 2.362 . . . . 0.0 112.393 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.53 65.95 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.734 -1.036 . . . . 0.0 112.957 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.3 t -76.95 62.03 2.05 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.648 1.724 . . . . 0.0 110.381 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 51.98 -138.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.31 . . . . 0.0 108.667 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.4 t 57.33 -139.55 0.87 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.121 0.873 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -62.41 -74.97 0.08 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.678 2.791 . . . . 0.0 110.095 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -19.54 114.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.738 2.415 . . . . 0.0 114.508 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.255 23.4 m -118.47 125.3 49.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 113.197 -1.819 . . . . 0.0 107.034 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -68.6 140.06 55.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.711 0.232 . . . . 0.0 110.462 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 -16.07 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 111.292 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.6 -154.45 24.23 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.223 0.92 . . . . 0.0 111.053 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 p -160.27 167.68 27.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.455 1.902 . . . . 0.0 107.125 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.1 m -50.63 -65.48 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 127.401 2.28 . . . . 0.0 105.051 -172.619 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.48 174.56 46.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -37.36 61.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.826 0.851 . . . . 0.0 110.587 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.415 ' HB2' HG11 ' A' ' 33' ' ' VAL . 5.3 t -71.48 -60.97 1.95 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 150.53 -60.69 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 130.027 3.331 . . . . 0.0 106.278 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -151.59 32.01 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.75 178.82 4.44 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.033 0.833 . . . . 0.0 110.603 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -61.19 98.26 0.08 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -109.26 124.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 124.538 1.135 . . . . 0.0 109.945 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -39.67 132.97 1.36 Allowed Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.003 1.321 . . . . 0.0 110.833 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -85.93 18.31 30.47 Favored 'Cis proline' 0 CA--C 1.535 0.559 0 CA-C-N 120.465 1.202 . . . . 0.0 114.881 0.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -74.6 64.47 1.21 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.217 1.371 . . . . 0.0 109.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -54.16 152.61 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.643 0.777 . . . . 0.0 111.685 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.5 t -70.54 -42.99 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.209 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.5 t -100.02 149.87 23.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.942 1.353 . . . . 0.0 110.985 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -101.62 169.17 9.01 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.943 2.097 . . . . 0.0 107.687 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -39.84 86.29 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -146.42 162.04 39.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.702 1.601 . . . . 0.0 107.688 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.8 -60.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.562 1.545 . . . . 0.0 113.702 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.27 60.89 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.124 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.17 -159.67 23.23 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.135 0.967 . . . . 0.0 111.564 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -118.66 159.29 44.74 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.362 1.465 . . . . 0.0 107.521 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.58 136.2 21.02 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.359 2.04 . . . . 0.0 110.943 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.5 m -136.4 -18.47 1.48 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.81 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 178.86 156.71 0.48 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -84.79 124.02 31.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.29 153.77 40.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -54.62 133.69 46.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.64 -2.02 49.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.035 -1.425 . . . . 0.0 113.401 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -90.19 147.68 23.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.29 2.045 . . . . 0.0 107.953 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 m -90.85 160.91 15.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.237 -0.289 . . . . 0.0 111.334 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.24 138.09 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 4' ' ' CYS . 55.7 t -106.36 157.81 6.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -151.54 -92.94 0.06 Allowed 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -76.53 52.94 0.83 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.313 1.845 . . . . 0.0 110.739 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.83 -36.01 1.23 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.833 2.635 . . . . 0.0 111.663 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -71.42 141.94 50.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.086 0.954 . . . . 0.0 110.491 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.25 115.68 28.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 129.385 3.074 . . . . 0.0 106.136 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -113.94 171.47 7.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.064 0.946 . . . . 0.0 109.213 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 m -151.14 146.71 26.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.68 137.73 39.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.399 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.89 79.17 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.783 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 1.9 p90 -146.66 -140.66 0.11 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.368 2.267 . . . . 0.0 112.942 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -79.18 115.15 18.67 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 130.17 3.388 . . . . 0.0 113.38 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.95 143.63 6.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.166 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.61 30.68 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.873 2.069 . . . . 0.0 106.746 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.8 t -83.39 -133.93 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.889 0.876 . . . . 0.0 108.955 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.49 110.09 55.68 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.72 113.92 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.401 2.734 . . . . 0.0 111.815 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.28 -0.32 37.78 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.6 p -77.02 44.37 0.39 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.461 2.13 . . . . 0.0 112.153 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 t70 42.13 -149.66 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.07 2.148 . . . . 0.0 111.579 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m 50.59 -76.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.145 2.578 . . . . 0.0 114.267 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -83.84 -53.59 5.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.967 1.707 . . . . 0.0 109.991 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.62 164.49 21.36 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.694 1.997 . . . . 0.0 112.749 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -159.1 138.37 11.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -88.27 138.47 31.41 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 109.705 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -14.65 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.621 1.169 . . . . 0.0 111.66 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 -152.17 20.91 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.04 140.01 20.1 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.07 1.348 . . . . 0.0 108.769 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' HG21 ' A' ' 33' ' ' VAL . 6.9 m -74.35 -53.34 9.85 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.808 0.813 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.068 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -173.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ptt? . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.205 0.526 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.46 36.46 2.04 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.65 -49.98 55.7 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.228 1.811 . . . . 0.0 110.426 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -69.99 -55.59 9.18 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 121.671 0.748 . . . . 0.0 109.895 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 161.35 -67.23 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 130.571 3.548 . . . . 0.0 104.428 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -156.51 26.15 0.34 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.979 0.912 . . . . 0.0 111.631 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.44 -165.96 1.47 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.575 0.625 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -71.83 85.09 0.94 Allowed 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.23 124.43 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.202 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -38.07 131.04 0.97 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.771 1.229 . . . . 0.0 111.85 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -90.21 23.77 24.23 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 120.445 1.195 . . . . 0.0 114.244 0.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.71 66.1 1.42 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.896 1.225 . . . . 0.0 109.53 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -51.95 156.91 1.38 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.964 0.888 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.29 -31.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.834 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.7 m -151.56 167.24 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.262 11.4 tmtt? -82.6 -38.99 22.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.449 2.299 . . . . 0.0 113.535 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.4 t70 167.56 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 1 C-N-CA 132.529 4.332 . . . . 0.0 102.713 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -111.51 175.41 5.44 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 128.194 2.598 . . . . 0.0 107.375 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.21 -55.8 5.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.43 66.95 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.308 0.883 . . . . 0.0 115.308 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.5 163.93 38.72 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.004 1.402 . . . . 0.0 111.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 164.9 51.4 Favored Pre-proline 0 C--O 1.217 -0.606 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.81 156.53 56.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.066 2.488 . . . . 0.0 114.352 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 m -141.07 -28.24 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 0.0 111.849 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -178.59 170.4 1.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 111.249 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -105.75 126.66 52.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.08 160.97 13.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.054 1.342 . . . . 0.0 109.435 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.76 125.88 2.92 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 111.715 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.59 -13.09 54.04 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.882 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.35 144.83 32.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 120.406 2.103 . . . . 0.0 107.781 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -98.71 158.74 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.756 0.422 . . . . 0.0 110.997 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.41 144.33 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.05 150.92 12.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.057 0.543 . . . . 0.0 110.594 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -156.91 133.48 10.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 46.35 33.79 2.01 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.457 1.903 . . . . 0.0 113.165 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.52 9.71 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.986 2.231 . . . . 0.0 112.576 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -78.11 139.94 39.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.629 1.214 . . . . 0.0 110.008 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.51 128.05 36.42 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 129.126 2.97 . . . . 0.0 107.615 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -128.26 167.61 16.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.519 1.127 . . . . 0.0 108.631 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -148.77 147.12 28.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.97 148.97 21.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.72 1.247 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -89.89 -36.42 15.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -132.09 -79.37 0.51 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.05 0.453 . . . . 0.0 111.852 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -157.44 132.62 8.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.777 2.031 . . . . 0.0 107.913 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -167.49 153.65 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.236 0.926 . . . . 0.0 110.107 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.29 34.24 0.65 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.675 1.59 . . . . 0.0 108.943 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 p -88.64 -100.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.189 0.596 . . . . 0.0 111.294 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.55 110.34 4.2 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.6 111.44 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.948 3.099 . . . . 0.0 113.586 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.71 -27.81 10.08 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.909 1.243 . . . . 0.0 111.867 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.1 t -76.47 65.47 2.34 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.323 1.062 . . . . 0.0 110.959 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 50.94 -128.21 2.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 t 72.45 -47.99 0.68 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.722 1.609 . . . . 0.0 112.813 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 -64.33 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.998 2.919 . . . . 0.0 105.906 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -11.91 121.54 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 129.074 2.95 . . . . 0.0 116.932 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 m -120.24 118.83 31.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 112.597 -2.092 . . . . 0.0 106.206 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -71.3 140.51 50.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -2.37 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.03 -152.53 24.24 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.7 m -147.64 142.14 26.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.779 1.232 . . . . 0.0 109.096 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 m -67.68 -46.51 72.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.726 0.774 . . . . 0.0 109.642 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--O 1.257 1.454 0 CA-C-O 115.559 -2.162 . . . . 0.0 105.25 -174.899 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 121.278 0.561 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.98 37.11 93.31 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -31.96 -45.77 0.11 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 129.31 3.044 . . . . 0.0 113.721 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.1 t -67.95 -52.63 33.87 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 121.215 0.531 . . . . 0.0 111.825 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 157.01 -57.6 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 130.517 3.527 . . . . 0.0 105.88 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -149.74 -5.6 0.36 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.393 1.077 . . . . 0.0 113.319 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.52 174.39 11.62 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.201 0.909 . . . . 0.0 112.024 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -54.31 103.85 0.09 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.524 1.13 . . . . 0.0 110.126 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.32 135.82 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 108.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -43.66 132.18 3.86 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.196 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -98.25 36.29 7.05 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 121.135 1.441 . . . . 0.0 113.593 -0.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -76.26 62.49 1.78 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.538 1.063 . . . . 0.0 108.738 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -52.55 150.89 4.61 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.458 1.103 . . . . 0.0 112.992 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -95.25 -29.52 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.231 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -64.33 -41.31 96.86 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.565 1.075 . . . . 0.0 111.407 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 mttt 57.29 -178.84 0.05 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.458 1.503 . . . . 0.0 112.79 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.54 -17.44 61.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.088 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -158.21 -74.33 0.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.743 0.701 . . . . 0.0 110.902 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.88 -52.6 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.11 0.564 . . . . 0.0 110.645 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.77 -11.86 54.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.705 0.669 . . . . 0.0 111.74 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.22 -177.05 32.84 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 122.11 0.839 . . . . 0.0 113.958 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -62.55 158.85 46.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.267 1.027 . . . . 0.0 110.338 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -64.49 168.26 13.35 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.114 1.876 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -154.2 -29.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.408 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 164.59 169.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.705 1.202 . . . . 0.0 110.418 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -107.02 128.15 54.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.09 162.59 13.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.728 1.211 . . . . 0.0 109.123 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -38.08 122.4 1.03 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.865 1.666 . . . . 0.0 112.012 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -15.27 45.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.475 -1.181 . . . . 0.0 114.384 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -76.19 138.53 40.72 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.534 2.167 . . . . 0.0 106.482 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -108.12 152.67 24.23 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.071 -0.393 . . . . 0.0 111.431 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -148.83 162.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.071 1.348 . . . . 0.0 107.659 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -116.02 151.37 17.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -157.07 119.47 3.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 40.36 76.21 0.07 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.726 2.011 . . . . 0.0 111.283 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.36 -47.11 0.68 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.913 1.72 . . . . 0.0 114.201 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -73.81 142.13 46.18 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.982 0.913 . . . . 0.0 113.122 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.9 tp -97.35 129.49 44.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 130.161 3.384 . . . . 0.0 107.236 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -133.19 156.29 47.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.83 0.852 . . . . 0.0 109.845 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.5 m -130.42 144.7 51.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.224 1.41 . . . . 0.0 107.701 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.9 149.92 24.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.058 0.932 . . . . 0.0 110.302 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.42 -33.42 17.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.942 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 17.7 p90 -143.46 -70.68 0.31 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.786 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -156.94 138.16 13.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.162 2.185 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -171.67 147.46 2.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.73 36.39 2.0 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.559 1.544 . . . . 0.0 107.616 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 m -126.56 153.0 45.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.667 1.187 . . . . 0.0 109.24 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.5 t -36.31 110.58 0.46 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.589 1.956 . . . . 0.0 112.787 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.01 138.16 43.68 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.073 3.182 . . . . 0.0 114.126 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.45 -43.67 1.59 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.997 0.808 . . . . 0.0 112.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.9 t -73.37 -41.89 62.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.619 0.767 . . . . 0.0 111.597 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.85 -111.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -161.26 171.36 18.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.144 1.378 . . . . 0.0 108.554 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m 64.73 18.36 11.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -112.61 157.52 21.11 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.116 1.766 . . . . 0.0 109.351 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 m -152.03 119.86 6.16 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -68.7 142.03 55.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 109.784 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.39 -6.97 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.3 1.04 . . . . 0.0 112.352 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.42 -155.44 26.4 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 p -154.04 150.06 27.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.935 1.294 . . . . 0.0 108.302 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -86.08 -47.09 9.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 122.266 1.031 . . . . 0.0 109.412 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 129.885 3.274 . . . . 0.0 105.024 -175.0 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -132.82 52.32 0.83 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p30 39.2 -126.29 0.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.516 1.526 . . . . 0.0 110.165 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 33' ' ' VAL . 3.3 m -98.58 -23.94 15.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.704 1.138 . . . . 0.0 109.925 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.59 20.61 12.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.916 1.287 . . . . 0.0 112.138 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -162.47 -45.21 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.928 1.291 . . . . 0.0 110.024 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.97 173.41 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -70.45 122.78 20.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.2 136.89 30.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 125.556 1.543 . . . . 0.0 109.71 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -46.08 133.22 7.17 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.045 1.293 . . . . 0.0 111.802 176.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -95.54 36.82 6.64 Favored 'Cis proline' 0 C--N 1.353 0.81 0 CA-C-N 121.563 1.594 . . . . 0.0 113.52 -0.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.76 66.04 1.43 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -59.82 147.69 37.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.403 0.62 . . . . 0.0 110.305 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.6 -43.76 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.544 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 t -91.48 146.72 23.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 122.626 1.203 . . . . 0.0 109.553 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -115.72 166.65 11.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.154 2.182 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -58.0 -34.83 70.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.393 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -158.49 170.26 22.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.607 1.963 . . . . 0.0 106.848 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.38 -60.69 0.48 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.781 1.632 . . . . 0.0 113.808 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.81 24.07 29.38 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.849 0.738 . . . . 0.0 112.062 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 -174.81 49.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 121.829 0.683 . . . . 0.0 113.19 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.82 154.45 75.64 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.58 154.28 31.46 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.214 1.943 . . . . 0.0 110.011 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.73 -4.89 0.31 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.81 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 165.59 167.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.22 1.008 . . . . 0.0 113.705 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -114.62 137.52 51.79 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.577 1.551 . . . . 0.0 107.099 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.21 168.65 9.22 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.366 1.066 . . . . 0.0 109.28 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.14 124.34 2.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 111.85 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.53 -14.43 55.29 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.701 1.143 . . . . 0.0 113.501 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -78.65 126.63 31.0 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.172 1.486 . . . . 0.0 109.204 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 p -91.5 164.13 13.91 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.886 1.674 . . . . 0.0 112.285 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.56 153.95 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG21 ' SG ' ' A' ' 4' ' ' CYS . 2.8 t -111.55 153.4 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 118.48 0.582 . . . . 0.0 109.521 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -161.38 129.17 4.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 33.16 74.2 0.06 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.136 1.774 . . . . 0.0 112.247 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.07 -40.7 0.33 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.677 2.084 . . . . 0.0 115.089 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -78.37 145.5 35.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.607 1.194 . . . . 0.0 112.716 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.4 tp -101.82 126.8 48.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 129.837 3.255 . . . . 0.0 106.923 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.75 152.76 49.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.443 0.697 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.1 m -128.63 140.04 51.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 109.203 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.01 141.76 40.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.865 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' N ' HD22 ' A' ' 42' ' ' ASN . 0.8 OUTLIER -89.41 -39.51 13.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.428 -178.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -133.5 -71.47 0.51 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -159.28 135.75 9.18 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 127.732 2.413 . . . . 0.0 106.561 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -168.19 157.05 9.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.236 0.926 . . . . 0.0 110.507 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.56 21.12 0.92 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.848 1.659 . . . . 0.0 109.277 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.5 p -91.25 164.23 13.96 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.7 t -52.14 111.81 2.8 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.388 0.675 . . . . 0.0 109.326 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.21 122.69 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.337 3.358 . . . . 0.0 113.445 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.84 -23.15 34.71 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.468 1.032 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 m -76.24 66.92 2.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.284 1.042 . . . . 0.0 110.666 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 47.2 -126.7 1.65 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.996 1.319 . . . . 0.0 108.847 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m 65.07 -40.87 0.29 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.467 2.307 . . . . 0.0 115.94 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p 179.34 -69.82 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.264 2.626 . . . . 0.0 106.224 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -8.91 112.98 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.723 3.209 . . . . 0.0 116.124 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.4 m -108.88 113.16 25.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 112.805 -1.998 . . . . 0.0 106.264 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -66.79 134.34 51.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -111.13 -9.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.686 0.794 . . . . 0.0 111.185 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.68 -167.64 32.63 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.103 0.865 . . . . 0.0 111.593 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -122.79 123.22 40.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -31.44 68.15 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.518 0 CA-C-O 114.84 -2.505 . . . . 0.0 107.05 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.56 139.69 6.25 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -33.55 -47.25 0.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.923 2.489 . . . . 0.0 113.734 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.8 t -64.75 -47.21 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.476 0.655 . . . . 0.0 111.951 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 155.98 -61.04 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 130.705 3.602 . . . . 0.0 104.849 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.1 0.85 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.463 1.105 . . . . 0.0 113.259 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.72 -175.29 5.2 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.092 0.86 . . . . 0.0 111.838 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.52 94.0 0.04 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.814 0.845 . . . . 0.0 111.003 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 p -96.6 131.81 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.0 135.73 11.33 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.856 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -93.87 33.47 9.62 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.636 1.263 . . . . 0.0 114.706 0.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -74.5 66.95 1.44 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.999 1.272 . . . . 0.0 108.336 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 9.6 m95 -50.86 160.86 0.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.989 1.316 . . . . 0.0 113.251 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.21 -29.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.938 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -110.9 147.78 33.87 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.773 2.829 . . . . 0.0 107.728 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -66.68 -29.11 69.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -152.63 157.87 41.6 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.624 1.17 . . . . 0.0 108.243 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.78 -60.73 0.69 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.363 1.865 . . . . 0.0 114.615 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.38 5.71 84.61 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.863 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.62 150.71 27.12 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.922 1.361 . . . . 0.0 110.677 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -68.67 151.59 97.16 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 50.6 Cg_exo -57.43 157.96 20.67 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 CA-C-N 119.655 0.912 . . . . 0.0 112.729 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 t -157.74 9.74 0.17 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.333 -1.318 . . . . 0.0 110.804 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -178.14 170.49 1.8 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-O 122.647 1.213 . . . . 0.0 113.843 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -115.06 98.56 6.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.874 2.07 . . . . 0.0 105.77 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.29 165.57 13.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.887 -0.508 . . . . 0.0 111.872 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.86 132.07 11.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.324 1.05 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 -10.06 34.93 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.338 -1.257 . . . . 0.0 113.339 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 40' ' ' THR . 8.6 mm-40 -78.99 156.41 28.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 120.062 1.931 . . . . 0.0 106.479 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -117.94 166.26 12.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.534 0.734 . . . . 0.0 110.524 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 tt -162.38 160.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 t -116.62 151.37 18.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.71 0.687 . . . . 0.0 109.729 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -162.62 134.85 5.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt 49.59 32.22 4.79 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.84 1.656 . . . . 0.0 112.686 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.09 -19.24 23.2 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.71 2.1 . . . . 0.0 112.874 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -85.53 145.1 27.55 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.702 1.251 . . . . 0.0 109.591 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tp -93.45 129.47 39.61 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.313 2.645 . . . . 0.0 107.178 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -127.62 164.78 21.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.346 1.058 . . . . 0.0 108.381 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' GLN . 57.7 m -146.24 145.6 30.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.36 144.5 26.36 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 111.108 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -93.45 -36.54 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.378 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -132.91 -78.01 0.49 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.281 0.563 . . . . 0.0 112.112 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -157.55 132.95 9.01 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -167.07 147.84 5.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.45 1.023 . . . . 0.0 111.022 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.3 15.72 4.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.158 1.383 . . . . 0.0 107.921 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -77.46 163.31 26.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.56 127.9 90.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -45.33 122.4 4.58 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.528 2.818 . . . . 0.0 112.844 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.09 -24.95 27.76 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.167 0.889 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -76.92 75.58 3.51 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.333 1.066 . . . . 0.0 109.558 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.81 -131.43 0.74 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 0.0 110.051 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t 67.7 -54.77 0.49 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.394 2.277 . . . . 0.0 113.979 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 p -172.45 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.548 1.139 . . . . 0.0 109.886 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -18.68 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.427 3.091 . . . . 0.0 116.715 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 m -143.43 130.99 21.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 112.583 -2.099 . . . . 0.0 107.057 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -74.0 141.21 45.86 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.6 -6.23 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.268 1.027 . . . . 0.0 113.027 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.7 -151.42 22.82 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -153.85 154.22 33.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.448 1.099 . . . . 0.0 109.324 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 m -87.27 -53.81 4.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 110.029 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtt . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.4 31.14 79.75 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.892 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -80.99 68.05 7.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.161 1.385 . . . . 0.0 108.015 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 p -9.95 84.98 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 130.568 3.547 . . . . 0.0 117.037 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.22 -23.8 9.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.009 2.524 . . . . 0.0 112.892 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -54.5 -38.06 66.05 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.21 152.65 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -46.84 122.43 4.3 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.468 0.707 . . . . 0.0 109.967 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.18 130.77 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 119.173 0.897 . . . . 0.0 109.096 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' HA ' HD11 ' A' ' 32' ' ' ILE . 30.6 t80 -47.98 136.48 11.04 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.523 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -91.49 24.03 24.98 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.944 1.016 . . . . 0.0 113.876 0.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -73.17 68.75 1.01 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 119.859 1.209 . . . . 0.0 109.807 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -52.22 157.05 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.741 0.782 . . . . 0.0 112.043 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.24 -21.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -145.15 166.83 24.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.063 0.935 . . . . 0.0 113.16 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.271 51.0 tttp -96.9 -40.1 9.07 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 128.543 2.737 . . . . 0.0 110.313 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 174.75 -40.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 1 C-N-CA 133.217 4.607 . . . . 0.0 102.926 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -113.57 166.52 11.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.76 -68.08 0.39 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.45 11.38 1.15 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.42 155.74 27.4 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.258 1.529 . . . . 0.0 110.187 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.9 121.05 42.79 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -50.94 152.95 9.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.449 2.1 . . . . 0.0 116.654 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 m -152.37 -17.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.081 0.952 . . . . 0.0 112.23 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 179.38 164.19 0.96 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.752 1.16 . . . . 0.0 110.973 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -100.09 141.49 32.85 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.72 169.76 8.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.735 1.214 . . . . 0.0 109.404 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.97 122.03 2.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.622 1.169 . . . . 0.0 111.358 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 -19.06 48.72 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.863 1.221 . . . . 0.0 113.215 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -76.92 131.98 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.257 1.528 . . . . 0.0 110.503 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.93 163.5 12.94 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.2 1.8 . . . . 0.0 112.087 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 10' ' ' TYR . 12.5 tt -167.02 149.42 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.176 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.92 153.61 3.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.407 1.003 . . . . 0.0 108.554 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -158.21 115.49 2.91 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 39.45 78.58 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.041 1.736 . . . . 0.0 112.132 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.27 -42.86 0.53 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.017 1.294 . . . . 0.0 115.825 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -81.57 145.39 30.67 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 122.041 0.924 . . . . 0.0 111.996 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tp -99.44 125.47 45.17 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 129.143 2.977 . . . . 0.0 106.317 177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.06 167.35 13.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.31 1.044 . . . . 0.0 108.749 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -148.59 142.88 26.17 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.72 144.21 29.51 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.148 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -95.73 -35.29 11.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.097 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -131.38 -75.42 0.52 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.382 0.426 . . . . 0.0 111.53 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -159.96 125.61 4.12 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.939 2.096 . . . . 0.0 107.921 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 t -167.41 150.57 6.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.979 1.263 . . . . 0.0 111.863 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.21 5.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.783 2.033 . . . . 0.0 108.061 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -71.26 162.99 28.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.39 120.6 53.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.89 122.98 9.04 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.211 2.608 . . . . 0.0 112.615 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.5 -30.44 9.62 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.4 m -75.94 73.38 2.84 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.534 1.167 . . . . 0.0 110.44 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 55.94 -133.2 1.54 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.806 1.242 . . . . 0.0 108.948 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t 59.52 -152.88 0.39 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -54.41 13.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.909 -0.494 . . . . 0.0 109.899 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -13.5 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.953 2.901 . . . . 0.0 117.505 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 m -117.97 126.89 53.2 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.44 2.296 . . . . 0.0 106.399 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.02 141.91 47.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -15.9 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.583 1.153 . . . . 0.0 111.873 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.92 -177.56 47.58 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.0 1.273 . . . . 0.0 112.213 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.5 p -137.03 110.86 8.15 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.932 1.693 . . . . 0.0 107.285 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.8 m -74.04 -37.89 64.16 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.269 0.557 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.83 41.59 94.15 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -43.95 -35.81 2.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.997 2.119 . . . . 0.0 113.586 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HB2' HG21 ' A' ' 33' ' ' VAL . 5.6 t -82.75 -48.75 10.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.261 1.024 . . . . 0.0 110.241 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.85 -55.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.845 3.258 . . . . 0.0 105.146 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -152.16 -2.68 0.27 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.615 1.166 . . . . 0.0 112.736 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.59 157.98 30.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.569 1.077 . . . . 0.0 111.07 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -39.5 106.85 0.06 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 126.509 1.924 . . . . 0.0 112.742 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.3 132.02 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.545 1.138 . . . . 0.0 108.762 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.61 133.77 6.27 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.597 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.27 34.42 8.57 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 120.982 1.386 . . . . 0.0 114.422 0.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -76.71 59.53 1.57 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.164 1.347 . . . . 0.0 108.118 176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . 0.267 7.2 m95 -55.66 156.83 4.5 Favored 'General case' 0 N--CA 1.412 -2.352 0 C-N-CA 129.356 3.062 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.38 -26.82 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.652 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 t -156.05 173.67 16.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 124.345 2.022 . . . . 0.0 116.0 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.38 -172.01 2.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 130.42 3.488 . . . . 0.0 106.499 171.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.44 -30.56 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.937 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -131.66 152.46 50.84 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 110.156 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.72 -63.35 0.52 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.89 2.076 . . . . 0.0 115.108 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 3.37 69.92 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.962 -176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.92 147.26 34.78 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 120.199 2.0 . . . . 0.0 111.069 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.35 120.16 80.06 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -38.74 159.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.838 3.692 . . . . 0.0 121.153 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 2.93 0.43 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 112.134 -2.303 . . . . 0.0 109.515 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 178.16 172.24 0.68 Allowed 'General case' 0 C--N 1.349 0.552 0 CA-C-N 120.307 1.412 . . . . 0.0 113.657 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -110.09 139.02 45.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.97 169.29 8.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.353 1.461 . . . . 0.0 109.281 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -42.26 123.86 2.62 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.922 1.289 . . . . 0.0 112.052 -177.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.17 -17.24 18.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.761 0.696 . . . . 0.0 113.751 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -75.03 128.22 35.05 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -100.76 164.67 11.75 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.3 tt -161.59 173.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.215 1.406 . . . . 0.0 108.233 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 4' ' ' CYS . 70.9 t -121.89 153.24 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.032 1.333 . . . . 0.0 110.452 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -158.05 114.19 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 41.18 81.74 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.617 2.367 . . . . 0.0 112.231 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.4 -44.05 0.58 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.57 1.557 . . . . 0.0 114.755 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.61 146.67 40.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.895 0.878 . . . . 0.0 111.739 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.0 tp -106.11 129.17 54.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 130.45 3.5 . . . . 0.0 106.993 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -132.33 162.46 30.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.267 1.027 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.0 m -134.53 144.58 48.09 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.335 1.454 . . . . 0.0 109.096 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.69 145.85 27.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.124 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' HB3' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-80 -86.8 -32.59 20.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.443 1.497 . . . . 0.0 111.492 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 17.9 p90 -148.96 -65.16 0.23 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 111.101 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -159.86 134.88 7.98 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 127.564 2.346 . . . . 0.0 107.629 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 t -174.32 144.29 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.057 0.844 . . . . 0.0 111.573 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.81 14.64 9.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.715 2.006 . . . . 0.0 107.932 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.52 165.81 23.86 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.3 t -57.24 118.69 26.18 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.493 -0.765 . . . . 0.0 108.954 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.05 119.17 5.67 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.551 2.168 . . . . 0.0 110.75 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.55 -26.72 9.36 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.3 t -73.43 80.14 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -41.17 139.67 0.93 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.777 1.631 . . . . 0.0 111.413 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t 163.57 -49.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.795 2.438 . . . . 0.0 106.301 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 t -146.56 11.06 1.11 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.979 1.712 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -113.54 156.41 23.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.26 1.024 . . . . 0.0 108.903 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -153.32 126.02 8.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -72.85 140.56 47.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.23 0.468 . . . . 0.0 110.004 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -17.13 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.901 1.281 . . . . 0.0 111.053 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.37 -157.35 29.78 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -154.27 140.72 18.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.886 1.674 . . . . 0.0 106.77 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.58 -44.28 11.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.553 0.615 . . . . 0.0 111.136 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.7 168.55 54.62 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.81 -42.57 36.5 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.628 0.771 . . . . 0.0 110.768 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.9 t -74.76 -58.59 3.19 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 122.198 0.999 . . . . 0.0 108.558 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 167.24 -58.02 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 129.747 3.219 . . . . 0.0 104.803 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -152.15 32.32 0.53 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.943 0.897 . . . . 0.0 112.117 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.03 155.63 24.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -32.54 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.587 1.955 . . . . 0.0 113.87 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -88.76 122.97 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -48.66 137.92 12.33 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 120.92 1.691 . . . . 0.0 109.998 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -92.21 36.12 6.64 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 120.612 1.254 . . . . 0.0 114.708 0.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -74.3 66.57 1.32 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.068 1.303 . . . . 0.0 107.86 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 6.3 m95 -50.55 164.44 0.13 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.533 1.533 . . . . 0.0 113.025 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.94 -33.0 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.139 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -144.57 172.63 12.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.266 86.8 tttt -99.49 -57.73 2.09 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.816 3.246 . . . . 0.0 109.582 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -158.07 -50.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.905 5.682 . . . . 0.0 101.913 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -113.28 175.26 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -58.88 3.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.06 -21.13 63.41 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.22 153.43 48.44 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -59.93 131.88 89.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 37.7 Cg_exo -60.89 160.34 25.8 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 N-CA-C 117.944 2.248 . . . . 0.0 117.944 -173.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -151.86 -7.92 0.22 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 112.448 -2.16 . . . . 0.0 110.4 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -174.41 173.29 3.0 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.58 123.3 41.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.745 2.418 . . . . 0.0 105.941 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.6 169.2 11.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.192 0.997 . . . . 0.0 111.669 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.77 128.16 20.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.29 -5.7 66.6 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.061 -1.411 . . . . 0.0 113.977 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.66 136.74 33.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.582 2.191 . . . . 0.0 106.252 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.1 m -98.36 157.51 16.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.224 0.535 . . . . 0.0 112.208 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 tt -152.05 162.9 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 t -121.86 145.4 28.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.655 0.661 . . . . 0.0 109.519 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -167.34 167.77 13.72 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 40.33 39.68 0.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.957 1.253 . . . . 0.0 112.933 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 53.39 36.79 54.18 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.963 1.744 . . . . 0.0 112.413 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -150.82 157.22 42.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.939 1.296 . . . . 0.0 110.194 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.3 tp -87.73 132.12 34.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.984 2.514 . . . . 0.0 109.392 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.74 156.79 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.515 1.126 . . . . 0.0 108.59 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 m -137.2 145.2 43.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.58 153.93 21.43 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.35 1.071 . . . . 0.0 110.584 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -91.08 -32.84 15.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.715 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -138.89 -146.0 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.483 1.513 . . . . 0.0 109.551 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.15 115.9 28.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.751 2.421 . . . . 0.0 106.038 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -157.46 156.57 32.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.131 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.79 20.06 4.19 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.418 1.887 . . . . 0.0 108.049 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -79.9 -179.35 6.92 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.23 120.47 73.4 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 55' ' ' TRP . 52.4 Cg_exo -54.51 127.37 25.73 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.572 2.848 . . . . 0.0 115.551 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.62 -38.41 1.05 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 123.688 0.661 . . . . 0.0 112.759 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -65.72 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.414 0.607 . . . . 0.0 110.814 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.88 179.89 6.9 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.551 0.691 . . . . 0.0 110.948 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -47.24 164.92 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.838 3.255 . . . . 0.0 115.508 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.2 p 71.95 4.72 5.12 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.637 2.775 . . . . 0.0 114.649 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 49' ' ' PRO . 98.6 m95 -117.2 149.23 40.73 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.779 1.231 . . . . 0.0 110.85 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 m -136.69 118.51 15.14 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.95 139.59 48.76 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -121.57 12.19 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.076 0.55 . . . . 0.0 112.257 -179.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.33 -150.86 17.91 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t -89.42 176.78 6.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -73.47 96.1 2.34 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 O-C-N 125.017 1.448 . . . . 0.0 109.724 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 ttp . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.72 46.77 0.02 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.07 69.72 2.68 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.849 1.66 . . . . 0.0 108.204 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -37.12 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 129.243 3.017 . . . . 0.0 116.45 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.63 -27.17 10.56 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.789 2.436 . . . . 0.0 111.342 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -54.3 -33.37 58.59 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.82 176.48 5.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.31 1.444 . . . . 0.0 109.067 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -60.37 118.41 6.41 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.84 137.06 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -55.52 135.24 70.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 120.704 1.593 . . . . 0.0 110.824 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -99.37 31.17 11.47 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 121.382 1.529 . . . . 0.0 113.319 -1.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -74.76 65.06 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 23' ' ' PRO . 39.4 m95 -48.59 152.41 0.96 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.88 0.848 . . . . 0.0 112.316 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.97 -25.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.137 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 m -153.19 169.99 21.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.527 1.632 . . . . 0.0 115.037 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.48 -166.5 1.09 Allowed 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 129.439 3.096 . . . . 0.0 108.305 173.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -53.97 -44.57 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.621 -2.081 . . . . 0.0 107.823 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -128.49 153.36 47.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.392 1.877 . . . . 0.0 109.728 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.44 -63.48 0.44 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.493 1.917 . . . . 0.0 115.174 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 4.73 79.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.677 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.76 154.0 46.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-N 120.487 2.144 . . . . 0.0 110.988 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.0 113.31 8.86 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 13' ' ' TRP . 51.5 Cg_exo -37.79 147.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 1 C-N-CA 125.746 4.297 . . . . 0.0 117.412 -173.2 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 p -139.74 -8.01 1.25 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -178.52 158.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 119.152 0.887 . . . . 0.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -99.21 113.77 26.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 3.4 tt0 -82.15 164.27 21.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.238 1.815 . . . . 0.0 110.615 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -47.63 127.51 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 120.804 -1.185 . . . . 0.0 112.603 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 -14.37 48.92 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.956 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -81.06 139.9 35.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.688 2.744 . . . . 0.0 107.216 178.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 p -94.25 164.65 12.95 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.262 -0.899 . . . . 0.0 111.919 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 tt -156.86 151.35 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -98.8 150.1 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -159.93 116.47 2.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 38.23 77.3 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.971 2.109 . . . . 0.0 112.541 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.63 -42.09 0.55 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.59 1.567 . . . . 0.0 113.981 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -78.24 151.08 33.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.083 0.944 . . . . 0.0 112.14 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tp -105.3 124.13 49.02 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 128.94 2.896 . . . . 0.0 106.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.55 168.92 11.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.6 m -150.82 148.84 28.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.76 146.92 25.42 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.921 0.867 . . . . 0.0 112.166 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -87.56 -36.4 17.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 29.3 p90 -139.14 -71.97 0.4 Allowed 'General case' 0 C--N 1.339 0.122 0 CA-C-O 120.889 0.376 . . . . 0.0 111.623 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -159.73 128.94 5.21 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.353 1.461 . . . . 0.0 108.454 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 t -166.55 150.98 7.53 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 119.134 0.879 . . . . 0.0 111.307 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.89 15.28 4.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.907 1.683 . . . . 0.0 107.996 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 p -87.9 172.02 9.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.41 123.82 83.93 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 111.607 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.26 140.25 72.38 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.513 2.808 . . . . 0.0 114.671 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.38 -45.73 2.11 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.655 1.121 . . . . 0.0 111.699 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -73.23 -45.14 57.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.503 0.721 . . . . 0.0 112.646 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.5 -167.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.583 1.182 . . . . 0.0 114.152 -172.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -57.76 140.92 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.758 3.223 . . . . 0.0 117.459 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t 62.39 23.41 13.88 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 128.142 2.577 . . . . 0.0 113.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -107.58 152.08 24.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.286 1.041 . . . . 0.0 111.116 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 m -153.63 134.09 13.55 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.62 138.47 37.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.579 0.752 . . . . 0.0 109.801 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.98 -4.37 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.084 0.954 . . . . 0.0 111.218 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.05 -151.65 23.77 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -145.77 156.37 43.55 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 107.491 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.9 t -67.44 -34.09 76.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.836 0.827 . . . . 0.0 111.047 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.514 0 CA-C-O 115.006 -2.426 . . . . 0.0 107.022 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.18 -152.94 12.12 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 119.524 1.057 . . . . 0.0 112.685 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -66.91 80.79 0.11 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.261 1.424 . . . . 0.0 110.363 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.277 0.1 OUTLIER -7.66 85.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 130.041 3.336 . . . . 0.0 115.844 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.72 64.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.434 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -57.99 -32.9 68.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.995 0.918 . . . . 0.0 110.467 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.01 171.17 7.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.727 1.211 . . . . 0.0 108.636 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -64.21 129.8 41.4 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.72 130.84 55.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 C-N-CA 124.454 1.101 . . . . 0.0 110.326 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -43.13 133.89 3.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.704 1.138 . . . . 0.0 110.975 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.48 31.08 11.68 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.613 1.255 . . . . 0.0 114.36 0.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -73.4 67.7 1.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.033 1.288 . . . . 0.0 108.252 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -54.82 151.73 8.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.751 -0.593 . . . . 0.0 111.383 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.62 -43.7 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -105.16 160.53 15.0 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 122.811 1.291 . . . . 0.0 112.733 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -116.67 162.21 18.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.126 2.57 . . . . 0.0 108.596 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.76 -30.67 70.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -157.03 156.59 33.14 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 108.89 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 73.7 0.05 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.039 1.736 . . . . 0.0 111.852 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.95 -20.1 0.76 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.316 1.436 . . . . 0.0 111.512 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.11 175.41 48.22 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.321 1.06 . . . . 0.0 110.895 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.36 151.2 87.59 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.71 139.6 23.94 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.132 1.888 . . . . 0.0 109.497 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.05 -7.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.625 -1.179 . . . . 0.0 112.922 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 176.4 164.76 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -111.38 140.37 46.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -108.48 173.4 6.33 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.849 1.26 . . . . 0.0 108.679 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.75 129.31 26.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.692 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -7.47 68.15 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.606 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -84.62 127.14 33.92 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.54 1.67 . . . . 0.0 109.611 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -89.47 166.41 13.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.374 1.07 . . . . 0.0 113.838 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 tt -170.91 154.25 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.665 1.586 . . . . 0.0 108.575 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.1 t -107.59 159.41 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -155.32 -66.64 0.12 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -117.32 96.35 5.38 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.838 1.655 . . . . 0.0 109.625 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 39.01 15.24 0.01 OUTLIER Glycine 0 CA--C 1.531 1.056 1 C-N-CA 131.005 4.145 . . . . 0.0 117.64 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -143.71 160.68 40.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.142 -1.211 . . . . 0.0 109.012 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.1 tp -89.4 124.14 34.19 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 127.208 2.203 . . . . 0.0 106.643 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -121.54 152.36 39.29 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.156 0.982 . . . . 0.0 108.628 178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 58' ' ' VAL . 77.4 m -134.18 145.31 49.1 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.26 146.41 28.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.539 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -90.41 -32.17 16.54 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.792 1.637 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -148.7 -140.76 0.1 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.221 2.208 . . . . 0.0 107.601 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -87.02 126.4 34.72 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 127.849 2.46 . . . . 0.0 108.48 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.8 143.54 8.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.34 43.17 1.77 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.863 1.265 . . . . 0.0 108.637 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -138.8 161.36 37.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -31.32 105.02 0.22 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 128.938 2.895 . . . . 0.0 113.769 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -51.06 138.4 43.91 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 124.379 3.386 . . . . 0.0 113.889 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.65 -36.83 0.59 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.158 1.361 . . . . 0.0 113.446 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.0 m -76.08 -45.58 33.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 112.382 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -97.37 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.982 0.355 . . . . 0.0 111.486 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -168.23 175.46 6.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.5 t 63.99 21.05 12.47 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.448 1.099 . . . . 0.0 109.834 -177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -123.09 140.43 53.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 124.236 1.014 . . . . 0.0 109.702 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -136.27 120.93 18.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.793 1.637 . . . . 0.0 106.677 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -70.73 134.05 47.13 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.431 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -110.08 -15.56 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.997 1.319 . . . . 0.0 111.802 -178.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.33 160.8 29.62 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.7 t -112.01 144.98 40.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 m -117.93 -48.72 2.54 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.281 0.632 . . . . 0.0 111.598 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.933 -172.208 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.432 0.635 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.46 150.52 13.64 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 107.303 -2.319 . . . . 0.0 107.303 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.29 149.29 0.4 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.278 1.031 . . . . 0.0 108.509 -177.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.492 ' H ' HG11 ' A' ' 33' ' ' VAL . 1.3 p -71.55 82.7 0.83 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.391 1.091 . . . . 0.0 111.194 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -39.8 -39.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.995 3.318 . . . . 0.0 113.866 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.03 -35.24 64.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.075 0.95 . . . . 0.0 111.029 179.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.94 153.87 18.06 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.505 1.122 . . . . 0.0 108.01 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -43.56 118.62 1.42 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.523 1.129 . . . . 0.0 111.476 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.69 127.68 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -49.7 135.07 19.58 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.335 176.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -93.07 25.15 23.26 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 121.321 1.507 . . . . 0.0 115.337 0.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -72.98 66.8 0.82 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.82 1.191 . . . . 0.0 108.119 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -53.58 154.79 3.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.38 -45.85 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.545 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -94.04 153.77 17.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 122.691 1.234 . . . . 0.0 110.179 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -112.72 166.8 11.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.39 2.276 . . . . 0.0 108.915 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.74 -32.66 74.23 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -157.35 158.65 36.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.993 1.317 . . . . 0.0 108.202 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.95 -61.21 0.67 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.262 1.825 . . . . 0.0 114.376 -177.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.47 12.88 65.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.541 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.17 -166.1 41.75 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.42 1.11 . . . . 0.0 111.625 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -100.24 160.68 26.41 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.923 1.289 . . . . 0.0 107.819 177.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.56 149.13 10.45 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.392 177.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.7 m -146.02 -19.35 0.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.308 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 177.85 166.05 0.69 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.365 0.984 . . . . 0.0 113.006 -175.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.66 113.41 26.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.57 167.97 16.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.662 0.785 . . . . 0.0 109.633 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' TRP . . . -42.35 126.88 3.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.977 1.311 . . . . 0.0 111.877 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.01 -8.18 57.98 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.153 178.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.37 126.45 32.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.661 1.73 . . . . 0.0 108.703 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -86.49 162.58 18.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.127 1.771 . . . . 0.0 112.518 -178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 tt -163.95 150.15 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.085 1.354 . . . . 0.0 108.224 177.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' H ' ' A' ' 4' ' ' CYS . 2.2 t -102.52 155.52 5.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -167.21 125.18 1.28 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 108.363 175.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 43.4 55.99 4.54 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 123.682 1.706 . . . . 0.0 111.44 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -36.06 1.11 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.704 2.573 . . . . 0.0 114.256 177.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -70.87 145.39 50.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.275 1.036 . . . . 0.0 110.443 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -101.95 119.66 39.14 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 129.088 2.955 . . . . 0.0 106.287 178.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -123.84 156.27 36.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.398 0.679 . . . . 0.0 110.051 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.8 m -132.58 143.01 49.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.583 1.153 . . . . 0.0 108.312 177.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.77 144.89 34.73 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.882 0.873 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.444 ' N ' HD22 ' A' ' 42' ' ' ASN . 0.8 OUTLIER -86.65 -37.68 17.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.334 -177.377 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 28' ' ' ALA . 18.1 p90 -144.69 -67.46 0.32 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.561 0.696 . . . . 0.0 110.368 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -155.42 142.05 18.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.821 2.448 . . . . 0.0 107.614 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 t -176.36 145.42 0.58 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 45.55 0.92 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.326 1.851 . . . . 0.0 106.516 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 56.2 p -106.96 -105.56 0.33 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.377 1.071 . . . . 0.0 113.106 -174.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.3 t -145.39 117.28 5.17 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.81 130.94 23.96 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.064 2.509 . . . . 0.0 115.885 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.79 -42.27 1.29 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.545 1.545 . . . . 0.0 113.025 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.8 m -59.33 -57.14 14.32 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.58 -25.43 41.57 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p 89.0 179.28 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.773 2.829 . . . . 0.0 110.48 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.1 t 78.76 28.34 0.43 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 -170.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -136.39 157.34 47.04 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 129.772 3.229 . . . . 0.0 106.591 -175.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -155.25 120.19 4.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.73 128.71 36.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.32 -13.04 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.369 1.068 . . . . 0.0 110.423 178.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.59 -156.64 28.38 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -152.63 134.8 14.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 88.5 m -91.21 -42.49 10.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.319 0.509 . . . . 0.0 111.921 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.921 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -171.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 121.313 0.578 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.11 112.71 5.22 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -26.51 -49.67 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.562 2.745 . . . . 0.0 114.966 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 t -53.44 -53.59 49.18 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.53 1.059 . . . . 0.0 111.566 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 151.88 -61.17 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.373 3.469 . . . . 0.0 106.467 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -151.68 2.8 0.39 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -82.2 -171.27 3.33 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.421 1.01 . . . . 0.0 111.098 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -69.65 97.76 1.09 Allowed 'General case' 0 C--N 1.338 0.096 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 7' ' ' ALA . 2.4 t -102.66 124.89 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.046 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -42.14 132.79 2.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 119.487 1.04 . . . . 0.0 111.15 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.72 27.29 15.01 Favored 'Cis proline' 0 C--N 1.35 0.638 0 N-CA-C 115.888 1.457 . . . . 0.0 115.888 1.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -74.71 66.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.153 1.342 . . . . 0.0 107.617 175.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -58.1 176.14 0.18 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 112.388 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.83 -33.07 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.12 -66.85 0.84 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -171.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' CG ' ' H ' ' A' ' 17' ' ' ASP . 3.5 tttm 53.51 -167.26 0.07 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 123.611 1.672 . . . . 0.0 112.487 -170.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.403 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 10.5 m-20 -82.0 -40.3 22.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.3 2.64 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -79.81 174.61 11.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.842 2.057 . . . . 0.0 114.566 -175.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.41 39.91 3.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.198 2.199 . . . . 0.0 106.923 174.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.09 47.58 0.04 OUTLIER Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.374 1.464 . . . . 0.0 110.623 -177.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.25 -157.49 9.78 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -78.09 -174.78 0.47 Allowed Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -110.12 158.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.909 1.739 . . . . 0.0 113.373 178.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -150.92 -12.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.39 0.676 . . . . 0.0 112.049 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 178.6 164.07 0.77 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.342 0.974 . . . . 0.0 111.02 -177.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -112.37 149.65 32.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.654 1.182 . . . . 0.0 108.078 177.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.18 172.71 8.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.66 0.784 . . . . 0.0 110.471 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.22 123.25 2.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.485 1.514 . . . . 0.0 112.088 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.39 -14.37 40.7 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.463 1.03 . . . . 0.0 113.779 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.49 118.06 21.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.295 1.547 . . . . 0.0 109.633 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -80.76 166.69 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 111.928 179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 tt -165.9 151.83 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.434 HG21 ' SG ' ' A' ' 61' ' ' CYS . 41.0 t -109.22 156.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -138.98 -126.56 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.36 84.19 1.44 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.277 1.399 . . . . 0.0 108.933 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.84 -45.28 0.87 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 127.993 2.711 . . . . 0.0 113.022 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -68.93 143.43 54.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.79 0.836 . . . . 0.0 111.675 -176.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.42 122.53 43.93 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 129.96 3.304 . . . . 0.0 106.621 177.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -122.84 170.79 9.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.824 1.25 . . . . 0.0 109.242 178.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -148.75 144.63 27.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.81 145.9 27.01 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.41 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -95.47 -31.39 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.221 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -134.18 -73.77 0.48 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 111.307 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -158.4 135.95 10.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.441 2.296 . . . . 0.0 108.441 -177.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -168.9 149.99 4.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.21 0.914 . . . . 0.0 109.677 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.97 37.0 0.86 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.131 1.772 . . . . 0.0 108.038 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.3 p -94.7 -103.93 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.018 0.927 . . . . 0.0 111.888 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.4 112.92 4.73 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.66 1.984 . . . . 0.0 106.056 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.1 121.02 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.421 2.747 . . . . 0.0 113.128 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.88 -17.59 57.7 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.995 0.807 . . . . 0.0 113.05 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -77.31 74.66 3.87 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.993 1.396 . . . . 0.0 109.453 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 t70 51.69 -132.19 1.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.362 1.065 . . . . 0.0 108.691 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t 57.7 -150.58 0.44 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.267 0.94 . . . . 0.0 109.136 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.45 -51.83 39.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.815 0.846 . . . . 0.0 109.702 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -20.06 130.66 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.156 2.582 . . . . 0.0 116.22 -175.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 m -136.77 128.76 29.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -75.3 141.03 43.48 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -14.06 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.87 1.268 . . . . 0.0 111.635 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.82 -148.12 13.31 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.553 1.069 . . . . 0.0 110.693 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -157.98 135.83 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.279 1.431 . . . . 0.0 108.827 178.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.434 ' SG ' HG21 ' A' ' 33' ' ' VAL . 2.7 m -68.11 -49.52 60.65 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.675 0.75 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 -175.067 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptm . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.705 0.764 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.23 66.41 2.9 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -16.44 -57.45 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.413 3.085 . . . . 0.0 115.853 -176.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 7' ' ' ALA . 40.4 t -54.34 -48.81 70.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.859 0.754 . . . . 0.0 112.907 -179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 104.87 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.25 3.02 . . . . 0.0 108.458 -175.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.61 40.82 1.11 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . -162.45 173.7 13.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.701 1.137 . . . . 0.0 109.093 174.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -48.83 107.3 0.13 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 125.189 1.396 . . . . 0.0 112.187 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.9 131.01 48.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.206 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -44.2 133.04 4.42 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.926 1.239 . . . . 0.0 110.404 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.9 35.97 7.43 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 121.202 1.465 . . . . 0.0 113.908 0.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.22 61.44 1.16 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.764 1.165 . . . . 0.0 108.237 176.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -55.38 156.02 4.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.775 0.798 . . . . 0.0 112.819 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -76.12 -53.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.608 178.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -80.82 143.31 32.9 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -124.61 165.91 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 112.069 -176.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -45.21 95.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.331 -1.758 . . . . 0.0 109.904 177.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.283 1.7 m95 21.24 166.4 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 136.471 5.908 . . . . 0.0 124.845 -177.365 . . . . . . . . 3 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 120.69 57.3 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 2 C-N-CA 136.595 5.958 . . . . 0.0 100.825 -173.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.28 59.34 3.37 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.647 2.546 . . . . 0.0 107.295 -173.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.35 -148.15 7.35 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 123.483 0.563 . . . . 0.0 111.949 -178.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -131.09 163.8 46.71 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.635 1.174 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.38 150.26 26.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.836 3.024 . . . . 0.0 110.477 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.91 -17.79 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.219 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -179.68 168.41 1.37 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -178.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -114.91 131.11 56.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.629 1.972 . . . . 0.0 107.567 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -104.58 165.05 11.32 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.968 0.907 . . . . 0.0 109.626 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.23 123.68 2.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.666 1.186 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.79 -12.43 57.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.157 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.77 139.31 39.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.263 2.031 . . . . 0.0 105.795 177.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -105.93 156.83 17.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.918 0.487 . . . . 0.0 111.079 -178.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -157.52 168.77 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.15 149.38 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.385 0.674 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.04 134.3 16.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.037 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 50.74 27.69 3.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.958 1.703 . . . . 0.0 113.915 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.0 -22.13 27.21 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 126.477 1.989 . . . . 0.0 112.231 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.97 138.08 36.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.424 1.112 . . . . 0.0 109.247 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 58' ' ' VAL . 6.8 tp -91.54 131.19 37.15 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 128.45 2.7 . . . . 0.0 108.435 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -135.52 159.45 41.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 109.666 178.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -132.95 142.42 48.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.446 1.498 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.22 150.21 27.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.163 0.983 . . . . 0.0 111.077 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.776 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -139.91 -75.85 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -161.25 125.98 3.54 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.27 2.228 . . . . 0.0 106.506 -176.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 t -168.1 154.47 7.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.835 1.198 . . . . 0.0 111.608 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.42 20.69 4.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.238 1.815 . . . . 0.0 106.737 174.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -82.21 146.96 29.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.3 t -46.88 121.98 7.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.788 0.835 . . . . 0.0 109.192 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.44 127.69 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.171 2.581 . . . . 0.0 113.831 -179.188 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.47 22.77 73.36 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.521 178.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 p -66.36 -71.57 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.307 1.053 . . . . 0.0 110.616 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -146.14 -32.67 0.34 Allowed 'General case' 0 C--O 1.23 0.069 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m -156.48 168.1 28.42 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.214 -0.929 . . . . 0.0 112.039 -174.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 p 70.53 0.39 3.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 130.303 3.441 . . . . 0.0 114.412 177.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.66 171.26 7.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.908 1.283 . . . . 0.0 112.573 -178.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -158.92 124.07 4.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.48 144.5 42.02 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.92 -6.52 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.873 0.869 . . . . 0.0 112.927 -178.974 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.49 -152.15 23.66 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 p -156.51 152.36 27.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.448 1.099 . . . . 0.0 109.029 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.93 -46.22 14.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.323 1.058 . . . . 0.0 108.91 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 129.86 3.264 . . . . 0.0 104.482 -174.988 . . . . . . . . 0 0 . 1 stop_ save_